000 Couv 2016 - heartonline.cnresource.heartonline.cn/20160517/1_wup8Zy2.pdf · RG. Stankovic RJ. Strange RO. Sukhorukov RG. Szabo RJ. Tan RL. Tapp RD. Tchétché RG. Toth RC. Ukena

WiFi: EUROPCR2016

Password: europcr2016

17-20 May 2016

Palais des Congrès

Paris, France

Level 1 Level 3

Level 0 Level 2

Training Village

Training Village

ExhibitorSupport Centre

RoomLearning

PCR TV

Training Village

PCR overflow

PCR overflow

Café ElyséesLunch bags

Café Trocadero*Lunch bags

Programme at a Glance

Charging tower

Mobile App Help Desk

Service Centre

Room

Restaurant& Lounge

LoungeStartingBlock

Investors Room

Room Arlequin

Rooms

National Societies and Working GroupsLounge

342B

342A


Charging tower

Poster Gallery

Lounge

Café Concorde*Lunch bags

Café MaillotLunch bags

Nurses andAllied Professionals

Corner

Bagpick-up

MAIN ARENA

252AB

PCR overflow


Charging tower

Poster Gallery


desks

MAIN ARENA

Badge purchase

Badge withdrawal

Guest Faculty DeskHelp Desk 101

Help Desk 102

Press

Badge withdrawal

Concierge

Touristic guide

Exhibitioninformation

Valid as of 25 April 2016Designations used by companies to distinguish their products are often claimed as trademarks.All brand names and product names used in this programme are trade names, service marks, trademarks or registered trademarks of their respective owners.

2

Course Directors

RAlberto Cremonesi RJean Fajadet RWilliam Wijns RStephan Windecker

EuroPCR Advisors

RMarie-Claude Morice RPatrick W. Serruys RAlec Vahanian

Course Co-Directors

RAndreas Baumbach RThomas Cuisset RJavier Escaned RMartine Gilard RMichael Haude RRan Kornowski RPhilip MacCarthy RFelix Mahfoud RChristoph K. Naber RAtul Pathak RNicolo Piazza RThomas Zeller

EAPCI Liaison

RGiulio Guagliumi RPetr Kala

Programme Committee Members

Nurses and Allied Professionnals Programme

Committee Members

REmanuele Barbato RJozef Bartunek RMiles Behan RAnne Bellemain-Appaix RMaurice Buchbinder RPatrick Calvert RDavide Capodanno RFausto Castriota RGregory Ducrocq REric Eeckhout RHany Eteiba RÖmer Göktekin RYann Gouëffi c RMichael Joner RArie Pieter Kappetein RAdnan Kastrati RPhilippe L’ Allier RThierry Lefèvre RMaciej Lesiak RFrancesco Maisano RFina Mauri RJulinda Mehilli

RThomas Modine RHelge Möllmann RMark Monaghan RJacques Monségu RMarko Noc RMartin Oberhoff RGöran Olivecrona RRadoslaw Parma RFlavio Ribichini RMarco Roffi RHelen Routledge RAntoine Sauguet RGoran Stankovic RJulian Strange RJean-François Tanguay RDidier Tchétché RGabor Toth RMarco Valgimigli RNicolas Van Mieghem ROlaf Wendler RAdam Witkowski

RSarah Carson RMarjo de Ronde RRicardo Esteves RHervé Faltot RSandra Griggio RLene Kløvgaard

RJohannes Laub RPia Lüttge Thomassen RVera Rodríguez García-Abad RTonny Van Hecke RDavid Zughaft

3

RS. Al Shaikh RO. Al Shammeri RK.F. Al-Shaibi RN. Amabile RH. Amin RA. Banning RE. Barbato RF.O. Baslaib RA. Baumbach RJ.J. Bax RM. Behan RA. Bellemain-Appaix RH. Benamer RM.W. Bergmann RF. Bourlon RE. Brochet RS. Brugaletta RF. Burzotta RH.J. Büttner RJ. Byrne RR. Byrne RP. Calvert RD. Capodanno RS. Carson RF. Castriota RG. Cayla RJ.L.K. Chan RK-T. Chan RC.Y. Chin RA. Cremonesi RT. Cuisset RP. Cummins RJ. Daemen

RR. Dawood RF. De Vroey RJ. Dens RR. Didier RC. Dubois RG. Ducrocq RD. Dudek R I. Durand Zaleski RA. Elghamaz RA. Elsaesser RJ. Escaned RS. Ewen RJ. Fajadet RB. Farah RS. Garg RP. Garot RA. Ghanem RZ. Ghazzal RM. Gilard RÖ. Göktekin RG. Guagliumi RM. Haude RK. Hayashida RF. Hellig RS.J. Hong RT. Johnson RW. Kehasukcharoen RD. Kettles RF-Y. Kuo RJ.F. Lassen RM.K-Y. Lee RT. Lefèvre RJ. Legutko

RM. Lesiak RE. Lev RR. Lorenzoni RT. Mabin RP. MacCarthy RF. Mahfoud RG. Manoharan RJ. Marco RJ. Mehilli RN. Melikian RE. Merkulov RD. Milasinovic RT. Modine RH. Möllmann RR. Mohd Ali RJ. Monségu RM-C. Morice RH. Mudra RP. Musialek RD. Mylotte RC.K. Naber RH. Nef RN-Q. Nguyen RG. Nickenig RK. Niemela RM. Noc RH.A. Noor RM. Ntsekhe RM. Oberhoff RA. Ochala RA. Ong RR.L.J. Osnabrugge RA. Pathak

RB. Prendergast RS.A. Pyxaras RS. Redwood RF. Ribichini RM. Roffi RA. Roguin RH. Routledge RA. Sauguet RT. Schmitz RG. Sengottuvelu RF. Sharif RE. Stabile RG. Stankovic RJ. Strange RO. Sukhorukov RG. Szabo RJ. Tan RL. Tapp RD. Tchétché RG. Toth RC. Ukena RA. Vahanian RN. Van Mieghem RS. Verheye RP. Wenaweser RO. Wendler RW. Wijns RW. Wojakowski RA. Wolf RA. Wong RK.K. Yeo RW-H. Yin RD. Zughaft

The ViTAL Programme will transform continuing medical education

ViTAL Members contributing to the 2016 EuroPCR Programme:

ViTAL is a unique Programme of personalised lifelong transformative learning for healthcare professionals. Its name is derived as follows: "Vi" = visionary, "T" = transformative, "A" = adult, "L" = learning. This Programme is based on PCR's founding principles which were developed by Professor Marco and aims at "training the trainers".

ViTAL therefore structures the various PCR Programmes by focusing them on three essential questions: - What does a healthcare professional expect from this session? - How can you implement in your daily practice what is learnt from this session?- How is it going to infl uence your patient's care?

4

Fu Wai Hospital, Chinese Academy of Medical Sciences,

National Centre for Cardiovascular Diseases - Beijing, China

R J. Cui, J. Qian, S. Qiao, Y. Wu, Y. Yang, Z. Zheng

R Invited Operator: H. Jilaihawi

Swiss Cardiovascular Centre, Bern University Hospital

Bern, Switzerland

R S. De Marchi, A. Moschovitis, T. Pilgrim, F. Praz, S. Stortecky,

P. Wenaweser, S. Windecker

Bristol Heart Institute - Bristol, United Kingdom

RA. Baumbach, C. Hanratty, T. Johnson, J. Strange

R Invited Operator: E. Tsuchikane

Maria Cecilia Hospital, GVM Care & Research - Cotignola, Italy

RF. Castriota, C. Grattoni, A. Micari

Rashid Hospital, Dubai Health Authority

Dubai, United Arab Emirates

RF. Baslaib

Contilia Heart and Vascular Centre, Elisabeth Hospital

Essen, Germany

RC.K. Naber, T. Schmitz

St. Thomas' Hospital - London, United Kingdom

RB. Prendergast, S. Redwood

Institut Cardiovasculaire Paris Sud - Massy, France

RH. Benamer, B. Chevalier, P. Garot, T. Hovasse, T. Lefevre

R Invited Operator: Y. Onuma

Rabin Medical Centre - Petah Tikva, Israel

RA. Assali, R. Kornowski, H. Vaknin Assa

Universitäres Herzzentrum Rostock - Rostock, Germany

RH. Ince (Universitäres Herzzentrum Rostock - Vivantes

Klinikum im Friedrichshain and Am Urban, Berlin), S. Kische,

M. Sherif

National Heart Centre Singapore – Singapore

RC.T. Chin, S.T. Lim, J. Tan, A. Wong, P. Wong

Clinique Pasteur - Toulouse, France

RN. Dumonteil, J. Fajadet, B. Farah, B. Honton, A. Sauguet, D. Tchétché

LIVE Centres are listed by city.

Operators are listed in alphabetic order.

The ViTAL LIVE principles for LIVE demonstrations at EuroPCR

LIVE Centres and Operators

The educational quality of the LIVE demonstrations is PCR's key priority.When preparing for their LIVE demonstrations, all Operators strive to respond to the two following fundamental questions:- What do I need to demonstrate during this LIVE case to help members of the audience improve their personal skills?- As a member of the audience, what would I like to see and understand during the LIVE demonstration that helps me improve my daily practice?

Read more:

LIVE-case demonstrations: putting patients fi rst J. Fajadet, S. Wood, W. Wijns European Heart Journal.

5

EuroPCR is the offi cial annual Meeting of the European Association for Percutaneous Cardiovascular Interventions (EAPCI)

EucoMedEuroPCR 2016 has been approved as COMPLIANT with the EucoMed Code of Ethical Business Practice. The overall appropriateness of the conference for sponsorship of Healthcare Professionals by Eucomed members has been assessed as fully compliant.

EBAC accreditationThe 2016 edition of EuroPCR is accredited by the European Board for Accreditation in Cardiology (EBAC) for 20 hours of External CME Credits.Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

US CME accreditationThe American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). Under the terms of this agreement, the AMA will convert CME credits certifi ed by the European Accreditation Council for Continuing Medical Education (EACCME), the accrediting arm of the UEMS, to AMA PRA Category 1 Credit™. Physicians may apply to convert EACCME credits into AMA PRA Category 1 Credit™ by submitting a form with an EACCME credit certifi cate attached. Download the form on www.ama-assn.org.

Your CME credits certificate will be

available online on europcr.com and

in the PCR App from 19 May 2016

Kindly note that you will not be able to claim

your CME credits on-site.

Course accreditations

Scientific Societies R Asian Interventional Cardiovascular Therapeutics (AICT) / Asian Pacifi c Society of Interventional Cardiology (APSIC) R Australia and New Zealand Endovascular Therapies Meeting (ANZET) R EAPCI Women Committee R ESC Working Group on Acute and Peripheral circulation R EuroIntervention Journal (EIJ) / European Heart Journal (EHJ) RGroupe de Réfl exion sur la Cardiologie Interventionnelle (GRCI) R IndiaLive R Innovations in Cardiovascular Interventions (ICI) R Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) R Left Main and Coronary Bifurcation Summit (CBS) and Asia Bifurcation Club RMontreal Live R Practical Course on Hypertension (PCH) R Sociedad Latino Americana de Cardiologia Intervencionista (SOLACI) R Stent For Life Initiative (SFL) RWarsaw Course on Cardiovascular Interventions (WCCI)

Contract Research Organisations R Cardialysis and the European Cardiovascular Research Institute (ECRI) R Cardiovascular European Research Centre (CERC) R Cardiovascular Research Centre (CRC) R Cardiovascular Research Foundation (CRF) R genae R Cardiovascular Imaging Core Laboratories (CICL) RMediolanum Cardiovascular Research (MCR) RUppsala Clinical Research Centre (UCR)

Market Monitoring company R Cardiovascular Innovation Pipeline (CV Pipeline)

EuroPCR collaborates with

Together we achieve more

6

National Societies and Working Groups

Algeria

Algerian Group of Interventional Cardiology (AGIC)www.sacardio.org

Argentina

Argentinian College of Interventional Cardioangiologists (CACI)www.caci.org.ar

Austria

Working Group on Interventional Cardiology of the Austrian Society of Cardiologywww.atcardio.at/en

Belarus

Belarusian Society of Interventional Cardiology and Endovascular Surgeryen.cardio.by

Belgium

Belgian Working Group of Interventional Cardiology (BWGIC)www.bwgic.org

Bosnia and Herzegovina

Working Group of Interventional Cardiology of the Association of Cardiologists of Bosnia and Herzegovina www.ukbih.com

Bulgaria

Bulgarian Society of Interventional Cardiologywww.bulsic.org

Croatia

Working Group on Interventional Cardiology of the Croatian Cardiac Societycrointervent.kardio.hr

Cyprus

Cyprus Interventional Cardiology Working Groupwww.cycardio.com

Czech Republic

Czech Interventional Cardiology Association (CICA)www.kardio-cz.cz

Denmark

Danish Working Group on Interventional Cardiologywww.cardio.dk

Egypt

Egyptian Working Group of Interventional Cardiology (EgIC)www.cardioegypt.com

Finland

Working Group on Interventional Cardiology of the Finnish Society of Cardiologywww.fincardio.fi

France

Atheroma Coronary and Interventional Cardiology Group of the French Society of Cardiology (GACI)www.sfcardio.fr

Germany

German National Working Group of Interventional Cardiology (AGIK) www.dgk.org

Greece

Greek Working Group of Interventional Cardiologywww.hcs.gr

Hungary

Hungarian Association of Cardiovascular Interventionwww.mkardio.hu

Iran

Iranian Society of Interventional Cardiology (ISOIC)www.isoic.ir

Iraq

Iraqi Working Group on Interventional Cardiology of the Iraqi Cardio-Thoracic Societywww.iraqi-cts67.org

7


Ireland

Irish Cardiac Society, Intervention sectionwww.irishcardiacsociety.com

Israel

Israel Working Group for Interventional Cardiologywww.israel-heart.org.il

Italy

Italian Society of Interventional Cardiology (SICI-GISE)www.gise.it

Jordan

Jordan Working Group on Interventional Cardiologywww.jordancardiac.com

Kazakhstan

Society of interventional cardiologists of Kazakhstanwww.kzcardio.org

Latvia

Working Group on Interventional Cardiology of the Latvian Society of Cardiologywww.kardiologija.lv

Lebanon

Lebanese Society of Cardiology Interventional Working Groupwww.lscardio.org

Luxemburg

Luxembourg Society of Cardiologywww.slcardio.lu

The Former Yugoslav Republic of Macedonia

Macedonian Society of Cardiologywww.mscardiology.org.mk

Moldova

Moldavian Working Group of Interventional Cardiologywww.icardiologie.md

Morocco

Working Group on Interventional Cardiology of the Moroccan Society of Cardiology (SMC)www.smcmaroc.org

The Netherlands

Dutch Working Group of Interventional Cardiology (WIC)www.nvvc.nl

Norway

Working Group of Interventional Cardiology of the Norwegian Society of Cardiologywww.legeforeningen.no

Poland

Association of Cardiovascular Interventions of the Polish Cardiac Societywww.aisn.pl

Portugal

Portuguese Association of Interventional Cardiology (APIC)www.spc.pt

Romania

Interventional Cardiology Working Group of the Romanian Society of Cardiologywww.cardioportal.ro

Russia

Russian Society of Interventional Cardioangiologywww.rnoik.ru

Russia (Siberia)

Siberian Association of Interventional Cardioangiologistswww.npsaik.ru

Saudi Arabia

Saudi Arabian Cardiac Interventional Society (SACIS)www.sacis.net

8


Scotland

Interventional Working Group of the Scottish Cardiac Societywww.scottishcardiac.org

Serbia

Working Group on Catheterisation and Percutaneous Coronary Interventions of the Cardiology Society of Serbiawww.uksrb.org

Slovakia

Slovak Working Group of Interventional Cardiologywww.cardiology.sk

Slovenia

Slovenian Working Group for Interventional Cardiologywww.sicardio.org

South Africa

South African Society of Cardiovascular Intervention (SASCI)www.sasci.co.za

Spain

Spanish Working Group on Interventional Cardiologywww.hemodinamica.com

Sweden

Working Group on Interventional Cardiology of the Swedish Society of Cardiologywww.cardio.se

Switzerland

Swiss Working Group for Interventional Cardiology and Acute Coronary Syndromewww.ptca.ch

Tunisia

The Tunisian Working Group on Interventional Cardiology (GTCI) www.stcccv.org

Turkey

Association of Percutaneous Cardiovascular Interventions of the Turkish Society of Cardiology (TAPCI/TSC-Interventions)old.tkd.org.tr

Ukraine

Ukrainian Association of Interventional Cardiology (UAIC)www.pci-ua.org

United Kingdom

British Cardiovascular Intervention Society (BCIS)www.bcis.org.uk

Visit the National Societiesand Working Groups Lounge

Open to all participants!

Discover more about all National Societies and Working Groups

participating in this year’s edition in a relaxed atmosphere for

discussions and networking.

Join in on level 3

9

Your A-Z for EuroPCR

AccreditationYour CME credits certificate will be available online on europcr.com and in the PCR App from 19 May 2016.For more information go to p5.

AppTo make the most of the Course, we encourage you to download the PCR App (available for Android, Windows phone and iPhone /iPad users).Use the free WiFi: name: EUROPCR2016 / Password: europcr2016

Badge scanningExhibitors and Course Representatives may ask to scan your badge to collect your personal information. This information may be used for commercial purposes.

Bag pick-upBadge-holding delegates can pick up their conference bag in the Exhibition Hall, level 2, Neuilly side (not applicable to Exhibitors and Industry Representatives without a booth).

CateringLunches and coffee breaks are served in the Exhibition Hall.

Coffee break: tea and coffee served in the Café - Exhibition HallTuesday ........................................................................................................................17:00Wednesday ......................................................................................... 10:00 and 16:15Thursday ............................................................................................. 10:00 and 16:15Friday ..............................................................................................................................10:30

Lunch bags served in the Café - Exhibition Hall – levels 1 and 2:Wednesday .................................................................................................................12:00Thursday .....................................................................................................................12:00

Lunch buffet served in the restaurant - level 3:Tuesday .........................................................................................................................12:00Wednesday .................................................................................................................12:00Thursday .....................................................................................................................12:00

Certificate of attendanceYour certificate will be available online from Thursday 19 May via the Course website or via the PCR App.

CloakroomLocated on level 0,5. It’s free of charge and has the same opening hours as the Course.

Concierge serviceLocated on level 0. This service will help you with your daily needs: courier services, dry-cleaning, restaurant reservations, flower delivery, train tickets, taxis…Opening hours:Monday ...........................................................................................................09:00-18:00 Tuesday ...........................................................................................................10:00-19:00Wednesday ...................................................................................................09:00-18:30Thursday .........................................................................................................09:00-18:00Friday ................................................................................................................09:00-12:30

Convention CentreThe Palais des Congrès de Paris is located at 2, place de la Porte Maillot, 75017 Paris.Metro: Porte Maillot.

Daily WireDistributed every morning hot off the press at the escalators and at self-serve points throughout the Palais des Congrès. The Daily Wire is also available via the PCR mobile application.

DefibrillatorLevel 1: Exhibitor Support CentreLevel 2: Guest Lounge Welcome DeskLevel 3: Press Office

Guest LoungeAccess to the Guest Lounge is reserved to Guest Faculty only.Badges are checked at the entrance. Located on level 2.

10

Lost and foundLost property is located at the Exhibitor Support Centre.Located on level 1.

Opening hoursCourse

Tuesday ..........................................................................................................10:00-18:45Wednesday ...................................................................................................08:30-18:30Thursday .........................................................................................................08:30-18:00Friday ................................................................................................................09:00-12:30

Exhibition Hall

Tuesday ..........................................................................................................08:30-18:45Wednesday ...................................................................................................07:30-18:30Thursday .......................................................................................................07:30-18:00Friday ................................................................................................................08:00-12:30

Registration

Sunday ...........................................................................................................14:00-18:00Monday .........................................................................................................07:00-19:00Tuesday ..........................................................................................................07:00-18:45 Wednesday ...................................................................................................07:30-18:30Thursday .......................................................................................................07:30-18:00Friday ................................................................................................................08:00-12:30

Speaker Service CentreFor Speakers only. All Speakers must upload their slides at least three hours before their presentation. The Speaker Service Centre is located on level 3 and opens as follows: Monday .........................................................................................................07:00-19:00Tuesday ..........................................................................................................07:00-19:00Wednesday ...................................................................................................07:30-19:00Thursday .........................................................................................................07:30-19:00Friday ................................................................................................................08:00-12:30

Overflow screensTwo screens will broadcast sessions that have reached maximum occupancy. Go to level 1 near booth F6 or between booths P13 and P15 to watch LIVE transmissions. For more information refer you to the floor plan.

PharmacyThe nearest pharmacy is on level 0 of the Palais des Congrès (shopping centre).

Session room capacityEach session room has a limited capacity and we are unable to reserve seats. As such, once the room is full, for security reasons we will not be able to allow access.

TouringFor tours of Paris or other tourist information, go to the PARISCityVISION desk. Located on level 0.Opening hours : Monday ...........................................................................................................09:00-17:00Tuesday to Thursday ...............................................................................10:00-18:00Friday ................................................................................................................10:00-13:00

TransportationFree shuttles will be available for free from Paris airports and train stations. Booking is mandatory via europcr.com. The meeting point is in front of the Palais des Congrès.

WiFiFree WiFi is availableWiFi name: EUROPCR2016 / Password: europcr2016Please note that access may be limited at peak periods.

Valid as of 25 April 2016

eeuro

20

16

Coronary Valvular Disease and Heart Failure Peripheral Hypertension and Stroke

LIVE demonstration Learning and PCR Sharing Centre All You Need to Know Sponsored Session

12

Main Arena

Op

en

ing

TAVIp.32

LBT p.32

Left main PCIp.43

Great Debate TAVIp.43

Edge-to-edge mitral repair

p.54

Ethica AwardEAPCI

Electionsp.54

LAA closurep.65

Room Learning

LearningTAP technique

p.35

LearningRadial access

p.46

LearningVascular access

p.57

LearningAortoiliac and

femoropopliteal - p.68

Room Ternes 1

CasesLeft main disease

p.35


p.46

CasesCoronary aneurysm

p.57

CasesStents and scaff olds

p.68

Room Ternes 2

CasesCarotid stenting, Ischaemic

stroke - p.35

CasesIliac / Femoral intervention

p.46

CasesCarotid stenting,

Ischaemic stroke - p.57

CasesArtery fi stula

p.68

10:00 12:25 13:30 14:25 15:25 15:5517:0011:1510:15

12:00 13:45 15:30 17:1517:00 18:4513:30 15:15

Do you know where to fi nd:Restaurant - Level 3 / Lunch bags and coff ee breaks – Levels 1 & 2

The Training Village - Level 1 (programme page 221)

The Nurses and Allied Professionals Corner - Level 2

The Poster Galleries - Levels 2 & 3

The National Societies and Working Groups Lounge - Level 3

13

Theatre Bleu

FFR / iFR-guided PCI in patients with MVD

p.33

PCI of complex bifurcation lesion

p.44

Left main bifurcation stenting

p.55

Stents and scaff oldsELIXIR MEDICAL

p.66

Room Maillot

Hot LineRenal denervation,

Carotid stenting - p.34

Hot Line Stents and scaff olds

p.45

Hot Line TAVIp.56

Stents and scaff oldsBOSTON SCIENTIFIC

p.67

Room 241

AbstractsPCR's Got Talent - Round 1

p.36


p.47


p.58

Stable CADACIST MEDICAL

p.69

Room 242AB

Young PractitionersSTEMI

p.37

Young PractitionersCoronary perforation

p.48

Young PractitionersCTOp.59

Young PractitionersBifurcation

p.69

Room 243

CasesNSTEMI

p.37

CasesOther peripheral

interventions - p.48

CasesCTOp.59



Room 251

What's new in hypertension?

p.37

Nurses and Allied ProfessionalsChallenges in complex PCI

p.48

Managementof hypertension

p.59

Heart failureMEDTRONIC

p.70

Room 252AB

Learning from bailout cases in complex PCI

CVIT - p.38

The most educational cases from Asia-Pacifi cAICT & APSIC - p.49

STEMI in Latin America and EuropeSOLACI - p.60

EBAC AEPNSTEMI, STEMI

ST. JUDE MEDICAL - p.70

Room 253Stents and scaff olds

p.38

STEMIp.49

AbstractsSTEMI

p.60

EAPCI General Assemblyp.71

12:00 13:45 15:30 17:1517:00 18:4518:1513:30 15:15



14

Theatre Bordeaux


p.33

Hot Line NSTEMI

p.44


p.55

TAVISYMETIS SA

p.66

Theatre HavaneTAVI in low-risk patients

p.34

Transcatheter aortic valve-in-valve implantation

p.45

Edge-to-edge repair of mitral regurgitation

p.56

Stents and scaff oldsABBOTT VASCULAR

p.67

Room 341

CasesOther valvular interventions

p.39

CasesTAVIp.50

CasesTAVIp.61

CasesCTOp.71

Room 342A

STEMI patients with cardiogenic shock

p.39

CasesCLI, Iliac / Femoral

p.50

CasesCTOp.61

Mitral valve replacement and repair

VALTECH - p.72

Room 342B


p.40

Key practical issues for antithrombotics

p.51

The Heart Team at work: complex coronary artery and

valvular disease - p.62

CasesBifurcation lesion, Stents and

scaff olds - p.72

Room 343

AbstractsRisk stratifi cation

p.40

AbstractsStents and scaff olds

p.51


p.62

CasesTransradial PCI

p.73

Room 351

AbstractsMitral valve replacement

and repair - p.41

AbstractsTAVIp.52

AbstractsTAVIp.63


p.73

Room 352A

How Should I Treat?STEMI

Finland & Norway - p.41

ComplicationsStable CAD

Bosnia and Herzegovina & Luxembourg - p.52

ComplicationsSTEMI, Stable CAD, CTO

Belarus & Siberia - p.63

CasesCoronary perforations

p.74

Room 352B

ComplicationsTAVI

Argentina & France - p.42

ComplicationsDissection, Perforation

Egypt & Turkey - p.53

ComplicationsSTEMI

Belgium & Scotland - p.64

CasesCTOp.74

Room 353

AbstractsBifurcation lesion

p.42


p.53

AbstractsSTEMI

p.64

AbstractsSTEMI

p.75

Room Arlequin

CasesNSTEMI, STEMI

p.43

AbstractsRenal denervation

p.54Images

p.65

Imagesp.75

12:00 13:45 15:30 17:1517:00 18:4513:30 15:15

15

Main ArenaTAVIp.78

Keynote lecture

p.88Left Main PCI

p.89

FFR/iFRp.99

Room Learning

LearningAntegrade CTO

p.80

LearningRetrograde CTO

p.91

LearningImaging for TAVI

p.102

Room Ternes 1


p.80


p.91


p.103

CasesMultivessel disease

p.109

Room Ternes 2



AbstractsCarotid stenting

p.92

CasesRenal denervation

p.103

CasesSTEMIp.110

08:30 10:30 12:3013:30 14:00 14:3010:0009:30 11:00 12:00








16

Theatre Bleu

BRS in the emerging worldIndiaLive

p.78

BRS in long lesionsp.89

Stents and scaff oldsTERUMO - p.100

Room Maillot

What to expect from second-generation BRS?

p.80Innovative devices

p.91

EBAC AEPNSTEMI, STEMI

ASTRAZENECA - p.102

Room 241

CasesCTO, Stents and scaff olds

p.81

The year in intervention - p.92EIJ / EHJ

TAVIST. JUDE MEDICAL

p.103

TAVIBOSTON SCIENTIFIC

p.110

Room 242AB

Young PractitionersTAVIp.82

Young PractitionersIntravascular imaging before and

after stent implantation - p.92

Young PractitionersFFR made easy

p.104

Room 243PCR Sharing Centre

Social media in my daily practice?p.82

How to critically analyse a published trial...

p.93

Non left main bifurcation techniquesp.104

Room 251

AbstractsSTEMI

p.82

Nurses and Allied ProfessionalsVentricular assist devices in critical ill patients - p.93

Stents and scaff olds

STENTYS - p.104

CTOMEDTRONIC - p.111

Nurses and Allied Professionals Corner

Moderated postersp.100

Room 252AB

Percutaneous treatment of AAAESC Working Group on Aortic &

Peripheral circulation - p.83

Aortoiliac bifurcation and CTOp.93


BIOTRONIK - p.105Stroke

ST. JUDE MEDICAL - p.111

Room 253LAA closure

p.83

Mitral valve replacement and repair

p.94

CasesTricuspid / Pulmonary

valve - p.105

CasesNSTEMI

p.112

08:30 10:30 12:3013:30 14:00 14:3010:00 12:00

wx

高亮

17

08:30 10:30 12:3013:30 14:00 14:3010:0009:30 11:30 12:00

Theatre Bordeaux

Hot Line Advances in PCI procedural technique

p.79

CV PipelineImaging and functional assessment

p.90

TAVIEDWARDS LIFESCIENCES - p.101

Theatre Havane

Patient requiring oral anticoagulation and percutaneous intervention

Montreal Live - p.79

Streamlining TAVI: how to balance simplifi cation, safety and effi cacy

p.90

Stents and scaff oldsALVIMEDICA MEDICAL TECHNOLOGIES

p.101

Room 341


p.84


p.94

CasesSTEMIp.105

CasesCoronary perforations

p.112

Room 342A

Critical appraisal of devices for the management of hypertension

p.85

Catheter-based renal denervation exchange forum around the globe

p.95

Stable CAD, CTO

ORBUSNEICH - p.106


REVA MEDICAL - p.112

Room 342B


p.85

Challenging decisions in NSTEMI patients

p.96

Clinical trialsCICLp.106

Clinical trialsMCRp.113

Room 343

AbstractsLAA closure

p.86

AbstractsTAVIp.96

Clinical trialsCRF

p.107

Clinical trialsgenaep.113

Room 351

AbstractsSTEMI

p.86

AbstractsSTEMI

p.97


ABBOTT VASCULAR - p.107

STEMI, Acute heart failureZOLL - p.114

Room 352A

How Should I Treat?STEMI, Acute heart failure

Croatia & Poland - p.87

How Should I Treat?TAVI

Czech Republic & Slovakia - p.97


p.108

CasesSTEMIp.114

Room 352B


Latvia & Russia - p.87

How Should I Treat?Stents and scaff olds

Germany & South Africa - p.98

How Should I Treat?CTO

United Kingdom, Cyprus & Greece - p.108

Room 353


p.88

AbstractsStable CAD

p.98

CasesAcute dissection

p.109

CasesSTEMIp.114

Room Arlequin

Will ABSORB III change my practice?

p.88

Will LEADERS FREE change my practice?

p.99

CasesNSTEMI

p.109

CasesSTEMIp.115



18

Main ArenaMitral valve

p.118

Room Learning

LearningLAA closure

p.120

LearningAcute stroke interventions

p.131

Room Ternes 1

CasesBifurcation lesion, Stents and scaff olds

p.120


p.131

Room Ternes 2

CasesOther peripheral interventions

p.121


p.132

14:45 16:3018:0016:1516:00 17:30






19

14:45 16:3018:00 18:3016:15

Theatre BleuPrimary PCI and MVD

p.118

EBAC AEPNSTEMI, Stents and scaff olds

ST. JUDE MEDICAL AND ORBUSNEICH - p.129

Room Maillot

Hot Line TAVI, Mitral valve replacement and repair, LAA closure

p.120

STEMI, Stable CADTERUMO

p.131

Room 241

CasesNSTEMI, STEMI, Bifurcation lesion

p.121

Complex PCIPHILIPS VOLCANO

p.132

Room 242AB

Young PractitionersAtherectomy for calcifi ed coronary plaques

p.122

LearningAlcohol septal ablation

p.133


How to critically analyse a published meta analysis

p.122

Practical use of CT scan for TAVI and structural interventional procedures: Fluoro-CT app

p.133

Room 251

Nurses and Allied ProfessionalsThe new Core Curriculum

p.122

TAVIDIRECT FLOW MEDICAL - p.133

Room 252AB

Femoropopliteal diseaseESC Working Group on Aortic & Peripheral circulation - p.123

Stents and scaff oldsBIOTRONIK - p.133

Room 253


p.123

CasesMitral valve replacement and repair

p.134



20

14:45 15:00 16:3018:0016:1516:00 17:30

Theatre Bordeaux

CV PipelineNew DEB and heart failure

p.119

Stents and scaff oldsABBOTT VASCULAR

p.130

Theatre HavaneChallenges in TAVI in Asia

p.119

Mitral valve replacement and repairABBOTT VASCULAR - PHILIPS

p.130

Room 341

AbstractsPCR's Got Talent- Round 1

p.124


p.134

Room 342AWill SPRINT change my practice?

p.128

TAVIMEDTRONIC

p.135

Room 342B

CasesSTEMIp.125


p.136

Room 343

AbstractsCTOp.125

AbstractsCTOp.136

Room 351

AbstractsStable CAD

p.126

LAA closureBOSTON SCIENTIFIC

p.137

Room 352A


Algeria & Lebanon - p.126

How Should I Treat?NSTEMI

Iran & Kazakhstan - p.137

Room 352B

ComplicationsCoronary interventions

Ireland & Switzerland - p.127

How Should I Treat?Stable CAD, TAVI

Israel & Slovenia - p.138

Room 353

AbstractsBifurcation lesion

p.127

AbstractsSTEMIp.138

Room ArlequinImages

p.128

Imagesp.139

21

08:30 10:30 12:3013:30 14:00 14:3010:0009:45 10:5509:35 12:00

Main ArenaCarotid stenting

p.142

EAPCI Awards

p.151

Imaging-guided PCIp.151

BRS for long lesionp.161

Room Learning

LearningDouble-kissing crush technique

p.144

LearningHow to simplify TAVI

p.154

Learning PCI in calcifi ed lesions

p.163

Room Ternes 1


p.144


p.154

CasesSTEMIp.164

CasesSTEMIp.171

Room Ternes 2


p.145


p.154

CasesTAVIp.164

CasesTAVIp.171








22

08:30 10:30 12:3013:30 14:00 14:3010:00 12:00

Theatre Bleu

Physiological and imaging guidance

p.142

PCI in a patient with diseased vein graft

p.152

Bifurcation lesion, Left main disease, Stents and scaff olds

TERUMO - p.162

Room Maillot

Novel stents and scaff olds from Asia

p.144

Hot Line FFR / iFR

p.153

TAVIBSCI & SIEMENS

HEALTHCARE - p.163


MEDTRONIC - p.170

Room 241


p.145


p.155

DCBBIOTRONIK - p.164

Tricuspid / Pulmonary valveMITRALIGN - p.171

Room 242ABPCR Clinical Research

I have a great idea. How to transform it into a study design?

p.146

I am participating in a clinical study. How can I improve my recruitment

rate? - p.155

Learning Left main stenting

p.164


Personalised medicine - treating a patient with bifurcation

lesion

p.146

X-ray exposurep.155

Ambulatory diagnostic and interventions

p.164

Room 251

AbstractsNurses and Allied Professionals

p.146

AbstractsNurses and Allied Professionals

p.156

Stents and scaff oldsBIOSENSORS INTERNATIONAL - p.165

Room 252AB

LearningBTK angioplasty

p.147

Revascularisation techniques in CLIp.156


ABBOTT VASCULAR - p.165

TAVIBAYER PHARMA AG

p.171

Room 253TAVIp.147


p.157

CasesMitral valve

replacement and repairp.166

CasesMitral valve

replacement and repairp.172

23

08:30 10:30 12:3013:30 14:00 14:3010:00 12:00

Theatre Bordeaux

CV PipelineTAVI and structural

p.143

CV PipelineMitral and tricuspid

p.152TAVI

MEDTRONIC - p.162

Theatre Havane

Acute and long-term stroke prevention in TAVI patients

p.143

LAA closure for stroke preventionp.153

CTOASAHI INTECC - p.163

Room 341


p.147


p.157

CasesSTEMI, Bifurcation lesion,

Stents and scaff oldsp.166

CasesNSTEMI, STEMI

p.172

Room 342A

Acute ischaemic stroke intervention

p.147

Pharmaco-invasive strategy for STEMI: worldwide perspective

p.157

TAVIST. JUDE MEDICAL - p.167

Room 342B

CasesSTEMIp.148

CasesSTEMIp.158

Clinical trialsCardialysis & ECRI

p.167

Clinical trialsUCRp.173

Room 343

AbstractsCTOp.148

AbstractsCLI

p.158

Clinical trialsCERCp.168

Clinical trialsCRC

p.173

Room 351

AbstractsLeft main disease

p.149

AbstractsTAVIp.159

Stents and scaff oldsHEXACATH - p.168

Room 352A


Denmark & Sweden - p.149

How Should I Treat?NSTEMI, STEMI

Bulgaria & Romania - p.159

Overcoming radiation exposure risk

EAPCI Women Committee - p.168

Room 352B


Macedonia & The Netherlands - p.150


Austria & Italy - p.160

ComplicationsSTEMI, Stable CAD, CTO

Iraq, Jordan & Tunisia - p.169

Room 353

AbstractsBifurcation lesion, Stents and

scaff olds - p.150

AbstractsTAVIp.160

CasesSTEMIp.169

CasesLAA closure, ASD / PFO

closure - p.174

Room ArlequinImages

p.151

Imagesp.161

Imagesp.170

Imagesp.174



24

14:45 16:3018:0016:1515:50 16:50

Main ArenaPCI of complex bifurcation

p.176

PCI of complex bifurcation p.185

Room Learning

LearningMitral edge-to-edge repair with MitraClip

p.178

LearningPericardiocentesis

p.187

Room Ternes 1


p.178

CasesStable CAD

p.188

Room Ternes 2


p.179

CasesBifurcation lesion, Stents and scaff olds

p.188






25

14:45 16:3018:0016:15

Theatre BleuDeveloping basic skills in antegrade CTO intervention

p.176

Developing basic skills in retrograde CTO interventionp.186

Room Maillot

Innovation in TAVI: new devices and outlook for new applications

p.178

CT innovation for TAVI optimisationp.187

Room 241

AbstractsRenal denervation

p.179


p.189

Room 242ABPCR Clinical Research

I have my clinical data. How can I analyse it by myself?p.180

I have completed my study. How to write an abstract and get it accepted?

p.189


Complex PCI in practice: cardiologists, nurses and allied professionals working together

p.180

How to recognise, anticipate and treat most frequent coronary complications

p.189

Room 251

Procedure-related complications Nurses and Allied Professionals

p.180

CasesNurses and Allied Professionals

p.190

Room 252AB

LearningCarotid artery stenting step by step

p.180

Carotid angioplasty anno 2016p.190

Room 253

AbstractsNSTEMI, STEMI, Stable CAD

p.181


p.190



26

14:45 16:3018:0016:15

Theatre BordeauxVulnerable plaque: future directions

p.177

CV PipelineDES and scaff olds

p.186

Theatre Havane

Devices for the interventional management of heart failure

p.177

CasesTAVIp.187

Room 341


p.181

CasesTAVIp.190

Room 342A

Coronary intervention downunderANZETp.181

STEMI and acute stroke: commonalities and dividesSFL Initiative

p.192

Room 342B

CasesSTEMIp.182


p.192

Room 343


p.182

AbstractsAcute heart failure

p.193

Room 351

AbstractsTAVIp.183


p.193

Room 352A

How Should I Treat?NSTEMI

Hungary & Serbia - p.183

ComplicationsNSTEMI, STEMI, Acute heart failure

Moldova & Ukraine - p.194

Room 352B

How Should I Treat?Bifurcation

Morocco & Saudi Arabia - p.184

How Should I Treat?TAVI, Mitral valve replacement and repair

Portugal & Spain - p.194

Room 353

AbstractsStable CAD

p.184

AbstractsAAAp.195

Room Arlequin

AbstractsTAVIp.185

CasesMitral valve replacement and repair

p.195

27

09:00 10:4510:3009:50 10:50 12:1512:00 12:3012:20

Main ArenaValvular interventions

p.198

Left main PCIp.209

TAVIp.219

Best Abstract Award

Best Clinical Case Award

p.220

Clo

sin

g

Room Learning

Learning STEMI

p.200

LearningBioresorbable scaff olds

p.211

Room Ternes 1

CasesOther peripheral interventions, Renal artery

stenting - p.200


p.211

Room Ternes 2

CasesSTEMI, Acute heart failure

p.201

CasesOther peripheral interventions, ASD / PFO closure

p.212








28

09:00 09:30 10:4510:3010:00 12:1511:4511:30

Theatre Bleu

Strategies for left main coronary artery disease and complex bifurcation lesionsCBS & Asian Bifurcation Club - p.198

Rotational atherectomy for challenging casesp.209

Room MaillotTranscatheter mitral valve implantation

p.200

Innovations in Cardiovascular InterventionsICI

p.211

Room 241


p.201

AbstractsTAVIp.212

Room 242A

AbstractsMitral valve replacement and repair

p.201

CasesSTEMIp.213

Room 242B


p.202


Join a team of young interventional cardiologists sharing their collaborative learning experience at EuroPCR

p.209

Room 251

Nurses and Allied ProfessionnalsTAVI: what's new!

p.202

Nurses and Allied Professionnals Research and studies

p.213

Nurses and Allied Professionals

Awards and Closing Ceremony - p.219

Room 252A

CasesSTEMIp.203


p.213

Room 252B


p.203

CasesTAVIp.214

Room 253


p.204

CasesSTEMIp.214

29

09:00 10:4510:30 12:1511:45

Theatre Bordeaux

CasesComplication Forum

p.199

CasesBifurcation lesion, Left main disease, Renal artery stenting

p.210

Theatre Havane

CasesBalloons and wires

p.199

CasesTAVIp.210

Room 341

AbstractsTAVIp.204

CasesCTOp.215

Room 342A

Rotational atherectomyGRCIp.205

BRS: a journey from present to the futureWCCIp.215

Room 342B

CasesSTEMIp.205


p.216

Room 343


p.206

CasesCTOp.216

Room 351

CasesCTOp.206

CasesCTOp.217

Room 352A

Gender bias in infarction: is it the end of the myth or not yet?EAPCI Women Committee

p.207Will PARTNER II change my practice?

p.217

Room 352B

CasesCTOp.207


p.218

Room 353


p.208

CasesOther valvular interventions

p.218

Room Arlequin

AbstractsIliac / Femoral intervention

p.208

CasesSTEMI, Left main disease

p.219


eeuro

20

16

-10:00 - 10:00 10:15

MAIN ARENA

Ceremony

EuroPCR 2016 Opening Ceremony Chairpersons: A. Cremonesi, J. Fajadet, W. Wijns, S. WindeckerPanellists: A.M. Al Abdullah, M. Chen, R. Mohd Ali, L. Sondergaard

V Welcome to EuroPCR 2016 - J. Fajadet, W. Wijns

10:15 11:15 MAIN ARENA

Focus Daily Practice

Valvular interventions: TAVI LIVE demonstration Chairpersons: A. Cremonesi, J. Fajadet, W. Wijns, S. WindeckerPanellists: A.M. Al Abdullah, M. Chen, R. Mohd Ali, L. Sondergaard

10:15 V Review of the tools to be used during the LIVE

demonstration - J. Fajadet

10:20 V LIVE demonstration from St. Thomas' Hospital -

London, United Kingdom

11:05 V Time to React@PCR

React@PCRPost your instant messages to the Chairpersons directly from your smartphone!

Discover every day's LIVE cases and Operators

in the Daily Wire and in the PCR App.

-11:00 - 11:20 12:20

MAIN ARENA

Focus Clinical Research

Hot Line

Late-breaking trials, registries and innovations Session comprising selected EuroPCR 2016 late-breaking

trial submissions

Chairpersons: A. Vahanian, W. Wijns, S. WindeckerPanellists: T. Cuisset, F. Hellig, A.P. Kappetein, N. Piazza, R. Waksman

11:20 V Biolimus A9 drug-coated stent vs. bare

metal stent in patients presenting with ACS -

a prespecified LEADERS FREE ACS substudy -

C.K. Naber

11:28 V Discussion - T. Cuisset

11:32 V Optical frequency domain imaging vs. IVUS in PCI:

the OPINION trial - one-year primary endpoint

results - T. Kubo

11:40 V Discussion - R. Waksman

11:44 V Transcatheter mitral valve replacement in native

mitral valve disease with severe mitral annular

calcification: results from the first global registry -

M. Guerrero

11:52 V Discussion - N. Piazza

11:56 V First look at long-term durability of transcatheter

heart valves: assessment of valve function up to

10 years after implantation - D. Dvir

12:04 V Discussion - A.P. Kappetein

12:08 V Three-month outcome of LAA closure in Europe:

post-procedural drug regimen, impact of

centre experience and leakage. Data from the

prospective 1,000 patient EWOLUTION registry -

M.W. Bergmann

12:16 V Discussion - F. Hellig

D+1 Find slides, videos, cases, exclusiveinterviews and daily reports onwww.pcronline.com onlineonline



32

wx

高亮

12:00 13:30 THEATRE BORDEAUX


Hot Line

Update on BRS Session comprising selected EuroPCR 2016 late-breaking

trial submissions

Chairpersons: A. Al Nooryani, M. JonerPanellists: P. Capranzano, T. Gori, S.M. Hiremath, G. Musumeci, A. Serra, A. Waqar

12:00 V Two-year clinical, angiographic and serial OCT

follow-up after implantation of everolimus-eluting

BRS and everolimus-eluting metallic stent: insights

from the randomised ABSORB Japan trial -

Y. Onuma

12:08 V Discussion and audience interaction

12:13 V Six-year follow-up of the first-in-man use of

a polylactide everolimus-eluting BRS for the

treatment of coronary stenosis: an assessment of

FFR by multislice CT - P.W. Serruys


12:26 V Effect of DAPT termination at 12 months on very

late scaffold thrombosis in regular clinical practice:

data of a regional collaboration including 868

patients - R.J. Van Geuns


12:39 V 30-day results of the Italian diffuse / multivessel

disease ABSORB prospective registry (IT-

DISAPPEARS) - A.S. Petronio


12:52 V Clinical outcomes following coronary

revascularisation with the everolimus-eluting BRS

in patients with diabetes: the ABSORB trial diabetic

study - G.W. Stone


13:05 V 30-day outcome of the Italian ABSORB registry

(RAI), a prospective registry of consecutive

patients treated with biovascular scaffold -

B. Cortese


13:18 V France ABSORB registry: in-hospital and one-

month results in 2,000 patients - R. Koning


-12:00 - 12:00 13:30

THEATRE BLEU

FFR / iFR-guided PCI in patients with multivessel disease Chairpersons: P. L' Allier, K.G. OldroydPanellists: M. Balghith, G. Cassel, B. De Bruyne, H.C. Gwon, G. Tarantini

Attend this session if you want:

VTo discuss similarities, differences and

controversies of pertinent stable coronary artery

disease / revascularisation guidelines

VTo identify key elements in decision making

VTo discuss management optimisation of stable

multivessel disease patients

12:00 V Session objectives - P. L' Allier

12:03 V How physiology can impact clinical management

and procedural strategy - V. Farooq



Vdemonstration - G. Cassel

12:23 V LIVE demonstration from Institut

Cardiovasculaire Paris Sud - Massy, France


13:13 V Which patient characteristics impact management

decisions? - A. Banning


13:27 V Session evaluation and key learnings - K.G. Oldroyd




33

12:00 13:30 ROOM MAILLOT


Hot Line

Renal and peripheral interventions Session comprising selected EuroPCR 2016 late-breaking

trial submissions

Chairpersons: T.F. Lüscher, F. MahfoudPanellists: S. Ewen, F. Fanelli, P.J. Fitzgerald, C. Setacci

12:00 V Dramatic change in quality of life for patients

undergoing percutaneous vascular interventions:

a study from the Blue Cross Blue Shield of

Michigan Cardiovascular Consortium


12:13 V New concepts of carotid artery stenting with

dual-layer micromesh stent system: 30-day primary

endpoint results in the CLEAR-ROAD trial - M. Bosiers


12:26 V Prospective evaluation of all-comer percutaneous

carotid revascularisation in symptomatic and

increased-risk asymptomatic carotid artery

stenosis using the Micronet-covered embolic

prevention stent system in 101 consecutive

patients: PARADIGM-101 - P. Musialek


12:39 V A randomised comparison between DEB and

conventional balloon angioplasty for lesions in the

penile artery in patients with erectile dysfunction:

the PERFECT-4 study - T.D. Wang


12:52 V A novel endovascular debranching technique

using a thoracic bifurcation and visceral manifold

for repair of thoracoabdominal aneurysms - P. Kelly


13:05 V Simplicity denervation system for pulmonary

artery denervation in patients with

residual pulmonary hypertension after

pulmonary thromboembolism and surgical

thromboendarterectomy (first-in-man study) -

B. Rudenko


13:18 V Alcohol-mediated endovascular renal denervation:

the PEREGRINE study - W. Wojakowski


12:00 13:30 THEATRE HAVANE

TAVI in low-risk patients Chairpersons: P. MacCarthy, T. WaltherPanellists: A.M. Al Abdullah, S. Saito, S. Von Bardeleben


VTo understand the remaining shortfalls of TAVI

VTo learn more about the main technological

innovations developed to improve TAVI results

VTo understand who are the low-risk patients with

aortic stenosis

12:00 V Session objectives - P. MacCarthy

12:03 V Which factors have made TAVI a valuable option

for low-risk patients? - H. Treede



demonstration and patient selection process -

S. Von Bardeleben

12:23 V LIVE demonstration from Universitäres

Herzzentrum Rostock - Rostock, Germany


13:13 V What is required for TAVI to become the new gold

standard - O. Wendler


13:27 V Session evaluation and key learnings - T. Walther






34

wx

高亮

wx

高亮

12:00 13:30 ROOM TERNES 2


Cases

Carotid stenting and acute ischaemic stroke interventions Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: Ö. Göktekin Panellists: C. Bahuleyan, S. Kedev, O. Özdemir

12:00 V Treating stroke patient with severe bilateral carotid

disease - C. Christou


12:13 V Large carotid artery dissection successfully treated

by a double-mesh new technology stent: an OCT-

guided procedure - R. Nerla


12:26 V Carotid intramural haematoma as a cause of stroke

in a young woman - C. Cigalini


12:39 V Acute posterior stroke intervention - K. Chawla


12:52 V Endovascular repair of spontaneous dissection of

petrous part of internal carotid artery in two cases -

M. Ostovan


13:05 V Endovascular management of a patient with

ischaemic stroke after cardiac surgery - I. Tasheva


13:18 V Hyperacute in-stent carotid thrombosis after

systemic recombinant tissue plasminogen

activator administration in acute ischaemic stroke

succesfully treated with mechanical recanalisation -

P. Kurray


12:00 13:30 ROOM LEARNING


Learning

Learning bifurcation: T and protrusion (TAP) technique Facilitators: B. Farah, D. Hildick-Smith, G. StankovicMedia Driver: E. Karacop


VTo understand what is the right strategy for each

individual patient, taking into consideration

specific anatomies

VTo learn how to perform the T and protrusion

(TAP) technique step by step:

- Planning: preprocedural aspects

- Treating: procedural tools and techniques

- Preventing and managing potential

procedure-related complications



Cases

Left main PCI techniques Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: P. StellaPanellists: S. Alkandari, G. Kumar, J. Legutko

12:00 V A novel technique for PCI of isolated ostial

coronary stenosis - A. Mechery


12:13 V Kissing-balloon technique of left main coronary

artery using 5Fr catheter with 0.014 inch wire -

Y. Hada


12:26 V Keep it simple - E. Asher


12:39 V PCI of left main, circumflex and intermediate

artery: balloon anchoring with T-stenting and

small protrusion - Z. Dimitriadis


12:52 V Simplified two-stent crush technique in left main

bifurcation - C.W. Khoo


13:05 V Emergency angioplasty in multivessel patient with

chronic occlusion of the left anterior descending

artery and complex injury of distal left main with

the double-kissing crush technique - L. Dallan


13:18 V Left main bifurcation by culotte technique in a

haemodynamically unstable patient - S. Gupta


35

12:42 V Euro16A-OP0819 – Physiological severity of

coronary artery stenosis depends on the amount

of myocardial mass subtended by the coronary

artery - J.H. Choi

12:46 V Euro16A-OP0843 – Geographical miss

phenomenon: device motion indicator,

a new insight into an angiographic curiosity -

R. Abu Fanne

12:50 V Euro16A-OP0870 – Long-term follow-up of

patients evaluated with FFR: the LA SPEZIA

registry - M. Arena

12:54 V Euro16A-OP1071 – OCT evaluation of the vascular

responses of the polylactide-based, novolimus-

eluting BRS from implantation to three years:

insights from the DESolve NX trial - D. Chamié

12:58 V Euro16A-OP0805 – Mental stress-induced

myocardial ischaemia - S. Arri

13:02 V Euro16A-OP0821 – Comparison of myocardial

mass subtended by main vessel and side:

allometric scaling analysis of fractional myocardial

mass subtended by 5,860 coronary arteries -

J.H. Choi

13:06 V Euro16A-OP0292 – Impact of proton-pump

inhibitors on clinical outcomes in patients treated

with a six-month or 24-month DAPT duration:

insights from the PRODIGY trial - F. Costa

13:10 V Euro16A-OP0224 – Crossover rates in transradial

catheterisation: are they really high? - C. Christou

13:13 V Deliberation

13:18 V Announcement of presentations selected for

round 2

Selected submitters will be given 3min to

present their work, without any support (no

slides, no posters), addressing 4 essential

questions in front of the jury. The jury will

deliberate at the end of the session to announce

the 4 participants who will go on to round 2.

12:00 13:30 ROOM 241


Abstracts

PCR's Got Talent - round 1: cathlab tools, techniques and pharmacology Session comprising selected EuroPCR 2016 abstract

submissions

Chairpersons: J.P. Collet, L. RäberJury Members: T. Adriaenssens, M. Al Zaibag, A. Bartorelli, J. Belardi, M.C. Morice, M. Radu

12:00 V Introduction

12:02 V Euro16A-OP0038 – OCT: influence of contrast

concentration on diagnostic certainty -

F. Blachutzik

12:06 V Euro16A-OP0104 – Comparison of adenosine

vs. regadenoson for the measurement of FFR:

a meta-analysis - I. Tanboga

12:10 V Euro16A-OP0110 – Effect of preloading with

high-dose of rosuvastatin in gene expression and

serum levels of inflammatory markers after PCI

with metallic stents - J. Slhessarenko

12:14 V Euro16A-OP0156 – Anti-scatter grid removal

during coronary angiography and PCI in low body

mass index patients: a simple and safe technique

for radiation dose reduction - J. Roy

12:18 V Euro16A-OP0233 – Randomised study comparing

strategies to treat radial artery spasm: the COMBAT

SPAM trial - C. Collet

12:22 V Euro16A-OP0245 – Major infection after coronary

bypass surgery and stenting in the randomised

SYNTAX trial: incidence, predictors and impact on

five-year mortality - R. Cavalcante

12:26 V Euro16A-OP0392 – Systematic review of non-

invasive CT-derived FFR studies: can we use it to

numerically predict invasive FFR and plan our

intervention virtually? - C. Cook

12:30 V Euro16A-OP0530 – Baseline coronary flow varies

with normal cardiac catheter laboratory stimuli -

B.N. Modi

12:34 V Euro16A-OP0621 – The long-term effects of PCI in

patients with coronary heart disease and a low left

ventricular ejection fraction - H. Fozilov

12:38 V Euro16A-OP0718 – Imaging and physiology-

guided PCI without contrast administration in

advanced renal failure: a feasibility, safety and

outcome study - A. Ziad



36

12:00 13:30 ROOM 251

What's new in hypertension? An update for interventionists With the collaboration of the Practical Course on

Hypertension (PCH)

Facilitators: A. Pathak, K. Tsioufis Panellists: R. Schmieder, C. Ukena, S. Worthley, T. Zeller


VTo be updated on new studies and recently

published data which will change your clinical

practice

VTo discuss current interventional and non-

interventional treatment strategies for

hypertensive patients at risk

VTo actively share your experience and get answers

to your burning questions

12:00 V Session objectives and audience poll - K. Tsioufis

12:05 V Changing landscape: impact of new studies in

hypertension (e.g. SPRINT, PATHWAY) on my

clinical practice - R. Schmieder


12:25 V Renal denervation for hypertension treatment:

what has happened in 2015 and where to go

next? - K. Tsioufis


12:45 V Innovations in catheter design - H. Sievert


13:05 V Extrarenal intervention for hypertension treatment

(carotid bulb restoration, arteriovenous fistula,

etc.) - C. Ukena


13:25 V Key learnings and session evaluation - A. Pathak

12:00 13:30 ROOM 242AB

Focus The Essentials for Young Practitioners

STENT

FOR LIFE

A STEMI patient approaching and I am on call: a practice guide to primary PCI in 2016 Senior Advisor: S.B. King IIIFacilitators: N. Amabile, S. Brugaletta, O. SukhorukovMedia Driver: S. Houssany


VTo re-appraise your strategy and technique in view

of new evidences in the field

VTo agree and... disagree on controversial topics

(e.g. thrombus aspiration, immediate complete

revascularisation in multivessel disease)

VTo take home an update on modern

antithrombotic strategies in different clinical

scenarios

12:00 13:30 ROOM 243


Cases

Complex lesions in ACS setting Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: K. NiemelaPanellists: M.A.K. Akanda, P. Barlis, H.C. Lee

12:00 V Single stage complete coronary revascularisation

in a post-CABG patient presenting with ACS -

H.K. Bali


12:13 V Use of DEB in de novo lesions - S. Athukorala


12:26 V Complex bifurcation PCI post-TAVI: specific issues

to deal with - L. Janssens


12:39 V V-stenting in critical bifurcation lesion - S. Banerjee


12:52 V Single inflation dilation in main and side branch -

S. Banerjee


13:05 V Make the angioplasty complex for more safety... -

A. Azzouz


13:18 V Two bifurcation techniques, same patient, same

setting - A. El Amrawy


37

12:00 13:30 ROOM 253


All you need to know about BRS Chairpersons: M. Haude, N.E.J. West


VTo review a comprehensive and clinically relevant

update on this field

VTo identify the current evidence base and existing

guidelines

VTo recognise the open questions that need

addressing in the near future

12:00 V Session objectives - M. Haude

12:05 V Background: current technology - H. Nef


12:25 V Clinical results - J. Byrne


12:45 V Recommendations: implantation technique -

J. Wykrzykowska


13:05 V Unresolved issues and outlook: the next

generation - A. Abizaid


13:25 V Session evaluation and key learnings - N.E.J. West

12:00 13:30 ROOM 252AB

CVIT@EuroPCR - Learning from bailout cases in complex PCI With the collaboration of the Japanese Association of

Cardiovascular Intervention and Therapeutics (CVIT)

Chairpersons: G. Guagliumi, M. NakamuraPanellists: E. Eeckhout, H. Eteiba, K. Kadota, T. Ueno


VTo discuss unexpected complications during PCI

VTo review useful bailout techniques when facing

complex complications

VTo share tips and tricks in order to prevent or

correct complications

12:00 V EuroPCR welcomes CVIT - G. Guagliumi

12:02 V Session objectives - M. Nakamura

12:05 V Complications and bailout techniques in complex

PCI - T.K. Kawasaki


12:25 V Role of physiology to understand the

pathophysiology in complex PCI - N.H. Pijls


12:45 V Tips and tricks for bailout from complex

complication - S. Sumitsuji


13:05 V Importance of imaging to demonstrate the

pathophysiology in complex PCI - P. Motreff


13:25 V Session evaluation and key learnings -

G. Guagliumi




38

12:00 13:30 ROOM 342A

Difficult decisions in STEMI patients with cardiogenic shock Chairpersons: M. Noc, H. ThielePanellists: D. Dudek, P.J.L. Ong


VTo learn optimal primary PCI strategy in STEMI

with cardiogenic shock

VTo assess options for haemodynamic support

beyond intra-aortic balloon pumping

VTo discuss how to deal with mechanical

complications in STEMI

12:00 V Session objectives - M. Noc

12:05 V Case 1: STEMI, cardiogenic shock and multivessel

disease - going beyond PCI of culprit lesion? -

M. Behan


12:25 V Case 2: extracorporeal membrane oxygenation

or / and percutaneous mechanical circulatory

support as first choice or only after failed intra-

aortic balloon pumping? - C. Spaulding


12:45 V Case 3: post-infarction ventricular septal rupture -

G. Pedrazzini


13:05 V Case 4: acute mitral insufficiency - H. Thiele


13:25 V Session evaluation and key learnings - H. Thiele

12:00 13:30 ROOM 341


Cases

Balloon aortic valvuloplasty as a forgotten therapy Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: A. CribierPanellists: R. Bhindi, S. Selvamani, R. Trillo Nouche

12:00 V Balloon aortic valvuloplasty as a forgotten therapy -

F. Safi


12:15 V Concurrent antegrade transseptal mitral and aortic

Inoue balloon valvuloplasty in an octogenarian

with rheumatic heart disease and pulmonary

oedema - Y. Chang


12:30 V Usefulness of intracardiac echocardiography

during balloon aortic valvuloplasty - K. Meguro


12:45 V Combined aortic valvuloplasty and alcohol

septal ablation in high-risk patient as bridge

to transcatheter aortic valve replacement -

F. Leite Vincenti


13:00 V Balloon dilatation of the aortic valve in a pregnant

patient with severe rheumatic aortic valve stenosis

- F. Maatouk


13:15 V Bailout TAVI: a successful case of emergency TAVI

in massive aortic regurgitation after balloon aortic

valvuloplasty - P. Gatto


39

12:00 13:30 ROOM 343


Abstracts

Importance of coronary anatomy in risk stratification Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: D. WagnerPanellists: V. Kumar, S. Munwar, H. Warda

12:00 V Euro16A-OP0825 – Prevalence, pattern and

management of myocardial bridges among 4,288

patients undergoing coronary angiography at a

tertiary care centre: ACE-BRIDGE study - D.S. Bisht


12:15 V Euro16A-OP1040 – Coronary anatomy and

complications during PCI: predict to prevent! -

J. Ribeiro


12:30 V Euro16A-OP0539 – Does coronary artery

dominance predict the outcome in coronary

artery disease? - S. Devadathan


12:43 V Euro16A-OP0331 – Coronary artery dominance in

the Bangladeshi population - M. Kalimuddin


12:58 V Euro16A-OP0676 – Usefulness of a novel

technique to quantify the extension of coronary

artery disease and percentage of myocardium at

risk of ischaemia: HemoTool - M. Garcia-Guimaraes


13:13 V Euro16A-OP0277 – Severe calcifications in

target lesions of patients with acute myocardial

infarction undergoing PCI predict adverse cardiac

events in long-term follow-up - W. Zimoch


Every EuroPCR abstract can be found

in the digital Book of Abstracts available online

and in the PCR App.

12:00 13:30 ROOM 342B


Cases

Coronary perforations: bailout strategies - part 2 Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: V. SchächingerPanellists: M. Ashraf Al Anie, C. Briguori, M. Loutfi

12:00 V Coronary perforation: home-made solution -

L. Nait Saidi


12:13 V Type III coronary perforation - a hole in your plan -

I. Dregoesc


12:26 V Elective PCI complicated by coronary rupture and

pericardial tamponade - C. Galvão Braga


12:39 V The enemy of perfection might be a perforation -

H. Abu-Hantash


12:52 V Massive coronary artery perforation: a second

rescue catheter can save life - K. Bejar


13:05 V Plugging the hole: an unconventional approach to

treating coronary artery perforation - C. McQuillan


13:18 V A clinical case of complication performing hybrid

culotte - J. Chavarria




40

12:00 13:30 ROOM 352A

How Should I Treat?

Finland and Norway share their most educational cases: anticoagulated patients undergoing PCI With the collaboration of the Working Group on

Interventional Cardiology of the Finnish Society of

Cardiology and the Working Group of Interventional

Cardiology of the Norwegian Society of Cardiology

Chairpersons: C. Eek, E. Ilveskoski


VTo understand both periprocedural and long-term

problems associated with PCI in anticoagulated

patient

VTo discuss different stent options in

anticoagulated patients

12:00 V Session objectives - E. Ilveskoski

12:05 V Case 1: atrial fibrillation patient on direct oral

anticoagulant and gastrointestinal bleeding

undergoing primary PCI for STEMI - T. Kiviniemi

12:10 V How would I treat the case? - T. Trovik

12:15 V How would I treat the case? - T. Rissanen

12:20 V How did I treat the case? - T. Kiviniemi


12:40 V Consensus - C. Eek

12:45 V Case 2: acute stent-thrombosis and simultaneous

bleeding - A. Hervold

12:50 V How would I treat the case? - T. Rissanen

12:55 V How would I treat the case? - T. Trovik

13:00 V How did I treat the case? - A. Hervold


13:20 V Consensus - E. Ilveskoski

13:25 V Session evaluation and key learnings - C. Eek

12:00 13:30 ROOM 351


Abstracts

Transcatheter mitral interventions: from sizing to clinical outcome Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: F. MaisanoPanellists: N. Dumonteil, G. Manoharan, H. Moellmann

12:00 V Euro16A-OP0910 – Annular sizing for transcatheter

mitral valve replacement -

M. Abdelghani


12:13 V Euro16A-OP0138 – One-year follow-up results of

mitral valve reconstruction system multicentre

trial - G. Nickenig


12:26 V Euro16A-OP0705 – Transcatheter mitral valve

replacement for severe mitral regurgitation: the

TENDYNE early feasibility trial - D. Muller


12:39 V Euro16A-OP0570 – Combined results on safety

and efficacy of two prospective, multicentre trials

for the treatment of functional mitral regurgitation

by percutaneous annuloplasty - H. Degen


12:52 V Euro16A-OP1083 – Direct access transcatheter

mitral repair with a sutureless neochordal device:

preclinical experience - A. Weber


13:05 V Euro16A-OP0260 – The EVEREST II REALISM

continued access study: one-year outcomes in

patients with degenerative mitral regurgitation

reported by baseline New York Heart Association

functional class - S. Kar


13:18 V Euro16A-OP0950 – Results of the multicentre

(PHASE II) mitral valve repair clinical trial (MAVERIC

trial) for the treatment of secondary mitral

regurgitation in chronic heart failure - A. Erglis




and in the PCR App.

41

12:00 13:30 ROOM 353


Abstracts

Bifurcation PCI: fate of the side branch Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: J. OrmistonPanellists: W.H. Ahmed, S. Garg

12:00 V Euro16A-OP0472 – An angiographic tool based on

visual estimation for risk prediction of side-branch

occlusion in coronary bifurcation intervention: the

V-RESOLVE score system - K. Dou


12:13 V Euro16A-OP0619 – Provisional stent technique

in coronary bifurcation lesions: predictors and

outcomes of side-branch occlusions -

A. Jurado-Roman


12:26 V Euro16A-OP0505 – How carina angle impact the

fate of side branch after main vessel stenting in

coronary bifurcation intervention: analysis from a

consecutive cohort of 1,200 bifurcation lesions -

D. Zhang


12:39 V Euro16A-OP0667 – CR12 registry: side-branch strut

opening after main vessel stenting in provisional

stent technique - A. Jurado-Roman


12:52 V Euro16A-OP0794 – Single-string technique for

stenting of complex coronary bifurcation stenoses -

G. Toth


13:05 V Euro16A-OP0693 – Modified jailed balloon

technique: a novel technique to avoid side-branch

occlusion regarding PCI for bifurcation lesions -

K. Shishido


13:18 V Euro16A-OP0810 – Feasibility and efficacy of

side-branch dilation using the dedicated balloon

combined with proximal optimisation after cross-

over stenting in the coronary bifurcation lesion -

Y. Murasato




and in the PCR App.

12:00 13:30 ROOM 352B

Complications

Argentina and France share their most educational cases: TAVI procedure complications With the collaboration of the Argentinian College

of Interventional Cardioangiologists (CACI) and the

Atheroma Coronary and Interventional Cardiology

Group of the French Society of Cardiology (GACI)

Chairpersons: A. Cherro, J. Monségu


VTo understand and identify acute complication

during TAVI procedure

VTo learn how to prevent TAVI complications

VTo share experiences on TAVI procedure

management

12:00 V Session objectives - J. Monségu

12:03 V Case 1: valve-in-valve in a patient with high risk of

left main occlusion during the procedure - safety

measures - J. Leguizamon


12:17 V Case 2: SAPIEN XT balloon rupture during inflation -

B. Faurie


12:31 V Case 3: valve embolisation during TAVI - J. Vicario


12:45 V Case 4: bailout of an Edwards SAPIEN 3 prosthesis

through an expandable sheath - F. Sawaya


12:59 V Case 5: paravalvular leak after transcatheter aortic

bicuspid and heavy calcified valve replacement -

A. Alvarez Iorio


13:13 V Case 6: left main occlusion during transfemoral

TAVI using an Edwards SAPIEN 3 prosthesis -

C. Tron


13:27 V Session evaluation and key learnings - A. Cherro



42



Coronary interventions: Left main PCI LIVE demonstration Chairpersons: I. Al Rashdan, J. FajadetPanellists: K. Al Faraidy, R. Byrne, S.L. Chen, T.H. Koh, M. Roffi, A. Witkowski

12:25 V Review of the technique to be used during the

LIVE demonstration - J. Fajadet

12:30 V LIVE demonstration from Rabin Medical Centre -

Petah Tikva, Israel





-13:00 - 13:30 14:20

MAIN ARENA

2016 Great Debate: extending TAVI to low risk patients Supported by an educational grant from MEDTRONIC

Debaters: D. Mylotte, J.F. Obadia, L. Sondergaard, T. Walther, G. Wimmer-Greinecker, S. Windecker

13:30 V Scope of the Great Debate and presentation of the

Debaters - A. Vahanian

13:35 V Great Debate moderated by A. Spencer

14:15 V What I will remember - A. Vahanian

12:00 13:30 ROOM ARLEQUIN


Cases

Anomalous coronary arteries and ACS Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: P. KalaPanellists: M. Babu, F. Begum, K. Toutouzas

12:00 V An anomalous STEMI - G. Sacchetta


12:13 V Primary PCI in a patient with a single coronary

artery arising from the right sinus of valsalva -

M. Boukhris


12:26 V A challenging PCI in an anomalous right coronary

artery from left coronary sinus: a hardware fiesta!


12:39 V Single right coronary artery occlusion, thrombus

aspiration - I. Tsiafoutis


12:52 V Paroxysmal supraventricular tachycardia and

recurrent ACS in a young lady: an unusual cause -

W. Alshamkhani


13:05 V Bifurcation stenting of left anterior descending,

right coronary artery - story of anomalous right

coronary - H.K. Bali


13:18 V Multivessel PCI transradial approach in

dextrocardia - D. Kaewkes



43

wx

高亮



Hot Line

Advances in treatment of ACS Session comprising selected EuroPCR 2016 late-breaking

trial submissions

Chairpersons: S. James, M. RoffiPanellists: P. Genereux, S.B. King III, M. Radu, L. Räber, L. Tokgozoglu, C. Von Birgelen

13:45 V Contemporary trends and outcomes associated

with the preprocedural use of oral P2Y12

inhibitors in patients undergoing PCI - D. Sukul


14:00 V Safety of a regional standardised protocol to

optimise the use of most effective platelet

inhibition in ACS treated with PCI: final results

from the Dutch, multicentre and Observational

Rijnmond Collective Cardiology Research (CCR)

study - R.J. Van Geuns


14:15 V Assessment of the plaque characteristics by OCT

in patients presenting with ACS: insights from the

OCT-FORMIDABLE registry - C. Moretti


14:30 V 18-month clinical follow-up of the BRS STEMI FIRST

study - R. Diletti


14:45 V Long-term follow-up after BRS implantation

in STEMI patients - PRAGUE-19 study update -

V. Kocka


15:00 V Safety and efficacy of biodegradable polymer DES

in management of patients with acute STEMI:

MASTER study - one-year clinical outcomes -

M. Valdés Chávarri


13:45 15:15 THEATRE BLEU

PCI of complex bifurcation lesion: when and why two stents are needed Chairpersons: T.H. Koh, G. StankovicPanellists: A. Bartorelli, M. Costa, J.M. De La Torre Hernandez, R. De Palma, D. Tresukosol, C. Zambakides


VTo understand current indications and choices for

two-stent techniques

VTo learn about procedural steps in the treatment

of complex bifurcation

VTo review the potential role of adjunctive tools

13:45 V Session objectives - G. Stankovic

13:48 V Which bifurcation lesions require an upfront

two-stent technique? - A. Chieffo



LIVE demonstration - R. De Palma




14:58 V Which technique: main vessel first or side branch

first? - G. Stankovic


15:12 V Session evaluation and key learnings - T.H. Koh






44



Hot Line

First-in-man and DES trials Session comprising selected EuroPCR 2016 late-breaking

trial submissions

Chairpersons: E. Edelman, M. JonerPanellists: H.M. Garcia-Garcia, T. Kimura, P. L' Allier, F.J. Neumann

13:45 V Fantom sirolimus-eluting BRS - A. Abizaid


13:58 V Safety and clinical performance of the drug-

eluting absorbable metal scaffold in the treatment

of subjects with de novo lesions in native coronary

arteries at 12-month follow-up BIOSOLVE-II - M.

Haude


14:11 V One-year results of first-in-man trial randomising

the sirolimus-eluting polylactide scaffold and

the everolimus-eluting polylactide scaffold -

P.W. Serruys


14:24 V Primary endpoint results from the NIREUS trial.

A prospective randomised trial comparing the

novel ridaforolimus-eluting BioNIR stent to the

zotarolimus-eluting Resolute stent - P. Smits


14:37 V In vivo healing response to bioresorbable,

abluminal polymer everolimus-eluting stents vs.

durable, conformal polymer zotarolimus-eluting

stents. TRANSFORM-OCT trial - G. Guagliumi


14:50 V Angiographic outcomes of Orsiro biodegradable

polymer sirolimus-eluting stents and Resolute

Integrity durable polymer zotarolimus-eluting

stents: results of ORIENT trial - S.H. Kang


15:03 V Nine-month clinical and angiographic outcomes

after coronary stenting of small vessels in

Japanese population using 2.25mm diameter

sirolimus-eluting stent with bioresorbable

polymer: CENTURY JSV study - primary endpoint -

S. Saito



Transcatheter aortic valve-in-valve implantation Chairpersons: T. Modine, C. RuizPanellists: J. Byrne, P.H.L. Kao, G. Nickenig, P. Wenaweser


VTo receive an update on the clinical evidence for

aortic valve-in-valve procedures

VTo understand the important steps in

preprocedural planning of an aortic valve-in-valve

procedure

VTo observe a step-by-step approach to aortic

valve-in-valve implantation

13:45 V Session objectives - G. Nickenig

13:48 V Bioprothetic valve failure: mechanisms and

treatment options - V. Bapat



demonstration - P. Wenaweser

14:08 V LIVE demonstration from Rabin Medical Centre -

Petah Tikva, Israel


14:58 V Valve-in-valve TAVI is not always the right option: a

note of caution - T. Modine


15:12 V Session evaluation and key learnings - T. Modine




45



Cases

Complex aortoiliac angioplasty Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: M.J. Bosiers Panellists: O. Al Shammeri, M.S. Mourali, H. Reinecke

13:45 V Endovascular therapy of chronic complicated

abdominal aorta dissection in a patient with

aortoiliac carrefour occlusive disease - R. Padalino


13:58 V Thrombosuction and balloon angioplasty of acute

abdominal aorta occlusion - S. Gupta


14:11 V A pitfall of endovascular treatment for Leriche

syndrome - Y. Kaetsu


14:24 V Aortic CTO - Q. Labarre


14:37 V Is it safe to puncture abdominal aorta with

a re-entry catheter? - E. Vuruskan


14:50 V Should we consider endovascular therapy for

internal iliac lesion as well as common and

external iliac lesion?


15:03 V Bifemoral approach with use of snare catheter

in iliac CTO - B. Teymen




Learning

Learning radial access for complex interventions Facilitators: H. Amin, S. Kedev, J. MonséguMedia Driver: L. Tapp


VTo better assess radial access for complex

interventions, including: bypass, complex

bifurcation, left main, CTO, acute myocardial

infarction



Cases

Left main PCI: is there still a place for IVUS? Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: K. Al-ShaibiPanellists: A. Erglis, O. Sakhov, P. Singh

13:45 V Selection of left main stem stent size and length

based on IVUS angiography co-registration -

N. Ryan


13:58 V Two catheters and two wires - C.W. Khoo


14:11 V Old technique - new DES: IVUS-guided culotte

stenting with new generation DES for a complex

bifurcational lesion - A. Menozzi


14:24 V IVUS-supported left main bifurcation stenting by

minicrush technique - R. Vijayvergiya


14:37 V Identification and management of longitudinal

stent distortion in the left main stem - N. Ryan


14:50 V Left main coronary artery stent retrieval - T. Snow


15:03 V Young female with Takayasu arteritis and atypical

chest pain - R. Garcia-Borbolla Fernández




46

14:27 V Euro16A-OP0552 – A single-centre experience

using internal endoconduit for unfavorable iliac

artery anatomy in patients undergoing TAVI from a

transfemoral approach - Y.T. Lee

14:31 V Euro16A-OP0657 – Transcatheter aortic valve-in-

valve implantation using the Lotus Valve system

for failed surgical bioprostheses: an early Italian

experience - R. Nerla

14:35 V Euro16A-OP0793 – Transfemoral TAVI induces

common femoral artery shrinkage - L. Paraggio

14:39 V Euro16A-OP0873 – Transcatheter valve-in-valve

implantation using the Portico system:

a multicentre registry - L. Testa

14:43 V Euro16A-OP0983 – Incidence, predictors and

clinical outcomes: who is going to need a

permanent pacemaker following TAVI? The

multicentre Brazilian TAVI registry revisited -

P.R.A. Caramori

14:47 V Euro16A-OP1068 – Treatment of severe aortic

stenosis with a new-generation recapturable

and repositionable self-expanding transcatheter

aortic valve system: a single-centre experience of

consecutive patients - N. Perrin

14:51 V Euro16A-OP1072 – Second-generation

percutaneous TAVI: single-centre experience

comparing outcomes of a self-expanding valve

system with a preloaded stent-mounted valve -

S. Khogali

14:55 V Euro16A-OP0190 – Outcomes of re-do

transcatheter aortic valve replacement for

the treatment of post-procedural and late

transcatheter valve failure - M. Barbanti



round 2







13:45 15:15 ROOM 241


Abstracts

PCR's Got Talent - round 1: TAVI - part 1 Session comprising selected EuroPCR 2016 abstract

submissions

Chairpersons: A.P. Kappetein, N. PiazzaJury Members: J. Bartunek, H. Baumgartner, M. Chen, N. Dumonteil, F. Maisano, M. Monaghan


13:47 V Euro16A-OP0041 – Impact of new cerebral

ischaemic lesions on the occurrence of delirium

after TAVI - M. Abawi

13:51 V Euro16A-OP0064 – Reduced need for permanent

pacemaker rates following Lotus device

implantation for transcatheter aortic valve

replacement due to modified implantation

protocol - F. Krackhardt

13:55 V Euro16A-OP0166 – Sheathless use of a new

transcatheter aortic valve system in complex

vascular access sites - F. Scalise

13:59 V Euro16A-OP0844 – Impact of permanent

pacemaker on mortality after TAVI: the PRAGMATIC

(Pooled Rotterdam - Milan - Toulouse in

Collaboration) pacemaker substudy -

R. Van Der Boon

14:03 V Euro16A-OP0197 – The effect of TAVI on cognition:

a prospective pilot study - R. de Vries

14:07 V Euro16A-OP0167 – A new percutaneous

technique for effective vascular access site closure

in patients receiving transfemoral TAVI and

thoracoabdominal aortic aneurysm repair -

F. Scalise

14:11 V Euro16A-OP0227 – Electrocardiogram predictors

of permanent pacemaker-dependency following

TAVI in a real-world cohort - T. Tichelbäcker

14:15 V Euro16A-OP0249 – Angiographic classification

of Access-Site and Access-Related Vascular

Injury (ASARVI) - stratifying TAVI-associated

complications beyond VARC-II - A. Sedaghat

14:19 V Euro16A-OP0470 – Occurrence of new-onset

intraventricular conduction delays after TAVI with

new-generation valves - C. Panico

14:23 V Euro16A-OP0535 – Single-centre evaluation

of a next-generation fully repositionable and

retrievable transcatheter aortic valve - M. Götberg

47

13:45 15:15 ROOM 251

Focus Nurses and Allied Professionals

Challenges in complex PCI - the role of nurses and allied professionals Facilitators: S. Carson, R. Esteves, H. FaltotMedia Driver: D. Zughaft


VTo understand patient selection and preparation

VTo gain confidence to assist during complex PCI

VTo improve patient outcome during and after

complex PCI

13:45 V Introduction of the Nurses and Allied Professionals

Programme at EuroPCR - A. Baumbach

13:50 V Session objectives - R. Esteves

13:52 V Case 1: CTO - R. Esteves


14:32 V Case 2: rotablator - S. Carson


15:12 V Session evaluation and key learnings - H. Faltot

Join the Nurses and Allied Professionals Corner!

A comfortable lounge dedicated to you located

next to Theatre Bleu on level 2 (Neuilly side).

13:45 15:15 ROOM 242AB


From smoke to explosion: a coronary perforation clinic Senior Advisor: S. El TobgiFacilitators: J. Adjedj, R. Didier, N. Van MieghemMedia Driver: V. Kunadian


VTo learn how to prevent coronary perforations

VTo discuss how to manage coronary perforations

VTo share what you have learnt from your most

frightening nightmare experiences with your

peers

13:45 15:15 ROOM 243


Cases

Peripheral complication management Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: M. BosiersPanellists: I. Alhaddad, F. Fanelli, H. Khamis

13:45 V Percutaneous closure of a giant ascending aortic

pseudoaneurysm leak - M. Vanegas


13:58 V Too much pressure? - A. Bucsa


14:11 V A nightmare after subclavian artery intervention -

W.C. Huang


14:24 V Successful catheter intervention for

retroperitoneal bleeding - K. Komiyama


14:37 V Strategic management of perforation and rupture

of external iliac artery induced by infrarenal aortic

aneurysm endovascular repair - R.K. Premchand


14:50 V Multilayer flow modulator device for

thoracoabdominal aneurysm complicated by iliac

artery avulsion - R.K. Premchand


15:03 V Endograft limb occlusion after endovascular aortic

repair - R. Vijayvergiya




48

13:45 15:15 ROOM 253


STENT

FOR LIFE

All you need to know about STEMI and multivessel disease Chairpersons: M. Behan, D. Dudek





guidelines



13:45 V Session objectives - D. Dudek

13:50 V Background: clinical scenarios and problems in

clinical practice - M. Behan


14:10 V Clinical trials on STEMI with bystander disease -

K.G. Oldroyd


14:30 V Guidelines and recommendations - up to date? -

G. Ducrocq


14:50 V Unresolved issues and outlook - when and how to

stage? - U. Landmesser


15:10 V Session evaluation and key learnings - M. Behan

13:45 15:15 ROOM 252AB

AICT and APSIC@EuroPCR - The most educational cases from Asia-Pacific With the collaboration of the Asian Interventional

Cardiovascular Therapeutics (AICT) and the Asian Pacific

Society of Interventional Cardiology (APSIC)

Chairpersons: C.K. Naber, H.C. TanPanellists: U. Kaul, I. Meredith, M.H. Pham


VTo discuss some of the most challenging and

educational cases performed in the Asia-Pacific

region

VTo discover some interventional techniques from

the Asia-Pacific region

VTo understand the East-West commonalities and

divides in intervention

13:45 V EuroPCR welcomes AICT and APSIC - C.K. Naber

13:47 V Session objectives - H.C. Tan

13:50 V A memorable TAVI case - I. Meredith


14:10 V A memorable left main PCI case -

W. Udayachalerm


14:30 V A memorable CTO PCI case - S. Sumitsuji


14:50 V A memorable bifurcation PCI case - U. Kaul


15:10 V Session evaluation and key learnings - H.C. Tan


49

13:45 15:15 ROOM 342A


Cases

Endovascular management for calcified lesion Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: M. BrodmannPanellists: R. Lorenzoni, A. Yildirim

13:45 V Heavily calcified occlusion of posterior tibial artery

in patient affected by critical limb ischaemia:

a stepwise approach - P. Sbarzaglia


13:58 V Angioplasty of anterior dominant peroneal artery

through transcollateral approach in second

metatarsus ostheomyelitis - P. Sbarzaglia


14:11 V The efficiency of debulking calcified lesion

with refractory of balloon expansion by using

debulking device under angioscope in critical

limb ischaemia patient with haemodialysis -

H. Uehara


14:24 V Endovascular treatment for femoropopliteal

arterial lesions with a no-stent zone - Y. Yanagita


14:37 V The role of hybrid surgery in the treatment of

critical limb ischaemia - M.P. Borrelli


14:50 V Unusual cause of critical limb ischaemia - S.T. Rab


15:03 V Successful angioplasty to chronic total occluded

popliteal artery in a patient with thromboangitis

obliterans - F. Kacmaz


13:45 15:15 ROOM 341


Cases

TAVI, tips and tricks Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: U. GerckensPanellists: J. Elias, G. Sorropago, H. Treede

13:45 V Bicuspid aortic valve stenosis and horizontal

aorta-challenging anatomy treated with second-

generation TAVI device - S. Khogali


13:58 V Low-flow low-gradient aortic stenosis: selecting

the right strategy to keep the TAVI procedure safe -

V. Esteves


14:11 V Gradient optimisation by intraprocedural

dilatation of a non-metallic repositionable TAVI

device - F. De Marco


14:24 V A case of TAVI in a patient with a previous mitral

bioprosthesis protruding in the outflow tract -

J. Kefer


14:37 V TAVI in challenging anatomy with new-generation

valve - N.H.V. Luk


14:50 V Challenging TAVI with a mechanically expanding

heart valve in a patient with primary aortic

regurgitation and congenital scoliosis - L. van Gils


15:03 V Contralateral sliding balloon technique to facilitate

sheath advancement across a calcified aortic

plaque during transfemoral TAVI - A. Allali




50

13:45 15:15 ROOM 343


Abstracts

Optimisation of BRS implantation to improve outcomes Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: H. NefPanellists: S. Brugaletta, H. Mehta

13:45 V Euro16A-OP0399 – A new novolimus-eluting BRS

for large coronary arteries: an OCT study of acute

mechanical performance - N. Boeder


13:58 V Euro16A-OP0209 – A hybrid strategy with BRS

and DES for complex coronary artery lesions

unsuitable for a pure scaffolding approach -

A. Ielasi


14:11 V Euro16A-OP0564 – Discrepancies in

measurements between OCT and quantitative

coronary angiography after implantation of

polymeric scaffolds and metallic stents - Y. Sotomi


14:24 V Euro16A-OP0754 – Characterisation of coronary

restenotic lesions following everolimus-eluting

vascular scaffolding - J. Chavarria


14:37 V Euro16A-OP0369 – The use of the hybrid approach

(BRS and DES) in left anterior descending

reconstruction: the BRIVIDO registry -

G. Boccuzzi


14:50 V Euro16A-OP0985 – Predictors of 30-day ischaemic

events after Absorb BRS implantation: a pooled

analysis of 1,933 from six multicentre registries -

A. Caixeta


15:03 V Euro16A-OP0079 – Clinical outcomes of a real-

world cohort following BRS implantation utilising

an optimisation strategy - A. Tanaka




and in the PCR App.

13:45 15:15 ROOM 342B

Key practical issues for antithrombotics in coronary interventions Chairpersons: T. Cuisset, M. ValgimigliPanellists: K. Al Faraidy, P. Urban


VTo review recent evidence on antithrombotics

in coronary interventions

VTo discuss how to integrate scientific data into

clinical decisions

VTo reflect on how to individualise treatment

for each patient

13:45 V Session objectives - M. Valgimigli

13:50 V Timing for initiation of P2Y12 blockers in coronary

interventions - R. Byrne


14:10 V Management of patients with oral anticoagulation

undergoing PCI - J. Mehilli


14:30 V DAPT duration after coronary interventions -

G. Cayla


14:50 V What to expect from the new drugs entering

the field of coronary interventions? (vorapaxar,

cangrelor) - D. Angiolillo


15:10 V Session evaluation and key learnings - T. Cuisset

51

13:45 15:15 ROOM 352A

Complications

Bosnia and Herzegovina, and Luxembourg share their most educational cases: stent loss and thrombosis during PCI With the collaboration of the Working Group of

Interventional Cardiology of the Association of

Cardiologists of Bosnia and Herzegovina and the

Luxembourg Society of Cardiology

Chairpersons: J. Beissel, I. Terzic


VTo care for stent dislodgment

VTo learn how to manage stent thrombosis during

PCI

VTo know about OCT complications

13:45 V Session objectives - I. Terzic

13:48 V Case 1: coronary disaster in a patient with NSTEMI

and poor medical pretreatment - D. Wagner


14:02 V Case 2: coronary dissection - easy to cause, but not

always easy to treat - S. Diedovic


14:16 V Case 3: a stent is never lost - B. Pereira


14:30 V Case 4: PCI on diagonal branch complicated

with left anterior descending subocclusion and

finished as bifurcation case by kissing-balloon

technique - I. Terzic


14:44 V Case 5: be careful with intracoronary thrombus -

J. Beissel


14:58 V Case 6: stent dislodgement during PCI - M. Kulic


15:12 V Session evaluation and key learnings - J. Beissel

13:45 15:15 ROOM 351


Abstracts

Imaging for TAVI: impact on procedural outcome Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: H. DanenbergPanellists: D. Lahidheb, J. Leipsic, F. Praz

13:45 V Euro16A-OP0195 – Non-contrast 3D magnetic

resonance imaging for preprocedural assessment

of aortic annulus dimensions in patients

undergoing TAVI - A. La Manna


13:58 V Euro16A-OP0580 – Quantification of aortic valve

calcification for TAVI screening - B. McHenry


14:11 V Euro16A-OP1042 – Benefit and utility of

baseline CT evaluation to improve outcomes in

transcatheter aortic valve replacement for failed

surgical bioprostheses: insights from the PARTNER

II valve-in-valve registry - D. Dvir


14:24 V Euro16A-OP0423 – IVUS: a way to prevent acute

kidney injury in patients undergoing TAVI? -

F. Giardinelli


14:37 V Euro16A-OP0126 – Is there any incremental value

of 2D transesophageal echocardiography for

annular sizing prior to TAVI? - W.K. Kim


14:50 V Euro16A-OP0521 – 4D multidetector CT

assessment of leaflet thickening and motion in

patients treated with a mechanically expanded

TAVI prosthesis - R. Gooley


15:03 V Euro16A-OP0346 – Device landing zone

calcification: impact on paravalvular leakage after

TAVI with two generations of ballon-expandable

devices - L. Conradi




and in the PCR App.



52

13:45 15:15 ROOM 353


Abstracts

Novel non-invasive approaches to diagnose coronary artery disease Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: O. GämperliPanellists: M. Lesiak, R. Singh, R. Thachathodiyl

13:45 V Euro16A-OP0549 – Seattle angina questionnaire

is able to predict the severity of coronary artery

disease as assessed by four angiographic scores -

W.V.N. Guimaraes


13:58 V Euro16A-OP0345 – Development of a model

for predicting radiological risks in interventional

cardiology - J.B. Maurice


14:11 V Euro16A-OP0775 – CT-derived atherosclerotic

plaque burden and morphology are associated

with haemodynamic significant coronary artery

stenoses using FFR independent of luminal

obstruction - R. Driessen


14:24 V Euro16A-OP0348 – Hybrid iFR - contrast medium

induced Pd / Pa ratio decision-making strategy -

K. Senda


14:37 V Euro16A-OP0237 – Integration of stress myocardial

blood flow, coronary flow reserve, and relative

flow reserve improves diagnostic performance of

myocardial perfusion imaging for identification of

functionally significant coronary artery stenosis -

J.M. Lee


14:50 V Euro16A-OP0193 – Angina status and presence

of ischaemia in echostress at two years after

implantation of drug-eluting BRS or metallic DES -

G. Veiga Fernandez


15:03 V Euro16A-OP0024 – Coronary magnetic resonance

imaging after implantation of BRS allows non-

invasive evaluation of vascular patency and

haemodynamics - C. Von Zur Mühlen




and in the PCR App.

13:45 15:15 ROOM 352B

Complications

Egypt and Turkey share their most educational cases: from dissection to perforation, worst scenario, best save With the collaboration of the Egyptian Working Group of

Interventional Cardiology (EgIC) and the Association of

Percutaneous Cardiovascular Interventions of the Turkish

Society of Cardiology (TAPCI/TSC-Interventions)

Chairpersons: A. Magdy, O. Yavuzgil


VTo understand the potential factors that

may cause left main complications during

interventions

VTo understand the seriousness of left main

complications and how to prevent them

VTo learn how to deal with left main complications

13:45 V Session objectives - A. Magdy

13:48 V Case 1: flush thrombus - E. Akkaya


14:02 V Case 2: left main thrombosis - when it became

dark - A. Sabri


14:16 V Case 3: not always complicated - E. Yeter


14:30 V Case 4: missing left main lesion is a mess! -

Y. Sadek


14:44 V Case 5: cutting wire - K. Tigen


14:58 V Case 6: left main dissection - a real nightmare! -

A. Alsayed Youssef


15:12 V Session evaluation and key learnings - O. Yavuzgil

53

-14:00 - 14:25 15:25

MAIN ARENA


Valvular interventions: Edge-to-edge mitral repair LIVE demonstration Chairpersons: J. Fajadet, S. WindeckerPanellists: M. Buchbinder, M.K.Y. Lee, F. Malik, G. Musumeci, L. Sondergaard, J. Webb


demonstration - S. Windecker







-15:00 - 15:25 15:40

MAIN ARENA

Ceremony

2016 Ethica Award Chairpersons: J. Fajadet, S. WindeckerPanellists: M. Buchbinder, M.K.Y. Lee, F. Malik, G. Musumeci, L. Sondergaard, J. Webb

V Announcement of the 2016 Ethica Award -

S. Windecker



Abstracts

Mid- and long-term outcome after renal denervation Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: F. SharifPanellists: J. Daemen, S. Ewen

13:45 V Euro16A-OP0762 – Resistant arterial hypertension:

is there still a role for renal sympathetic

denervation? - M. Nobre Menezes


13:58 V Euro16A-OP0418 – Renal denervation using the

EnligHTN renal denervation system in alternative

hypertensive populations: 24-month results from

the EnligHTN II study - S. Worthley


14:11 V Euro16A-OP0467 – Who are the non-responders

to renal denervation? An insight from real-world

patients - B. Brochado


14:24 V Euro16A-OP0230 – Six-month invasive safety

assessment in humans of renal artery denervation

using Simplicity Spyral applied in the main trunk

and branches - J. Davies


14:37 V Euro16A-OP0437 – Safety and performance of the

EnligHTN renal denervation system in patients

with drug-resistant hypertension: pooled analyses

from the EnligHTN 1, 2 and 3 trials - S. Worthley


14:50 V Euro16A-OP1033 – Six-month results from the

PEREGRINE study of alcohol-mediated renal

denervation in refractory hypertension -

W. Wojakowski


15:03 V Euro16A-OP0304 – Long-term (three-year)

safety and effectiveness from the global

SYMPLICITY registry of renal denervation in a

real-world patient population with uncontrolled

hypertension - F. Mahfoud




and in the PCR App.



54



Hot Line

Late-breaking trials and trial updates in coronary interventions Session comprising selected EuroPCR 2016 late-breaking

trial submissions

Chairpersons: T. Cuisset, J.F. TanguayPanellists: S. Cook, M. Sabaté, M. Valgimigli, R. Vijayvergiya, P. Vranckx, A. Yildirim

15:30 V The balance of thrombosis and bleeding in

patients at high-bleeding risk from LEADERS FREE

trial - P. Urban


15:43 V Six-month vs. 12-month DAPT following long-

length everolimus-eluting stent implantation -

M.K. Hong


15:56 V Randomised, double-blinded, placebo-controlled

trial of intramyocardial autologous bone marrow

CD133+ cells on left ventricle perfusion and

function in patients with inducible ischaemia and

refractory angina (REGENT-VSEL) - W. Wojakowski


16:09 V The final five-year results from the COMPARE

II trial: the first real long-term results between

biodegradable polymer biolimus-eluting stent

and durable polymer everolimus-eluting stent -

P. Smits


16:22 V Five-year non-enrolled TWENTE: clinical outcome

of participants in the randomised TWENTE trial vs.

non-enrolled eligible patients, treated with the

same second-generation DES - C. Von Birgelen


16:35 V Three-year clinical follow-up of the RIBS V

randomised clinical trial - F. Alfonso Manterola


16:48 V A randomised control trial comparing two

DES on the degree of early stent healing and

late neointima progression using longitudinal

sequential OCT follow-up: the OCT-ORION study -

S. Lee



Left main bifurcation stenting: what is different from other bifurcations lesions? Chairpersons: H. Amin, A. BanningPanellists: M. Alasnag, G. Amoroso, S.L. Chen, G. Davidavicius, M. Lesiak, J. Mehilli


VTo define the strategy for optimal left main

stenting

VTo learn the provisional side-branch technique

from A to Z

VTo understand when two stents are needed and

which technique to use

15:30 V Session objectives - H. Amin

15:33 V What is different about left main bifurcation? -

K.G. Oldroyd



LIVE demonstration - F. Hellig

15:53 V LIVE demonstration from St Thomas' Hospital -



16:43 V One stent vs. two for the left main bifurcation:

when and how - K. Al-Shaibi


16:57 V Session evaluation and key learnings - A. Banning




55



Hot Line

TAVI registries Session comprising selected EuroPCR 2016 late-breaking

trial submissions

Chairpersons: A. Cribier, A.S. PetronioPanellists: M. Chen, U. Gerckens, K. Hayashida, G. Richard

15:30 V Late outcomes of TAVI in high-risk patients:

FRANCE 2 registry - M. Gilard


15:43 V SOURCE 3 post-approval registry - early outcomes

in 1,946 TAVI patients with a third-generation

balloon expandable transcatheter heart valve -

O. Wendler


15:56 V 30-day registry results using a second-generation

transfemoral aortic valve implantation system

for the treatment of patients with severe aortic

stenosis - H. Moellmann


16:09 V Implantation of novel balloon-expandable

transcatheter heart valves into degenerated

surgical aortic bioprostheses: matched

comparison and insights from the Valve-In-Valve

International Data (VIVID) registry - M. Seiffert


16:22 V Acute and 30-day outcomes of women after TAVI:

results from the first Women IN Transcatheter

Aortic Valve Implantation (WIN-TAVI) real-world

registry - A. Chieffo


16:35 V TAVI in hospitals with and without on-site cardiac

surgery department: insights from the prospective

German Aortic valve replacement QUality

Assurance registry (AQUA) in 17,919 patients -

H. Eggebrecht


16:48 V The RESPOND study: safety and efficacy of a fully

repositionable and retrievable aortic valve used in

routine clinical practice - V. Falk



Percutaneous edge-to-edge repair of mitral regurgitation: current status Chairpersons: S. Baldus, A. VahanianPanellists: T. Feldman, C. Grasso, J.F. Obadia, S. Von Bardeleben


VTo be updated on the results of edge-to-edge

repair for primary mitral regurgitation

VTo understand the technical difficulties

encountered during these procedures and how to

overcome them

VTo gain insights into optimal case selection

15:30 V Session objectives - S. Baldus

15:34 V Review of the MitraClip device - S. Von Bardeleben




16:39 V Anatomical suitability: what are the limits? -

C. Grasso


16:56 V Session evaluation and key learnings - A. Vahanian






56



Cases

Supra-aortic aneurysm repair and carotid angioplasty Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: F. CastriotaPanellists: S. Kedev, M.S. Lin, E. Vuruskan

15:30 V Snare-assisted treatment of giant aneurysms of

the left subclavian artery and descending aorta -

D. Zverev


15:43 V Internal carotid artery sacrifice for treatment of a

giant aneurysm - F. Safi


15:56 V A challenging bilateral common carotid artery

stenting with one-year follow-up in Takayasu

arteritis with almost total lesions - K. Amber


16:09 V Innominate artery stenting under cerebral

protection through brachial approach -

M.P. Borrelli


16:22 V A case of bailout for iatrogenic occlusion of

subclavian artery - M. Kishi


16:35 V Modified DEB angioplasty for treatment of high-

risk carotid in-stent restenosis - C.W. Wang


16:48 V Percutaneous treatment of restenosis of the

right internal carotid artery with multiple

stenting in patient submitted to previous

thromboendoarterectomy - C. Moncalvo




Learning

Learning vascular access for peripheral interventions: from stick to closure Facilitators: F. Mahfoud, A. Micari, T. ZellerMedia Driver: J. Molina-Martin de NicolasExpert Panellists: R. Ferraresi, L.M. Palena


VTo understand how to better assess which access

to choose

VTo learn how to perform the different accesses

step by step:

- Femoral antegrade and retrograde

- Popliteal

- Transpedal

- Radial

- Brachial



Cases

Complex management of coronary aneurysm Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: A. WitkowskiPanellists: J. Al Dhaheri, M. Degertekin, H.C. Tan

15:30 V Tertiary syphilis - J. Vasquez Gongora


15:45 V Ice burg! How to manage huge burden of

thrombus?


16:00 V Coronary aneurysm following BRS implantation:

keep it in mind! - L. Barbieri


16:15 V Complex angioplasty to coronary aneurysm -

A. Hailan


16:30 V How to treat a calcified aneurysmal left anterior

descending artery - S.T. Rab


16:45 V Complex management of coronary aneurysm

feeding a CTO - R.A. Latini


57

16:08 V Euro16A-OP0075 – Long-term outcomes of an

octogenarian cohort whom underwent rotational

atherectomy during complex PCI - J. Palazuelos

16:12 V Euro16A-OP0147 – Factors influencing operator's

decision for same-day discharge after PCI -

M. Agelaki

16:16 V Euro16A-OP0185 – Outcomes of re-attempt

PCI for CTO: two-year data from RETROGRADE

SUMMIT registry - S. Ishihara

16:20 V Euro16A-OP0248 – Long-term outcomes of PCI

and CABG in patients with unprotected left main

coronary artery disease: a pooled analysis of

individual patient level data from the SYNTAX and

PRECOMBAT randomised trials - R. Cavalcante

16:24 V Euro16A-OP0566 – Intervention rates and

outcomes of CTO in comparison to other types of

coronary artery disease - O. Odunukan

16:28 V Euro16A-OP0755 – Outcomes of orbital

atherectomy in patients with severe left

ventricular systolic dysfunction - E. Shlofmitz

16:32 V Euro16A-OP0771 – FFR compared with

angiographic estimation of coronary artery

disease: impact of diabetes - J. Adjedj

16:36 V Euro16A-OP0816 – Clinical and angiographic

profile, and management trends in patients

presenting with coronary CTOs in a tertiary care

centre in South India - T. Hussain

16:40 V Euro16A-OP1017 – Change of anticoagulant

therapy in rotational atherectomy in a population

at high cardiovascular risk - J. Palazuelos

16:44 V Euro16A-OP1070 – Clinical and angiographic

one-year outcomes of mini-crush stenting for the

treatment of true coronary bifurcations in an all-

comer population - A. Nicolino



round 2







15:30 17:00 ROOM 241


Abstracts

PCR's Got Talent - round 1: clinical and angiographic subsets in PCI Session comprising selected EuroPCR 2016 abstract

submissions

Chairpersons: A. Bartorelli, R. KoningJury Members: H. Call, A. Colombo, D.S. Gambhir, A. Mehta, D. Mylotte, S. Verheye


15:32 V Euro16A-OP0074 – Utility of slow-speed

rotational atherectomy in patients with severe

left ventricular dysfunction undergoing PCI -

J. Palazuelos

15:36 V Euro16A-OP0244 – Non-invasive coronary CT

angiography-based Heart Team assessment

using the SYNTAX score II for the selection of

the revascularisation strategy in patients with

multivessel coronary disease: a subanalysis of the

SYNTAX II trial - R. Cavalcante

15:40 V Euro16A-OP1043 – IVUS-guided wiring of ostial

coronary CTO: a single-centre experience -

N. Ryan

15:44 V Euro16A-OP0681 – Dedicated paclitaxel-

eluting bifurcation stent for unprotected left

main coronary artery disease: a single-centre

experience - I. Petrov

15:48 V Euro16A-OP0247 – Long-term impact of proximal

left anterior descending artery lesions in patients

with three-vessel and / or left main coronary

artery disease: a patient-level pooled analysis of

3,280 patients from the SYNTAX, PRECOMBAT and

BEST trials - R. Cavalcante

15:52 V Euro16A-OP0076 – Complications in unstable

patients referred to complex PCI when rotational

atherectomy and bivaluridin are used -

J. Palazuelos

15:56 V Euro16A-OP0857 – Determinants of PCI success in

repeat procedures following a failed initial attempt

in CTO - N. Ryan

16:00 V Euro16A-OP0027 – Percutaneous coronary

revascularisation for CTO: a novel predictive score

of technical failure - M. Boukhris

16:04 V Euro16A-OP0063 – Prevalence of ischaemia in

patients with a CTO and preserved left ventricular

ejection fraction - W. Stuijfzand



58

15:30 17:00 ROOM 251

Personalised management of hypertension in everyday practice: learning through cases With the collaboration of the Practical Course on

Hypertension (PCH)

Chairpersons: F. Sharif, K. TsioufisPanellists: R.J. Gil, R. Schmieder


VTo learn how to manage a hypertensive patient

in your daily practice through a step-by-step

personalised approach based on clinical cases

VTo review current strategies on how to diagnose

secondary hypertension

VTo understand how to treat and follow up your

patient with hypertension

15:30 V Session objectives and collection of audience

expectations - F. Sharif

15:35 V Case presentation: different blood pressure

measurement modalities - S. Ewen

15:40 V How to confirm hypertension? - F. Sharif


16:00 V Case presentation: exclusion of secondary causes -

C. Ukena

16:05 V How to exclude a secondary cause? - R. Schmieder


16:25 V Case presentation: management and follow-up -

S. Ewen

16:30 V How to manage and follow-up your patient with

hypertension? - K. Tsioufis


16:50 V Session evaluation and key learnings through a

checklist process made By and For the audience -

K. Tsioufis

15:30 17:00 ROOM 242AB


My patient has a short CTO. When should I attempt an antegrade PCI? And if yes... how? Senior Advisor: J. EscanedFacilitators: H. Nef, A. OngMedia Driver: L. Koltowski


VTo identify ideal candidates for antegrade PCI of

a CTO

VTo learn about materials to be used in this setting

and a stepwise algorithm to stay out of trouble

VTo understand when to stop

15:30 17:00 ROOM 243


Cases

Urgent treatment of a CTO you said? Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: T. SchmitzPanellists: A. Khan, H. Mehta, C. Moris

15:30 V Primary retrograde PCI of right coronary artery

CTO to treat inferior STEMI complicated by cardiac

arrest due to vein graft occlusion -

N. Kumar


15:45 V A challenging CTO case of a patient presenting

after an out-of-hospital cardiac arrest - H. Lu


16:00 V Single-catheter retrograde recanalisation of ostial

left anterior descending CTO in an unstable

patient - R. Parisi


16:15 V Refractory angina pectoris referred to heart

transplant due to unattainable revascularisation -

P. Pinto-Teixeira


16:30 V Acute life-threatening presentation of a previously

untreated left anterior descending coronary artery

CTO - A. Silvestro


16:45 V A case of total occlusion of three vessels with

severe left ventricular dysfunction relieved by

step-by-step revascularisation - Y. Murasato


59

15:30 17:00 ROOM 253


Abstracts

Out-of-hospital cardiac arrest and cardiogenic shock Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: H. ThielePanellists: V. Bogana Shanmugham, G. Olivecrona, N.H. Pijls

15:30 V Euro16A-OP0353 – Distance to invasive

heart centre, performance of acute coronary

angiography and angioplasty and associated

outcome in out-of-hospital cardiac arrest: a

nationwide study - T. Tranberg


15:43 V Euro16A-OP0924 – Post-resuscitation

electrocardiogram for selection of patients for

early invasive coronary treatment strategies in

comatose survivors of out-of-hospital cardiac

arrest - S.R. Kandan


15:56 V Euro16A-OP0017 – Reduction in ventricular

tachyarrhythmia with prior statin therapy in

patients with acute myocardial infarction - J.S. Park


16:09 V Euro16A-OP0338 – Prediction of 30-day outcome

for Out-of-Hospital Cardiac Arrest Survivors

(OHCAS) - C. Tatar


16:22 V Euro16A-OP0114 – Evaluation of the use of intra-

aortic balloon pump in a tertiary centre - U. Rao


16:35 V Euro16A-OP0296 – 30-day survival in patients with

cardiogenic shock: Impella 2.5 vs. Impella 4.0 -

A. Algin


16:48 V Euro16A-OP0788 – Early predictors of weaning

failure from venoarterial extracorporeal

membrane oxygenation in patients with acute

myocardial infarction-induced cardiac arrest -

A. Sugiura




and in the PCR App.

15:30 17:00 ROOM 252AB

STENT

FOR LIFE

SOLACI@EuroPCR - STEMI in Latin America and Europe. The current management in our countries With the collaboration of the Sociedad Latinoamericana

de Cardiologia Intervencionista (SOLACI)

Chairpersons: R. Lluberas, F. MauriPanellists: J.L. Leiva Pons, P. Lemos, O. Mendiz, E.E. Ribeiro


VTo understand the reality of reperfusion in STEMI

in Latin America and Europe

VTo learn about the arterial approach currently used

in STEMI in our countries

VTo review existing or developing STEMI

programmes in both continents

15:30 V EuroPCR welcomes SOLACI - F. Mauri

15:32 V Session objectives - R. Lluberas

15:35 V The Mexican experience in reperfusion in STEMI -

M.A. Alcocer


15:55 V Stent for Life in Latin America - J. Belardi


16:15 V The radial approach for primary percutaneous

transluminal coronary intervention: the

Uruguayan experience - J. Mayol


16:35 V Pharmaco-invasive strategy in STEMI: how is it

applied in our countries? - A. Protopopov


16:55 V Session evaluation and key learnings - R. Lluberas



60

15:30 17:00 ROOM 342A


Cases

CTO interventions: difficult anatomy / epicardial approach Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: M. YamanePanellists: H.J. Büttner, V. Reddy, G. Sianos

15:30 V Successful retrograde CTO PCI to proximal right

coronary artery with anomalous origin - M. Tanabe


15:43 V Twin challenges: CTO intervention in left

anterior descending artery from an anomalously

originating left main coronary artery from right

sinus - K. Balakrishnan


15:56 V Ipsilateral retrograde kissing-wire technique using

an epicardial channel - H. Sakai


16:09 V Revascularisation of a long left anterior

descending artery CTO using contemporary IVUS

guidance technique - M. Kodaira


16:22 V Successful retrograde CTO revascularisation via

an epicardial collateral using a single 6Fr guiding

catheter - T. Schäufele


16:35 V Retrograde CTO PCI via ipsilateral collaterals -

V. Kodoth


16:48 V Double critics - F. Malik


15:30 17:00 ROOM 341


Cases

TAVI: aortic and coronary complications Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: C. TamburinoPanellists: A.M. Al Abdullah, H. Eltchaninoff, G. Sengottuvelu

15:30 V The higher the better - E. Pllaha


15:43 V Advantages of repositionnable valve systems for

valve-in-valve interventions - F. Praz


15:56 V Successful use of automated resuscitation

following haemodynamic collapse during TAVI -

A. Mechery


16:09 V Annular aortic rupture during transcatheter

aortic valve replacement treated with unusual

conservative strategy - M. Crisci


16:22 V TAVI under local anaesthesia: fast and effective

treatment of a serious complication - E. Roberts


16:35 V Vascular damage during TAVI: unusual cause -

C. Topaloglu


16:48 V A disturbing surprise during TAVI - A. Albarran



61

15:30 17:00 ROOM 343


Abstracts

Thromboaspiration: the oculothrombotic reflex Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: H. GamraPanellists: F. Addad, C. Berry, U. Zeymer

15:30 V Euro16A-OP0949 – Thrombus aspiration

alone during primary percutaneous coronary

angioplasty in selected patients with STEMI -

L.L. Gheorghe


15:43 V Euro16A-OP0013 – Forward and back aspiration

during STEMI: a feasibility study - V. Farooq


15:56 V Euro16A-OP1054 – The use of glycoprotein IIb /

IIIa inhibitors in patients with STEMI treated

without a thrombectomy device - M. El Garhy


16:09 V Euro16A-OP0212 – Calculate or re-calculate TIMI

thrombus burden: relation of thrombus burden

with clinical outcomes in patients with STEMI -

I. Tanboga


16:22 V Euro16A-OP1066 – Circadian impact of manual

thrombus aspiration on myocardial infarction

size in patients with STEMI undergoing primary

PCI: a propensity-matched score analysis of the

Acute Myocardial Infarction in Switzerland (AMIS)

registry - S. Fournier


16:35 V Euro16A-OP0211 – Routine manual thrombus

aspiration in STEMI: a meta-analysis of 20,874

patients - I. Tanboga


16:48 V Euro16A-OP0861 – Manual thrombectomy and

simultaneously intracoronary glycoprotein IIb / IIIa

inhibitor infusion during primary PCI can preserve

the index of microcirculatory resistance in patients

with anterior STEMI - S.L. Woo




and in the PCR App.

15:30 17:00 ROOM 342B

The Heart Team at work: difficult decisions in patients with complex coronary artery and valvular disease Facilitators: E. Barbato, P. Kolh, T. Modine, C.K. Naber


VTo exchange about indications for surgery and PCI

in complex patients

VTo discuss the relevance on the clinical outcome

for the individual patient

VTo experience that a true Heart Team approach

provides real benefit for the patient

15:30 V Session objectives - C.K. Naber

15:36 V Case 1: a patient with left main and multivessel

coronary artery disease - T. Modine

15:41 V How would I treat? - E. Barbato


15:57 V Conclusion of the case and take-home message

from the Heart Team - P. Kolh

16:02 V Case 2: a patient with coronary artery disease and

mitral valve regurgitation - C.K. Naber

16:07 V How would I treat? - T. Modine



from the Heart Team - E. Barbato

16:28 V Case 3: a patient with coronary artery disease and

aortic stenosis - P. Kolh

16:33 V How would I treat? - C.K. Naber



from the Heart Team - T. Modine

16:54 V Session evaluation and key learnings - E. Barbato



62

15:30 17:00 ROOM 352A

Complications

Belarus and Siberia share their most educational cases: challenging complicated PCI With the collaboration of the Belarusian Society of

Interventional Cardiology and Endovascular Surgery

and the Siberian Association of Interventional

Cardioangiologists

Chairpersons: V. Ganyukov, O. Polonetsky


VTo understand the causes of complications during

PCI

VTo share technical and tactical approach to solve

the problem of complicated PCI

VTo learn how to prevent the complications of PCI

15:30 V Session objectives - V. Ganyukov

15:33 V Case 1: severe dissection of left main, left

circumflex and first obtuse marginal during

attempt of left anterior descending artery chronic

occlusion recanalisation - D. Yurlevich


15:47 V Case 2: thrombosis of three vascular regions

in the hospital period in patient with stable

coronary artery disease with hybrid strategy of

revascularisation - R. Tarasov


16:01 V Case 3: unsuccessful CTO recanalisation with

arteriovenous fistula formation (left circumflex

artery to coronary sinus) - V. Stelmashok


16:15 V Case 4: rupture of left main in ACS patient treated

with grafting procedure - S. Evtyagin


16:29 V Case 5: complicated PCI in case of myocardial

infarction due to fibromuscular arterial dysplasia

and intramural thrombus formation leading to

arterial occlusion - P. Chernoglaz


16:43 V Case 6: MGuard stent dislocation in primary PCI -

A. Shilov



O. Polonetsky

15:30 17:00 ROOM 351


Abstracts

New-generation TAVI devices: outcome from registries Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: P. MacCarthyPanellists: F. Bedogni, T. Pilgrim, S.N. Rizvi

15:30 V Euro16A-OP0494 – The DISCOVER trial: three-year

outcomes of a fully repositionable and retrievable

non-metallic transcatheter aortic valve - F. De Marco


15:43 V Euro16A-OP0797 – First-in-man experience with

TAVI in severe aortic stenosis using the hydra

self-expanding aortic bioprosthetic valve -

S. Srimahachota


15:56 V Euro16A-OP0991 – Safety and performance of

the Portico Valve in patients with severe aortic

stenosis and excessive surgical risk: a first report of

30-day results from the PORTICO I study -

L. Sondergaard


16:09 V Euro16A-OP0792 – Transcatheter aortic valve

replacement with J-Valve for the treatment of

pure aortic regurgitation and aortic stenosis:

first-in-human China clinical trial - J. Ye


16:22 V Euro16A-OP0173 – Initial experience of a

second-generation self-expanding transcatheter

aortic valve: the United Kingdom and Ireland

IMPLANTERS registry - S. Kalra


16:35 V Euro16A-OP0739 – Procedural and 30-day clinical

outcomes following TAVI with the Lotus valve:

results of the RELEVANT study - R.A. Montone


16:48 V Euro16A-OP0626 – A third-generation balloon

expandable transcatheter heart valve: European

one-year clinical follow-up of transfemoral

intermediate and high surgical risk patients -

J. Webb




and in the PCR App.

63

15:30 17:00 ROOM 353


Abstracts

Understanding platelet reactivity, personalising DAPT Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: S. GargPanellists: G. Cayla, K. El Merri, D. Ghosh

15:30 V Euro16A-OP0317 – Impact of greater than

12-month DAPT duration on mortality: drug-

specific or a class-effect? - a meta-analysis -

F. Costa


15:43 V Euro16A-OP0516 – Six vs. 12 months of

clopidogrel therapy after DES in patients with ACS:

a subgroup analysis of the ISAR-SAFE study -

J. Michel


15:56 V Euro16A-OP0523 – Impact of chronic kidney

disease on two-year clinical outcomes in patients

treated with a six-month or 24-month DAPT

duration: insights from the PRODIGY trial -

A. Santucci


16:09 V Euro16A-OP0433 – Prevalence and relation of

CYP2C19 polymorphism with cardiovascular

outcome in Iraqi Kurdish patients undergoing PCI -

A. Barwari


16:22 V Euro16A-OP0783 – Impact of test conditions on

the results of platelet function testing - A.D. Dézsi


16:35 V Euro16A-OP0299 – Gender differences in platelet

reactivity in patients receiving DAPT - M. Verdoia


16:48 V Euro16A-OP0544 – Predicting the value of platelet

reactivity on ischaemic events and bleeding in

Eastern Asian PCI patients - Y.D. Tang




and in the PCR App.

15:30 17:00 ROOM 352B

Complications

Belgium and Scotland share their most educational cases: coronary complications With the collaboration of the Belgian Working Group of

Interventional Cardiology (BWGIC) and the Interventional

Working Group of the Scottish Cardiac Society

Chairpersons: W. Desmet, H. Eteiba


VTo understand spontaneous coronary dissection

and appreciate the complexity of managing STEMI

early post-CABG and aortic valve replacement

VTo learn about possible technical defects of stent

delivery systems and share the experience of

treating left main occlusion and haemodynamic

collapse following non-coronary intervention

VTo learn about problems with coronary stents

protruding in the aorta and reflect on the

significance of unusual angiographic appearance

and subsequent recurrent STEMI

15:30 V Session objectives - W. Desmet

15:33 V Case 1: burning down the house - managing left

main occlusion and haemodynamic collapse post-

radiofrequency ablation - R. Good


15:47 V Case 2: spontaneous coronary dissection: from

bad to worse - N. Hiltrop


16:01 V Case 3: sound of silence - managing inferior STEMI

with early prosthetic aortic valve replacement

thrombosis - M. Lindsay


16:15 V Case 4: fracture of a stent delivery system -

P.J. Palmers


16:29 V Case 5: caught in a trap - unexpected finding

leading to recurrent STEMI - A. Stewart


16:43 V Case 6: a previously stented coronary ostium, an

open door? Or not? - B. Drieghe


16:57 V Session evaluation and key learnings - H. Eteiba



64

Image 7: a timeline of strategies to treat high

risk aortic stenosis

16:48 V Image 7: facilitated audience image interpretation -

N. Amabile

16:52 V Image 7 unveiled and key findings - V. Ng

16:56 V Image 7: discussion and audience interaction -

N. Amabile


Ceremony

EAPCI elections Chairpersons: J. Fajadet, S. WindeckerPanellists: M. Buchbinder, M.K.Y. Lee, F. Malik, G. Musumeci, L. Sondergaard, J. Webb

15:40 V EAPCI elections and appointment of the new

Board - J. Fajadet , S. Windecker



Stroke prevention: Left atrial appendage closure LIVE demonstration Chairpersons: M. Haude, W. WijnsPanellists: I. Alhaddad, Z. Ghazzal, G. Guagliumi, P. L' Allier, M. Ntsekhe


demonstration - W. Wijns








Focus Imaging

Images

An image is worth 1,000 words Session comprising selected EuroPCR 2016 image

submissions

Facilitators: N. Amabile, S. Brugaletta, M. Monaghan

Image 1: main branch compromise after

crossover stenting toward the side branch


N. Amabile

15:34 V Image 1 unveiled and key findings - Y. Murasato


N. Amabile

Image 2: in-stent restenosis but no sign of a

stent


S. Brugaletta

15:47 V Image 2 unveiled and key findings - J. Wiebe


S. Brugaletta

Image 3: no more late surprises


M. Monaghan

16:00 V Image 3 unveiled and key findings - G. Ison

16:05 V Image 3: discussion and audience interpretation -

M. Monaghan

Image 4: sighting of the "death star"


N. Amabile

16:13 V Image 4 unveiled and key findings - A. Azzano


N. Amabile

Image 5: family business


S. Brugaletta

16:26 V Image 5 unveiled and key findings - A. Alahmar


S. Brugaletta

Image 6: discovery of an embolised Amplatzer

device six months following implantation


M. Monaghan

16:39 V Image 6 unveiled and key findings - A. Davies


M. Monaghan

65


Tools and Techniques

ACURATE TAVI: simple and effective treatment for severe aortic stenosis patients Sponsored by SYMETIS SA

Chairperson: T. WaltherCo-Chairperson: C. Tamburino


VTo learn about the multiaccess ACURATE neo TAVI

system

VTo observe the easy ACURATE neo two-step

implantation procedure

VTo review results from the global ACURATE neo

transfemoral registry

17:15 V Session objectives - T. Walther

17:17 V ACURATE TAVI technology - S. Toggweiler


demonstration - T. Walther




18:19 V Results from the global registry SAVI TF -

H. Moellmann

18:31 V Challenging cases using ACURATE neo: ensuring

minimal paravalvular leak and a low new

pacemaker implantation rate - A. Ruck


C. Tamburino




-17:00 - 17:15 18:45

THEATRE BLEU


Evolving BRS techniques to the acute myocardial infarction patient: Elixir DESolve to Amity Sponsored by ELIXIR MEDICAL

Chairperson: M.B. LeonCo-Chairperson: I. MeredithPanellists: A. Abizaid, H. Nef, J. Ormiston, S. Verheye


VTo learn the features and clinical programme

for AMITY, the first scaffold designed for acute

myocardial infarction

VTo understand Elixir Medical's DESolve BRS next

generation platforms and future clinical studies

17:15 V Session objectives - M.B. Leon

17:22 V DESolve NX data update - A. Abizaid

17:32 V DESolve real-world experience and learning /

DESolve CX: recorded case from University

Hospital Giessen - Giessen, Germany - H. Nef

17:42 V DESolve engineering science - J. Ormiston

17:47 V AMITY BRS - S. Verheye

17:55 V Ongoing and future DESolve clinical programmes -

I. Meredith


18:10 V Session evaluation and key learnings - M.B. Leon






66


Case in Point

The Synergy stent: expanding treatment options in complex PCI Sponsored by BOSTON SCIENTIFIC

Chairperson: K.G. OldroydCo-Chairperson: F.J. Neumann


VTo recognise how biodegradable polymer DES

design may impact DAPT duration and clinical

outcomes

VTo learn how the Synergy stent is being used in

complex patient subsets

VTo understand the current clinical evidence,

latest available clinical data and interventional

cardiology pipeline

17:15 V Session objectives - K.G. Oldroyd

17:20 V Case 1: biodegradable polymer DES in bifurcation

lesion - R. Byrne


17:38 V Case 2: FFR assessment in multivessel PCI -

J. Escaned


17:56 V Case 3: biodegradable polymer DES in left main

PCI - S. Kedev


18:14 V Case 4: the European experience with hybrid

approach in CTO PCI - the RECHARGE registry -

J. Dens


18:32 V Building the next chapter in complex PCI :

biodegradable polymer DES, fully resorbable stent

and beyond - K. Dawkins


F.J. Neumann


Symposium

From evidence to case experience - assessing an expanding number of lesion options with bioresorbable vascular scaffolds Sponsored by ABBOTT VASCULAR

Chairperson: J. FajadetCo-Chairperson: A. SerraPanellists: V.O. Kwok, E. Schampaert


VTo learn more about optimal patient indications

for bioresorbable vascular scaffolds

VTo learn about the feasibility to treat patients with

bioresorbable vascular scaffolds through case

presentations

VTo share evidence-based guidance on the ideal

patient for bioresorbable vascular scaffolds

17:15 V Session objectives - J. Fajadet

Bioresorbable vascular scaffolds for

reconstructing tortuous long lesions

17:21 V What did I learn from my case? - A. Latib

17:29 V What does evidence tell us? - M. De Carlo


The optimal patient for bioresorbable vascular

scaffolds: young patient with multivessel

disease

17:47 V What did I learn from my case? - F. Cuculi

17:55 V What does evidence tell us? - L. Testa


Primary PCI patient: are these patients a

suitable candidate for bioresorbable vascular

scaffolds?

18:13 V What did I learn from my case? - V. Kocka

18:21 V What does evidence tell us? - M. Sabaté


18:39 V Session evaluation and key learnings - A. Serra


67



Cases

Treatment of coronary artery fistula Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: F. EberliPanellists: D. Hildick-Smith, B. Karadag, F. Ribichini

17:15 V Percutaneous closure of congenital coronary

artery fistula with one year follow-up in two

challenging cases - K. Amber


17:30 V Giant left coronary artery to coronary sinus fistula

closure - M. Orzalkiewicz


17:45 V Giant coronary fistula presenting with cardiac

arrest secondary to ACS: a rare case report -

B. Popovic


18:09 V Transcatheter closure of a tortuous coronary fistula

using an Amplatzer vascular plug - J.S. Byon


18:24 V PCI in active coronary giant cell arteritis -

K. Sarathy


18:39 V Just an unstable ACS? - J. Palazuelos




Learning

Learning aortoiliac and femoropopliteal angioplasty Facilitators: E. Blessing, E. VuruskanMedia Driver: A. Bacaksiz


VTo learn how to perform the procedure step by

step:



- Preventing and managing potential procedure-

related complications



Cases

Late and very late stent thrombosis Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: A. WitkowskiPanellists: O. El Khateeb, A. Finkelstein, A. Junker

17:15 V STEMI in a pregnant patient - W. Trenkner


17:28 V A combination of reasons would lead to a lethal

event - G. Tsigkas


17:41 V Recurrent stent thrombosis after STEMI -

W. Trenkner


17:54 V Stent thrombosis associated with stent fracture

and antiplatelet treatment discontinuation -

A. Jurado-Roman


18:07 V Simultaneous two-vessel stent thrombosis -

P.P. Sadarmin


18:20 V Double trouble: STEMI due to very late

simultaneous stent thrombosis in two coronary

arteries - A. Sourgounis


18:33 V All just a little bit of history repeating - D. Collison




68

17:15 18:45 ROOM 243


Cases

Venous interventions Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: H. BaumgartnerPanellists: A. Micari, M.S. Mourali

17:15 V Arteriovenous malformation embolisation -

C.W. Khoo


17:28 V Massive bleeding right hand arteriovenous fistulae

- J. Molina-Martin de Nicolas


17:41 V Innominate vein CTO angioplasty - P.S. Kanattu


17:54 V Catheter-directed intervention in submassive

pulmonary embolism - H. Gurjar


18:07 V Balloon angioplasty of CTO of long segment

of inferior vena cava and bilateral iliac veins -

R. Bhardwaj


18:20 V Percutaneous transluminal angioplasty with

venous stenting of CTO of subclavian and bilateral

brachiocephalic veins - S. Kasturi


18:33 V Superior vena cava stenting - M. Orzalkiewicz


17:15 18:15 ROOM 241

Symposium

Next generation FFR and IVUS technology: catheter-based FFR and high-definition IVUS Sponsored by ACIST MEDICAL

Chairperson: N. Van MieghemCo-Chairperson: M.C. Morice


VTo understand the value(s) of guided PCI

VTo discuss about the clinical relevance and

benefits of microcatheter-based FFR technology

VTo learn how microcatheter-based FFR device RXi

and high definition IVUS HDi can optimise the

quality of pre- and post-stent assessments

17:15 V Session objectives - N. Van Mieghem

17:20 V The CONTRACT study: insights form a single-

centre clinical and economical evaluation with the

RXi Rapid-Exchange FFR device - J. Daemen


17:37 V The value of catheter-based FFR and high-

definition IVUS in the setting of complex PCI -

A. Chieffo


17:54 V Assessment of catheter-based interrogation and

standard techniques for FFR measurement - the

ACIST FFR trial - M. Price


18:11 V Session evaluation and key learnings - M.C. Morice

17:15 18:45 ROOM 242AB


This coronary bifurcation needs two stents: a stepwise approach to bailout or systematic double stenting Senior Advisor: M. LesiakFacilitators: A. Elghamaz, D. MilasinovicMedia Driver: C. De Biase


VTo understand which bifurcation lesions require

two stents from the beginning

VTo be able to identify the best technique for each

anatomy

VTo review the technical steps of current two-stent

procedures

69

17:15 18:45 ROOM 252AB

Focus Imaging

EBAC Accredited

Educational

Programme

FFR-guided PCI: are we ready to move to ACS? Organised by OLV Ziekenhuis Aalst, Belgium

Course Director: E. Barbato

Programme supported by an unrestricted educational

grant from ST. JUDE MEDICAL

Chairperson: E. BarbatoCo-Chairperson: T. Cuisset


VTo be updated on the latest news on FFR

technology and physiology indices

VTo learn about the evidence showing the benefits

of full revascularisation in ACS

VTo learn more about absolute flow as more reliable

index to assess the microcirculation

17:15 V Session objectives - E. Barbato

17:17 V The diagnostic dilemmas and management

strategies in daily practice - P. MacCarthy


17:36 V Optimal use of the PressureWire in the

contemporary ACS patient - E. Barbato


18:04 V FFR-guided full revascularisation vs. culprit only

in ACS patients: is the evidence strong enough to

move it in daily PCI? - E. Van Belle


18:23 V Routine assessment of the microcirculation and

absolute flow: a glimpse to the future - N.H. Pijls


18:40 V Session evaluation and key learnings - T. Cuisset

This programme is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credit. Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME) which is an institution of the European Union of Medical Specialists (UEMS).In compliance with EBAC/EACCME guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations.The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities.

17:15 18:45 ROOM 251

Symposium

Interventional cardiologists at the edge of a new era: miniaturised transcatheter pacing systems and insertable cardiac monitors Sponsored by MEDTRONIC

Chairperson: W. WijnsCo-Chairperson: W. Jung


VTo get familiarised, as an interventional

cardiologist, with monitoring technologies (Reveal

LINQ) and transcatheter cardiac pacing (Micra)

VTo discuss specific unmet needs that miniaturised

cardiac pacing and monitoring technologies

may address in patient population addressed by

interventional cardiologists

VTo discuss the way forward for interventional

cardiologists implanting transcatheter cardiac

pacing and monitoring technologies

17:15 V Session objectives - W. Jung

17:20 V New miniaturised insertable cardiac monitors for

patients with suspected arrhythmias: indications

and case reports - R. Hatala

17:35 V The role of miniaturised implantable cardiac

monitors in post-myocardial infarction patients -

A. Bauer


18:00 V Implantation of a novel transcatheter pacing

system - X. Vinolas

18:15 V Micra Transcatheter Pacing System: indications,

experience and case reports - P. Ritter


18:40 V Session evaluation and key learnings - W. Wijns



70

17:15 18:45 ROOM 341


Cases

CTO interventions: when to use OCT? Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: M. OchiaiPanellists: C. Moris, S.A. Pyxaras, K.K. Yeo

17:15 V CT-scan and OCT-guided CTO recanalisation by

retrograde approach - L. Teruel


17:28 V Dissections, aneurysms, and eccentric remodelling

after CTO percutaneous transluminal coronary

angioplasty - J. Marques


17:41 V Wire across, microcatheter would not pass, what

next? Use of excimer laser to facilitate balloon

passage and intracoronary insights with optical

frequency domain imaging - A. Khurana


17:54 V Intravascular insights with OCT in a case of CTO of

the right coronary artery - A. Khurana


18:07 V A case of OCT-guided PCI for CTO in the

anomalous origin of right coronary artery from the

left coronary sinus - Y. Otaki


18:20 V Two-way strategies of excimer laser coronary

angioplasty for STEMI including bifurcation lesion

by OCT guidance - T. Ashikaga


18:33 V A difficult case of coronary CTO and left main

angioplasty - E. Tieranu


17:15 18:45 ROOM 253

EAPCI General Assembly Chairpersons: A. Baumbach, M. Haude, P. Kala

17:15 V Welcome - M. Haude

17:17 V EAPCI Elections 2016 results - M. Haude

17:22 V EAPCI membership - A. Baumbach

17:27 V EAPCI new Constitution announcement -

A. Baumbach

17:28 V EuroIntervention - P. Cummins, P.W. Serruys

17:33 V Website and Communication Committee -

E. Stabile

17:38 V Education and Training Committee -

L. Gonçalves, R. Trillo Nouche

17:43 V EAPCI Training and Research grants programme -

M. Gilard

17:48 V Databases and Registries Committee - A.S. Petronio,

F. Weidinger

17:53 V Scientific Documents and Initiatives Committee -

M. Valgimigli

17:58 V EAPCI@ESC Congress 2016 - J.P. Collet

18:03 V Stent for Life Initiative - P. Kala

18:08 V Announcement of successor for SFL chairmanship -

M. Haude

18:09 V Valve for Life Initiative - A. Baumbach, M. Haude

18:14 V EAPCI budget - M. Haude

18:19 V New Initiatives for Young Interventionalists

Committee - D. Capodanno, M. Radu

18:24 V EAPCI Women Committee - F. Mauri, J. Mehilli

18:29 V Nurses and Allied Professionals in Interventional

Cardiology Committee - L. Kløvgaard , D. Zughaft

18:34 V National Societies and International Affairs

Committee - D. Dudek

18:40 V Adjourn - M. Haude

71

17:15 18:45 ROOM 342B


Cases

Bifurcation PCI: is there a place for OCT? Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: M. PanPanellists: F. Burzotta, B.K. Kim, I. Kranjec

17:15 V Optimising left main bifurcation angioplasty with

optical frequency domain imaging: how to obtain

the best result? - M. Araya


17:28 V Parallel coronary bifurcation treated with Axxess

DES: offline 3D OCT reconstruction demonstrating

stent implantation and avoidance of carina shift -

Z. Yao


17:41 V Left main coronary bifurcation treated with

T-stenting and protrusion: 3D OCT demonstrating

severe left main stent malapposition flow cross-

over left main left anterior descending stenting -

Z. Yao


17:54 V OCT-guided PCI using V / simultaneous kissing

stenting technique for left anterior descending

diagonal bifurcation disease - N.B. Senguttuvan


18:07 V Hybrid culotte technique, complex strategy at the

beginning that becomes simple in the future -

J. Chavarria


18:20 V More proximally, clearly, regionally - guideliner-

assisted OCT-guided PCI facilitates complex lesion

and complex patient background - H. Iwama


18:33 V OCT and left main disease - A. Kristensen


17:15 18:45 ROOM 342A

Symposium

Cardioband for mitral repair: a new clinical reality Sponsored by VALTECH

Chairperson: A. VahanianCo-Chairperson: S. Baldus


VTo understand how to perform mitral repair in

patients with functional mitral regurgitation

VTo learn more about case examples of the

Cardioband procedures

17:15 V Session objectives - A. Vahanian

17:20 V A Cardioband case. Step by step - G. Nickenig

17:45 V Comments on the Cardioband case - F. Maisano


18:05 V Echo guidance: navigation throughout the

procedure - S. Von Bardeleben


18:25 V The ideal Cardioband patient based on a

successful case presentation - S. Baldus





72

17:15 18:45 ROOM 351


Cases

Stent thrombosis after PCI Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: T. AdriaenssensPanellists: M. Al Zaibag, A. Cequier, M. Loutfi

17:15 V CTO and stent thrombosis treated with

bioabsorbable stent - A. Jurado-Roman


17:28 V Complex PCI guided by OCT in a young patient

with STEMI and cardiogenic shock -

H.D. Mejia-Renteria


17:41 V How to overcome donor artery thrombosis during

retrograde CTO intervention - M.W. Kim


17:54 V Longitudinal stent deformation during bifurcation

stenting - R. Vijayvergiya


18:07 V Coronary intramural haematoma characterised by

OCT: a new mechanism for acute stent thrombosis -

I.J. Amat-Santos


18:20 V Safety and efficacy of delayed stenting in

STEMI after successful balloon angioplasty and

establishing TIMI 3 flow when there is heavy

thrombus burden - S. Sangaraju


18:33 V Long-term consequence of underexpanded stent -

W. Trenkner


17:15 18:45 ROOM 343


Cases

Challenges and complications during transradial PCI Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: O. BertrandPanellists: S. Dutta, I.C. Hsieh, D. Tresukosol

17:15 V Radial artery perforation treated with guide

catheter - K. Hassan


17:28 V Should free radial artery perforation abort PCI? -

S. Mansour


17:41 V Radial / brachial artery loops are not that bad after

all! - H. Abu-Hantash


17:54 V Securing the way in ACS: radial artery angioplasty

and right coronary artery PCI - A. Lux


18:07 V Radial access trouble shooting - A. Javed


18:20 V Oversheath retrieval of kinked guide catheter

through radial loop - K. Longman


18:33 V Removal of severely kinked diagnostic catheter

in radial artery using modified novel homemade

snare - P. Surunchupakorn


73

17:15 18:45 ROOM 352B


Cases

Perforations / rupture during CTO PCI Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: M. OstojicPanellists: S. El Tobgi, H. Ouda, G. Sianos

17:15 V A great number of complications in a tolerant

patient - R. Khameneh Bagheri


17:28 V How I managed a case of left anterior descending

perforation with minimal complication -

A. Mohammadi


17:41 V Complications in CTO: a successful case of

treatment of vessel perforation - A. La Manna


17:54 V Septal collateral perforation during retrograde

CTO PCI - A. Kalnins


18:07 V Double coronary perforation during percutaneous

CTO recanalisation - F. Colombo


18:20 V Successful retrograde ipsilateral CTO recanalisation

complicated by coronary perforation - F. Colombo


18:33 V Management of massive coronary perforation

after BRS: consecutive ping-pong and child-in-

mother techniques - I.J. Amat-Santos


17:15 18:45 ROOM 352A


Cases

Coronary perforations: bailout strategies - part 1 Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: M. NocPanellists: H. Gamra, B.C. Kalmath, J. Legutko

17:15 V A very delicate left anterior descending coronary

artery - M. Nobre Menezes


17:28 V A sipper-like covered stent - M. Verdoia


17:41 V Covered stent delivery through a five-in-six

mother and child catheter to treat Ellis grade 3

coronary perforation - N. Kumar


17:54 V Bailout covered-stent implantation for left main

bifurcation perforation - N. Moriyama


18:07 V The perils of a calcified left anterior descending

artery - H. Khan


18:20 V Coronary perforation, BRS and graft stent: what

can we see? - S.J. Camacho Freire


18:33 V Complication during treatment of a bifurcation

lesion in an elderly patient - N. Kumar




74


Focus Imaging

Images


submissions

Facilitators: L. Räber, D. Walters, T. Zeus

Image 8: what happened exactly?


D. Walters

17:20 V Image 8 unveiled and key findings - D.A. Zabalawi


D. Walters

Image 9: failure after mitral valve-in-valve: how

we should have made the diagnosis elegantly


L. Räber

17:35 V Image 9 unveiled and key findings - D. Dvir


L. Räber

Image 10: heart of stone

17:45 V Image 10: facilitated audience image

interpretation - T. Zeus

17:50 V Image 10 unveiled and key findings - P. Degrell


T. Zeus

Image 11: tachycardia-induced angina


interpretation - D. Walters

18:05 V Image 11 unveiled and key findings - I. Hendrickx


D. Walters

Image 12: coronary artery anomaly: ischaemia

evaluation


interpretation - L. Räber

18:20 V Image 12 unveiled and key findings - J. Adjedj


L. Räber

Image 13: an elderly patient with shock:

multivessel disease? What's the cause? How to

treat?


interpretation - T. Zeus

18:35 V Image 13 unveiled and key findings -

O. Hashimoto


T. Zeus

17:15 18:45 ROOM 353


Abstracts

Primary PCI for STEMI: focus on the myocardium Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: B. AlekyanPanellists: M. Meuwissen, P. Motreff, D. Pahlajani

17:15 V Euro16A-OP0945 – Coronary venous return as

a perfusion myocardial indicator after primary

angioplasty - L.E. Berumen Dominguez


17:28 V Euro16A-OP0913 – Intramyocardial haemorrhage

is highly frequent in the early phase after

successfully reperfused acute myocardial

infarction - R. Tijssen


17:41 V Euro16A-OP0823 – The impact of acute

alterations in glucose homeostasis on myocardial

microvascular function in the setting of STEMI -

M.A. Van Lavieren


17:54 V Euro16A-OP0852 – Impact of direct stenting on

in-hospital outcomes in diabetic patients with

STEMI - I. Bessonov


18:07 V Euro16A-OP1007 – Simple vs. complex stenting

strategy for the treatment of coronary true

bifurcation lesions with major side-branch

involvement in patients with acute myocardial

infarction - T. Seker


18:20 V Euro16A-OP0243 – The simultaneous application

of bone marrow cell therapy and PCI in patients

with STEMI and late admission may be a new

useful strategy to prevent severe heart failure -

A. Nemkov


18:33 V Euro16A-OP1116 – Primary PCI: 24 / 7 service at

tertiary care public sector hospital in a developing

country - S.N Rizvi




and in the PCR App.

75


eeuro

20

16

- 08:00 - 08:30 09:30

MAIN ARENA


Valvular interventions: TAVI LIVE demonstration Chairpersons: J. Escaned, J. FajadetPanellists: S. Al Shaikh, M. Chen, Ö. Göktekin, J. Hill, J. Monségu, H.C. Tan










IndiaLive@EuroPCR - BRS in the emerging world With the collaboration of IndiaLive

Chairpersons: V. Bahl, C.K. NaberPanellists: S.M. Hiremath, N.N. Khanna, V. Kumar, A. Mehta, D. Pahlajani, R. Sethi


VTo understand the optimal role of BRS in real-life

PCI patients

VTo learn how to safely and efficiently use BRS

in complex lesion subsets

VTo give insights into the next-generation BRS

08:30 V EuroPCR welcomes IndiaLive - C.K. Naber

08:32 V Session objectives - V. Bahl

08:35 V BRS in long lesions, diffuse disease and small

vessels: the Indian methods - G. Sengottuvelu

08:40 VReview of the tools to be used during the LIVE

demonstration - C.K. Naber

08:46 VLIVE demonstration from the National Heart

Centre Singapore - Singapore


09:35 V OCT insights and lessons learned from BRS in

complex real-world patients: the Indian camera

trick - A. Mullasari


09:45 V Experience with MeRes100: the next-generation

Indian BRS - U. Kaul


09:55 V Session evaluation and key learnings - V. Bahl







78


Montreal Live@EuroPCR - Integrated approach to patients requiring oral anticoagulation and percutaneous intervention With the collaboration of Montreal Live

Chairpersons: B. Farah, P. L' AllierPanellists: D. Angiolillo, J.-F. Dorval, S. Doucet, M.Nosair


VTo understand how to plan and perform LAA

closure

VTo discuss available interventional options to treat

patients with high risk of bleeding

VTo learn about the best pharmacological practices

to reduce bleeding complications

08:30 VEuroPCR welcomes Montreal Live - B. Farah

08:32 VSession objectives - P. L' Allier


demonstration

08:40 VLIVE demonstration from Swiss Cardiovascular

Centre, Bern University Hospital - Bern,

Switzerland

09:25 VTime to React@PCR

09:35 VHow to reduce bleeding in high-risk patients

requiring triple therapy - J-F. Tanguay


09:45 VState-of-the-art LAA closure - I. Reda


09:55 VSession evaluation and key learnings - P. L' Allier






Hot Line

Advances in PCI procedural technique Session comprising selected EuroPCR 2016 late-breaking

trial submissions

Chairpersons: I. Al Rashdan, W. WijnsPanellists: D. Kettles, R. Mohd Ali, S. Nakamura, S. Pala, A. Pichard, M. Singh Sandhu

08:30 V Radial vs. femoral access in patients with ACS with

or without ST-segment elevation (Matrix access) -

B. Cortese


08:42 V The first report of a prospective, controlled,

randomised, open-labelled, multicentre, clinical

study ‘rap and beat trial’; to evaluate safety

and efficacy of novel 6Fr small outer diameter

sheath for transradial coronary angiography and

intervention - S. Saito


08:54 V What is the better stent and the better access

for the treatment of the left main in the era of

second-generation DES? Insights from

FAILS-2, a multicentre registry including

1,270 patients - C. Moretti


09:05 V Upper extremity function post-transradial

(TR)-PCI: interim results - E. Zwaan


09:16 V Sealing intermediate non-obstructive coronary

SVG lesions with DES as a new approach to

maintaining vein graft patency and reducing

cardiac events: the VELETI II randomised clinical

trial - J. Rodes Cabau


09:27 V Prospective randomised comparison of clinical

and angiographic outcomes between everolimus-

eluting vs. zotarolimus-eluting stents for treatment

of coronary restenosis in DES: IVUS volumetric

analysis - S.J. Hong


09:38 V Impact of coronary CT angiography on planning

of bifurcation PCI - R. Wolny


09:49 V Structural damage of jailed guidewire during the

treatment of coronary bifurcations: a microscopic

randomised trial - M. Pan


79



Learning

Learning antegrade CTO Facilitators: E. Barbato, H.J. BüttnerMedia Driver: L. Koltowski


VTo review the techniques needed for antegrade

approach

VTo better understand the most appropriate

equipment selection

VTo find out how to overcome or manage the most

frequent issues



Cases

BRS in daily practice Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: A. Al NooryaniPanellists: P. Capranzano, H. Khamis

08:30 V Outstanding conformability of BRS - F. De Vroey


08:43 V Complex hybrid BRS / DES revascularisation -

M. Leoncini


08:56 V What is the best approach to treat restenosis

in drug-eluting coronary BRS? - D. Deleanu


09:09 V How to deliver BRS in a balloon-uncrossed CTO

calcified lesion? - W.C. Huang


09:22 V Usefulness of second-generation BRS in complex

cases - G. Vizzari


09:35 V BRS implantation in a 61-year-old female

patient allergic to chromium and cobalt with

malignant recurrent in-stent restenosis and

neoatherosclerosis - P. Kubler


09:48 V IVUS and OCT-guided BRS implantation for

spontaneous coronary dissection -

M.M. Mahmood



Focus Innovation

What to expect from second-generation BRS? Chairpersons: J. Ormiston, R. VirmaniPanellists: H. Call, C. Di Mario, H. Mudra, E. Tenekecioglu


VTo acquire basic knowledge on mechanical

properties of bioresorbable materials

VTo understand the key physicochemical factors of

bioresorbable materials and their implications on

scaffolding properties and microenvironment

VTo provide an overview of the second-generation

BRS, their mechanical properties and the expected

clinical benefit

08:30 V Session objectives - R. Virmani

08:35 V Synopsis of unresolved issues with first-generation

BRS - L. Räber


08:55 V How to manufacture a thinner and stronger

scaffold with faster resorption? - A. Lafont


09:15 V How to improve blood rheology around struts? -

C. Bourantas


09:35 V Insights from preclinical studies and translation

into clinical practice - M. Joner


09:55 V Session evaluation and key learnings - J. Ormiston



80

08:30 10:00 ROOM 241


Cases

Challenging indications for rotablator - part 1 Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: A. OngPanellists: D.S. Gambhir, J.H. Heo, F. Mauri

08:30 V Is it possible to leave nothing behind in a heavily

calcified coronary artery? - A. Allali


08:43 V Plaque modification with bioreabsorbable

technology and drug-coated balloon for diffuse

and severe calcified bifurcated lesion - M. Fuertes


08:56 V Rotational atherectomy in CTO over retrograde

externalised rotawire - A. Katona


09:09 V PCI of heavily calcified and very old CTO in post-

CABG patient using out-of-the box technique -

L. Sayami


09:22 V PCI for unexpanded stent, rotablator or excimer

laser - S. Hosogi


09:35 V Stent ablation: a challenging option in

underexpanded stent? A technical example -

F. Del Furia


09:48 V Rotational atherectomy of the left anterior

descending through a stented left main -

N. Gonzalo




Cases

Aortic endovascular strategies for challenging clinical settings - part 1 Session comprising selected EuroPCR 2016 clinical case

submissions

Chairpersons: Y. Gouëffic, C. Setacci

08:30 V Endovascular repair of ascending aorta

pseudoaneurysm in a patient with previous

aortic valve replacement: looking for a tailored

approach... - R. Nerla


08:43 V Key learnings - E. Blessing

08:45 V Endovascular treatment of post-CABG aortic

pseudoaneurysm by patent ductus arteriosus pfm

medical coil - M. Ostovan


08:58 V Key learnings - A. Micari

09:00 V Covered cheatham-platinum stenting of

coarctation of aorta with thoracic aortic aneurysm

- S. Kasturi


09:13 V Key learnings - A.K. Bozkurt

09:15 V Suprarenal aortic aneurysm with contained

rupture, complex anatomy, managed with

Thoracic EndoVascular Aortic Repair (TEVAR) -

R. Kapoor


09:28 V Key learnings - J.C. Van Den Berg

81

08:30 10:00 ROOM 251


Abstracts

STENT

FOR LIFE

Reperfusion treatment for STEMI: the network matters! Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: Z. KaifoszovaPanellists: M. Al Mutairi, G. Olivecrona, V. Schächinger

08:30 V Euro16A-OP0834 – Time of arrival at hospital

impacts on time to treatment of patients with

STEMI - Y. Mizuguchi


08:43 V Euro16A-OP0306 – Single-centre experience of

different primary angioplasty activation service

models - S. Kalra


08:56 V Euro16A-OP0322 – Primary PCI: a single-centre

registry - F. Malik


09:09 V Euro16A-OP0737 – No difference in mortality

between weekday vs. weekend admissions in

patients undergoing primary PCI for STEMI -

J. Farley


09:22 V Euro16A-OP0340 – Pharmaco-invasive therapy:

hybrid approach as a feasible alternative for STEMI

in developing countries - T.S. Huq


09:35 V Euro16A-OP0961 – Evolution of the interventional

reperfusion strategy and reperfusion times in

acute STEMI - S. Azzaz


09:48 V Euro16A-OP0815 – Cost-effectiveness of

reperfusion strategies for STEMI: real-world data

from the Stent For Life initiative in Italy - G. Callea




and in the PCR App.

08:30 10:00 ROOM 242AB


A primer on transfemoral TAVI, from vascular access to vascular closure Senior Advisor: A. VahanianFacilitators: D. Mylotte, A. WolfMedia Driver: S.A. Pyxaras


VTo discuss the preliminary workup for patient

selection and procedural planning

VTo review the essential steps to a successful TAVI

procedure

VTo understand what are the current rates of

complications and how to prevent them

08:30 10:00 ROOM 243

PCR Sharing Centre

What are the rewards and risks of social media in my daily practice? Facilitators: S. Brugaletta, M. Gilard, R. Lassiaille




82

08:30 10:00 ROOM 253


All you need to know about LAA closure Chairpersons: R. Birkemeyer, E. EeckhoutPanellists: F. Hellig, A. Tzikas





guidelines



08:30 V Session objectives - E. Eeckhout

08:35 V Background and clinical data - R. Birkemeyer


08:55 V Technical aspects - LAA closure with imaging

guidance - S. Berti


09:15 V Recommendations: established indications and

results - H. Sievert


09:35 V Unresolved issues and outlook - O. Muller



R. Birkemeyer

08:30 10:00 ROOM 252AB

Percutaneous treatment of abdominal aortic aneurysm With the collaboration of the ESC Working Group on

Aortic and Peripheral circulation

Chairperson: M.J. BosiersPanellists: I. Alhaddad, F. Fanelli, E. Stabile


VTo discuss what is the standard percutaneous

treatment of abdominal aortic aneurysm

08:30 V Session objectives - M.J. Bosiers


demonstration - F. Fanelli

08:39 V LIVE demonstration from Clinique Pasteur -

Toulouse, France


09:53 V Session evaluation and key learnings



83

09:12 V Euro16A-OP0674 – Patient selection for TAVI: the

Heart Team approach - H. Makki

09:16 V Euro16A-OP0741 – Prognostic impact of early

recovery in ejection fraction after TAVI in patients

with baseline left ventricular dysfunction -

M. Angelillis

09:20 V Euro16A-OP0747 – Mild residual aortic

regurgitation after TAVI: follow-up evolution,

impact and predictors of poor outcomes after five

years - N. Buzzatti

09:24 V Euro16A-OP0876 – Persistence of severe

pulmonary hypertension after transcatheter aortic

valve replacement: incidence and prognostic

impact - L. Testa

09:28 V Euro16A-OP0383 – Off-pump aortic valve

resection - S. Pokorny

09:32 V Euro16A-OP0925 – Cost-effectiveness of TAVI vs.

surgical aortic valve replacement: the CoreValve

High Risk trial from a European perspective -

R.L.J. Osnabrugge

09:36 V Euro16A-OP988 – Impact of antithrombotic

therapy on TAVI outcomes - D. Matos

09:40 V Euro16A-OP0500 – Physical activity during

hospitalisation post-TAVI - an important part of

patient rehabilitation - T.W. Andersen



round 2







08:30 10:00 ROOM 341


Abstracts

PCR's Got Talent - round 1: TAVI - part 2 Session comprising selected EuroPCR 2016 abstract

submissions

Chairpersons: P. MacCarthy, C. RuizJury Members: A.M. Al Abdullah, F. Castriota, M.K.Y. Lee, R. Makkar, F. Ribichini, T. Walther


08:32 V Euro16A-OP0194 – Post-procedural troponin

elevation and clinical outcomes following TAVI -

K. Koskinas

08:36 V Euro16A-OP0206 – Spinal analgesia improves

outcomes of transapical aortic valve implantation -

a single-centre experience - M. Silaschi

08:40 V Euro16A-OP0365 – Establishing a TAVI

programme at a hospital without a cardiac

surgery department: an example of successful

cooperation of the Heart Team with external

cardiosurgical support - H. Eggebrecht

08:44 V Euro16A-OP0382 – New nitinol thin-film heart

valves: analysis of the nickel immersion -

S. Pokorny

08:48 V Euro16A-OP0877 – The failing right heart:

implication and evolution in high-risk patients

undergoing transcatheter aortic valve

replacement - L. Testa

08:52 V Euro16A-OP0451 – Prognostic value of renal

function in patients with aortic stenosis treated

with TAVI - R.A. Meneguz-Moreno

08:56 V Euro16A-OP0512 – Post-implant geometry of self-

expandable transcatheter heart valve in patients

with bicuspid aortic valve stenosis - Z. Zhao

09:00 V Euro16A-OP0557 – Significant aortic regurgitation

as a result of the interaction of self-, balloon- and

mechanically-expanded transcatheter heart valves

with the aortic root - R. Rodriguez Olivares

09:04 V Euro16A-OP0560 – Patients' experiences of

recovery after TAVI: a qualitative study - B.H. Kirk

09:08 V Euro16A-OP0643 – Prognostic impact,

imaging predictors of improvement, and

potential percutaneous management of mitral

regurgitation after transcatheter aortic valve

replacement: a multicentre study -

I.J. Amat-Santos



84

08:30 10:00 ROOM 342B


Cases

Acute and early stent thrombosis Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: M. SabatéPanellists: A. El Etriby, J.B. Lee, O. Varenne

08:30 V Acute stent thrombosis: technical complication or

predisposition? - I. Stanca


08:45 V Unsolvable stent thrombosis during complex

bifurcation PCI in STEMI with cardiogenic shock -

R. Costa


09:00 V Acute STEMI: a challenging thrombotic

complication - P. Deharo


09:15 V Stent or drug failure? Managing heat when it gets

too hot - M. Wolfrum


09:30 V OCT-guided intervention in STEMI patient due to

acute stent thrombosis - S. Furkalo


09:45 V The great detour of the wire -

A.M. Muthuppalaniappan


08:30 10:00 ROOM 342A

Critical appraisal of devices for the management of hypertension With the collaboration of the Practical Course on

Hypertension (PCH)

Chairpersons: T.F. Lüscher, F. MahfoudPanellists: E. Edelman, K. Tsioufis


VTo appreciate the design of currently available

devices and how these devices are validated in

clinical trials

VTo discuss most recent data from ongoing clinical

trials in interventional hypertension treatment

VTo get a glimpse on current and future

development in the field of device for the

management of hypertension

08:30 V Session objectives - F. Mahfoud

08:31 V Boston Scientific's trial programme: REINFORCE -

M.B. Leon

08:38 V Strengths and limitations of the study - T.F. Lüscher


08:46 V Medtronic's trial programme: GLOBAL SYMPLICITY

SPYRAL - D. Kandzari



09:01 V St Jude's trial programme: ENLIGHTN - F. Mahfoud

09:08 V Strengths and limitations of the study - T. Zeller


09:16 V Recor's trial programme: RADIANCE HTN -

J. Daemen



09:31 V Kona's trial programme: WAVE IV - R. Schmieder



09:46 V Ablative Solutions' trial programme - S. Bertog



09:59 V Session evaluation and key learnings - T.F. Lüscher

85

08:30 10:00 ROOM 351


Abstracts

Intravenous adjunctive antithrombotic therapies for PCI Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: M. McEntegartPanellists: A. Bartorelli, W. Desmet, J. Ezhilan

08:30 V Euro16A-OP0118 – Local intracoronary bolus

administration of eptifibatide and streptokinase

combination in primary angioplasty - Z. Mukhtar


08:43 V Euro16A-OP1023 – Use of intracoronary

recombinant tissue plasminogen activator on top

of tirofiban administration in patients with high

residual thrombus burden after failed manual

thrombectomy - A. Nicolino


08:56 V Euro16A-OP0525 – Phosphate- or citrate-buffered

tirofiban vs. unfractionated heparin on the rates

of thrombocytopenia and outcomes in patients

with NSTE-ACS: a post hoc analysis from the

platelet receptor inhibitor in ischaemic syndrome

management trial - S. Ariotti


09:09 V Euro16A-OP0664 – Incidence, predictors, and

outcomes of thrombocytopenia after PCI: a

pooled, patient-level analysis of the CHAMPION

trials - M. Price


09:22 V Euro16A-OP0584 – Impact of anticoagulation

strategy with bivalirudin or heparin for PCI on

non-access site bleedings: a meta-analysis of

randomised trials - M. Verdoia


09:35 V Euro16A-OP0393 – Post-procedural bivalirudin

infusion combined with potent P2Y12 inhibition

following primary PCI to reduce stent thrombosis -

T. Kinnaird


09:48 V Euro16A-OP0671 – Clinical outcomes associated

with bailout glycoprotein IIb / IIIa inhibitor use

during PCI in the CHAMPION PHOENIX trial -

J. Abtan




and in the PCR App.

08:30 10:00 ROOM 343


Abstracts

LAA closure: what's new? Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: P. KolhPanellists: J.K. Min, L. Varghese

08:30 V Euro16A-OP0066 – LAA closure for stroke

prevention in atrial fibrillation: the Belgian registry -

J. Kefer


08:43 V Euro16A-OP0144 – Safety and efficacy of

intracardiac vs. transesophageal echocardiography

for LAA closure with Watchman: a comparative

single-centre consecutive cohort study - R. Binder


08:56 V Euro16A-OP0255 – Thrombus formation after LAA

closure with the Amplatzer Amulet device -

A. Sedaghat


09:09 V Euro16A-OP0200 – Device-associated thrombus

formation after LAA closure: a systematic review of

events reported with the Watchman Device, the

Amplatzer Cardiac Plug and the Amulet -

M. Lempereur


09:22 V Euro16A-OP0476 – Short-term (45 days)

therapeutic anticoagulation following LAA closure

has no effect on clinical outcomes -

M. Buchbinder


09:35 V Euro16A-OP0742 – Anticoagulation vs. antiplatelet

therapy during the first 45 days after LAA closure:

efficacy and safety results of a registry - A.R.G.

Francisco


09:48 V Euro16A-OP0264 – Single-centre experience of

LAA closure with the Amplatzer Cardiac Plug

device in elderly patients - S. Fateh-Moghadam




and in the PCR App.



86

08:30 10:00 ROOM 352B

How Should I Treat?

Latvia and Russia share their most educational cases: first hours of STEMI - modern trends in the treatment With the collaboration of the Working Group on

Interventional Cardiology of the Latvian Society of

Cardiology and the Russian Society of Interventional

Cardioangiology

Chairpersons: A. Erglis, D.G. Iosseliani


VTo understand the effectiveness of early

myocardial reperfusion using combined

pharmacological and endovascular techniques

VTo learn modern trends in the treatment of STEMI

VTo reflect on the maximally early restoration of

antegrade blood flow in the infarct-related artery

08:30 V Session objectives - A. Erglis

08:35 V Case 1: delayed intervention in a patient with ACS

and reinfarction - D. Sondore

08:40 V How would I treat the case? - S.P. Semitko

08:45 V How would I treat the case? - I. Kumsars

08:50 V How did I treat the case? - D. Sondore


09:10 V Consensus - D.G. Iosseliani

09:15 V Case 2: early myocardial reperfusion in STEMI

using combined thrombolytic and endovascular

therapy - D. Asadov

09:20 V How would I treat the case? - I. Kumsars

09:25 V How would I treat the case? - S.P. Semitko

09:30 V How did I treat the case? - D. Asadov


09:50 V Consensus - A. Erglis


D.G. Iosseliani

08:30 10:00 ROOM 352A

How Should I Treat?

Croatia and Poland share their most educational cases: high-risk left main PCI in acute myocardial infarction and cardiogenic shock With the collaboration of the Working Group on

Interventional Cardiology of the Croatian Cardiac Society

and the Association of Cardiovascular Interventions of

the Polish Cardiac Society

Chairpersons: D. Dudek, E. Margetic


VTo understand differences in left main PCI

technique used for high-risk patients with STEMI

and shock in comparison to elective stable

patients

VTo learn about advantages and limitations of

advanced mechanical support (left ventricular

assist device, extracorporeal membrane

oxygenation) for high-risk left main PCI

VTo reflect on optimal concomitant

pharmacotherapy for high-risk left main PCI

08:30 V Session objectives - E. Margetic

08:35 V Case 1: high-risk left main PCI for acute myocardial

infarction with cardiogenic shock facilitated

by venoarterial extracorporeal membrane

oxygenation - Z. Baricevic

08:40 V How would I treat the case? - W. Wojakowski

08:45 V How would I treat the case? - V. Tomulic

08:50 V How did I treat the case? - Z. Baricevic


09:10 V Consensus - D. Dudek

09:15 V Case 2: high-risk left main PCI with left ventricular

assist device support early after inferior myocardial

infarction complicated by cardiogenic shock - J.

Legutko

09:20 V How would I treat the case? - V. Tomulic

09:25 V How would I treat the case? - W. Wojakowski

09:30 V How did I treat the case? - J. Legutko


09:50 V Consensus - E. Margetic

09:55 V Session evaluation and key learnings - D. Dudek

87



Will ABSORB III change my practice? Chairpersons: A. Baumbach, C. Tamburino


VTo achieve a detailed understanding of the results

of a particular published trial that may impact

your clinical practice

VTo evaluate the relevance of new results for the

treatment of your patients

VTo share the current and future practice with

colleagues from around the world

08:30 V Introduction - the trial headlines - A. Baumbach

08:35 V A representative case from the study: how should

I treat? - H. Nef

08:40 V Discussion: what is common practice where you

work?

08:45 V What was known before ABSORB III? - S. Cook

08:55 V Trial(ist) review: methods, results, conclusions -

D. Capodanno

09:10 V Discussion and audience interaction: do we need

to change practice?

09:15 V Case conclusion: how does this apply to my

practice? - H. Nef


09:25 VConcluding remarks - C. Tamburino

- 09:00 - 09:30 10:00

MAIN ARENA

2016 Keynote lecture Chairpersons: J. Escaned, J. FajadetPanellists: S. Al Shaikh, M. Chen, Ö. Göktekin, J. Hill, J. Monségu, H.C. Tan

09:30 V 2016 Keynote lecture - Early percutaneous

intervention for valvular disease: an opportunity

for improving patient outcomes - P.W. Serruys



08:30 10:00 ROOM 353


Abstracts

Stent thrombosis: predictors and preventives Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: A. GershlickPanellists: T. Adriaenssens, N. Amabile, P. Lemos

08:30 V Euro16A-OP0132 – BRS and thrombosis: insights

from the GHOST-EU registry - H. Kawamoto


08:43 V Euro16A-OP1041 – Long-term risk of stent

thrombosis and restenosis after treatment with

DES: a report from SCAAR - E. Omerovic


08:56 V Euro16A-OP0847 – Quantitative coronary

angiography parameters do not predict the

one-year incidence of scaffold thrombosis or

device-oriented events following implantation of

BRS: quantitative coronary angiography data from

the BVS-EXAMINATION study - T. Gori


09:09 V Euro16A-OP1097 – Three-year clinical results of

patients randomised to three- or 12-month DAPT

after zotarolimus-eluting stent implantation -

R. Costa


09:22 V Euro16A-OP0524 – Gender-related impact on two-

year clinical outcomes in patients treated with

six-month or 24-month DAPT duration: insights

from the PRODIGY trial - G. Gargiulo


09:35 V Euro16A-OP0391 – One-year outcome after PCI

with polymer-free amphilimus-eluting stents in

patients needing very short DAPT: the Italian Cre8

stent registry - C. Godino



patients presenting with definite or probable stent

thrombosis after DES implantation - R. Costa




and in the PCR App.



88


BRS in long lesions: optimising implantation results Chairpersons: C. Cook, M. HaudePanellists: E. Edelman, T. Gori, D. Holmes, U. Kaul, J. Ormiston


VTo review available evidence of BRS

VTo learn about practical applications and

limitations

VTo discuss the potential benefits of new

technologies

10:30 V Session objectives - C. Cook

10:33 V BRS for long lesions: what is known from clinical

studies? - J. Hill


10:47 V OCT and other techniques for procedural

guidance - T. Adriaenssens



demonstration - U. Kaul

11:07 V LIVE demonstration from the National Heart



11:57 V Session evaluation and key learnings - M. Haude




- 10:00 - 10:00 10:55

MAIN ARENA


Coronary interventions: Left main PCI LIVE demonstration Chairpersons: A. Baumbach, T. CuissetPanellists: A. Al Nooryani, D. Hildick-Smith, N. Hopkins, F. Malik, L. Sondergaard, F. Weidinger

10:00 V LIVE demonstration from the National Heart







89


Streamlining TAVI: how to balance simplification, safety and efficacy Chairpersons: M. Gilard, C. TamburinoPanellists: R. Makkar, H. Moellmann, R. Mohd Ali


VTo learn how to select patients for a streamlined

approach to TAVI

VTo learn more about simplifying in-hospital

management of TAVI patients

10:30 V Session objectives - C. Tamburino

10:33 V How to streamline TAVI procedures - A. Linke



demonstration - M. Gilard

10:52 V LIVE demonstration from Swiss Cardiovascular


Switzerland


11:42 V Achieving the balance between simplification and

safety - P. MacCarthy


11:57 V Session evaluation and key learnings - M. Gilard





Focus Innovation

Imaging and functional assessment Session comprising selected EuroPCR 2016

Cardiovascular innovation pipeline submissions

Chairpersons: B. De Bruyne, J. EscanedPanellists: J.J. Bax, C. Kyriakakis, M. Monaghan, L. Räber, H. Samady, R. Waksman

10:30 V First-in-man evaluation of a compact, cardiac-

oriented, dual tube CT scanner - R. Rubinshtein


10:42 V Non-invasive identification of high-risk vulnerable

coronary atherosclerotic plaque using 18F-sodium

fluoride positron emission tomography in patients

with stable coronary artery disease - J.M. Lee


10:54 V Haemodynamic force analysis improves non-

invasive prediction of risk of ACS: the results

of first-in-man EMERALD study (exploring

the mechanism of the plaque rupture in

acute coronary syndrome using coronary CT

angiography and computational fluid dynamics) -

B.K. Koo


11:05 V PlaqueTec liquid biopsy system - N.E.J. West


11:16 V Intravascular assessment of arterial diseases using

compensated OCT: comparison and validation

with histology - N. Foin


11:27 V Quantitative assessment of microcirculatory

blood flow and resistance: a new window on the

coronary microcirculation - N.H. Pijls


11:38 V A novel way of performing FFR: the first

dedicated infusion and pressure wire delivery

microcatheter - A. Elghamaz


11:49 V 100% non-contrast pretreatment CT and

percutaneous endovascular aortic abdominal

aneurysm repair using image fusion -

L.R. Virgen-Carrillo




90



Learning

Learning retrograde CTO Facilitators: O. Gämperli, Ö. Göktekin Media Driver: A. BacaksizExpert Panellists: H.J. Büttner, R. Garbo


VTo review the techniques needed for retrograde

approach

VTo learn how to perform the technique step by

step:







Cases

BRS: from simple to very complex lesions Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: I. Al RashdanPanellists: N. Melikian, S. Nakamura, A. Serra

10:30 V Scaffold edge dissection in a primary PCI: is BRS

post-dilation safe in STEMI culprit lesions? -

A. Sanchez-Espino


10:43 V Excimer laser facilitated coronary angioplasty

of a heavily calcified lesion treated with BRS -

R. Jabbour


10:56 V True ostial left anterior descending lesion treated

with BRS - A. Menozzi


11:09 V Bioabsorbable vascular scaffold therapy in a

patient with sclerotic left anterior descending

disease and myocardial bridging - G. Friedrich


11:22 V Treating BRS restenosis with another newer novel

BRS - A. Bhatia


11:35 V Pushing BRS to their limits: coronary perforation

and left main stem culotte - M. Jackson


11:48 V Disruption of BRS struts due to loss of radial

integrity - A.R. Ramalho



Focus Innovation

Innovative devices for tailored management of patients with decompensated heart failure Chairpersons: J. Bartunek, S. VerheyePanellists: J. Goicolea, G. Tarantini, J. Van Der Heyden, D. Weiss


VTo become familiar with the role of new

device-based interventions for the management

of heart failure

VTo understand how clinical and pathological

factors govern device selection

VTo understand the clinical outcomes associated

with devices for the interventional treatment of

advanced heart failure

10:30 V Session objectives - J. Bartunek

10:35 V Direct invasive monitoring of congestive heart

failure


10:55 V Left ventricular offloading in chronic heart failure -

D. Burkhoff


11:15 V New pacing targets for neuromodulation in heart

failure - A. Erglis


11:35 V When every therapy fails - catheter-based

approach for pump failure - J. Bartunek


11:55 V Session evaluation and key learnings - S. Verheye

91

10:30 12:00 ROOM 241

The year in intervention: essential publications from the EuroIntervention Journal and the European Heart Journal With the collaboration of the EuroIntervention Journal

and the European Heart Journal (EIJ-EHJ)

Chairpersons: P.W. Serruys, W. WijnsPanellists: P. Cummins, S.B. King III


VTo appraise these essential papers in the form of

robust, solid summaries

VTo reflect on the impact of these publications in

your daily practice

10:30 V Session objectives - P.W. Serruys

10:35 V Percutaneous valvular intervention and TAVI -

N. Van Mieghem


11:00 VCoronary intervention in ACS and STEMI -

D. Angiolillo


11:20 V Hypertension - J. Daemen


11:30 V Coronary intervention in stable coronary artery

disease - P.G. Steg


11:50 V Session evaluation and key learnings - W. Wijns

10:30 12:00 ROOM 242AB


This coronary is puzzling, turn the light on (or rather the ultrasound?): intravascular imaging before and after stent implantation Senior Advisor: G. GuagliumiFacilitators: P. Calvert, M. RaduMedia Driver: L. Tapp


VTo understand when IVUS should be preferred to

OCT, and vice versa

VTo appreciate the advantages of intracoronary

diagnostics for procedural planning and

optimisation

VTo get insights into the proper execution of

intravascular imaging



Abstracts

Vascular supra-aortic disease: an expanding area for endovascular interventions Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: Y. GouëfficPanellists: I.C. Hsieh, H. Khamis, B. Reimers

10:30 V Euro16A-OP0171 – Long-term outcome of

patients undergoing carotid artery stenting in

high-volume centres - J. Schofer


10:48 V Euro16A-OP0636 – Outcomes of carotid

artery stenting with different types of embolic

protection - M. Malevannyi


11:06 V Euro16A-OP0675 – Carotid artery stenting with

double cerebral embolic protection technique in

asymptomatic patients: diffusion-weighted MRI

study - E. Vuruskan


11:24 V Euro16A-OP0371 – Outcomes of stent retriever

thrombectomy for acute ischaemic stroke

treatment - Y. Kulikovskikh


11:42 V Euro16A-OP0914 – Retrieval of larger thrombi

during thrombectomy is associated with

improved neurological recovery - A.S. Autar




and in the PCR App.



92

wx

高亮

10:30 12:00 ROOM 252AB

Treatment options for aortoiliac bifurcation and CTO Chairpersons: A. Cremonesi, H. ReineckePanellists: O. Al Shammeri, M. Bosiers, R. Lorenzoni, E. Stabile


VTo discuss what is the standard approach for a safe

aortoiliac procedure today in:

- Bifurcation lesions

- CTO lesions

10:30 V Session objectives - H. Reinecke


demonstration - H. Reinecke


Toulouse, France



A. Cremonesi



10:30 12:00 ROOM 243


PCR Sharing Centre

How to critically analyse a published trial to improve my daily practice: randomised clinical trial Facilitators: R. Byrne, D. Capodanno

10:30 12:00 ROOM 251


Ventricular assist devices in critical ill patients - the role of nurses and allied professionals Facilitators: S. Carson, H. Faltot


VTo understand what ventricular assist devices are

and how they work

VTo gain knowledge in the risk and benefits of

ventricular assist devices

VTo recognise the principal ethical issues with

patients in critical condition

10:30 V Session objectives - H. Faltot

10:35 V Ventricular assist devices - rationale and

management in the cathlab - R. Esteves


11:02 V Ventricular assist devices - problems and issues -

J. Andersson


11:29 V Ventricular assist devices - bridge to survival -

M. Sailer


11:56 V Session evaluation and key learnings - H. Faltot




93

10:30 12:00 ROOM 341


Abstracts

PCR's Got Talent - round 1: stents and scaffolds Session comprising selected EuroPCR 2016 abstract

submissions

Chairpersons: C. Di Mario, R. KoningJury Members: A. Bartorelli, G. Cayla, N. Curzen, A. De Belder, J. Koolen, P. Ludman


10:32 V Euro16A-OP0086 – Clinical outcomes after

implantation of BRS in a real-world setting

with predilatation, guided by IVUS and OCT -

C. Costantini

10:36 V Euro16A-OP0146 – Everolimus-eluting BRS

thrombosis: is it myth or reality? A trial sequential

meta-analysis, clinical and statistical significance

analysis - I. Tanboga

10:40 V Euro16A-OP0222 – Stent thrombosis of DES and

BRS: evidence from a network meta-analysis of

147 trials - S.H. Kang

10:44 V Euro16A-OP0276 – Procedural safety and

intermediate term efficacy of zotarolimus-eluting

Resolute Integrity stents in the management of

native very-long segment coronary artery lesions:

a prospective observational real-world study with

12-month follow-up - S. Patra

10:48 V Euro16A-OP0373 – Clinical outcomes of diabetic

patients treated with an amphilimus-eluting stent

and a short duration of DAPT in routine clinical

practice: first results of the Utrecht Cre8 (U-Cre8)

registry - R. Rozemeijer

10:52 V Euro16A-OP0427 – Impact of gender on one-year

outcomes after implantation of drug-eluting BRS -

M. Baquet

10:56 V Euro16A-OP0483 – Comparison of intracoronary

brachytherapy outcomes among patients with

in-stent restenosis post-single and multiple DES

implantation - J. Singh

11:00 V Euro16A-OP0572 – Impact of the vessel size on

the angiographic and clinical outcome after

implantation of everolimus-eluting BRS during

daily practice: insights from the ISAR-ABSORB

registry - J. Wiebe

11:04 V Euro16A-OP0624 – Can BRS be adequately

implanted without intracoronary imaging? -

V. Flore

10:30 12:00 ROOM 253


All you need to know about percutaneous mitral valve repair Chairpersons: N. Moat, A. Vahanian





guidelines



10:30 V Session objectives - N. Moat

10:35 V Background: mitral valve anatomy and

pathophysiology - A. Vahanian


10:55 V Technical aspects - MitraClip procedure with

imaging guidance - S. Von Bardeleben


11:15 V Recommendations - established indications and

results - E. Brochet


11:35 V New systems and procedures in the pipeline -

C. Grasso





94

10:30 12:00 ROOM 342A

Catheter-based renal denervation exchange forum around the globe: building the future By and For your experience With the collaboration of the Practical Course on

Hypertension (PCH)

Chairpersons: C. Lotan, K. TsioufisPanellists: M. Ntsekhe, A. Witkowski


VTo learn and share your experience in the field of

catheter-based renal denervation

VTo actively review and discuss current evidence

VTo express your opinion on how to reconcile the

future of device-based therapies

10:30 V Session objectives - K. Tsioufis

10:38 V Hypertension around the globe: different

phenotypes, similar challenges! - M. Ntsekhe


10:53 V The global SYMPLICITY registry: what to learn from

3,000 patients treated around the globe -

R. Schmieder


11:08 V How to reconcile the evidence - F. Mahfoud


11:23 V The French DENER-HTN study: extended follow-up

- A. Pathak


11:38 V The nationwide United Kingdom registry on renal

denervation - A. Sharp


11:53 V Session evaluation and key learnings - C. Lotan

11:08 V Euro16A-OP0692 – A meta-analysis of the safety

and efficacy of BRS vs. DES in ischaemic heart

disease - J. Yap

11:12 V Euro16A-OP0743 – Plastic healing of spontaneous

coronary artery dissection using BRS: a multicentre

registry - F. Zilio

11:16 V Euro16A-OP0745 – PROcedure-related

microvascular ACTIVation in long lEsions treated

with BRS vs. everolimus-eluting stent implantation

(PROACTIVE trial) - M. Pellicano

11:20 V Euro16A-OP0752 – Outcomes of bioresorbable-

polymer vs. durable-polymer everolimus-eluting

stents in patients with complex clinical and

anatomical characteristics - M. Mennuni

11:24 V Euro16A-OP0766 – An everolimus-eluting

platinum-chromium stent with durable polymer

evaluated in a real-world all-comer population

in Rotterdam Cardiology Hospital (the P-SEARCH

registry) - Lemmert

11:28 V Euro16A-OP0865 – Difference in haemodynamic

microenvironment in vessels scaffolded with BRS:

a preclinical study of endothelial shear stress -

E. Tenekecioglu

11:32 V Euro16A-OP0907 – Clinical outcomes after

immediate vs. delayed invasive intervention in

patients with NSTEMI: long-term follow-up of the

randomised RIDDLE-NSTEMI study - D. Milasinovic

11:36 V Euro16A-OP0964 – Register of comparative

clinical use of the first Russian coronary stent with

bioabsorbable polymer and zotarolimus DES -

A. Sozykin

11:40 V Euro16A-OP1053 – Bioresorbable coronary

devices in diabetic patients: immediate and 30-

day results of the REPARA registry - F. Hernandez

11:44 V Euro16A-OP1064 – Clinical outcomes of multiple,

overlapping everolimus-eluting BRS: a subanalysis

of the prospective multicentre Italian RAI registry -

M. Mojoli



round 2






the 4 participants who will go on to round 2. 95

10:30 12:00 ROOM 343


Abstracts

TAVI in complex situations Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: G. ManoharanPanellists: A.M. Al Abdullah, K. Hayashida, M.S. Lin

10:30 V Euro16A-OP0205 – Is bivalirudin the anticoagulant

of choice for diabetic patients with aortic stenosis

undergoing TAVI? Insights from the BRAVO-3 study

- E. Van Belle


10:43 V Euro16A-OP0275 – Impact of coronary artery

disease on clinical outcomes among patients

undergoing TAVI: an age- and sex-matched cohort

study - A. Franzone


10:56 V Euro16A-OP0738 – Acute and medium-term

outcomes of TAVI in patients with cirrhosis -

A. Tanaka


11:09 V Euro16A-OP0548 – Combined percutaneous

treatment of aortic stenosis and mitral

regurgitation - M. Patanè


11:22 V Euro16A-OP0471 – Severe predicted patient-

prosthesis mismatch as a predictor of long-term

mortality after aortic valve-in-valve: insights from

the Valve-in-Valve International Data registry

(VIVID) - M. Simonato


11:35 V Euro16A-OP0217 – Safety and efficacy of a fully

repositionable and retrievable transcatheter

heart valve in patients with bicuspid aortic valve

stenosis: an analysis from the RESPOND study -

D. Blackman


11:48 V Euro16A-OP0457 – Adverse effects of low body

weight on outcomes in patients undergoing TAVI

or surgical aortic valve replacement - M. Spaziano




and in the PCR App.

10:30 12:00 ROOM 342B

Challenging decisions in NSTEMI patients Chairpersons: S. James, M. RoffiPanellists: L. Bolognese, M. Degertekin


VTo discuss optimal interventional treatment

strategies in NSTEMI patients

VTo assess options for periprocedural

pharmacotherapy

VTo review the relevant recommendations from the

2015 ESC practice guidelines

10:30 V Session objectives - S. James

10:35 V Case 1 - NSTEMI in a patient on haemodialysis -

C. Hamm


10:55 V Case 2 - NSTEMI and multivessel coronary disease -

J. Mehilli


11:15 V Case 3 - NSTEMI in the elderly - S. Savonitto


11:35 V Case 4 - NSTEMI patient anticoagulated for atrial

fibrillation undergoing PCI - J.P. Collet


11:55 V Session evaluation and key learnings - M. Roffi




96

10:30 12:00 ROOM 352A

How Should I Treat?

Czech Republic and Slovakia share their most educational cases: how to handle the potential complications during transfemoral TAVI With the collaboration of the Czech Interventional

Cardiology Association (CICA) and the Slovak Working

Group of Interventional Cardiology

Chairpersons: V. Fridrich, J. Stasek


VTo understand potential complication of the

transfemoral TAVI

VTo learn how to handle potential complications

during the procedure

VTo share the experience on how to resolve

indication in complicated patients

10:30 V Session objectives - V. Fridrich

10:35 V Case 1: TAVI complicated by closure of left main

during the procedure - J. Petrus

10:40 V How would I treat the case? - M. Mates

10:45 V How would I treat the case? - S. Juhas

10:50 V How did I treat the case? - J. Petrus


11:10 V Consensus - J. Stasek

11:15 V Case 2: TAVI valve-in-valve implantation in a

patient with very small anatomy - M. Branny

11:20 V How would I treat the case? - S. Juhas

11:25 V How would I treat the case? - M. Mates

11:30 V How did I treat the case? - M. Branny


11:50 V Consensus - V. Fridrich

11:55 V Session evaluation and key learnings - J. Stasek

10:30 12:00 ROOM 351


Abstracts

Newer oral and intravenous P2Y12 inhibitors for PCI Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: A. GershlickPanellists: S. Alam, M. Hernández-Enríquez, P. Meier

10:30 V Euro16A-OP0986 – Premature disruption and

discontinuation of prasugrel and ischaemic

outcomes among patients with STEMI - L. Räber


10:43 V Euro16A-OP0756 – Duration of PCI procedure and

risk of thrombotic and bleeding complications:

insights from the CHAMPION PHOENIX trial -

P. Genereux


10:56 V Euro16A-OP0085 – Safety and effectiveness of the

new P2Y12r inhibitors agents vs. clopidogrel in

ACS patients according to the geographic area:

East Asia vs. Europe - F. D'Ascenzo


11:09 V Euro16A-OP0344 – Effect of pretreatment with

P2Y12 receptor antagonists on mortality in

patients undergoing PCI - a report from SCAAR - E.

Omerovic


11:22 V Euro16A-OP0904 – Impact of prasugrel vs.

clopidogrel therapy in complex PCI for ACS: results

from the PROMETHEUS study -

J. Chandrasekhar


11:35 V Euro16A-OP0310 – Cangrelor is associated with

similar ischaemic risk but lower severe bleeding

risk compared with clopidogrel and routine

glycoprotein IIb / IIIa inhibitors: a propensity-score

matched analysis from the CHAMPION trials -

M. Vaduganathan


11:48 V Euro16A-OP0600 – Cangrelor P2Y12-inhibition in

real-life patients with STEMI - D. Erlinge




and in the PCR App.

97

10:30 12:00 ROOM 353


Abstracts

Functional assessment of coronary stenosis: from invasive to non-invasive Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: G. DucrocqPanellists: S. Doucet, J. Dugal, S. Sen

10:30 V Euro16A-OP1009 – Increased dose of adenosine

does not improve accuracy in FFR - D. Zughaft


10:45 V Euro16A-OP0770 – Clinical implications of guiding

extubation during FFR measurements -

C. Pouillot


11:00 V Euro16A-OP0948 – Impact of diabetes on

contrast-based FFR performance - G. Esposito


11:15 V Euro16A-OP1030 – Feasibility and diagnostic

precision of in-procedure computed FFR: the

Wire-free Invasive Functional Imaging (WIFI) study

- Krogsgaard Andersen


11:30 V Euro16A-OP0827 – FFR prediction model

based on conventional quantitative coronary

angiography and the amount of myocardium

subtended by an intermediate coronary artery

stenosis - L. Di Serafino


11:45 V Euro16A-OP1027 – An FFR CT diagnostic strategy

vs. usual care in patients with suspected coronary

artery disease planned for coronary angiography

at German sites: results of a subgroup analysis of

the PLATFORM study - R. Colleran




and in the PCR App.

10:30 12:00 ROOM 352B

How Should I Treat?

Germany and South Africa share their most educational cases: how should I treat early and late BRS failure? With the collaboration of the German National Working

Group of Interventional Cardiology (AGIK) and the South

African Society of Cardiovascular Intervention (SASCI)

Chairpersons: A. Elsaesser, D. Kettles


VTo understand the different mechanisms and

causes underlying BRS failure

VTo reflect on the role of intravascular imaging in

assessing BRS failure

VTo learn possible treatment strategies for acute

and late BRS-related complications

10:30 V Session objectives - A. Elsaesser

10:35 V Case 1: early and late BRS failure, expect the

unexpected! - T. Schmitz

10:40 V How would I treat the case? - S. Pandie

10:45 V How would I treat the case? - M. Abdel-Wahab

10:50 V How did I treat the case? - T. Schmitz


11:10 V Consensus - D. Kettles

11:15 V Case 2: good technique, bad result - D. Jankelow

11:20 V How would I treat the case? - M. Abdel-Wahab

11:25 V How would I treat the case? - S. Pandie

11:30 V How did I treat the case? - D. Jankelow


11:50 V Consensus - A. Elsaesser

11:55 V Session evaluation and key learnings - D. Kettles



98

- 11:00 - 11:00 12:00

MAIN ARENA


Coronary interventions: FFR/iFR-guided PCI LIVE demonstration Chairpersons: T.H. Koh, C.K. NaberPanellists: K. Al-Shaibi, D. Foley, S. Saito, R. Virmani, J. Webb


demonstration - C.K. Naber









Will LEADERS FREE change my practice? Chairpersons: M. Behan, M.B. Leon









10:30 V Introduction - the trial headlines - M. Behan

10:35 V A representative case from the study: how should I

treat? - K.G. Oldroyd


work?

10:45 V What was known before LEADERS FREE? -

G.G. Stefanini


M. Valgimigli


to change practice?


practice? - K.G. Oldroyd


11:25 V Concluding remarks - M.B. Leon


99



Left main and complex bifurcation stenting Sponsored by TERUMO

Chairperson: M.C. MoriceCo-Chairperson: M. Al MutairiPanellists: R. Das, F. Fabbiocchi, R. Garbo, N.R. Holm, R. Kornowski, J. Stewart


VTo understand how to propose the best treatment

option for the patients presenting with left main

and complex bifurcation lesions

VTo learn how to optimise both strategy and

technique using novel imaging technologies and

PCI devices

VTo share the latest Ultimaster DES results in left

main and bifurcations

12:30 V Session objectives - M.C. Morice


demonstration - M.C. Morice




13:25 V Long-term clinical outcome of bifurcation lesions

treated with Ultimaster - F. Fabbiocchi

13:30 V A new device for complex PCI - FineDuo

Microcatheter - R. Das


demonstration - M.C. Morice





M. Al Mutairi




- 12:00 - 12:30 13:30

NURSES AND ALLIED

PROFESSIONALS

CORNER


Abstracts

Nurses and Allied Professionals moderated posters Session comprising selected EuroPCR 2016 abstract

submissions

Chairpersons: M. De Ronde, R. Esteves

12:30 V Euro16A-POS1037 – Teaching of radiographic staff

in the cathlab - S. Crown

12:38 V Euro16A-POS0560 – Patients' experiences of

recovery after TAVI: a qualitative study - B.H. Kirk

12:46 V Euro16A-POS0543 – Study and imaging preTAVI -

M. Longoni

12:54 V Euro16A-POS0920 – Occupational exposures to

ionising radiation from interventional cardiology:

literature and practice review - A. Maschera

13:02 V Euro16A-POS0581 – Wearable cardioverter

defibrillator, a bridge-to-decision protection for

patients with ischaemic heart failure - T. Odeneg

13:10 V Euro16A-POS0009 – The prevention and

management of complications during

percutaneous interventions - M. Van Der Heijden

13:18 V Euro16A-POS0885 – Interim results of a new

paclitaxel-coated DEB in real-world PCI indications -

A.G. Van Driel



and in the PCR App.






100



PCI in diabetic patients: turning challenges into today's solution Sponsored by ALVIMEDICA MEDICAL TECHNOLOGIES

Chairperson: S. VerheyeCo-Chairperson: E. EeckhoutPanellists: R. Byrne, G. Sardella, P. Stella


VTo understand how, and in which way, to improve

PCI clinical outcome in diabetic patients

VTo share how to manage complex PCIs in diabetic

patients through transmitted LIVE case

VTo learn the added efficacy and safety value

provided by the amphilimus-eluting polymer-free

DES - Cre8

12:30 V Session objectives - S. Verheye


demonstration - S. Verheye


Toulouse, France


13:34 V How the controlled formulation elution of

the polymer-free Cre8 DES impacts efficacy in

diabetics - R. Byrne

13:41 V The latest Cre8 clinical evidence in diabetics

empowers unique amphilimus formulation

efficacy - G. Sardella

13:51 V The polymer-free Cre8 DES in my everyday clinical

practice - P. Stella

13:58 V Session evaluation and key learnings - E. Eeckhout






What is required for TAVI to become the standard of care in aortic stenosis patients? Sponsored by EDWARDS LIFESCIENCES

Chairperson: J. Rodes CabauCo-Chairperson: A. OwensPanellists: J.J. Bax, M. Guenoun, F. Leclercq, J. Webb


VTo understand whether TAVI can be considered

standard of care for aortic stenosis patients

VTo understand the TAVI perspective of a general

cardiologist

VTo learn whether guideline changes are required

to allow TAVI to be an option for more patients

VTo learn how innovation of the new SAPIEN 3

system further streamlines the procedure and

advances patient care

12:30 V Session objectives: 'What are the main drivers for

treatment choice in aortic stenosis today' -

J. Rodes Cabau

12:33 V Why would I like to see more patients treated with

TAVI ?' - perspective of a general cardiologist -

M. Guenoun


demonstration - A. Owens




13:30 V How to implement clinical practice in the absence

of new guidelines? - J.J. Bax

13:35 V The Edwards SAPIEN 3 Ultra system: further

streamlining the TAVI procedure: recorded case

from St. Paul's Hospital - Vancouver, Canada -

J. Webb


14:22 V TAVI: from an option for few patients to an option

for many patients - what is required? - F. Leclercq

14:27 V Session evaluation and key learnings - A. Owens ,

J. Rodes Cabau




101

13:30 V Future risk: risk assessment and long-term

treatment of the patient with an acute coronary

syndrome / coronary artery disease - U. Zeymer


13:55 V Session evaluation and key learnings - S. James




Learning

Learning imaging for TAVI Facilitators: D. Mylotte, N. PiazzaMedia Driver: V. KunadianExpert Panellist: M. Chen


VTo better understand the different imaging

modalities before, during and after TAVI in 2016,

including:

- Sizing

- Access

- Device choice

VTo find out how to overcome or manage the

potential complications


EBAC Accredited

Educational

Programme

Managing the patient with an acute coronary syndrome / coronary artery disease: optimising antiplatelet treatment and reducing future risk Organised by the Sahlgrenska Academy, University of

Gothenburg, Sweden

Course Director: Prof. Karl Swedberg

Programme supported by an unrestricted educational

grant from ASTRAZENECA

Chairperson: P.G. StegCo-Chairperson: S. JamesPanellists: R. Mehran, M. Valgimigli, U. Zeymer

Attend this session if you want: VTo appreciate the clinical pathway for patients with an acute coronary syndrome / coronary artery disease and the critical decision points with regard to treatment and surgical intervention VTo understand the current treatment options for patients with an acute coronary syndrome / coronary artery disease and the roles of DAPT in reducing ongoing cardiovascular disease VTo recognise the factors guiding long-term clinical care plans for patients with an acute coronary syndrome / coronary artery disease and explore the optimal time of initiation and duration of DAPT

12:30 V Session objectives - P.G. Steg

12:35 V The patient with an acute coronary syndrome: a

clinical case study to optimise DAPT - key decision

points - M. Valgimigli


13:05 V Current control: treatment options for the patient

with an acute coronary syndrome / coronary

artery disease - R. Mehran




102

12:30 13:30 ROOM 241

Symposium

Portico transcatheter aortic valve: when novel technology drives optimal clinical outcomes Sponsored by ST. JUDE MEDICAL

Chairperson: S. WorthleyCo-Chairperson: F. Maisano


VTo learn about the latest worldwide developments

with the St. Jude Medical Portico aortic valve

VTo review and discuss a selection of complex TAVI

cases and how the total resheathing technology

helps solving them

VTo review the use of Portico and Solopath

re-collapsible sheath for the challenging femoral

access

12:30 V Session objectives - S. Worthley

12:35 V St. Jude Medical overview programme milestones -

Transfemoral European clinical results update -

H. Moellmann


12:52 V How Portico helps solve challenging cases:

horizontal aorta and calcified annulus -

L. Sondergaard


13:09 V The use of the Solopath re-collapsible sheath

for troublesome femoral access with the Portico

transcatheter valve - A. Linke


13:26 V Session evaluation and key learnings - F. Maisano



Cases

PCI for thrombotic left main lesion Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: M. Boccalatte

12:30 V Left anterior descending primary PCI resulting in

unexpected left main stenting - I. Ntarladimas


12:43 V Key learnings - S.L. Chen

12:45 V Thrombotic lesion of a large left main: long and

dubious road to success - I. Hadzibegovic


12:58 V Key learnings - B. Livarek

13:00 V Thrombus at left main coronary artery: destiny or

coincidence? - E. Karacop


13:13 V Key learnings - I. Sheiban

13:15 V A simple solution to a complex primary PCI -

P. Manoria


13:28 V Key learnings - S.M. Hiremath



Cases

Resistant hypertension management Session comprising selected EuroPCR 2016 clinical case

submissions

Chairpersons: F. Mahfoud, F. Ribichini

12:30 V Repeated sympathetic renal denervation with a

tetrapolar radiofrequency catheter three years

after ablation with unipolar catheter - F. Ribichini


12:43 V Key learnings - A. Pathak

12:45 V Simultaneous renal denervation and coronary

stenting in ACS - T. Szük


12:58 V Key learnings - F. Sharif

13:00 V Resistant hypertension secondary to aortic

isthmus atresia treated with radiofrequency

perforation and covered stent - F. Scalise


13:13 V Key learnings - K. Tsioufis

13:15 V Critical stenosis of the renal artery in patient

with hypertension refractory to medical therapy

treated with self-expandable DES - C. Moncalvo


13:28 V Key learnings - E. Stabile

103

12:30 13:30 ROOM 251

Case in Point

Left main disease: solving the procedural challenges with a balloon-delivered self-apposing sirolimus-eluting stent Sponsored by STENTYS

Chairperson: C. TamburinoCo-Chairperson: A. Baumbach


VTo understand how self-apposing stents can

overcome the challenges of sizing and apposition

in left main stenting

VTo understand how balloon delivery of self-

apposing stents allows accurate positioning and

simplifies the treatment of left main disease

VTo learn about the data and ongoing trials

supporting the use of self-apposing stents in left

main


12:36 V Optimising management of a large diameter

mismatch between left main and left anterior

descending - C. Briguori


12:53 V Optimising management of ostial disease with a

single-stent strategy - M. Meyer-Gessner


13:10 V Optimising management of left main stenting as a

bifurcation - C. Kaiser



A. Baumbach

12:30 14:00 ROOM 242AB


I'm not treating a stenosis, I'm treating a patient with ischaemia! FFR made easy Senior Advisor: B. De BruyneFacilitators: P. Deharo, G. TothMedia Driver: F. Della Rosa


VTo learn a practical protocol for FFR use in your

cathlab

VTo get insights into the proper execution of FFR

VTo appreciate strengths and opportunities of FFR,

iFR and hybrid strategies in the diagnostics of

coronary atherosclerosis

12:30 14:00 ROOM 243

PCR Sharing Centre

Non left main bifurcation techniques: step-by-step procedural strategy Facilitators: N. Amabile, G. Stankovic



104

12:30 13:30 ROOM 253


Cases

Percutaneous interventions in the tricuspid valve and the pulmonary veins Session comprising selected EuroPCR 2016 clinical case

submissions

Chairpersons: G. Manoharan, G. Nickenig

12:30 V Percutaneous balloon valvotomy in pericardial

bioprosthetic tricuspid valve stenosis -

C. Kanaderm


12:43 V Key learnings - J. Goicolea

12:45 V First report of successful tricuspid valvuloplasty

using the MitraClip system - R. Jabbour


12:58 V Key learnings - P. Musialek

13:00 V The first reported percutaneous angioplasty with

self-apposing DES implantation for pulmonary

vein stenosis: a one year follow-up - M. Mielczarek


13:13 V Key learnings - G. Manoharan

13:15 V Pulmonary vein in-stent restenosis: a snake biting

its tail - A. Azzano


13:28 V Key learnings - I. Reda

12:30 13:30 ROOM 341


Cases

How to deal with coronary perforation in ACS setting? Session comprising selected EuroPCR 2016 clinical case

submissions

Chairpersons: T. Mabin, J. Spratt

12:30 V Coronary perforation after post-dilation -

A.A. Farsavian


12:43 V Key learnings - A.G. Osiev

12:45 V Coronary artery perforation during primary

angioplasty - R. Bhardwaj


12:58 V Key learnings - F. Saia

13:00 V Coronary perforation in a patient presenting with

STEMI - F.C. Fernandez


13:13 V Key learnings - V. Schächinger

13:15 V Coronary perforation managed with covered stent

and pericardiocentesis - T.R. Iragavarapu


13:28 V Key learnings - G. Ghanem

12:30 13:30 ROOM 252AB

Symposium

Orsiro - strengths and evidence for an ultrathin strut bioabsorbable polymer DES in complex lesions Sponsored by BIOTRONIK

Chairperson: J.F. Lassen


VTo explore mechanical properties of modern,

ultrathin strut, stent design

VTo experience the acute performance of Orsiro in

complex coronary lesions

VTo understand the long-term clinical evidence

supporting Orsiro also in high-risk subgroups

12:30 V Session objectives - J.F. Lassen

12:33 V Review of design attributes and mechanical

properties of a modern ultrathin DES - N. Foin


12:47 V Complex lesions - case and follow-up: e.g. calcified

and tortuous lesions - J. Van Der Heyden


13:00 V Complex lesions - case and follow-up: e.g.

bifurcations - H.C. Gwon


13:13 V Three-year outcomes for Orsiro in high-risk

subgroups - J.F. Iglesias


13:27 V Session evaluation and key learnings - J.F. Lassen

105

12:30 13:30 ROOM 342B


CRO / ARO

Planned and ongoing clinical trials: a status update from Cardiovascular Imaging Core Laboratories (CICL) With the collaboration of Cardiovascular Imaging Core

Laboratories (CICL)

Chairpersons: H.G. Bezerra, H. Samady


VTo be updated on planned or ongoing clinical

trials that may change our future practice

VTo gain in-depth understanding of trial design and

execution

VTo learn about upcoming milestones for trial

recruitment, analysis and presentation plan

12:30 V Session objectives - H.G. Bezerra

12:35 V OCT assessment of acute and nine-month follow-

up results of bioresorbable vascular scaffolds

implantation in CTO - A. La Manna


12:45 V A comparison of FFR CT, invasive FFR and OCT for

the assessment of coronary artery disease severity

- H.G. Bezerra


12:55 V Evaluation of wall-shear stress and neointimal

healing following PCI of angulated vessels with

Resolute Integrity zotarolimus-eluting coronary

stent compared to Xience Xpedition everolimus-

eluting coronary stent - the SHEAR-STENT study -

H. Samady


13:05 V Volumetric assessment by OCT of vascular

resistance ratio in comparison with invasive FFR -

H.G. Bezerra


13:15 V The REALITY study - prospective, multicentre, IVUS

/ angiographic core lab adjudicated observational

study to assess atherectomy device effectiveness

to debulk moderate and severely calcified

femoropopliteal artery atherosclerotic lesions

in patients with symptomatic peripheral arterial

disease - K. Rocha-Singh


13:25 V Session evaluation and key learnings - H. Samady

12:30 13:30 ROOM 342A

Case in Point

Your complex PCI: how can new technologies enhance procedural success? Sponsored by ORBUSNEICH

Chairperson: M. HaudeCo-Chairperson: M. Joner


VTo review CTO techniques with a new generation

balloon (Sapphire II Pro) to increase your success

rates in the most difficult cases

VTo review solutions for highly-calcified lesions with

complex anatomy where scoring balloons can be

an alternative to rotablation

VTo share your own clinical experience in similar

scenarios and learn from each other

12:30 V Session objectives - M. Haude

12:35 V Simplifying CTO: the right device selection is

critical for success - R. Van Der Schaaf


13:00 V The challenge in tackling calcified lesions with

complex anatomy - T. Kinnaird


13:25 V Session evaluation and key learnings - M. Joner



106

12:30 13:30 ROOM 351

Symposium

Bioresorbable vascular scaffolds in your daily practice: why and how to start? Sponsored by ABBOTT VASCULAR

Chairperson: C.K. NaberCo-Chairperson: A. Colombo


VTo understand how bioresorbable vascular

scaffolds can progress PCI beyond the acute

treatment

VTo learn more about which patients benefit

most from longer-term benefits of bioresorbable

vascular scaffolds

VTo learn from beginning to advanced usage - how

to handle the learning curve

12:30 V Session objectives - C.K. Naber

12:35 V Exploring the potential benefits of bioresorbable

vascular scaffolds for your patients - N.E.J. West


12:52 V How did I overcome my learning curve with

bioresorbable vascular scaffolds? - T. Gori


13:09 V From beginning to advanced experience with

bioresorbable vascular scaffolds - which patients

to select best? - C.K. Naber


13:26 V Session evaluation and key learnings - A. Colombo

12:30 13:30 ROOM 343


CRO / ARO

Update on new clinical trials at the Cardiovascular Research Foundation (CRF) With the collaboration of Cardiovascular Research

Foundation (CRF)

Chairpersons: O. Ben-Yehuda, G.W. Stone




VTo gain in-depth understanding of trial design and

execution



12:30 V Session objectives - O. Ben-Yehuda

12:35 V HORIZONS-ABSORB: harmonising outcomes with

revascularisation, stents and Absorb in acute

myocardial infarction - G.W. Stone


12:45 V TAVR UNLOAD: transcatheter aortic valve

replacement to unload the left ventricle

in patients with advanced heart failure - a

randomised trial - M.B. Leon


12:55 V Early TAVR: evaluation of a strategy of transcatheter

aortic valve replacement compared to a strategy

of medical observation in the treatment of

asymptomatic severe aortic stenosis -

P. Genereux


13:05 V Biorest liposomal alendronate administration for

diabetic patients undergoing DES percutaneous

coronary intervention - O. Ben-Yehuda


13:15 V Reducer: coronary sinus reducer for refractory

angina - G.W. Stone


13:25 V Session evaluation and key learnings - G.W. Stone

107

12:30 14:30 ROOM 352B

How Should I Treat?

Cyprus, Greece and the United Kingdom share their most educational cases: complications during coronary intervention: if they cannot be avoided, how should they be treated? With the collaboration of the Cyprus Interventional

Cardiology Working Group, the Greek Working Group of

Interventional Cardiology and the British Cardiovascular

Intervention Society (BCIS)

Chairpersons: S. Constantinides, A. De Belder, G. Sianos


VTo understand the risks of complications during

coronary interventions and their mechanisms

VTo appreciate the importance of promptly

recognising these complications

VTo learn ways of dealing with various

complications safely and successfully

12:30 V Session presentation - S. Constantinides

12:32 V Session objectives - G. Sianos

12:34 V Case 1: catheter-induced left main dissection

during PCI - recognition and management -

N. Eteokleous

12:39 V How would I treat the case? - A. Banning

12:44 V How would I treat the case? - S. Theodorou

12:49 V How did I treat the case? - N. Eteokleous


13:06 V Consensus - S. Constantinides

13:10 V Case 2: epicardial channel perduring the

retrograde approach - N. Konstantinidis

13:15 V How would I treat the case? - S. Theodorou

13:20 V How would I treat the case? - K. Raisakis

13:25 V How did I treat the case? - N. Konstantinidis


13:42 V Consensus - G. Sianos

13:46 V Case 3: management of wire detachment in a

coronary artery - N. Curzen

13:51 V How would I treat the case? - K. Raisakis

13:56 V How would I treat the case? - A. Banning

14:01 V How did I treat the case? - N. Curzen


14:18 V Consensus - A. De Belder

14:22 V Session evaluation and key learnings - A. De Belder

12:30 13:30 ROOM 352A


Cases

Left main disease and cardiogenic shock Session comprising selected EuroPCR 2016 clinical case

submissions

Chairpersons: D. Dudek, A. Ghanem

12:30 V Critical left main coronary artery stenosis

bifurcation stenosis in ACS with cardiogenic shock

tackled successfully - A. Kandoria


12:43 V Key learnings - S. Alkandari

12:45 V Ménage à trois for left main trifurcation disease for

cardiogenic shock - N. Kumar


12:58 V Key learnings - F. Kiemeneij

13:00 V STEMI with cardiogenic shock: what is the best

way to salvage myocardium and the patient? -

A. Khurana


13:13 V Key learnings - C. Spaulding

13:15 V Left main STEMI in polycythemia vera with

cardiogenic shock - D. Kaewkes


13:28 V Key learnings - A. Elghamaz



108

- 13:00 - 13:35 14:35

ROOM TERNES 1


Cases

PCI in multivessel disease: from evidence-based recommendations to daily practice Session comprising selected EuroPCR 2016 clinical case

submissions

Chairpersons: H. Amin, A. Marchese

13:35 V Complex coronary angioplasty: which would be

your coronary stenting strategy? - L. Paiva


13:48 V Key learnings - H. Danenberg

13:50 V Complex angioplasty in multivessel disease and

severe ventricular dysfunction - haemodynamic

support with Impella - J.M. Benitez Peyrat


14:03 V Key learnings - P. Calvert

14:05 V What... and when are we going to do? A complex

case of STEMI with multiple decisions to make -

I. Calin


14:18 V Key learnings - G. Cassel

14:20 V Less is more but sometimes more is better: a

complex case of three-vessel disease - L. Barbieri


14:33 V Key learnings - O. Varenne

12:30 13:30 ROOM 353


Cases

Acute dissection during PCI Session comprising selected EuroPCR 2016 clinical case

submissions

Chairpersons: K. Al-Shaibi, F. Eberli

12:30 V When the nightmare keeps coming back -

J. Leon Jimenez


12:43 V Key learnings - J.F. Tanguay

12:45 V Spontaneous coronary dissection: clinical case -

A. Paggi


12:58 V Key learnings - M. Al Zaibag

13:00 V An unreported complication of PCI - G. Manik


13:13 V Key learnings - P. Karjalainen

13:15 V Coronary dissection during PCI: past, present and

future - P. Calvert



Cases

Management of large coronary aneurysm Session comprising selected EuroPCR 2016 clinical case

submissions

Chairpersons: H. Amin, M. Noc

12:30 V IVUS-guided treatment of large coronary

aneurysm - A. Khashaba


12:43 V Key learnings - K. Niemela

12:45 V Management of coronary aneurysms: the bigger,

the better? - A. Schaffer


12:58 V Key learnings - M. Lesiak

13:00 V Percutaneous coiling of circumflex aneurysm -

K. Longman


13:13 V Key learnings - F. Mauri

13:15 V Giant coronary aneurysm in a patient with non-ST

myocardial infarction - A.R.G. Francisco


13:28 V Key learnings - H. Gamra

109

13:35 14:35 ROOM 241

Symposium

The Lotus Valve: simplifying treatment strategies and optimising outcomes in the real world Sponsored by BOSTON SCIENTIFIC

Chairperson: I. MeredithCo-Chairperson: T. FeldmanDiscussant: K. Dawkins


VTo recognise key features and procedural aspects

of the Lotus valve

VTo learn how paravalvular leak can be minimised

despite anatomical complexities

VTo understand the current clinical evidence, latest

clinical data and pipeline

13:35 V Session objectives - I. Meredith

13:40 V My real-world experience with the Lotus valve -

M. Götberg


13:55 V The Lotus valve: the benefit of total control to

simplify clinical practice - F. Castriota


14:10 V TAVI in intermediate-risk patients - L. Sondergaard


14:25 V Building the next chapter in transcatheter valves -

Lotus Edge and beyond - K. Dawkins

14:31 V Session evaluation and key learnings - T. Feldman



Cases

When IVUS is mandatory Session comprising selected EuroPCR 2016 clinical case

submissions

Chairpersons: J.M. De La Torre Hernandez, A. Pichard

13:35 V IVUS-guided management of spontaneous

coronary dissection presenting with localised

coronary thrombus - S. Sangaraju


13:48 V Key learnings - J. Legutko

13:50 V To aspirate or not - M.C.L. Sim-Apura


14:03 V Key learnings - J. Goicolea

14:05 V A rare cause of ACS - the usage of intravascular

imaging - L.C. Sung


14:18 V Key learnings - H.M. Garcia-Garcia

14:20 V Unexpected refractory coronary spasm after

stenting caused by not only overstretching, but

also... - S. Cho


14:33 V Key learnings - G. Ghanem




110

13:35 14:35 ROOM 252AB

Symposium

Restoring the balance in atrial fibrillation stroke prophylaxis with LAA occlusion: how to prevent strokes while avoiding bleeds Sponsored by ST. JUDE MEDICAL

Chairperson: H. SievertCo-Chairperson: D. Hildick-Smith


VTo understand which patients may benefit from

LAA occlusion based on recent developments,

guidelines and consensus statements

VTo learn about implanting LAA occlusion devices

VTo know how to start a LAA occlusion programme

and how to get patients referred

13:35 V Session objectives - H. Sievert

13:39 V Patient selection: should we change our practice

based on new data? - L. Sondergaard


13:52 V LAA anatomy; the LAA is unique as a fingerprint,

how to close those successfully? - H. Omran


14:05 V How to treat the untreatable; what are the

options? - D. Arzamendi


14:18 V How to successfully build a referral LAA practice?

Involving referrals is key, but how to do that? -

W. Budts


14:31 V Session evaluation and key learnings - D. Hildick-

Smith

13:35 14:35 ROOM 251

Case in Point

Individualised treatment decision and novel technology to improve patient outcome in complex PCI Sponsored by MEDTRONIC

Chairperson: T. CuissetCo-Chairperson: D. Kandzari


VTo discuss individualised treatment decision to

improve patient outcome in complex PCI

VTo reflect on current technique to solving complex

PCI challenges: CTO, complex left main and long

diffuse disease

VTo learn about usefulness of novel technology in

the treatment of complex PCI

13:35 V Session objectives - T. Cuisset

13:40 V A patient with long diffuse lesions -

P. De Araujo Goncalves


13:57 V A patient with coronary CTO - O. Mendiz


14:14 V A patient with complex left main - R. Mohd Ali


14:31 V Session evaluation and key learnings - D. Kandzari

111

13:35 14:35 ROOM 342A

Symposium

Advancing BRS through innovative biomaterials Sponsored by REVA MEDICAL

Chairperson: A. AbizaidCo-Chairperson: N. Frey


VTo gain insight into Reva's novel biomaterials

VTo get a better understanding of the implant and

imaging advantages of the Fantom scaffold

VTo see current clinical data from the FANTOM BRS

clinical trial series

13:35 V Session objectives - A. Abizaid

13:40 V Advantages of desaminotyrosine polycarbonate

polymers - G.W. Stone


13:57 V Case reviews: results from selected Fantom clinical

cases - L. Koltowski


14:14 V FANTOM II trial: clinical results from the Fantom

sirolimus-eluting BRS - N. Frey


14:31 V Session evaluation and key learnings - A. Abizaid

13:35 14:35 ROOM 253


Cases

ACS with unexpected scenario Session comprising selected EuroPCR 2016 clinical case

submissions

Chairpersons: P. Ludman, A. Ochala

13:35 V Spontaneous coronary artery dissection: if stable,

wait and see - K. Bejar


13:48 V Key learnings - M. Bunc

13:50 V High-risk ACS with vanishing three-vessel disease -

S.A Pyxaras


14:03 V Key learnings - A. El Etriby

14:05 V Successful treatment in a patient of

cardiopulmonary arrest with ACS and abdominal

aortic aneurysm rupture - K. Dan


14:18 V Key learnings - M.J. Bosiers

14:20 V Course of early ischaemic mitral regurgitation

during NSTEMI in the era of PCI - F. Boukerche


14:33 V Key learnings - A. Low

13:35 14:35 ROOM 341


Cases

Sealing strategies for coronary perforations Session comprising selected EuroPCR 2016 clinical case

submissions

Chairpersons: J. Belardi, H. Eteiba

13:35 V Cardiogenic shock caused by pericardial and

intraventricular haematoma with right ventricle

obstruction caused by coronary intervention -

O. Hashimoto


13:48 V Key learnings - A. Erglis

13:50 V Plugging the leak - J. Kolanthaivelu


14:03 V Key learnings - M. Lesiak

14:05 V The successful haemostasis with gelatine sponge

for the coronary perforation - T. Iwaki


14:18 V Key learnings - W. Kehasukcharoen

14:20 V It is never too late for a complication - K. Hassan


14:33 V Key learnings - H.C. Tan



112

13:35 14:35 ROOM 343


CRO / ARO

Planned and ongoing clinical trials: a status update from genae With the collaboration of genae

Chairpersons: M. Brodmann, A. Talen




VTo gain in depth understanding of trial design and

execution



13:35 V Session objectives - A. Talen

13:40 V An update on the DESSOLVE programme -

M. Vrolix


13:50 V ACIST-FFR study: rationale and status update -

W. Fearon


14:00 V ILLUMINATE: an update on the Stellarex drug-

coated balloon clinical programme -

M. Brodmann


14:10 V Study objectives, design and status of the MValve

mitral valve replacement system - J. Bartunek


14:20 V The SAPIEN 3 global clinical experience - M. Urena



M. Brodmann

13:35 14:35 ROOM 342B


CRO / ARO

Planned and ongoing clinical trials: a status update from Mediolanum Cardiovascular Research (MCR) With the collaboration of Mediolanum Cardiovascular

Research (MCR)

Chairpersons: A. Colombo, M.C.J. Jori




VTo gain in depth understanding of trial design and

execution



13:35 V Session objectives - M.C.J. Jori

13:40 V The ELDERLY ACS 2 study: a comparison of

reduced-dose prasugrel and clopidogrel in elderly

patients with ACS undergoing early PCI - an

update - S. Savonitto


13:50 V BIO.DETECT HF IV - SELENE HF: selection of

potential predictors of worsening heart failure -

a prospective, multicentre, exploratory study -

A. Gargaro


14:00 V The DEB SFA-LONG study: safety and efficacy

of the DEB for the treatment of the superficial

femoral artery ischaemic vascular disease in

symptomatic patients presenting with long

lesions: lesson learned and perspectives - an

update - A. Micari


14:10 V The WOLARE trial: women LAA morphology

difference trial - a multicentre prospective

observational trial - M. Mennuni


14:20 V The AURORE SD registry: a long term

observational study of LAA closure - why another

registry - G. Vicedomini


14:30 V Session evaluation and key learnings - A. Colombo

113

13:35 14:35 ROOM 352A


Cases

PCI and cardiac support: from intra-aortic balloon pump to extracorporeal membrane oxygenation Session comprising selected EuroPCR 2016 clinical case

submissions

Chairpersons: T.H. Koh, M. Noc

13:35 V Impellent impeller - F. Costa


13:51 V Key learnings - G. Olivecrona

13:55 V PCI in cardiogenic shock under venoarterial

extracorporeal membrane oxygenation

(VA-ECMO) support - J.S. Park


14:11 V Key learnings

14:15 V Extracorporeal membrane oxygenation-supported

double vessel STEMI PCI followed by severe

platelet reduction - N. Kuroiwa


14:31 V Key learnings - D. Dudek

13:35 14:35 ROOM 353


Cases

Diagnostic insights from OCT Session comprising selected EuroPCR 2016 clinical case

submissions

Chairpersons: T. Adriaenssens, F. Prati

13:35 V STEMI in a teenager with acne: aetiological

insights from imaging - H.D. Mejia-Renteria


13:52 V Key learnings - T. Akasaka

13:55 V Misfortune never goes singly! - C.F. Lin


14:12 V Key learnings

14:15 V OCT-guided primary PCI: an ignored culprit lesion

discovered by OCT! - C.F. Lin


14:32 V Key learnings - A. Al Nooryani

13:35 14:35 ROOM 351

Symposium

Sudden cardiac death risk management: are you screening and protecting your post-acute myocardial infarction patients? Sponsored by ZOLL

Chairperson: M. HaudeCo-Chairperson: H. Nef


VTo understand the risk of sudden cardiac death

after acute myocardial infarction

VTo discuss how to protect the post-myocardial

infarction patient from sudden cardiac death with

the Wearable Cardioverter Defibrillator

VTo learn more about the actual Wearable

Cardioverter Defibrillator data and screening tools

13:35 V Session objectives - H. Nef

13:38 V Clinical case scenario part I: evaluation and

treatment of the myocardial infarction patient -

G. Nickenig

13:48 V Clinical updates - sudden cardiac death risk

assessment and the guidelines - J. Monségu

14:03 V Screening protocols and the Wearable

Cardioverter Defibrillator: a systematic way to

protect myocardial infarction patients from

sudden cardiac death - P.A.M. Sinha

14:18 V Clinical case scenario part II: using the Wearable

Cardioverter Defibrillator to protect the post-

myocardial infarction patient - G. Nickenig


14:32 V Session evaluation and key learnings - M. Haude



114



Cases

Management of aneurysm in acute myocardial infarction Session comprising selected EuroPCR 2016 clinical case

submissions

Chairpersons: F. Hellig, U. Kaul

13:35 V Treatment of an ectatic right coronary artery

in a STEMI case - G. Amoroso


13:48 V Key learnings - R. Parma

13:50 V STEMI in an aneurysmatic right coronary artery:

a challenging case - M. Siry


14:03 V Key learnings - A.G. Osiev

14:05 V Recurrent thrombotic occlusion of aneurysmal

right coronary artery - P. Pati


14:18 V Key learnings - I. Alhaddad

14:20 V Coronary aneurysm: just an innocent bystander? -

M. Pellicano


14:33 V Key learnings - M. Balghith


115


eeuro

20

16

- 14:00 - 14:45 16:00

MAIN ARENA


Valvular interventions: Mitral valve intervention LIVE demonstration Chairpersons: M. Haude, P. MacCarthyPanellists: A. Al Nooryani, K. Al-Shaibi, H. Ince, P. L' Allier, J. Mehilli, J. Wykrzykowska


demonstration - M. Haude

14:50 V LIVE demonstration from Swiss Cardiovascular


Switzerland






STENT

FOR LIFE

Primary PCI and multivessel disease: strategies for optimal complete revascularisation Chairpersons: E. Eeckhout, F. MalikPanellists: M. Balghith, C. Cook, C. Dubois, A. Gershlick, J. Koolen, M. Strozzi


VTo learn about the different revascularisation

strategies during primary PCI for multivessel

disease

VTo understand how to assess residual ischaemia

in patients with multivessel disease who have

undergone primary PCI

VTo know more about the evidence for complete

revascularisation in this setting

14:45 V Session objectives - F. Malik

14:48 V Complete revascularisation for multivessel disease

after primary PCI: what is the evidence? - S. James


15:02 V Review of the tools and techniques to be used

during the LIVE demonstration - C. Cook

15:08 V LIVE demonstration from St Thomas' Hospital -



15:58 V Staging of procedures: when and how? -

G.G. Stefanini


16:12 V Session evaluation and key learnings - E. Eeckhout







118


Challenges in TAVI in Asia With the collaboration of AsiaPCR, PCR-CIT China

Chengdu Valves and PCR Tokyo Valves

Facilitators: C.K. Naber, N. Piazza Panellists: M. Chen, K. Hayashida, P.H.L. Kao, R. Mohd Ali, S. Saito


VTo appreciate particular challenges for

percutaneous treatment of aortic valve stenosis

in Asia

VTo discuss with experts about challenging

transfemoral TAVI cases and potential solutions

VTo exchange with colleagues on daily practice of

TAVI in Asia

14:45 V EuroPCR welcomes AsiaPCR, PCR-CIT China

Chengdu Valves and PCR Tokyo Valves - C.K. Naber

14:48 V Case 1: TAVI in a patient with small sinus of

valsalva - R. Mohd Ali

14:56 V How would I treat? - Y. Wu


15:08 V How did I treat? - R. Mohd Ali

15:16 V Case 2: TAVI in a patient with bicuspid valve -

M. Chen

15:24 V How would I treat? - S. Saito


15:36 V How did I treat? - M. Chen

15:44 V Case 3: TAVI in a patient with severely calcified

aortic valve - K. Hayashida

15:52 V How would I treat? - P.H.L. Kao


16:04 V How did I treat? - K. Hayashida

16:12 V Session evaluation and key learnings - N. Piazza


Focus Innovation

New DEB (part 1) / Novel device-based therapies for heart failure (part 2) Session comprising selected EuroPCR 2016

Cardiovascular innovation pipeline submissions

Chairpersons: E. Edelman, M. JonerPanellists: A. Abizaid, F. Alfonso Manterola, D. Burkhoff, M. Cayli, T. Gori, P. Stella

14:45 V Paclitaxel coated-balloon catheters with an ePTFE

surface: first-evaluation in the porcine coronary

model - B. Scheller


14:57 V Next generation DEB catheter: adjustable, no

shear, evaginating DEB design - R.J. Solar


15:09 V A novel sirolimus coated-balloon catheter - in-

vivo evaluation in a porcine coronary model -

B. Scheller


15:20 V Six-month angiographic and IVUS results of the

first-in-human study of a new DEB catheter for de

novo coronary lesions - A. Abizaid


15:31 V Novel nanocarrier sirolimus-coated balloon for

coronary application - S. Dani


15:42 V ePTFE balloon with a paclitaxel-coating

engineered for enhanced arterial retention -

A. Tzafriri


15:53 V Aortic autonomic neuromodulation for heart

failure - D. Weiss


16:04 V Endovascular post-myocardial infarction scar-

exclusion in ischaemic heart failure - C. Schmitz


119

wx

高亮

wx

高亮



Learning

Learning LAA closure Facilitators: M. Behan, M.W. BergmannMedia Driver: S. HoussanyExpert Panellist: S. Berti


VTo understand how to define the scope of the

problem of atrial fibrillation

VTo learn how to select patients for LAA occlusion

VTo learn the key steps when performing LAA

occlusion using Amplatzer and Watchman

devices



Cases

BRS in bifurcation lesions Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: H. OudaPanellists: J.H. Heo, H. Nef, A. Serra

14:45 V Utility of OCT while stenting using BRS during a

primary PCI in a double bifurcation - W. Elabbassi


14:58 V Double bifurcation (left main bifurcation and left

anterior descending-D1) treated with single BRS -

R. Bhagwat


15:11 V BRS adjustment in ostial lesion with Szabo

technique - C. Galvão Braga


15:24 V Spontaneous left anterior descending artery

missed dissection presented with ACS treated first

with DEB and with full left anterior descending

BRS jacket and T-scaffolding of left anterior

descending / first diagonal bifurcation: FFR and

IVUS-guided procedure - F. Fouladvand


15:37 V BRS in bifurcation lesions - W.C. Huang


15:50 V T-stenting and small protusion (TAP) technique

with BRS - K. Longman


16:03 V Treatment of a coronary bifurcation lesion using

one dedicated sirolimus-eluting bifurcation stent

in combination with a BRS: a novel option for

coronary bifurcation approach - J. Benezet




Hot Line

New valvular interventions and enabling technologies Session comprising selected EuroPCR 2016 late-breaking

trial submissions

Chairpersons: M. Buchbinder, T. FeldmanPanellists: P.J. Fitzgerald, R. Makkar, G. Manoharan, I. Reda

14:45 V Does use of a direct thrombin inhibitor prevent

the occurrence of cerebral emboli during TAVI?

Insights from the BRAVO-3 study - E. Van Belle


14:58 V A pooled analysis of Triguard cerebral protection

compared to unprotected transcatheter aortic

valve replacement. Results of a pooled patient

level analysis - A. Lansky


15:11 V 12-month results of a novel large access closure

device: insights from the FRONTIER II trial -

A. Schwindt


15:24 V LAA occlusion vs. standard care in patients with

atrial fibrillation and intracranial haemorrhage:

a propensity matched score follow-up study -

J.E. Nielsen-Kudsk


15:37 V One-year follow-up date of a novel self-

expanding TAVI system in a prospective,

bicentric, single-arm pilot trial - T. Schuetz


15:50 V Mitral valve repair using a novel percutaneous

septal sinus shortening device - G. Manoharan


16:03 V Millipede percutaneous mitral annuloplasty ring -

R. Lashinski




120

14:45 16:15 ROOM 241


Cases

Challenging indications for rotablator - part 2 Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: F. MauriPanellists: A.B. Catakoglu, A. Ong, G. Sengottuvelu

14:45 V OCT-supported PCI of calcified left anterior

descending lesion - R. Vijayvergiya


14:58 V Calcium can challenge but diamonds can bring

sparkle in life - A.K. Chaurasia


15:11 V Rotational atherectomy in a patient with ACS and

complex multivessel disease - J. Jose Erungaren


15:24 V Transradial rotational atherectomy and T-stenting

and small Protusion (TAP) of a severely calcified

and occluded right coronary artery - Z. Ruzsa


15:37 V How to tackle a calcified vessel during primary

PCI? - H. Khan


15:50 V Elective use of Impella 2.5L to support

percutaneous treatment of an inoperable patient

with complex coronary artery disease and severe

aortic stenosis - G. Visconti


16:03 V High-risk rotational atherecomy with

percutaneous mechanical circulatory support -

K. Wilczek




Cases

Aortic endovascular strategies for challenging clinical settings - part 2 Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: B. ReimersPanellists: M.J. Bosiers, F.Y. Kuo, T.D. Wang

14:45 V Endovascular treatment of juxtarenal aneurysm

with low profile stent-graft and chimney

technique - M.P. Borrelli


14:58 V Hybrid solution for a complicated acute B type

aortic dissection puzzle - M. Stolcova


15:11 V A rare case of thoraco abdominal aortic aneurysm

with asymptomatic mesenteric ischaemia: how

did I treat? - A. Mohanty


15:24 V Aortic aneurysm with mesenteric artery disease

- R. Llano


15:37 V Pararenal aneurysm after aortic surgery:

endovascular aneurysm sealing and double

chimneys - M.P. Borrelli


15:50 V Pull-down technique of stent graft for abdominal

aortic aneurysm with double renal arteries -

K. Kawaguchi


16:03 V Post-thoracic endovascular aortic repair, delivery

system entrapment - R. Vijayvergiya


121

14:45 16:15 ROOM 251


The new Core Curriculum for cathlab nurses and allied professionals in Europe An initiative from the EAPCI Nurses and Allied

Professionals group

Chairpersons: L. Kløvgaard, T. Van HeckePanellists: S. Carson, R. Esteves


VTo become familiar with the new Core Curriculum

VTo get inspired on how to implement it

VTo become integrated in the European Nurses

and Allied Professionals network

14:45 V Session objectives - L. Kløvgaard

14:48 V Presentation of the Core Curriculum -

L. Hinterbuchner

Implementation - how is practice today and

is it possible to translate and implement the

education programme into daily practice?

15:03 V From a German point of view - M. Jacobs

15:10 V From a Danish point of view - M. Norgaard

Wetendorff


Future - is there a need for certification?

15:35 V Introduction to the ESCeL learning platform -

S. Coelho


15:52 V Exchanging knowledge: networking in our

community - V. Rodriguez Garcia-Abad


16:10 V Session evaluation and key learnings - T. Van Hecke




14:45 16:15 ROOM 242AB


Atherectomy for calcified coronary plaques: diamonds are an interventionalist's best friend Senior Advisor: E. GrubeFacilitators: P. Calvert, J. DaemenMedia Driver: C. Jensen


VTo understand which calcified plaques need

rotational atherectomy

VTo learn (or revise) the modern technique of


VTo learn how to avoid and deal with

complications

14:45 16:15 ROOM 243


PCR Sharing Centre

How to critically analyse a published meta analysis to improve my daily practice Facilitators: D. Capodanno, M. Ntsekhe, R.L.J. Osnabrugge




122

14:45 16:15 ROOM 253


Abstracts

OCT to assess the acute and long-term PCI results Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: F. PratiPanellists: T. Akasaka, A. Omeish, M. Radu

14:45 V Euro16A-OP1078 – Novel method for direct stent

strut length assessment using 3D OCT - I.R. Balleby


15:00 V Euro16A-OP0996 – Clinical impact of suboptimal

stenting and residual intrastent plaque /

thrombus protrusion in patients with ACS: the

Centro per la Lotta contro l'Infarto-Optimisation

of PCI (CLI-OPCI) ACS study - L. Gatto


15:15 V Euro16A-OP0531 – OCT-guided excimer laser

coronary angioplasty for in-stent restenosis after

DES implantation - S. Hashimoto


15:30 V Euro16A-OP0696 – De novo lesions and in-

stent restenosis in coronary SVG: data from the

OCTOPUS study - T. Roleder


15:45 V Euro16A-OP0916 – Multianalysis with OCT and

vasomotion in everolimus-eluting coronary stents

and scaffolds: the MOVES trial - S. Puricel


16:00 V Euro16A-OP0517 – Five-year serial OCT for

assessment of lumen morphology (eccentricity

and asymmetry) changes after complete

resorption of BRS in ABSORB cohort B trial -

P. Suwannasom




and in the PCR App.

14:45 16:15 ROOM 252AB

Femoropopliteal disease With the collaboration of the ESC Working Group on

Aortic and Peripheral circulation

Chairperson: F. CastriotaPanellists: M. Brodmann, M. De Carlo, R. Ferraresi


VTo discuss what is the standard approach for

a safe femoropopliteal procedure today in:

- Stenosis of popliteal segment

- Occlusion of superficial femoral artery

14:45 V Session objectives

14:48 V How to manage calcified lesions and in-stent

restenosis - M. Brodmann


demonstration - J.C. Van Den Berg


Toulouse, France


16:08 V Session evaluation and key learnings - F. Castriota



123

15:27 V Euro16A-OP0902 – Study to evaluate safety and

efficacy of stem cell therapy using bone marrow

mononuclear cells in patients with severe left

ventricular systolic dysfunction - R. Anantharaman

15:31 V Euro16A-OP0955 – Clinical characterisation of

cerebrovascular events after LAA closure - X. Freixa

15:35 V Euro16A-OP0998 – 3D heart models and

simulators for planning of percutaneous tricuspid

interventions - M. Taramasso

15:39 V Euro16A-OP1031 – Five-year experience with

a multilayer flow modulator stent in aortic

dissections and aneurysms - I. Petrov

15:43 V Euro16A-OP1022 – Outcomes and predictors of

success for paravalvular leak closure: an analysis of

the SpanisH real-wOrld paravalvular LEaks closure

registry (HOLE registry) - D. Arzamendi

15:47 V Euro16A-OP1090 – Endovascular therapy of

subtotal carotid stenosis - combined carotid and

coronary atherosclerosis - Tsonev

15:51 V Euro16A-OP0683 – Stenting of total occlusions

of the renal arteries in patients with resistant

hypertension - I. Petrov

15:55 V Euro16A-OP0763 – Efficacy and safety of

percutaneous LAA closure in patients with atrial

fibrillation: results of a six-year registry -

M. Nobre Menezes



round 2







14:45 16:15 ROOM 341


Abstracts

PCR's Got Talent - round 1: structural and peripheral interventions Session comprising selected EuroPCR 2016 abstract

submissions

Chairpersons: Ö. Göktekin, S. VerheyeJury Members: F. Bedogni, D. Erlinge, A. Micari, E. Stabile, E. Vuruskan, O. Wendler


14:47 V Euro16A-OP0018 – Intracardiac ultrasound-

guided endovascular ASD closure - I. Buzaev

14:51 V Euro16A-OP0192 – Predictors of procedural

outcomes of LAA closure in patients with atrial

fibrillation - K. Koskinas

14:55 V Euro16A-OP0207 – Transcutaneous transcatheter

technique in treatment of ischaemic stroke -

I. Maksimovich

14:59 V Euro16A-OP0250 – LAA closure with use of

minimal contrast dye - A. Sedaghat

15:03 V Euro16A-OP0378 – Incidence and clinical impact

of device-associated thrombus and peri-device

leak following LAA closure with the Amplatzer

Cardiac Plug - A. Tzikas

15:07 V Euro16A-OP0526 – OCT after carotid stenting

with new generation mesh-covered stents: rate of

stent malapposition, plaque prolapse and fibrous

cap rupture compared with conventionally

designed carotid stents - T. Umemoto

15:11 V Euro16A-OP0598 – Stent-based isolation of

pulmonary veins - G. Van Langenhove

15:15 V Euro16A-OP0665 – Five-year outcomes of

transcatheter mitral repair in the real-world -

N. Buzzatti

15:19 V Euro16A-OP1062 – Septal Occluder device for

percutaneous closure of PFO associated with

atrial septal aneurysm: short- and mid-term

clinical and echocardiographic outcomes - D. Chin

15:23 V Euro16A-OP0795 – Drug-eluting vs. plain balloon

angioplasty for femoropopliteal artery disease:

an updated meta-analysis supplemented by

sensitivity analyses and Bayesian estimation -

D. Giacoppo



124

14:45 16:15 ROOM 343


Abstracts

New approaches to CTO Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: O. GämperliPanellists: M. Al-Kuraishi, T.H. Koh, G. Werner

14:45 V Euro16A-OP0748 – Can the J-CTO score be

improved? - A.R.G. Francisco


14:58 V Euro16A-OP0646 – Contemporary use of BRS vs.

metallic DES in the treatment of coronary CTO -

S. Ojeda


15:11 V Euro16A-OP0311 – Time to Resorb: mid-term

clinical outcomes for everolimus-eluting BRS in

CTO - A. May


15:24 V Euro16A-OP0776 – Everolimus-eluting BRS for

treatment of complex CTO - R. Diletti


15:37 V Euro16A-OP0946 – Results of X-ray equipment

modification on radiation exposure in CTO-PCI -

J. Reifart


15:50 V Euro16A-OP0090 – Implications of

intraprocedural coronary CT angiography during

coronary CTO intervention - B.K. Kim


16:03 V Euro16A-OP0660 – Safety and feasibility of the

transradial approach in the treatment of chronic

CTO, tailored by a low-intermediate grade J-CTO

score: a single-centre experience - F. Del Furia




and in the PCR App.

14:45 16:15 ROOM 342B


Cases

There is thrombus in the lesion Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: F. WeidingerPanellists: A. Ochala, D. Pahlajani, K. Punamiya

14:45 V Acute myocardial infarction in a 28-year-old male

patient - M. Nobre Menezes


14:58 V A very large thrombus containing right coronary

artery in a patient presenting with STEMI - H. Lu


15:11 V Guideliner catheter used as a thrombectomy

device in vein graft primary PCI - K. Sandhu


15:24 V An unusual rescue PCI - S. Kubba


15:37 V The challenging triad: STEMI and a huge

thrombotic aneurysm


15:50 V Saddle thrombus in the left main - S. Rahman


16:03 V Primary PCI for left main occlusion - K. Altahmody


125

14:45 16:15 ROOM 352A

How Should I Treat?

Algeria and Lebanon share their most educational cases: complex primary PCI in high-risk STEMI patients With the collaboration of the Algerian Group of

Interventional Cardiology (AGIC) and the Lebanese

Society of Cardiology Interventional Working Group

Chairpersons: M. Chettibi, Z. Ghazzal


VTo understand how to identify the degree of

difficulties to treat complex lesions in acute

situations

VTo learn tips and tricks

VTo be aware of potential errors in judgment and

how to avoid them

14:45 V Session objectives - M. Chettibi

14:50 V Case 1: STEMI with left main lesion - W. Takdemt

14:55 V How would I treat the case? - J. Elias

15:00 V How would I treat the case? - R. Senoussaoui

15:05 V How did I treat the case? - W. Takdemt


15:25 V Consensus - Z. Ghazzal

15:30 V Case 2: STEMI with multivessel disease -

F.A. Jaoude

15:35 V How would I treat the case? - R. Senoussaoui

15:40 V How would I treat the case? - J. Elias

15:45 V How did I treat the case? - F.A. Jaoude


16:05 V Consensus - M. Chettibi

16:10 V Session evaluation and key learnings - Z. Ghazzal

14:45 16:15 ROOM 351


Abstracts

Resting vs. hyperaemic functional indices of coronary stenosis severity Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: C. Di MarioPanellists: H. Abu-Hantash, D. Al Khdair, S.A. Pyxaras

14:45 V Euro16A-OP0152 – One year clinical follow-up

outcome of onsite iFR-FFR hybrid approach:

j-DEFINE registry - M. Nakamura


14:58 V Euro16A-OP0385 – Discordances of tandem

lesion treatment based on iFR pullback curve vs.

hyperaemic iFR pullback curve: is it always the

same? - J. Kikuchi


15:11 V Euro16A-OP0356 – Differences in iFR

performance in the right and left coronary artery

- L.X. Van Nunen


15:24 V Euro16A-OP0434 – Predictive value of resting Pd

/ Pa on hyperaemia FFR in intermediate coronary

artery stenosis - C. Bietau


15:37 V Euro16A-OP0258 – Diagnostic performances

of resting and hyperaemic invasive physiologic

indices to define myocardial ischaemia:

validation with 13N-ammonia positron emission

tomography - D. Hwang


15:50 V Euro16A-OP0575 – Relationship between

non-invasive coronary flow reserve and the

FFR for guiding PCI for significant left anterior

descending coronary lesions - T. Moustafa


16:03 V Euro16A-OP0534 – FFR result post-PCI is

suboptimal in long diffuse coronary artery disease

treated with newer-generation DES -

A. Baranauskas




and in the PCR App.



126


14:58 V Euro16A-OP0184 – Three-year clinical follow-

up of the COBRA study (COmplex coronary

BifuRcation lesions: rAndomised comparison

of a strategy using a dedicated self-expanding

biolimus A9-eluting stent vs. a culotte strategy

using everolimus-eluting stents) - J. Bennett


15:11 V Euro16A-OP1052 – Favourable clinical long-

term follow-up of the mini-crush technique for

treatment of true bifurcations in an all-comer

population - A. Nicolino


15:24 V Euro16A-OP0542 – Treatment of bifurcation

lesions with a thin-strut DES with bioresorbable

polymer: three-year clinical outcomes of the

CENTURY II trial - R. Kornowski


15:37 V Euro16A-OP0594 – Intracoronary

electrocardiography changes predict mortality

at mid-term follow-up (up to 60 months) after

stenting coronary bifurcation lesions from

intracoronary electrocardiogram and myonecrosis

after bifurcation stenting - K. Karamfiloff


15:50 V Euro16A-OP0186 – Five-year clinical follow-up of

the PYTON (prospective evaluation of the Tryton

side-branch stent with an additional Xience-V

everolimus-eluting stent in coronary bifurcation

lesions) study - J. Bennett


16:03 V Euro16A-OP0599 – Bifurcation culprit lesion

in STEMI: interventional strategies, procedural

success and clinical outcomes at five years of

follow-up - H.D. Mejia-Renteria




and in the PCR App.

14:45 16:15 ROOM 352B

Complications

Ireland and Switzerland share their most educational cases: you thought that coronary interventions were low risk With the collaboration of the Irish Cardiac Society,

Intervention section and the Swiss Working Group

for Interventional Cardiology and Acute Coronary

Syndrome

Chairpersons: D. Foley, M. Roffi


VTo know how to immediately recognise major

coronary complications

VTo know how to treat major coronary

complications

VTo know the equipment needed to handle major

coronary complications

14:45 V Session objectives - D. Foley

14:48 V Case 1: stuck in the middle of you - C. O'Sullivan


15:02 V Case 2: five stents to plug the hole - A.J. Peace


15:16 V Case 3: nightmare in the cathlab - A. Zuffi


15:30 V Case 4: just finishing up, we'll be done in two

minutes - T. Kiernan


15:44 V Case 5: an unusual complication following a usual

one - I. Moarof


15:58 V Case 6: when the coronary hardware just lets you

down - S. O'Connor



14:45 16:15 ROOM 353


Abstracts

Mid- and long-term follow-up after bifurcation PCI Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: D. WagnerPanellists: S. Brugaletta, I.H. Chae, D. Kettles

14:45 V Euro16A-OP0157 – Long-term clinical outcomes

of T-stenting with small protrusion for coronary

bifurcation lesions treated with second-

generation DES - R. Jabbour

127

Image 19: an unusual cause of myocardial

infarction in a 28-year-old


interpretation - N. Van Mieghem


Y. Abdelmonem


N. Van Mieghem

- 15:00 - 15:00 16:00

ROOM 342A


Will SPRINT change my practice? Chairpersons: R. Schmieder, W. Wijns









15:00 V Introduction - the trial headlines - W. Wijns


I treat? - K. Tsioufis


work?

15:15 V What was known before SPRINT? - S. Ewen


F. Mahfoud


to change practice?


practice? - A. Pathak


15:55 V Concluding remarks - R. Schmieder


Focus Imaging

Images


submissions

Facilitators: F. Kiemeneij, A. Pichard, N. Van Mieghem

Image 14: first time in a cathlab


interpretation - F. Kiemeneij

14:50 V Image 14 unveiled and key findings - A. Bucsa


F. Kiemeneij

Image 15: how IVUS can guide treatment in

ACS?


interpretation - A. Pichard


M.T. Lopez Lluva


A. Pichard

Image 16: TAVI in calcified root with extreme

narrowing at the sino-tubular junction


interpretation - N. Van Mieghem

15:20 V Image 16 unveiled and key findings - S. Cannata


N. Van Mieghem

Image 17: just an ordinary PCI


interpretation - F. Kiemeneij

15:35 V Image 17 unveiled and key findings - K. Koegler


F. Kiemeneij

Image 18: what's wrong with this MitraClip?


interpretation - A. Pichard

15:50 V Image 18 unveiled and key findings - G. Bruschi


A. Pichard



128


18:27 V Session evaluation and key learnings - T. Adriaenssens





- 16:00 - 16:30 18:30

THEATRE BLEU

EBAC Accredited

Educational

Programme

Innovation and new evidence in OCT and vessel preparation to achieve better patient outcomes Organised by OLV Ziekenhuis Aalst, Belgium

Course Director: E. Barbato Programme supported by an unrestricted educational

grant from ST. JUDE MEDICAL AND ORBUSNEICH

Chairperson: C. TamburinoCo-Chairperson: T. AdriaenssensPanellists: T. Kinnaird, J.F. Lassen, H. Nef, L. Räber


VTo see the benefits of the latest OCT technology

and learn about the clinical evidence supporting

the use of OCT in complex lesions

VTo understand where lesion preparation with

a scoring balloon can improve outcomes in

complex situations

VTo discover the value of OCT in scaffold implantation


16:32 V Why OCT is a valuable tool for decision making

before DES and BRS implantation? - L. Räber

16:39 V Why vessel preparation with a scoring balloon is

key before DES or BRS implantation - T. Kinnaird



Toulouse, France


17:44 V Why OCT is a valuable tool to reduce late failure in

DES and BRS? - H. Nef


17:55 V Recorded case from Righspitalet - Copenhagen,

Denmark - J.F. Lassen


129


Symposium

MitraClip: controversies in intervention and imaging Sponsored by ABBOTT VASCULAR - PHILIPS

Chairperson: A. VahanianCo-Chairperson: F. Maisano


VTo learn about new developments and data in

mitral intervention and imaging

VTo learn new approaches to MitraClip imaging

and anaesthesia

VTo participate in challenging discussion on mitral

intervention and imaging

16:30 V Session objectives - A. Vahanian

Controversy 1: does the latest survival data

already predict COAPT outcomes?

16:35 V Yes - M. Swaans

16:42 V No - A. Vahanian


Controversy 2: optimal procedural guidance:

fusion imaging or only Echo

16:55 V Fusion imaging is needed - M. Swaans

17:02 V Echo is enough - S. Von Bardeleben


Controversy 3: in light of more than 30,000

patients treated with MitraClip what will be the

respective role of repair vs. replacement?

17:15 V Transcatheter valve repair will remain the most

popular - F. Maisano

17:22 V Transcatheter mitral valve replacement will be the

winner - V. Bapat


Controversy 4: general or local anaesthesia:

what's better for the patient?

17:35 V General anaesthesia - S. Von Bardeleben

17:42 V Local anaesthesia - H. Sievert


17:55 V Session evaluation and key learnings - F. Maisano



Symposium

Bioresorbable vascular scaffolds in the real world – considering the ongoing evidence for safety and efficacy Sponsored by ABBOTT VASCULAR

Chairperson: P.W. SerruysCo-Chairperson: P. SmitsPanellist: H.C. Gwon


VTo learn about the early and mid-term safety and

efficacy of bioresorbable vascular scaffolds in

all-comer patients

VTo learn more about all-comer registries on lesion

indications based on available evidence

VTo discuss the incremental value of real-world

registries

16:30 V Session objectives - P. Smits

16:35 V Review of the available meta-analyses - P.W. Serruys


16:50 V Acute results from the FRANCE ABSORB registry -

R. Koning

16:58 V Acute results from the all-comer United Kingdom

registry - J. Hill

17:06 V Acute results from the RAI registry - B. Cortese


17:24 V Mid-term results from the GABI-R registry -

C. Hamm

17:32 V Mid-term results from real-world REPARA registry -

F. Hernandez


17:55 V Session evaluation and key learnings - P.W. Serruys




130

wx

高亮



Cases

Mid- and long-term follow-up after BRS Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: N.E.J. WestPanellists: H. Al Guindy, P. Kala, M. Kurdi

16:30 V BRS in a case of severe in-stent restenosis -

T. Choudhury


16:43 V Aneurysmatic remodeling after CTO PCI with

a BRS - M. Vlachojannis


16:56 V Application of BRS in a right coronary artery CTO

case with one year follow-up - W.C. Huang


17:09 V Risk stratification of earlier antiplatelet

discontinuation after BRS for STEMI: neointimal

coverage assessment by OCT -

L. Leite


17:22 V Restored physiological vasomotion imitating

intrascaffold restenosis three years after BRS

implantation - M.B. Ancona


17:35 V 13-month OCT follow-up of full-plastic jacket BRS

implantation - R. Jabbour


17:48 V Progression of calcification after implantation

of a fully BRS: a serial and combined IVUS-OCT

follow-up of five years - Y. Zeng



Symposium

STENT

FOR LIFE

Sharing solutions to frequent challenges in PCI strategies with complex anatomies and patients Sponsored by TERUMO

Chairperson: P. UrbanCo-Chairperson: C. Spaulding


VTo learn about strategies to address challenges in

complex patients and interventions

VTo explore technical choices in complex PCIs

VTo discuss DAPT in high bleeding risk patients

16:30 V Session objectives - P. Urban

16:33 V A challenging bifurcation case - A. Colombo

16:41 V Is there an alternative strategy? - J. Mehilli


16:59 V Key learnings - P. Urban

17:01 V A challenging STEMI patient - G. Sardella

17:09 V Is there an alternative strategy? - C. Moris


17:27 V Key learnings - C. Spaulding

17:29 V A challenging high bleeding risk patient -

M. Valgimigli

17:37 V Is there an alternative strategy? - B. Chevalier


17:55 V Key learnings - P. Urban


C. Spaulding



Learning

Learning acute stroke interventions Facilitators: A. Cremonesi, Ö. Göktekin, O. ÖzdemirMedia Driver: E. KaracopExpert Panellist: M. Meuwissen


VTo assess optimal patient indications for

endovascular acute stroke treatment, using

a stent or a balloon


step:



- Preventing and managing: potential procedure-


131

16:30 18:00 ROOM 241

Focus Imaging

Case in Point

Strategies for complex PCI treatment: optimising your procedural outcomes while managing costs through novel and innovative technologies Sponsored by PHILIPS VOLCANO

Chairperson: A. BanningCo-Chairperson: F. Pinto


VTo understand how physiology can help you

guide, decide and confirm your treatment

strategies in complex anatomy

VTo appraise how novel image guidance

technologies can improve complex PCI

procedures

VTo specifically discuss the health economics

considerations of novel imaging and physiology-

driven treatment strategies

16:30 V Session objectives - A. Banning

16:35 V Resolving serial and diffuse lesions with iFR Scout -

F. Hellig


16:51 V Using IVUS co-registration imaging technologies

to improve left main lesion guidance and

associated outcomes - D. Dudek


17:07 V Identifying the revascularisation targets in a

multivessel disease with physiology and IVUS

guidance - J. Escaned


17:23 V Complex bifurcation lesion treatment can be

made easier with the novel cardiac RoadMap

image guidance technology - T. Zeus


17:39 V Reflections on the impact of imaging and

physiolgy-related innovative technologies: what

is in it for you? - L. Annemans

17:54 V Session evaluation and key learnings - F. Pinto



Cases

Unusual peripheral complication Session comprising selected EuroPCR 2016 clinical case

submissions

Chairpersons: B. Reimers , E. Vuruskan

16:30 V Successful retrieval of trapped inferior vena cava

filter during May-Thurner syndrome intervention


16:43 V Key learnings - I. Alhaddad

16:45 V Embolic complication post TAVI - Q. Labarre


16:58 V Key learnings - E. Vuruskan

17:00 V Successful retrieval of lodged metal catheter tip

from severely calcified tibial artery - M. Kimura


17:13 V Key learnings - H. Reinecke

17:15 V Unusual percutaneous extraction - A.R.G. Francisco


17:28 V Key learnings - A.K. Bozkurt



132

16:30 18:00 ROOM 252AB


Resorbable magnesium scaffold Magmaris*: opening a new era Sponsored by BIOTRONIK

* CE mark pending

Chairperson: R. WaksmanCo-Chairperson: J. KoolenPanellist: R. Mohd Ali


VTo understand the fundamental mechanics of

magnesium as natural element and scaffold

material

VTo learn from users how to optimise the scaffold

implantation

VTo review the clinical outcomes of Biotronik

magnesium scaffold

16:30 V Session objectives - J. Koolen

16:33 V The ABCs of Magnesium - J. Maier

16:40 V Bioresorption of magnesium - M. Joner

16:47 V BIOSOLVE-II data - C. Von Birgelen


16:59 V Magmaris: recorded case from Städtische

Kliniken Neuss, Lukaskrankenhaus GmbH -

Neuss, Germany - M. Haude


17:34 V Technical and procedural aspects - R. Tölg

17:44 V Current potential indications for scaffolds vs.

modern DES - W. Wijns

17:51 V Session evaluation and key learnings - R. Waksman

16:30 18:00 ROOM 242AB


Learning

Learning alcohol septal ablation Facilitators: I. Al Rashdan, T. Cuisset, G. TothMedia Driver: J. Molina-Martin de Nicolas


VTo share tips and tricks to make septal ablation

easy and successful

VTo discuss how to prevent and manage potential

complications

VTo discuss how to integrate available evidence

into daily practice

16:30 18:00 ROOM 243

PCR Sharing Centre

Practical use of CT scan for TAVI and structural interventional procedures: Fluoro-CT app Facilitators: M. Chen, N. Piazza

16:30 18:00 ROOM 251

Symposium

Direct Flow Medical innovations in the aortic and mitral programmes Sponsored by DIRECT FLOW MEDICAL

Chairperson: J.J. PopmaCo-Chairperson: N. Moat


VTo learn the newest clinical and technological

developments in the aortic and mitral

programmes

VTo learn how to avoid aortic regurgitation in

simple steps using the Direct Flow Medical aortic

valve

VTo understand the key implant learnings for TAVI

to optimise results

16:30 V Session objectives - N. Moat

16:35 V What do the data tell us? - C.K. Naber


16:55 V Avoiding aortic regurgitation in simple steps -

A. Linke


17:15 V Advanced techniques to optimise results -

F. De Marco


17:35 V Mitral programme update - A. Latib


17:55 V Session evaluation and key learnings - J.J. Popma

133

16:30 18:00 ROOM 341


Abstracts

PCR's Got Talent - round 1: ACS Session comprising selected EuroPCR 2016 abstract

submissions

Chairpersons: R. Kornowski, P. L' AllierJury Members: R. Byrne, D. Capodanno, C. Di Mario, P. Lemos, J.F. Tanguay, F. Weidinger


16:32 V Euro16A-OP0037 – Angiographic findings and

revascularisation success in patients with acute

myocardial infarction and previous coronary

bypass surgery - F. Blachutzik

16:36 V Euro16A-OP0043 – Mechanical aspiration in a

27-year-old patient and subacute STEMI - J. Hakim

16:40 V Euro16A-OP0073 – Slow-speed rotational

atherectomy in ACS: a single-centre experience in

78 high-risk patients - J. Palazuelos

16:44 V Euro16A-OP0411 – Temporal trends in incidence,

management and neurologically intact survival

following out-of-hospital cardiac arrest in the UK -

T. Patterson

16:48 V Euro16A-OP0416 – Indications and findings of

emergency coronary angiograms in patients with

sudden cardiac arrest - M. Cardenas Manilla

16:52 V Euro16A-OP0519 – Five-year follow-up of

polymer-free sirolimus- and probucol-eluting

stents vs. new generation zotarolimus-eluting

stents in patients presenting with STEMI -

R. Colleran

16:56 V Euro16A-OP1091 – Correlates of early, late and

very late stent thrombosis following implantation

of first- and second-generation DES in daily

clinical practice - R. Costa

17:00 V Euro16A-OP0761 – Prognostic impact of

thrombus aspiration in patients with STEMI: a

report from the Swedish coronary angiography

and angioplasty registry - O. Angeras

17:04 V Euro16A-OP0773 – Everolimus-eluting BRS vs.

metallic DES for treatment of patients presenting

with acute myocardial infarction: insights from

the maximal footprint analysis - R. Diletti

17:08 V Euro16A-OP0911 – Newer antiplatelet and

anticoagulant strategies following PCI and

subsequent bleeding: a real-world comparison of

multiple combinations - R. Amin

16:30 18:00 ROOM 253


Cases

MitraClip unusual cases and tips and tricks Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: H. IncePanellists: E. Brochet, D. Kahali, W.H. Yin

16:30 V Fortuitous catheter entrapment during left

anterior mitral leaflet pushing manoeuver for

MitraClip implantation: a word of caution -

I.J. Amat-Santos


16:43 V Percutaneous mitral valve repair after

annuloplasty ring dehiscence: clip the gap! -

E.W. Holy


16:56 V Uncle SAM MitraClip treatment for severe mitral

regurgitation due to stress-induced systolic

anterior motion - P. Denti


17:09 V Percutaneous transcatheter mitral valve repair:

two weeks after implantation - J.F. Velu


17:22 V MitraClip-induced systolic anterior motion

complicated by pericardial effusion - A. Levi


17:35 V MitraClip repair with concomitant left ventricle

thrombus: can we (safely) do it? - N. Buzzatti


17:48 V Looking for solutions... Left Amplatz catheter to

place MitraClip in a patient with asymmetrical

tethering - R. Nerla




134

16:30 18:00 ROOM 342A

Case in Point

Experience Evolut R in complex cases Sponsored by MEDTRONIC

Chairperson: U. GerckensCo-Chairperson: G. ManoharanPanellists: H. Danenberg, I. Meredith, T. Modine, F. Ribichini


VTo discuss complex situations in TAVI with experts

commenting cases

VTo discuss technical points in leverage specific

features of the CoreValve Evolut R system to

achieve superior outcomes

16:30 V Session objectives - U. Gerckens

16:35 V Evolut R recapture: when and how? - I. Meredith


16:55 V TAVI / PCI concomitant procedure - F. Ribichini


17:15 V Evolut R in failed surgical valves - H. Danenberg


17:35 V Evolut R through alternative access - T. Modine



G. Manoharan

17:12 V Euro16A-OP0931 – Invasive coronary treatment

strategies for out-of-hospital cardiac arrest: in-

hospital mortality and outcomes at six months

from a single-centre registry - S. Muraglia

17:16 V Euro16A-OP0934 – Systematic OCT-guided

implantation of BRS in STEMI patients -

A. Al Nooryani

17:20 V Euro16A-OP1075 – Monocyte subpopulation

1 and 2 and their phagocytic activity predict

major adverse cardiac events (MACE) post-STEMI -

A. Ghattas

17:24 V Euro16A-OP0982 – Circadian pattern of

symptoms onset and major cardiac adverse

events in acute myocardial infarction patients -

N.Q. Nguyen

17:28 V Euro16A-OP1002 – Changes in coronary blood

flow responses after myocardial infarction:

combined results from a patient study and an

experimental porcine model - G. De Waard

17:32 V Euro16A-OP1039 – Impact of baseline SYNTAX

score on the effects of immediate vs. delayed

invasive intervention in NSTEMI patients: a

subanalysis of the randomised RIDDLE-NSTEMI

study - D. Milasinovic

17:36 V Euro16A-OP1044 – Influence of gender on delays

and early mortality in STEMI: insight from the first

French meta-registry, 2005-2012 patient-level

pooled analysis - S. Manzo-Silberman

17:40 V Euro16A-OP0967 – Prognostic value of arterial

lactate level on admission in patients with acute

myocardial infarction - N.Q. Nguyen

17:44 V Euro16A-OP0644 – Coronary artery perforation

in patients suffering from ACS: the worst

complication in the worst clinical scenario -

I.J. Amat-Santos



round 2







135

16:30 18:00 ROOM 343


Abstracts

Mid- and long-term outcome of CTO Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: T.H. KohPanellists: A. Al Ghamdi, R. Lorenzoni, W. Udayachalerm

16:30 V Euro16A-OP0514 – Survival after failed complete

revascularisation in patients with coronary CTO -

A. Toma


16:43 V Euro16A-OP0445 – Long-term follow-up in

patients with ventricular arrhythmias after

revascularisation of total occluded coronary

artery - C. Bietau


16:56 V Euro16A-OP0028 – Percutaneous

revascularisation of the collateral supply vessel

for patients with multivessel disease and a

chronically occluded vessel - W. Sumaya



patients with previous CABG undergoing PCI for

CTO - A. Toma


17:22 V Euro16A-OP0051 – Long-term clinical results of

PCI for CTO: latest report from Retrograde Summit

registry - H. Park


17:35 V Euro16A-OP0515 – Survival after PCI for coronary

CTO in elderly patients - A. Toma


17:48 V Euro16A-OP0154 – Evaluation of antegrade

approach for coronary CTO: subanalysis of a

Japanese multicentre registry - W. Nagamatsu




and in the PCR App.

16:30 18:00 ROOM 342B


Cases

Visceral and unexpected peripheral interventions Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: T. ZellerPanellists: R. Akdemir, E. Blessing, F. Fanelli

16:30 V Endovascular management of chronic mesenteric

ischaemia - R. Vijayvergiya


16:43 V Superior mesentric artery stenting in mesentric

ischaemia - A. Patil


16:56 V Endovascular treatment of an aberrant splenic

artery aneurysm - M.P. Borrelli


17:09 V An unusual cause of recurrent haemoptysis and

its successful intervention - S. Chidambaram


17:22 V Chest pain caused by fractured inferior vena cava

filter stuck within heart and successful removal by

catheter intervention - O. Hashimoto


17:35 V Acute upper extremity ischaemia successfully

treated by catheter-based intra-arterial

thrombolysis - S.H. Jo


17:48 V Early SVG axillary to brachial artery disease treated

with BRS - H. Abu-Hantash




136

16:30 18:00 ROOM 352A

How Should I Treat?

Iran and Kazakhstan share their most educational cases: complexity of coronary PCI in acute setting With the collaboration of the Iranian Society of

Interventional Cardiology (ISOIC) and the Society of

interventional cardiologists of Kazakhstan

Chairpersons: M. Hashemian, O. Sakhov


VTo discuss the different revascularisation

strategies in NSTEMI patients and multivessel

coronary artery disease

VTo discuss the importance of IVUS study in

left main stenting, and complete coverage of

coronary dissection

VTo share effective techniques that can be useful

for difficult PCI cases

16:30 V Session objectives - O. Sakhov

16:35 V Case 1: NSTEMI and multivessel disease in

a patient with obesity - M. Kudratullayev

16:40 V How would I treat the case? - B. Geraiely

16:45 V How would I treat the case? - M. Aripov

16:50 V How did I treat the case? - M. Kudratullayev


17:10 V Consensus - M. Hashemian

17:15 V Case 2: iatrogenic left main dissection during PCI

of an ACS - A. Firouzi

17:20 V How would I treat the case? - M. Aripov

17:25 V How would I treat the case? - B. Geraiely

17:30 V How did I treat the case? - A. Firouzi


17:50 V Consensus - O. Sakhov


M. Hashemian

16:30 17:30 ROOM 351

Case in Point

Expanding treatment options in LAA closure patients - Watchman Sponsored by BOSTON SCIENTIFIC

Chairperson: T. FeldmanCo-Chairperson: D. Hildick-Smith


VTo learn which patients benefit from LAA and

how to balance best the risk of stroke and

bleeding

VTo know the latest clinical data and guidelines for

LAA closure

VTo understand the expected benefits of

Watchman in complex anatomies

16:30 V Session objectives - T. Feldman

16:35 V Case 1: my 66-year-old patient has uncontrolled

hypertension and already suffered a stroke -

D. Foley


16:52 V Case 2: my patient has a challenging anatomy of

the LAA and a high bleeding risk - M. Sandri


17:09 V Case 3: my patient cannot take warfarin - not

even for six weeks - M.W. Bergmann



D. Hildick-Smith

137

16:30 18:00 ROOM 353


Abstracts

The radial approach revisited Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: S. SaitoPanellists: H.H. Ho, P. Jagtap, S.A. Pyxaras

16:30 V Euro16A-OP0845 – Transradial approach for

coronary intervention: data from the CENTURY II

study - D. Carrié


16:43 V Euro16A-OP0297 – Safety and feasibility of same-

day discharge after transradial PCI: a multicentre

prospective registry - J.G. Córdoba Soriano


16:56 V Euro16A-OP0932 – Radial artery spasm:

prevalence, prevention and safety vasodilators

agents in a prospective randomised meta-

analysis - J. Adjedj


17:09 V Euro16A-OP0778 – Assessment of acute and

chronic effects on the radial artery after a

transradial coronary intervention by OCT -

R. Rihani


17:22 V Euro16A-OP0952 – Femoral vs. radial access for

coronary intervention (PCI) in patients with acute

myocardial infarction (NSTEMI and STEMI): results

from a large monitor-controlled German registry

(QuIK) - J. Reifart


17:35 V Euro16A-OP0556 – Transradial vs. the transfemoral

approach in alcohol septal ablation - F. Sawaya


17:48 V Euro16A-OP0039 – Relationship between femoral

vascular closure devices and short-term mortality

from 271,845 PCI procedures performed in the

United Kingdom between 2006-2011:

a propensity score corrected analysis from the

British Cardiovascular Intervention Society (BCIS) -

V. Farooq




and in the PCR App.

16:30 18:00 ROOM 352B

How Should I Treat?

Israel and Slovenia share their most educational cases: patients with severe coronary artery disease and severe symptomatic aortic stenosis: what should be performed first, PCI or TAVI? With the collaboration of the Israel Working Group for

Interventional Cardiology and the Slovenian Working

Group for Interventional Cardiology

Chairpersons: M. Bunc, A. Finkelstein


VTo understand the complexity of patients with a

combination of severe coronary artery disease

and severe aortic stenosis

VTo discuss the main considerations in choosing

the therapeutic strategy including what should

be performed first: PCI or TAVI

VTo share and learn tips and tricks in performing

PCI in patients with severe aortic stenosis or

patients who have undergone TAVI

16:30 V Session objectives - A. Finkelstein

16:35 V Case 1: urgent TAVI for deteriorating critical aortic

stenosis with extensive anterior wall myocardial

infarction - K. Orvin

16:40 V How would I treat the case? - M. Noc

16:45 V How would I treat the case? - A. Segev

16:50 V How did I treat the case? - K. Orvin


17:10 V Consensus - M. Bunc

17:15 V Case 2: TAVI in a patient with a significant left

anterior descending lesion - M. Cercek

17:20 V How would I treat the case? - A. Segev

17:25 V How would I treat the case? - M. Noc

17:30 V How did I treat the case? - M. Cercek


17:50 V Consensus - A. Finkelstein

17:55 V Session evaluation and key learnings - M. Bunc



138


Focus Imaging

Images


submissions

Facilitators: O. Muller, B. Scheller, O. Wendler

Image 20: juxtarenal aneurysm


interpretation - B. Scheller

16:35 V Image 20 unveiled and key findings - I. Petrov


B. Scheller

Image 21: left main dissection, left anterior

descending, acute closure, left circumflex

dissection - all in one


interpretation - O. Muller


G. Katsimagklis


O. Muller

Image 22: a surprising appearance in an

elective diagnostic angiogram


interpretation - O. Wendler

17:05 V Image 22 unveiled and key findings - R. Bogle


O. Wendler

Image 23: poor outcome after surgical aortic

valve replacement


interpretation - B. Scheller

17:20 V Image 23 unveiled and key findings - L. Paiva


B. Scheller

Image 24: why to fish a nosecone?


interpretation - O. Muller

17:35 V Image 24 unveiled and key findings - G. Gelpi


O. Muller

V Image 25: what has happened with plaque?


interpretation - O. Wendler

17:50 V Image 25 unveiled and key findings - T. Roleder


O. Wendler 139


eeuro

20

16

- 08:00 - 08:30 09:35

MAIN ARENA


Stroke prevention: Carotid stenting LIVE demonstration Chairpersons: F. Hellig, W. WijnsPanellists: E. Grube, K. Hayashida, F. Malik, M. Roffi, A. Witkowski


demonstration - W. Wijns 08:35 V LIVE demonstration from Maria Cecilia Hospital,

GVM Care & Research - Cotignola, Italy 09:25 V Time to React@PCR





Physiological and imaging guidance in non-culprit lesions after primary PCI for STEMI Chairpersons: H. Samady, N. Van RoyenPanellists: F. De Vroey, K. El Merri, D. Holmes, J. Koolen


VTo discuss the limitations of angiography as a

method to guide complete revascularisation in

patients with STEMI and multivessel disease

VTo review current evidence on the use of

intracoronary functional testing to select proper

treatment in patients with STEMI

VTo consider the value of intracoronary imaging to

take decisions relevant to revascularisation of the

culprit and non-culprit lesions in STEMI patients

08:30 V Session objectives - N. Van Royen 08:33 V How could intracoronary physiology contribute

to improve outcomes in patients with STEMI? - J. Escaned

08:40 V Time to React@PCR 08:47 V Review of the tools to be used during the LIVE

demonstration - K. El Merri 08:53 V LIVE demonstration from Rashid Hospital,

Dubai Health Authority - Dubai, United Arab

Emirates 09:33 V Time to React@PCR 09:43 V How could imaging modify the strategy of

primary PCI? - G. Guagliumi 09:50 V Time to React@PCR 09:57 V Session evaluation and key learnings - H. Samady







142


Acute and long-term stroke prevention in TAVI patients Chairpersons: A. Lansky, C.K. NaberPanellists: M. Balghith, A. Linke, F.J. Neumann, L. Sondergaard


VTo learn how to select the best TAVI strategy for

patients with high risk of periprocedural stroke

VTo learn how to minimise stroke risk using

medical therapy

VTo observe a LIVE case involving the use of a distal

protection device

08:30 V Session objectives - C.K. Naber 08:33 V Cerebral embolic protection devices for

prevention of periprocedural stroke - C. Tamburino 08:40 V Time to React@PCR 08:47 V Review of the tools to be used during the LIVE

demonstration - C.K. Naber 08:53 V LIVE demonstration from Clinique Pasteur -

Toulouse, France 09:33 V Time to React@PCR 09:43 V Antithrombotic treatment for prevention of

post-procedural stroke - M. Valgimigli 09:50 V Time to React@PCR 09:57 V Session evaluation and key learnings - A. Lansky





Focus Innovation

TAVI and structural Session comprising selected EuroPCR 2016 Cardiovascular innovation pipeline submissions Chairpersons: T. Modine, C. RuizPanellists: F. Bedogni, H. Eltchaninoff, T. Keles, M.K.Y. Lee, B. Prendergast, G. Tarantini

08:30 V Foldavalve: a novel 14Fr repositionable and

retrievable TAVI - A. Kheradvar 08:37 V Discussion and audience interaction 08:42 V New transcatheter prosthesis aiming zero

paravalvular leak - D. Gaia 08:49 V Discussion and audience interaction 08:54 V Integrated embolic protection platform - A. Behne 09:01 V Discussion and audience interaction 09:05 V A novel bioprosthesis designed for optimisation

of valve-in-valve procedures: bench-testing,

chronic animal and human cadaveric implants - D. Dvir

09:12 V Discussion and audience interaction 09:16 V Nitinol thin-film heart valve leaflets - S. Pokorny 09:23 V Discussion and audience interaction 09:27 V A novel non-implant-based approach for treating

calcified aortic valves - G. Manoharan 09:34 V Discussion and audience interaction 09:38 V Heart access technology: paradigm change in

structural disease treatment - W. Sherman 09:45 V Discussion and audience interaction 09:49 V Unidirectional left-to-right interatrial shunt for the

treatment of heart failure: results of the first-in-

human multicentre experience - J. Rodes Cabau 09:56 V Discussion and audience interaction

143



Learning

Learning bifurcation: double-kissing crush technique Facilitators: S.L. Chen, J.F. Lassen, H. RoutledgeMedia Driver: L. Tay


VTo understand what is the right strategy for each

individual patient, taking into consideration

specific anatomies

VTo learn how to perform the double-kissing crush

technique step by step:







Cases

Left main PCI in challenging clinical situations Session comprising selected EuroPCR 2016 clinical case submissions Chairperson: T. LefevrePanellists: Z. Ghazzal, M. Loutfi, M. Ridha

08:30 V Ostial circumflex stenosis with recurrent

pulmonary oedema - M. Sreedharan 08:38 V Discussion and audience interaction 08:43 V Unprotected left main and complex circumflex

PCI in an unstable patient - K. Sandhu 08:51 V Discussion and audience interaction 08:56 V Hybrid polymer-free biolimus-coated stent and

drug-coated balloon angioplasty in anterior

STEMI involving ostial left main disease in high

bleeding risk patient - D.A. Sinaga 09:04 V Discussion and audience interaction 09:09 V Two lives at stake - A.F. Omar 09:17 V Discussion and audience interaction 09:22 V But the patient can't lie flat... Long-term success

of complex cathlab procedures in semi-upright

position - E. Roberts 09:30 V Discussion and audience interaction 09:35 V Caugh responsible for myocardial infarction -

N. Zaoui 09:43 V Discussion and audience interaction 09:48 V PCI with stenting of left main coronary artery and

stenting of left subclavian artery in a young girl

with Takayasu arteritis - S. Kasturi 09:56 V Discussion and audience interaction


Focus Innovation

Novel stents and scaffolds from Asia Chairpersons: A. Laffont, P.W. SerruysPanellists: J.J Cheng, N. Foin, E. Lehto


VTo become familiar with stent, scaffold that have

been developed in Asia

VTo learn about potential indications and specific

techniques for deployment of novel stents and

scaffolds

VTo appreciate the potential of nanotechnologies

for novel drug delivery systems in development

08:30 V Session objectives 08:36 V Firesorb: poly-L-lactide-based fully bioresorbable

scaffold with thinner strut and target sirolimus-

eluting - Q. Luo 08:45 V Discussion and audience interaction 08:49 V Polymer-free nanoporous sirolimus-eluting stent

and NeoVas fully-biodegradable sirolimus-eluting

stent - P. Suwannasom 08:58 V Discussion and audience interaction 09:02 V Cobalt chromium-based biodegradable polymer

sirolimus-eluting stent - Y.L. Han 09:11 V Discussion and audience interaction 09:15 V Sirolimus-eluting fully bioresorbable scaffold with

mixed poly-L-lactide / poly-D-lactide - A. Lafont 09:24 V Discussion and audience interaction 09:28 V MeRes 100: fully bioresorbable poly-L-lactide

scaffold eluting-sirolimus - U. Kaul 09:37 V Discussion and audience interaction 09:41 V Nanomicrosphere for drug-elution - M. Doshi 09:50 V Discussion and audience interaction 09:54 V Session evaluation and key learnings - P.W. Serruys



144

wx

高亮

08:30 10:00 ROOM 241


Abstracts

DES for selected angiographic subsets Session comprising selected EuroPCR 2016 abstract submissions Chairperson: R.J. Van GeunsPanellists: J. Byrne, A. Chieffo, S.Y. Choi

08:30 V Euro16A-OP0360 – Treatment of severely calcified

coronary lesions in patients with ACS using

newer-generation DES: two-year clinical outcome - J. Huisman

08:38 V Discussion and audience interaction 08:43 V Euro16A-OP0484 – Clinical outcomes following

implantation of 44mm / 48mm biodegradable

polymer-coated sirolimus-eluting stents in long

coronary lesions: results from the real-world FLEX-

LONG study - R.S. Polavarapu 08:51 V Discussion and audience interaction 08:56 V Euro16A-OP0496 – Two-year clinical outcome in

1,811 all-comers treated with novel coronary DES

in at least one small vessel vs. larger sized vessels

only - L.C. Van Der Heijden 09:04 V Discussion and audience interaction 09:09 V Euro16A-OP0216 – Five-year clinical outcomes

in a real-world population of patients with long

coronary lesions treated with the 38mm cobalt-

chromium everolimus-eluting stent - J. Benezet 09:17 V Discussion and audience interaction 09:22 V Euro16A-OP0503 – Impact of severe target lesion

calcification on the outcome of patients with

stable angina pectoris treated with newer-

generation permanent polymer-coated DES - J. Huisman

09:30 V Discussion and audience interaction 09:35 V Euro16A-OP0838 – Clinical impact of various

types of stent on long-term prognosis of patients

with vasospastic angina - R. Hata 09:43 V Discussion and audience interaction 09:48 V Euro16A-OP0358 – Small vessel treatment with

novel newer-generation DES in all-comers: which

threshold is most appropriate for defining small

coronary vessels? - L.C. Van Der Heijden 09:56 V Discussion and audience interaction



and in the PCR App.



Cases

Multiple cases of DES in-stent restenosis Session comprising selected EuroPCR 2016 clinical case submissions Chairperson: A. MehtaPanellists: E. Lev, R. Natarajan, O. Varenne

08:30 V There are no two without three - A. Jurado-Roman 08:38 V Discussion and audience interaction 08:43 V Re-restenosis after DES in bare-metal stent -

S. Gupta 08:51 V Discussion and audience interaction 08:56 V Between the stents... - P.H. Chan 09:04 V Discussion and audience interaction 09:09 V A case of recurrent in-stent restenosis caused

by calcified nodule: serial observation by OCT - N. Makiguchi

09:17 V Discussion and audience interaction 09:22 V A case of PCI for in-stent restenosis which had

been deployed in the subintimal lumen - T. Asada 09:30 V Discussion and audience interaction 09:38 V The time course of restenosis with black holes

after implantation of platinum-chromium

everolimus-eluting stent: observation using

optimal frequency domain imaging - S. Kikuchi 09:43 V Discussion and audience interaction 09:48 V In-scaffold restenosis, a new kid in the block! -

H. Abu-Hantash 09:56 V Discussion and audience interaction

145

08:30 10:00 ROOM 251


Abstracts

Abstract session for nurses and allied professionals Session comprising selected EuroPCR 2016 abstract submissions Chairpersons: J. Laub, D. Zughaft

08:30 V Euro16A-OP0370 – 3D OCT: from educational tool

to clinical use, a single-centre overview - K. Witberg

08:38 V Discussion and audience interaction 08:43 V Euro16A-OP0384 – Are non-contrast flushing

agents in coronary OCT feasible alternatives to

contrast flushing? - C.H. Egeland 08:51 V Discussion and audience interaction 08:56 V Euro16A-OP0214 – Barriers against improving

flow and capacity in the cathlab: a challenge for

nurse managers - M. Ghorbati 09:04 V Discussion and audience interaction 09:09 V Euro16A-OP0908 – Risk of contrast-induced

nephropathy in patients with impaired kidney

function undergoing ambulatory coronary

angiography - E. Girukwishaka 09:17 V Discussion and audience interaction 09:22 V Euro16A-OP0867 – Reduction of radiation

exposure in the cathlab after addition of new

radiation protocols and sensitisation of cathlab

personnel - L. De Block 09:30 V Discussion and audience interaction 09:35 V Euro16A-OP0140 – High procedural radiation eye

dose found for scrub nurse (second operator)

compared to physician (primary operator):

discovered deficiencies in current, above table

shielding - G. Ison 09:43 V Discussion and audience interaction 09:48 V Euro16A-OP0187 – Prospective study of

peripheral vascular events and one-month

follow-up in patients who have undergone

transfemoral aortic valve replacement - V. Rodriguez Garcia-Abad




and in the PCR App.

08:30 10:00 ROOM 242AB


I have a great idea. How to transform it into a study design? Facilitators: D. Capodanno, C. Cook, R.L.J. OsnabruggeExpert Advisors: L. VerheesMedia Driver: C. Cavazza


VTo understand the pros and cons of different

study designs

VTo be able to select the right trial design to prove

your hypothesis

VTo calculate the sample size of your trial

The PCR Clinical Research Course continues!

Join the next session at 10:30 in Room 242AB.

Seats are limited.

08:30 10:00 ROOM 243

PCR Sharing Centre

Personalised medicine - treating a patient with bifurcation lesion: why we do what we do! Facilitators: R. Mohd Ali, T. Schmitz, G. Sengottuvelu




146

08:30 10:00 ROOM 341


Abstracts

PCR's Got Talent - round 2: session 1 Session comprising selected EuroPCR 2016 abstract submissions Chairpersons: O. Bertrand, A. SauguetJury Members: N. Curzen, B. Honton, F. Kiemeneij, G. Nickenig, I. Petrov, D. Wagner

9 participants selected during the first round

will give a 5min presentation of their abstract

using slides followed by a 3min discussion with

the jury and audience. The jury will deliberate

at the end of the session to announce the

2 participants who will go on to round 3.

08:30 10:00 ROOM 342A

Acute ischaemic stroke intervention Chairpersons: Ö. Göktekin, N. HopkinsPanellists: A. Cremonesi, B. Reimers


VTo discuss proper patient selection in view of

existing evidence

VTo appreciate why it is critical to create or

integrate an acute stroke network for optimal

endovascular treatment

VTo discuss how endovascular treatment can be

safely performed

08:30 V Session objectives - Ö. Göktekin 08:33 V Patient selection - O. Özdemir 08:43 V Discussion and audience interaction 08:51 V New evidence in recent stroke trials - B. Reimers 09:01 V Discussion and audience interaction 09:09 V Practical clinical case - N. Hopkins 09:19 V Discussion and audience interaction 09:27 V Roundtable and discussion and audience

interaction: why it is critical to create or integrate

an acute stroke network for optimal endovascular

treatment - A. Cremonesi , Ö. Göktekin, N. Hopkins, B. Reimers

09:57 V Key learnings and session evaluation - N. Hopkins

08:30 10:00 ROOM 252AB


Learning

Learning below-the-knee angioplasty Facilitators: E. Blessing, T. ZellerMedia Driver: A. BacaksizExpert Panellists: H. Reinecke, E. Vuruskan



step:





08:30 10:00 ROOM 253


All you need to know about TAVI Chairpersons: R. Kornowski, N. Piazza





guidelines



08:30 V Session objectives - R. Kornowski 08:35 V Clinical results with established TAVI devices -

N. Piazza 08:48 V Discussion and audience interaction 08:55 V Technical issues: adjunctive technology to

facilitate and improve outcomes - S. Redwood 09:08 V Discussion and audience interaction 09:15 V Guidelines and recommendations 2016 -

A.S. Petronio 09:28 V Discussion and audience interaction 09:35 V Unresolved issues and outlook - new indications,

new valve systems - D. Mylotte 09:48 V Discussion and audience interaction 09:55 V Session evaluation and key learnings - N. Piazza

147

08:30 10:00 ROOM 343


Abstracts

CTO interventions: it's all about techniques! Session comprising selected EuroPCR 2016 abstract submissions Chairperson: D. DudekPanellists: S. Mansour, M. Ochiai, W. Udayachalerm

08:30 V Euro16A-OP0380 – Predictors for procedure

failure of PCI for CTO with prior CABG surgery:

two-year data from Japanese retrograde SUMMIT

registry - M. Tanabe 08:38 V Discussion and audience interaction 08:43 V Euro16A-OP0963 – Primary use of channel dilator

for antegrade recanalisation of coronary CTO - J. Reifart

08:51 V Discussion and audience interaction 08:56 V Euro16A-OP0105 – Percutaneous intervention

in coronary CTO due to in-stent restenosis:

a multicentre registry - A. Subinas 09:04 V Discussion and audience interaction 09:09 V Euro16A-OP0443 – Treatment of bifurcation

lesions involved in the recanalisation process of

coronary CTO - S. Ojeda 09:17 V Discussion and audience interaction 09:22 V Euro16A-OP0150 – A novel manoeuvre to

facilitate retrograde wire externalisation during

retrograde CTO PCI - R. Jabbour 09:30 V Discussion and audience interaction 09:35 V Euro16A-OP0529 – Outcomes of the antegrade

dissection and re-entry technique as part of the

contemporary, hybrid CTO-PCI practice:

the RECHARGE registry - J. Maeremans 09:43 V Discussion and audience interaction 09:48 V Euro16A-OP0029 – Retrograde approach in CTO:

10-year experience - M. Boukhris 09:56 V Discussion and audience interaction



and in the PCR App.

08:30 10:00 ROOM 342B


Cases

OCT in ACS Session comprising selected EuroPCR 2016 clinical case submissions Chairperson: F. PratiPanellists: M. Ashraf Al Anie, A.B. Catakoglu, N. Uren

08:30 V Unraveling the pathophysiology of non-culprit

disease in ACS: insights from OCT imaging - K. De Silva

08:39 V Discussion and audience interaction 08:45 V Usefulness of OCT in STEMI without culprit lesion -

G. Mouillet 08:54 V Discussion and audience interaction 09:00 V Migrating outflow disease: the value of

intracoronary imaging - H. Khan 09:09 V Discussion and audience interaction 09:15 V Ventricular tachycardia in thrombus recanalisation -

A. Pavei 09:24 V Discussion and audience interaction 09:30 V Severe coronary vasospasm presenting with

STEMI - V. Ploscaru 09:39 V Discussion and audience interaction 09:45 V PCI of a tapered circumflex in a STEMI case -

G. Amoroso 09:54 V Discussion and audience interaction



148

08:30 10:00 ROOM 352A

How Should I Treat?

Denmark and Sweden share their most educational cases: complete revascularisation in STEMI With the collaboration of the Danish Working Group on Interventional Cardiology and the Working Group on Interventional Cardiology of the Swedish Society of Cardiology Chairpersons: T. Engstroem, N. Witt


VTo understand the complexity and the diversity of

the clinical scenarios among patients presenting

with STEMI and multivessel coronary artery

disease

VTo learn about the current evidence base for

different treatment options in this setting

(timing of remote vessel PCI, lesion selection by

physiologic assessment and imaging)

VTo reflect on the prognostic implications of

complete revascularisation in STEMI patients

08:30 V Session objectives - N. Witt 08:35 V Case 1: a STEMI patient with multivessel disease

including a coronary CTO - J. Odenstedt 08:40 V How would I treat the case? - E. Christiansen 08:45 V How would I treat the case? - E. Omerovic 08:50 V How did I treat the case? - J. Odenstedt 09:00 V Discussion and audience interaction 09:10 V Consensus - T. Engstroem 09:15 V Case 2: right coronary artery STEMI with a subtotal

occlusion of the left anterior descending artery - K. Tange Veien

09:20 V How would I treat the case? - E. Omerovic 09:25 V How would I treat the case? - E. Christiansen 09:30 V How did I treat the case? - K. Tange Veien 09:40 V Discussion and audience interaction 09:50 V Consensus - N. Witt 09:55 V Session evaluation and key learnings -

T. Engstroem

08:30 10:00 ROOM 351


Abstracts

Optimising the outcome of left main PCI Session comprising selected EuroPCR 2016 abstract submissions Chairperson: V. SchächingerPanellists: W.H. Ahmed, R. Parma, B. Singh

08:30 V Euro16A-OP0604 – Should we abandon percent

diameter stenosis as an index of left main stenosis

severity? - H.D. Mejia-Renteria 08:38 V Discussion and audience interaction 08:43 V Euro16A-OP0124 – EuroSCORE II strongly predicts

all-cause mortality during follow-up in patients

with significant left main coronary artery disease

undergoing PCI or CABG surgery - S. Moura-Ferreira

08:51 V Discussion and audience interaction 08:56 V Euro16A-OP1073 – Use of customised

measurement planes in imaging of the left main

coronary artery bifurcation: feasibility and first

comparison to standard imaging - T.M. Nielsen 09:04 V Discussion and audience interaction 09:09 V Euro16A-OP0121 – Procedures for left main

coronary artery disease in the real-world clinical

practice - stents, CABG, or hybrid procedures:

a single-centre experience - S. Moura-Ferreira 09:17 V Discussion and audience interaction 09:22 V Euro16A-OP0117 – Choice of revascularisation

mode in relation to coronary artery anatomy,

comorbidities and outcome in patients with

unprotected left main coronary artery stenosis - J.L. Persson

09:30 V Discussion and audience interaction 09:35 V Euro16A-OP0125 – Predictors of all-cause

mortality during follow-up after non-emergent

CABG surgery or PCI due to left main coronary

artery disease - S. Moura-Ferreira 09:43 V Discussion and audience interaction 09:48 V Euro16A-OP0609 – Comparative evaluation of

the left main coronary bifurcation stenting using

different generations of DES - D. Maximkin 09:56 V Discussion and audience interaction



and in the PCR App.

149

08:30 10:00 ROOM 353


Abstracts

BRS for bifurcation PCI Session comprising selected EuroPCR 2016 abstract submissions Chairperson: A. SerraPanellists: P. Agarwal, P. Ludman, J. Wykrzykowska

08:30 V Euro16A-OP0678 – Sequential proximal

optimising technique in provisional bifurcation

stenting with everolimus-eluting BRS - F. Derimay 08:38 V Discussion and audience interaction 08:43 V Euro16A-OP0765 – Everolimus-eluting BRS

implanted in coronary bifurcation lesions:

impact of polymeric wide struts on side-branch

impairment - R. Diletti 08:51 V Discussion and audience interaction 08:56 V Euro16A-OP0731 – Impact of side-branch

post-dilation with a single balloon on scaffold

geometry during the treatment of bifurcation

coronary lesions with simple strategy: an OCT

analysis - J. Suarez de Lezo 09:04 V Discussion and audience interaction 09:09 V Euro16A-OP0061 – In vivo evaluation of the

provisional strategy for an everolimus-eluting

BRS for coronary bifurcation lesions: interim OCT

results - N. Jepson 09:17 V Discussion and audience interaction 09:22 V Euro16A-OP0078 – Clinical outcomes following

bifurcation double stenting with BRS - A. Tanaka 09:30 V Discussion and audience interaction 09:35 V Euro16A-OP0059 – Bifurcational coronary lesions

treated with everolimus-eluting BRS: procedural

strategies and clinical outcomes - D. Robaei 09:43 V Discussion and audience interaction 09:48 V Euro16A-OP1020 – One-year outcomes

of the use of BRS to treat bifurcations - J. Molina-Martin de Nicolas




and in the PCR App.

08:30 10:00 ROOM 352B

How Should I Treat?

Macedonia and the Netherlands share their most educational cases: managing TAVI complications With the collaboration of the Macedonian Society of Cardiology and the Dutch Working Group of Interventional Cardiology (WIC) Chairpersons: S. Kedev, J. Vos


VTo understand the limitations and potential

complications associated with currently available

TAVI devices

VTo learn the potential mechanisms of different

TAVI complications

VTo share various techniques for managing TAVI

complications from real-life practice

08:30 V Session objectives - S. Kedev 08:35 V Case 1: primary PCI for anterior STEMI in a patient

after CoreValve implantation - I. Vasilev 08:40 V How would I treat the case? - J. Baan 08:45 V How would I treat the case? - S. Antov 08:50 V How did I treat the case? - I. Vasilev 09:00 V Discussion and audience interaction 09:10 V Consensus - J. Vos 09:15 V Case 2: transfemoral TAVI in tortuous aorta -

P. Den Heijer 09:20 V How would I treat the case? - S. Antov 09:25 V How would I treat the case? - J. Baan 09:30 V How did I treat the case? - P. Den Heijer 09:40 V Discussion and audience interaction 09:50 V Consensus - S. Kedev 09:55 V Session evaluation and key learnings - J. Vos



150

- 09:00 - 09:35 09:45

MAIN ARENA

Ceremony

2016 EAPCI Award s Chairpersons: F. Hellig, W. WijnsPanellists: E. Grube, K. Hayashida, F. Malik, M. Roffi, F. Weidinger, A. Witkowski

V Announcement of the EAPCI Training and

Research grant Awards - M. Haude



Coronary interventions: Imaging-guided PCI LIVE demonstration Chairpersons: H. Amin, G. StankovicPanellists: A.M. Al Abdullah, G. Ducrocq, H. Gamra, R. Koning, T. Mabin, F. Weidinger


demonstration - H. Amin 09:55 V LIVE demonstration from Bristol Heart Institute -

Bristol, United Kingdom 10:40 V Time to React@PCR





Focus Imaging

Images

An image is worth 1,000 words Session comprising selected EuroPCR 2016 image submissions Facilitators: J.J. Bax, D. Kettles, F. Ribichini

Image 26: rare stent malfunction 08:30 V Image 26: facilitated audience image

interpretation - J.J. Bax 08:35 V Image 26 unveiled and key findings - K. Koegler 08:40 V Image 26: discussion and audience interaction -

J.J. Bax Image 27: atypical shortness of breath with

an equally atypical cause 08:45 V Image 27: facilitated audience image

interpretation - D. Kettles 08:50 V Image 27 unveiled and key findings - V. Ng 08:55 V Image 27: discussion and audience interaction -

D. Kettles Image 28: an unusual cause of inferior

ischaemia 09:00 V Image 28: facilitated audience image

interpretation - F. Ribichini 09:05 V Image 28 unveiled and key findings - R. Hammami 09:10 V Image 28: discussion and audience interpretation

Image 29: a surprising image of 3D optical

frequency domain imaging in left main

bifurcation 09:15 V Image 29: facilitated audience image

interpretation - J.J. Bax 09:20 V Image 29 unveiled and key findings - S. Ishihara 09:25 V Image 29: discussion and audience interpretation -

J.J. Bax Image 30: inflatable valve in the heart


interpretation - D. Kettles 09:35 V Image 30 unveiled and key findings - G. Bruschi 09:40 V Image 30: discussion and audience interpretation -

D. Kettles Image 31: tough access to the renal artery

intervention? 09:45 V Image 31: facilitated audience image

interpretation - F. Ribichini 09:50 V Image 31 unveiled and key findings -

W. Wojakowski 09:55 V Image 31: discussion and audience interaction -

F. Ribichini 151


Focus Innovation

Mitral and tricuspid Session comprising selected EuroPCR 2016 Cardiovascular innovation pipeline submissions Chairpersons: N. Piazza, A. VahanianPanellists: H. Ince, M.B. Leon, H. Moellmann, G. Nickenig

10:30 V Medtronic Intrepid transcatheter mitral valve

replacement - R. Taneja 10:37 V Discussion and audience interaction 10:42 V M-Valve: a novel approach for treatment of mitral

regurgitation - latest update - M. Buchbinder 10:49 V Discussion and audience interaction 10:54 V MIA and Permavalve: transcatheter valve repair

and replacement - W. Hennemann 11:01 V Discussion and audience interaction 11:05 V AccuFit transapical mitral valve replacement

system: technical update - P.W. Serruys 11:12 V Discussion and audience interaction 11:16 V Four-leaflet elliptical transcatheter mitral valve -

G. Agreli 11:23 V Discussion and audience interaction 11:28 V Novel catheter-guided tricuspid valved stent for

secondary tricuspid regurgitation: verification in

chronic animal studies - J.L. Navia 11:35 V Discussion and audience interaction 11:39 V Functional tricuspid regurgitation: an innovative

transcatheter valve repair solution - F. Maisano 11:46 V Discussion and audience interaction 11:50 V Percutaneous tricuspid valve repair: imaging

techniques and early clinical results - F. Praz 11:57 V Discussion and audience interaction

- 10:00 - 10:30 12:00

THEATRE BLEU

PCI in a patient with diseased vein graft Chairpersons: H. Eteiba, M. GilardPanellists: S. Alam, F. Della Rosa, F. Eberli, U. Kaul, F. Malik, S. Mathew


VTo learn the critical issues in patients with

previous CABG

VTo better understand the choice of drugs, stents

and techniques for SVG PCI

VTo learn the tips and tricks for the transradial PCI

of the graft

10:30 V Session objectives - H. Eteiba 10:33 V When and in whom to treat the diseased vein

graft? - P. Kala 10:40 V Time to React@PCR 10:47 V Review of the tools to be used during the LIVE

demonstration - F. Della Rosa 10:53 V LIVE demonstration from Clinique Pasteur -

Toulouse, France 11:33 V Time to React@PCR 11:43 V Which technique, which stent, which approach? -

J. Mehilli 11:50 V Time to React@PCR 11:57 V Session evaluation and key learnings - M. Gilard






152



Hot Line

FFR / iFR Session comprising selected EuroPCR 2016 late-breaking trial submissions Chairperson: C. Di Mario, N.R. HolmPanellists: C. Berry, N. Curzen, J. Davies, L. Di Serafino

10:30 V Impact of routine FFR on management decision

and one-year clinical outcome of ACS patients

insights from the POST-IT and R3F integrated

multicentre registries - implementation of FFR in

routine practice (PRIME-FFR) - L. Raposo 10:42 V Discussion and audience interaction 10:48 V DEFINE REAL: a prospective, observational,

non-randomised, European, multicentre registry,

collecting real-life information for the utilisation

of iFR in assessing coronary stenosis relevance in

the multivessel disease patients population - E. Van Belle

11:00 V Discussion and audience interaction 11:06 V Image-based FFR during coronary catheterisation -

M. Pellicano 11:18 V Discussion and audience interaction 11:24 V Diagnostic accuracy of a fast computational

approach to derive FFR from coronary X-ray

angiography: results from the international

multicentre FAVOR (Functional Assessment by

Various flOw Reconstructions) pilot study - S. Tu 11:36 V Discussion and audience interaction 11:42 V iFR / FFR and IVUS-guided percutaneous coronary

revascularisation with new-generation DES in

patients with de novo three-vessel disease:

30-day outcomes of the SYNTAX II trial - P.W. Serruys



LAA closure for stroke prevention Chairpersons: M.W. Bergmann, E. EeckhoutPanellists: S. Gafoor, F. Hellig, D. Holmes, T. Schmitz


VTo gain insights into the LAA occlusion procedure

VTo understand the strategic work-up, different

devices and implantation techniques

VTo learn about latest data and future

developments

10:30 V Session objectives - M.W. Bergmann 10:33 V Patient selection focused on imaging 10:40 V Time to React@PCR 10:47 V Review of the tools to be used during the LIVE

demonstration - M.W. Bergmann 10:53 V LIVE demonstration from Swiss Cardiovascular


Switzerland 11:33 V Time to React@PCR 11:43 V From recent data to patient follow-up - S. Gafoor 11:50 V Time to React@PCR 11:57 V Session evaluation and key learnings - E. Eeckhout




153



Cases

How to deal with in-stent restenosis bifurcation? Session comprising selected EuroPCR 2016 clinical case submissions Chairperson: A.G. OsievPanellists: M.A.K. Akanda, R. Kumar, M. Pan

10:30 V Treatment dilemma in an aggressive early in-stent

restenosis post bifurcation coronary angioplasty - P. Raju

10:38 V Discussion and audience interaction 10:43 V Fixing a broken shotgun - S.R. Kandan 10:51 V Discussion and audience interaction 10:56 V How to treat an in-stent restenosis in a bifurcation

previously treated with the technique of

minicrushing which was not finished with the

kissing balloon? - L. Dallan 11:04 V Discussion and audience interaction 11:09 V A novel child catheter helps you overcome

difficult coronary stent delivery: dramatic

improvement of backup support - T. Isawa 11:17 V Discussion and audience interaction 11:22 V Management of complex DES in-stent restenosis -

the value of OCT imaging in decision making - S. Balakrishnan Nair

11:30 V Discussion and audience interaction 11:38 V Ostial circumflex in-stent restenosis treated with

BRS - H. Tizon 11:43 V Discussion and audience interaction 11:48 V A stent re-restenosis case after DEB treatment -

S. Mogi 11:56 V Discussion and audience interaction



Learning

Learning how to simplify TAVI Facilitators: S. Redwood, C. Tamburino, N. Van MieghemMedia Driver: S.A. PyxarasExpert Panellists: K. Hayashida, N. Jaussaud


VTo understand who is a suitable patient for TAVI

without general anaesthesia

VTo understand how to safely plan and perform a

simplified transfemoral TAVI

VTo identify the potential benefits of a simplified

procedure



Cases

Challenging anatomy for left main PCI Session comprising selected EuroPCR 2016 clinical case submissions Chairperson: A. BartorelliPanellists: P. Agarwal, S. Salama, E. Torresani

10:30 V Anomalous left main stem from right coronary

cusp and segmental origin of left anterior

descending and left circumflex - H. Shaalan 10:38 V Discussion and audience interaction 10:43 V Primary percutaneous reconstructed left main

stenting in very young patient after repaired

anomalous left coronary artery from the

pulmonary artery - M. Crisci 10:51 V Discussion and audience interaction 10:56 V When the culprit is left main ostium -

S. Narayanan 11:04 V Discussion and audience interaction 11:09 V A challenging case of a large tapered left main

PCI - H. Lu 11:17 V Discussion and audience interaction 11:22 V Sequence and approach of acute total occlusion

of left main stem during diagnostic angiography

in two challenging cases - K. Amber 11:30 V Discussion and audience interaction 11:38 V Complex stenting of ectatic left main stenoses -

P. Kubler 11:43 V Discussion and audience interaction 11:48 V Complex left main bifurcation and left anterior

descending: how do I treat? - M.G. Pillai 11:56 V Discussion and audience interaction



154

10:30 12:00 ROOM 242AB


I am participating in a clinical study. How can I improve my recruitment rate? Facilitators: S. Kedev, M.C. Morice, D. MylotteExpert Advisors: F. Mahfoud, L. Verhees, D. ZughaftMedia Driver: C. Cavazza


VTo learn how to build an efficient team

VTo understand how to set up the logistics for your

recruitment activity

VTo learn tips and tricks on how to improve your

recruitment rate



Seats are limited.

10:30 12:00 ROOM 243

PCR Sharing Centre

X-ray exposure: how to stay healthy and continue practice interventional cardiology Facilitators: P. Capranzano, A. Roguin

10:30 12:00 ROOM 241


Abstracts

PCI procedural optimisation with BRS: advanced technologies Session comprising selected EuroPCR 2016 abstractsubmissions Chairpersons: T. Gori, J. OrmistonPanellists: A. Lafont, L. Räber

10:30 V Euro16A-OP1107 – Quantitative coronary

angiography-maximal lumer diameter as

guidance for appropriate size selection and

deployment of the ABSORB BRS - Y. Ishibashi 10:39 V Discussion and audience interaction 10:45 V Euro16A-OP1111 – Do we need intravascular

imaging for optimisation or quantitative coronary

angiography is enough? - Y. Onuma 10:54 V Discussion and audience interaction 11:00 V Euro16A-OP1109 – Quantification by OCT

imaging of the ablation volume obtained with

the orbital atherectomy system in calcified

coronary lesions - Y. Sotomi 11:09 V Discussion and audience interaction 11:15 V Euro16A-OP1106 – The impact of post-procedural

asymmetry, expansion and eccentricity of

bioresorbable everolimus-eluting scaffold and

metallic everolimus-eluting stent on clinical

outcomes in the ABSORB II trial - P. Suwannasom 11:24 V Discussion and audience interaction 11:30 V Euro16A-OP1110 – Quantitative assessment of

the stent / scaffold strut embedment analysis by

OCT - Y. Sotomi 11:39 V Discussion and audience interaction 11:45 V Euro16A-OP1108 – Shear stress analyses after PCI

with BRS - a convincing tool for seeing results of

optimisation follow-up! - E. Tenekecioglu 11:54 V Discussion and audience interaction



and in the PCR App.


155

10:30 12:00 ROOM 252AB

Revascularisation techniques in critical limb ischaemia Chairpersons: R. Ferraresi, A. SauguetPanellists: I. Alhaddad, M. Bosiers, J.C. Van Den Berg, T. Zeller


VTo discuss what is the standard revascularisation

approach in critical limb ischaemia, specifically in:

- Long tibial CTO

- Focal tibial stenosis

10:30 V Session objectives - R. Ferraresi 10:33 V Review of the tools to be used during the LIVE

demonstration 10:39 V LIVE demonstration from Maria Cecilia Hospital,

GVM Care & Research - Cotignola, Italy 11:39 V Discussion and audience interaction

11:53 V Review of the DEB and DES trials - T. Zeller 11:57 V Session evaluation and key learnings - A. Sauguet



10:30 12:00 ROOM 251


Abstracts

Abstract session for nurses and allied professionals Session comprising selected EuroPCR 2016 abstract submissions Chairpersons: L. Kløvgaard, T. Van Hecke

10:30 V Euro16A-OP0500 – Physical activity during

hospitalisation post-TAVI - an important part of

patient rehabilitation - T.W. Andersen 10:38 V Discussion and audience interaction 10:43 V Euro16A-OP0170 – New training for cathlab /

cardiac care unit nurses - D. Mulder 10:51 V Discussion and audience interaction 10:56 V Euro16A-OP0444 – Radial artery compression

after transradial coronary angiography: does

compression device matter? - N. Due-Tønnessen 11:04 V Discussion and audience interaction 11:09 V Euro16A-OP0309 – The effect of vasodilatory

medications on radial artery spasm in patients

undergoing transradial coronary artery

procedures: a systematic review - E. Curtis 11:17 V Discussion and audience interaction 11:22 V Euro16A-OP0241 – Prehospital cardiac patients

are triaged by nurse specialists - L. Haaber Cohen 11:30 V Discussion and audience interaction 11:35 V Euro16A-OP0726 – Mind the gap: gender

inequities in cardiovascular care - R. Deible 11:43 V Discussion and audience interaction






156

10:30 12:00 ROOM 342A

STENT

FOR LIFE

Pharmaco-invasive strategy for STEMI: worldwide perspective Chairpersons: K. Al-Shaibi, T. CuissetPanellists: E. Merkulov, A. Protopopov


VTo understand the current role of thrombolytic

therapy in the treatment of STEMI

VTo discuss how to optimise the use of pharmaco-

invasive strategy in a non-PCI capable hospital

VTo appraise when and how to apply PCI after lysis

10:30 V Session objectives - T. Cuisset 10:35 V Case 1: how should I treat? Clinical scenario: high-

risk early anterior myocardial infarction with an

anticipated significant transfer delay to PCI centre

in non-PCI centre - K. Al Faraidy 10:40 V How would I treat this patient in India? -

R. Chakraborty 10:47 V How would I treat this patient in Africa? - S. Khan 10:54 V How would I treat this patient in South-East Asia? -

N.Q. Nguyen 11:01 V How did I treat? - K. Al Faraidy 11:31 V Pharmaco-invasive treatment of STEMI: the

evidence "STREAM and beyond" - T. Cuisset 11:41 V How to reduce bleeding risk in pharmaco-

invasive strategy? - G. Cayla 11:51 V Discussion and audience interaction: burning

questions 11:56 V Session evaluation and key learnings - K. Al-Shaibi

10:30 12:00 ROOM 253


Cases

Rotablator for the treatment of calcified left main lesions Session comprising selected EuroPCR 2016 clinical case submissions Chairperson: F. MauriPanellists: T. Lall, A. Marchese, S. Padhi

10:30 V Complex distal left main stem PCI - U.E. Sheikh 10:38 V Discussion and audience interaction 10:43 V Left main bifurcation - rotablation and V stenting -

S.M. Sista 10:51 V Discussion and audience interaction 10:56 V Calcified left main coronary artery stenosis

bifurcation: how do we do? - M.G. Pillai 11:04 V Discussion and audience interaction 11:09 V Left main rotational atherectomy - S.T. Rab 11:17 V Discussion and audience interaction 11:22 V Reverse wire technique followed by rotablation

for calcified distal left main bifurcation lesion - H.R. Li

11:30 V Discussion and audience interaction 11:35 V Rotablation of left main coronary artery stenosis

in NSTE-ACS - M. Sreedharan 11:43 V Discussion and audience interaction 11:48 V Urgent left main rotational atherectomy

supported by extracorporeal membrane

oxygenation in cardiogenic shock patient - K. Wilczek


10:30 12:00 ROOM 341


Abstracts

PCR's Got Talent - round 2: session 2 Session comprising selected EuroPCR 2016 abstract submissions Chairpersons: M. Brodmann, I. MeredithJury Members: H. Faltot, J. Laub, H. Reinecke, M. Valgimigli, S. Von Bardeleben, E. Vuruskan

9 participants selected during the first round

will give a 5min presentation of their abstract

using slides followed by a 3min discussion with

the jury and audience. The jury will deliberate



157

10:30 12:00 ROOM 343


Abstracts

Critical limb ischaemia and below-the-knee interventions Session comprising selected EuroPCR 2016 abstract submissions Chairperson: F. RibichiniPanellists: B. Honton, M.S. Mourali

10:30 V Euro16A-OP0622 – Below-the-knee angioplasty

as limb salvage in critical ischaemia - A.P. Mollon 10:38 V Discussion and audience interaction 10:43 V Euro16A-OP0651 – 24-month results of hybrid

interventions in patients with critical lower limb

ischaemia - D. Maximkin 10:51 V Discussion and audience interaction 10:56 V Euro16A-OP0906 – Outcomes with percutaneous

below-the-knee balloon angioplasty

interventions in patients with critical leg

ischaemia - O. Ozcan Celebi 11:04 V Discussion and audience interaction 11:09 V Euro16A-OP0909 – Minimal footprint implant for

dissection repair after below-the-knee balloon

angioplasty - L. Kubicek 11:17 V Discussion and audience interaction 11:22 V Euro16A-OP1056 – Invasive treatment of critical

hand ischaemia - Z. Ruzsa 11:30 V Discussion and audience interaction 11:35 V Euro16A-OP0691 – BRS for the endovascular

treatment of infrapopliteal lesions in critical limb

ischaemia - D. Garcia 11:43 V Discussion and audience interaction 11:48 V Euro16A-OP0473 – Endovascular arteriovenous

fistula for haemodialysis: initial outcomes from

the Novel Endovascular Access Trial (NEAT) - K. Thomson




and in the PCR App.

10:30 12:00 ROOM 342B


Cases

STEMI in the young: place of OCT Session comprising selected EuroPCR 2016 clinical case submissions Chairperson: H.M. Garcia-GarciaPanellists: D.A. Sinaga, V. Sirbu, K. Toutouzas

10:30 V Acute myocardial infarction following diagnostic

catheterisation in a young woman - A. Bairam 10:38 V Discussion and audience interaction 10:43 V It is not easy with the young - M.A. Ahmed 10:51 V Discussion and audience interaction 10:56 V Usefulness of OCT for the diagnosis and

management of an ACS in a very young patient - C. Biagioni

11:04 V Discussion and audience interaction 11:09 V Myocardial infarction in a very young patient -

V. Rubimbura 11:17 V Discussion and audience interaction 11:22 V STEMI caused by a spontaneous coronary artery

dissection in two vessels: how to manage? - O. Toleva

11:30 V Discussion and audience interaction 11:35 V OCT-supported PCI of spontaneous coronary

artery dissection - R. Vijayvergiya 11:43 V Discussion and audience interaction 11:48 V OCT-guided approach to post-partum coronary

artery dissection: a case report - S. Nava 11:56 V Discussion and audience interaction



158

10:30 12:00 ROOM 352A

How Should I Treat?

Bulgaria and Romania share their most educational cases: challenging situations in the treatment of patients with ACS With the collaboration of the Bulgarian Society of Interventional Cardiology and the Interventional Cardiology Working Group of the Romanian Society of Cardiology Chairpersons: S.D. Mot, D. Trendafilova


VTo understand the possible complexity of so-

called simple primary PCI procedures

VTo learn the techniques that can solve difficult

situations

VTo share the expertise after a large experience in

treating STEMI with primary PCI

10:30 V Session objectives - D. Trendafilova 10:35 V Case 1: left main treatment in a patient with ACS -

I. Jeleva 10:40 V How would I treat the case? - D. Deleanu 10:45 V How would I treat the case? - D. Vassilev 10:50 V How did I treat the case? - I. Jeleva 11:00 V Discussion and audience interaction 11:10 V Consensus - S.D. Mot 11:15 V Case 2: multiple complications of a STEMI case

with a very large thrombus burden - M. Postu 11:20 V How would I treat the case? - D. Vassilev 11:25 V How would I treat the case? - D. Deleanu 11:30 V How did I treat the case? - M. Postu 11:40 V Discussion and audience interaction 11:50 V Consensus - D. Trendafilova 11:55 V Session evaluation and key learnings - S.D. Mot

10:30 12:05 ROOM 351


Abstracts

TAVI in contemporary practice - part 2 Session comprising selected EuroPCR 2016 abstract submissions Chairperson: L. SondergaardPanellists: J. Abdullakutty, M. Ashmawy, U. Gerckens

10:30 V Euro16A-OP0672 – Comparison of balloon-

expandable and mechanically expanded

transcatheter aortic valves: matched comparison

from a single-centre experience - M. Abdel-Wahab 10:38 V Discussion and audience interaction 10:42 V Euro16A-OP0257 – Clinical and

echocardiographic outcome 30-days and one-

year after second-generation balloon expandable

transcatheter heart valve implantation (Edwards

SAPIEN 3) - S. Fateh-Moghadam 10:50 V Discussion and audience interaction 10:54 V Euro16A-OP0266 – Impact of implantation depth

on pacemaker rate and paravalvular leakage after

balloon-expandable TAVI (Edwards SAPIEN 3) - S. Fateh-Moghadam

11:02 V Discussion and audience interaction 11:06 V Euro16A-OP0435 – Multicentre clinical

study evaluating a novel self-expanding and

resheathable transcatheter aortic valve system

six-month results - J. Johnson 11:14 V Discussion and audience interaction 11:18 V Euro16A-OP0350 – Early outcomes of TAVI using

the new-generation CoreValve Evolut R: results

from a single-centre experience - M. Barbanti 11:26 V Discussion and audience interaction 11:30 V Euro16A-OP0826 – Correlation of CoreValve

implantation "true cover index" with paravalvular

regurgitation: implantation depth really matters - K. Kalogeras

11:38 V Discussion and audience interaction 11:42 V Euro16A-OP0151 – Short- and mid-term clinical

outcomes with the repositionable Lotus TAVI

system: a single-centre experience of 100 cases - L. McCormick

11:50 V Discussion and audience interaction 11:54 V Euro16A-OP0372 – Real-life TAVI and isolated

surgical aortic valve replacement, French hospital

data: trends, outcomes and improvements - Candolfi




and in the PCR App.159

10:30 12:00 ROOM 353


Abstracts

Stroke post-TAVI: predictors and preventives Session comprising selected EuroPCR 2016 abstract submissions Chairperson: R. MakkarPanellists: R. Bhindi, A. Bonafé, D. Davidson

10:30 V Euro16A-OP0439 – Prevalance and etiopathology

of thromboembolic debris during transcather

interventional aortic valve replacement:

preliminary results of the SENTINEL H-study - C. Jensen

10:38 V Discussion and audience interaction 10:43 V Euro16A-OP0198 – Silent cerebral injury after TAVI

and the preventive role of embolic protection

devices: a systematic review and meta-analysis - M. Pagnesi

10:51 V Discussion and audience interaction 10:56 V Euro16A-OP0099 – A diffused-weighted-

magnetic resonance imaging and multislice CT

study to assess predictors of cerebral embolism

during TAVI - J. Schofer 11:04 V Discussion and audience interaction 11:09 V Euro16A-OP0937 – Subclinical brain infarctions

but not cerebrovascular microembolic events

after TAVI negatively impact cognitive function

and cerebral morphology in long-term follow-up - A. Ghanem

11:17 V Discussion and audience interaction 11:22 V Euro16A-OP0856 – LAA thrombus in TAVI:

prevalence, clinical impact and the role of cardiac

CT - P.D. Williams 11:30 V Discussion and audience interaction 11:35 V Euro16A-OP0098 – First clinical experience with

the third-generation cerebral embolic protection

device during TAVI - J. Schofer 11:43 V Discussion and audience interaction 11:48 V Euro16A-OP0254 – Procedural and clinical

predictors for 30-day stroke rate after transfemoral

TAVI - S. Fateh-Moghadam 11:56 V Discussion and audience interaction



and in the PCR App.

10:30 12:00 ROOM 352B

How Should I Treat?

Austria and Italy share their most educational cases: challenging TAVI, more than one solution? With the collaboration of the Working Group on Interventional Cardiology of the Austrian Society of Cardiology and the Italian Society of Interventional Cardiology (SICI-GISE) Chairpersons: G. Musumeci, T. Neunteufl


VTo critically assess the chances for a successful

TAVI implantation in patients with atherosclerotic

aortic disease

VTo learn how to manage complex anatomical

situations and procedural complications

10:30 V Session objectives - T. Neunteufl 10:35 V Case 1: transfemoral aortic valve implantation

in a patient with severely calcified low flow, low

gradient aortic stenosis and severely calcifying

atherosclerosis (aorta, aortic arch, femoral vessels,

etc.) - A. Geppert 10:40 V How would I treat the case? - C. Gandolfo 10:45 V How would I treat the case? - G. Delle-Karth 10:50 V How did I treat the case? - A. Geppert 11:00 V Discussion and audience interaction 11:10 V Consensus - G. Musumeci 11:15 V Case 2: double trouble during transfemoral aortic

valve implantation - S. Berti 11:20 V How would I treat the case? - G. Delle-Karth 11:25 V How would I treat the case? - C. Gandolfo 11:30 V How did I treat the case? - S. Berti 11:40 V Discussion and audience interaction 11:50 V Consensus - T. Neunteufl 11:55 V Session evaluation and key learnings -

G. Musumeci



160



Coronary interventions: BRS for long lesion LIVE demonstration Chairpersons: B. Prendergast, W. WijnsPanellists: M. Al Mutairi, Ö. Göktekin, M. Ntsekhe, J.F. Tanguay, A. Witkowski, K.K. Yeo


demonstration - W. Wijns 11:00 V LIVE demonstration from Rashid Hospital,

Dubai Health Authority - Dubai, United Arab

Emirates 11:45 V Time to React@PCR





Focus Imaging

Images

An image is worth 1,000 words Session comprising selected EuroPCR 2016 image submissions Facilitators: J. Bartunek, E. Brochet, T. Modine

Image 32: inferior STEMI in right coronary

artery ectasia 10:30 V Image 32: facilitated audience image

interpretation - J. Bartunek 10:35 V Image 32 unveiled and key findings - M. Jimenez

Kockar 10:40 V Image 32: discussion and audience interaction -

J. Bartunek Image 33: 46-year-old woman complaining of

mild exertional dyspnea 10:45 V Image 33: facilitated audience image

interpretation - E. Brochet 10:50 V Image 33 unveiled and key findings -

A. Lopez Suarez 10:55 V Image 33: discussion and audience interaction -

E. Brochet Image 34: who can do more can the worst?


interpretation - T. Modine 11:05 V Image 34 unveiled and key findings - N. Zaoui 11:10 V Image 34: discussion and audience interaction -

T. Modine Image 35: Swiss cheese or a coronary artery?


interpretation - J. Bartunek 11:20 V Image 35 unveiled and key findings -

A.R.G. Francisco 11:25 V Image 35: discussion and audience interaction -

J. Bartunek Image 36: interventionist perils concealed

in a parasternal cicatrix 11:30 V Image 36: facilitated audience image

interpretation - E. Brochet 11:35 V Image 36 unveiled and key findings - T. Adrega 11:40 V Image 36: discussion and audience interaction -

E. Brochet Image 37: please mind the gap between the

stent struts and... 11:45 V Image 37: facilitated audience image

interpretation - T. Modine 11:50 V Image 37 unveiled and key findings - D. D'Amario 11:55 V Image 37: discussion and audience interaction -

T. Modine


161



Achieving procedural excellence and efficiency with the CoreValve Evolut R system Sponsored by MEDTRONIC Chairperson: L. SondergaardCo-Chairperson: N. PiazzaPanellists: R. Bekeredjian, A. Latib, D. Mylotte, G. Nickenig


VTo learn more on how the evolution in patient

characteristics will impact the TAVI procedure

VTo learn more about the importance of patient

selection, sizing and procedural planning when

attempting to simplify your TAVI procedure safely

VTo learn how to optimise TAVI with Evolut R

without compromise on clinical outcomes and

patient safety

12:30 V Session objectives - L. Sondergaard 12:35 V Treating tomorrow's patients: are all TAVI

technologies created equal? - G. Nickenig 12:45 V LIVE demonstration from Swiss Cardiovascular


Switzerland 13:25 V Time to React@PCR 13:30 V Pre procedural planning: the key for TAVI

simplification - D. Mylotte 13:40 V Time to React@PCR 13:45 V Optimising the TAVI procedure: leveraging

the unique features of the Evolut R system - R. Bekeredjian

13:55 V Time to React@PCR 14:00 V Simplified Evolut R procedure: recorded case

from San Raffaele Hospital - Milan, Italy - A. Latib 14:20 V Time to React@PCR 14:25 V Session evaluation and key learnings - N. Piazza




- 12:00 - 12:30 14:30

THEATRE BLEU


Complex PCI and transradial approach Sponsored by TERUMO Chairperson: J. FajadetCo-Chairperson: C.K. NaberPanellists: A. Al Nooryani, A. Aminian, R. Calvino, M. Gilard, H. Khamis, E.E. Ribeiro, O. Sakhov


VTo appreciate the value of transradial approach

for complex PCI

VTo demonstrate how to optimise challenging

PCI using new dedicated devices in transradial

approach

VTo acknowledge Ultimaster DES results in

complex patients population

12:30 V Session objectives - J. Fajadet 12:33 V Review of the tools to be used during the LIVE

demonstration - J. Fajadet 12:38 V LIVE demonstration from Clinique Pasteur -

Toulouse, France 13:18 V Time to React@PCR 13:25 V Long-term clinical outcomes of patients with

multivessel disease treated with Ultimaster DES - R. Calvino

13:30 V Innovation in transradial access - A. Aminian 13:35 V Review of the tools to be used during the LIVE

demonstration - J. Fajadet 13:40 V LIVE demonstration from Clinique Pasteur -

Toulouse, France 14:20 V Time to React@PCR 14:27 V Session evaluation and key learnings - C.K. Naber






162


Case in Point

Building the next chapter in structural heart - imaging and intervention Sponsored by BOSTON SCIENTIFIC AND SIEMENS HEALTHCARE Chairperson: B. PrendergastCo-Chairperson: A. Vahanian


VTo understand the benefits of advanced

imaging techniques in complex structural heart

interventions

VTo learn how paravalvular leak can be minimised

despite anatomical complexities

VTo expand the usage of LAA closure

12:30 V Session objectives - B. Prendergast 12:35 V Case 1: bicuspid aortic valve - how imaging

improves accuracy of sizing - N. Van Mieghem 12:43 V Discussion and audience interaction 12:52 V Case 2: imaging of complex LAA anatomy and

choice of the right device - T. Schmitz 13:00 V Discussion and audience interaction 13:09 V Case 3: hybrid TAVI and LAA closure - does

imaging optimise outcomes? - H. Ince 13:17 V Discussion and audience interaction 13:26 V Session evaluation and key learnings - A. Vahanian



Learning

Learning PCI in calcified lesions Facilitators: F. Hellig, E. Merkulov, A. OngMedia Driver: L. Tay


VTo review the basic principles, patient and lesion

selection

VTo understand how to safely and successfully use


VTo find out how to overcome or manage the

most frequent issues



Innovative solutions for complex PCI and coronary CTO treatment Sponsored by ASAHI INTECC Chairperson: M. OchiaiCo-Chairperson: G. WernerPanellists: E. Christiansen, R. Garbo, G. Sianos, J. Spratt


VTo improve your skills as a CTO operator

VTo learn about the latest innovations in devices

12:30 V Session objectives - M. Ochiai 12:35 V LIVE demonstration from Bristol Heart Institue -

Bristol, United Kingdom


13:20 V Why should we focus on guiding catheters? -

M. Ochiai 13:30 V Is there place for another microcatheter? -

G. Sianos 13:35 V Guidewire algorithm for complex PCI and CTO

treatment - J. Spratt 13:40 V LIVE demonstration from Bristol Heart Institue -

Bristol, United Kingdom


14:25 V Session evaluation and key learnings - G. Werner




163

12:30 13:30 ROOM 241

Case in Point

A user's guide to drug-coated balloons: enhancing your toolbox for daily practice Sponsored by BIOTRONIK Chairperson: R. ByrneCo-Chairperson: M.V. WainsteinPanellist: P.J.L. Ong


VTo share practical step-by-step teaching how to

use drug-coated balloons in your daily practice

VTo appraise the available evidence for drug-

coated balloons in both in-stent restenosis and

de novo disease

12:30 V Session objectives - R. Byrne 12:35 V Drug-coated balloons in in-stent restenosis: case

presentation - M.V. Wainstein 12:45 V Drug-coated balloons in in-stent restenosis:

concept and evidence - R. Byrne 12:53 V Discussion and audience interaction 13:00 V Drug-coated balloons in de novo disease: case

presentation - M. Vink 13:10 V Drug-coated balloons in de novo disease:

concept and evidence - J. Wöhrle 13:18 V Discussion and audience interaction 13:25 V Session evaluation and key learnings -

M.V. Wainstein

12:30 14:00 ROOM 242AB


Learning

Learning left main stenting Facilitators: D. Kettles, E. KretovMedia Driver: V. KunadianExpert Panellists: K. Al-Shaibi, R. Mohd Ali


VTo discuss possible strategies for optimal left main

stenting

VTo understand what is the best strategy for

each individual patient, taking anatomy into

consideration

VTo better assess the role of imaging

12:30 14:00 ROOM 243

PCR Sharing Centre

Ambulatory diagnostic procedures and interventions: the lounge concept Facilitators: H. Benamer, F. Kiemeneij, E. Van Laer



Cases

Unusual causes of ACS - part 1 Session comprising selected EuroPCR 2016 clinical case submissions Chairpersons: J. Byrne, F. Weidinger

12:30 V A case of coronary stent abscess - A. Vupputuri 12:38 V Discussion and audience interaction 12:43 V Key learnings - A. Mehta 12:45 V Non-compaction cardiomyopathy presenting

as acute myocardial infarction with multivessel

thrombi - a case series - S. Sangaraju 12:53 V Discussion and audience interaction 12:58 V Key learnings - R. Parma 13:00 V Two cases of Kounis syndrome - D.F. Filip 13:08 V Discussion and audience interaction 13:13 V Key learnings - N. Uren 13:15 V Late coronary embolisation from a transcatheter

aortic valve - M. Neuss 13:23 V Discussion and audience interaction 13:28 V Key learnings - M. Sobhy



Cases

How to avoid and solve technical difficulties? Session comprising selected EuroPCR 2016 clinical case submissions Chairpersons: A. Cribier, H. Eltchaninoff

12:30 V Positioning of next-generation balloon-

expandable devices during aortic valve-in-valve:

what all should know - D. Dvir 12:38 V Discussion and audience interaction 12:43 V Key learnings - J. Mehilli 12:45 V TAVI in degenerative sutureless bioprosthesis -

U. Landes 12:53 V Discussion and audience interaction 12:58 V Key learnings - P.H.L. Kao 13:00 V Late coronary artery occlusion after transcatheter

valve-in-valve: a case report - C. Fiorina 13:08 V Discussion and audience interaction 13:13 V Key learnings - G. Wimmer-Greinecker 13:15 V Antegrade transseptal approach for crossing the

valve during a valve-in-valve TAVI procedure - J.G. Córdoba Soriano

13:23 V Discussion and audience interaction 13:28 V Key learnings - L. Nombela-Franco



164

12:30 13:30 ROOM 252AB

Symposium

DES, BRS and DAPT duration – do we now know what's best for our patients? Sponsored by ABBOTT VASCULAR Chairperson: M. ValgimigliCo-Chairperson: R. MehranPanellists: T. Kimura, T. Palmerini, R. Virmani


VTo review and discuss the available evidence on

DAPT duration after DES or BRS implantation

VTo understand the characteristics of polymers and

the impact on patient outcome

VTo learn more about the first evidence on DAPT

duration after BRS implantation

12:30 V Session objectives - R. Mehran Debate on weighing the evidence on DAPT

duration post-DES implantation 12:32 V Pro shorter-term DAPT - M. Valgimigli 12:39 V Pro longer-term DAPT - R. Mehran 12:46 V Discussion and audience interaction

12:53 V Role of polymer thromboresistance in DAPT - R. Virmani

13:03 V Optimal management of my high bleeding risk

patient - T. Palmerini 13:10 V Discussion and audience interaction 13:14 V DAPT discontinuation one year after BRS

implantation - R.J. Van Geuns 13:21 V Discussion and audience interaction 13:25 V Session evaluation and key learnings -

M. Valgimigli

12:30 14:00 ROOM 251

Case in Point

STENT

FOR LIFE

From LEADERS FREE to clinical practice: a case-based approach in tailoring stent treatment to patients and their bleeding risk Sponsored by BIOSENSORS INTERNATIONAL Chairperson: P. UrbanCo-Chairperson: C. Tamburino


VTo understand the criteria for high bleeding risk

patients and to identify these patients in clinical

practice

VTo understand how a drug-coated stent allows

DAPT to be shortened and tailored to the

individual patient

VTo explore how biodegradable-polymer and

polymer-free drug-coated stents provide

solutions to patients with or without a high

bleeding risk

12:30 V Session objectives - C. Tamburino 12:35 V Case 1: from DAPT to triple therapy, increasing the

risk of bleeding - G. Richardt 12:43 V Discussion and audience interaction 12:55 VCase 2: elderly patient with multiple

comorbidities - G. Sardella 13:03 V Discussion and audience interaction 13:15 V Case 3: uncertain bleeding risk in the case of

STEMI - D. Carrié 13:23 V Discussion and audience interaction 13:35 V Case 4: coronary stenting in patients scheduled

for TAVI - R. Moreno 13:43 V Discussion and audience interaction 13:55 V Session evaluation and key learnings - P. Urban

165

wx

高亮

12:30 13:30 ROOM 341


Cases

How to improve the guiding support? Session comprising selected EuroPCR 2016 clinical case submissions Chairpersons: S. Khan, P. L' Allier

12:30 V Novel use of guiding extension catheter in the

complex bifurcation lesion - T. Warisawa 12:38 V Discussion and audience interaction 12:43 V Key learnings - I. Petrov 12:45 V Novel use of a guide catheter extension and the

telescope technique to facilitate primary PCI in a

patient with anterior STEMI and a severely dilated

aortic root - S. Velu 12:53 V Discussion and audience interaction 12:58 V Key learnings - E. Stabile 13:00 V The use of a novel guide catheter extension

system during PCI of an anomalous right

coronary artery arising from the left sinus of

Valsalva - T. Isawa 13:08 V Discussion and audience interaction 13:13 V Key learnings - H. Gamra 13:15 V Szabo technique to stabilise a dancing stent -

A. Bairam 13:23 V Discussion and audience interaction 13:28 V Key learnings - K. Niemela

12:30 13:30 ROOM 253


Cases

Mitral valvuloplasty, unusual cases Session comprising selected EuroPCR 2016 clinical case submissions Chairpersons: F. Begum, E. Brochet

12:30 V The sole witnessed catecholamine-induced

iatrogenic Takotsubo cardiomyopathy during

percutaneous balloon mitral valvuloplasty - M. Toluey

12:38 V Discussion and audience interaction 12:43 V Key learnings - J. Goicolea 12:45 V Subacute transient atrioventricular block after

percutaneous mitral valvuloplasty - S. Mayordomo Gómez

12:53 V Discussion and audience interaction 12:58 V Key learnings - S. El Tobgi 13:00 V Percutaneous balloon mitral valvotomy and PCI in

a patient with kyphoscoliosis in the same sitting - J.P. Gnanaraj

13:08 V Discussion and audience interaction 13:13 V Key learnings - S. Von Bardeleben 13:15 V A non-thrombotic cerebral accident

during percutaneous transvenous mitral

commissurotomy - A. Firouzi 13:23 V Discussion and audience interaction 13:28 V Key learnings - E. Eeckhout



166

12:30 13:30 ROOM 342B


CRO / ARO

Planned and ongoing clinical trials: a status update from Cardialysis and the European Cardiovascular Research Institute (ECRI) With the collaboration of Cardialysis and the European Cardiovascular Research Institute (ECRI) Chairpersons: P.W. Serruys, G.A. Van Es




VTo gain in depth understanding of trial design

and execution



12:30 V Session objectives - G.A. Van Es 12:35 V SYNTAX III revolution - P.W. Serruys 12:42 V Discussion and audience interaction 12:45 V AF-PCI: edoxaban in PCI patients with atrial

fibrillation - P. Vranckx 12:52 V Discussion and audience interaction 12:55 V TARGET AC: all-comer trial - W. Wijns 13:02 V Discussion and audience interaction 13:05 V ACCUFIT first-in-man study - F. Maisano 13:12 V Discussion and audience interaction 13:15 V High bleeding risk under DAPT - P. Smits 13:22 V Discussion and audience interaction 13:25 V Session evaluation and key learnings - P.W. Serruys

12:30 14:00 ROOM 342A

Case in Point

The Portico valve: where expertise meets simplicity. Please join us for case studies to learn more about the true ease of use advantages in prep, placement and control of this system Sponsored by ST. JUDE MEDICAL Chairperson: R. MakkarCo-Chairperson: G. Manoharan


VTo understand how a novel technology - Portico -

is addressing current therapy pitfalls

VTo learn about use of Portico valve for challenging

femoral access and how it optimises treatment of

complex clinical scenarios

VTo learn more about the aortic replacement and

master tips and tricks in a real case simulation

12:30 V Session objectives - R. Makkar 12:35 V Case 1: unique case without arterial introducer

sheaths in patients with reduced-caliber, tortuous

and calcified vessels by using the new-generation

aortic prosthesis Portico valve - G. Sorropago 12:43 V Discussion and audience interaction 12:55 V Case 2: the use of Portico valve in challenging

femoral accesses - M. Van Wely 13:03 V Discussion and audience interaction 13:15 V Case 3: Portico valve - how a recapturable system

designed for positioning accuracy is changing

the game in highly challenging cases - J. Kefer 13:23 V Discussion and audience interaction 13:35 V Case 4: why is Portico valve the choice in patient

with severe coronary artery disease - F. Nietlispach 13:43 V Discussion and audience interaction 13:55 V Session evaluation and key learnings -

G. Manoharan

167

12:30 14:00 ROOM 351

Case in Point

My patient is presenting with an acute coronary syndrome (ACS) requiring PCI: TiNOX coated bioactive stent is non-inferior to Xience V (everolimus-eluting) stent! Sponsored by HEXACATH Chairpersons: B. De Bruyne, P. KarjalainenFacilitators: T. Cuisset, J. MarcoSpeakers: V. Kanic, G. Mobilia, M. MosseriMedia Driver: G. Kompara

By attending this session, together we will

critically reflect on the use of DES in patients

presenting with ACS in order to:

VCollaboratively consider for which patients it is

better to avoid DES and why

VPropose an evidence-based alternative to

everolimus-eluting stent (Xience V) for ACS

patients

12:30 14:00 ROOM 352A

Overcoming radiation exposure risk in interventional cardiology With the collaboration of the EAPCI Women Committee Chairpersons: P. Presbitero, A. RoguinPanellists: N. Karan, G. Mikhail


VTo learn about radiation exposure and risks

VTo learn about radiation exposure as a female

interventional cardiologist

VTo learn about radiation and technical issues

12:30 V Session objectives - P. Presbitero 12:35 V Biological effect of chronic radiation - results of

the GISI survey - E. Piccaluga 12:43 V Discussion and audience interaction 12:55 V How do I protect patient and myself in complex

procedures - A. Chieffo 13:03 V Discussion and audience interaction 13:15 V Catheter intervention during pregnancy - is it

really a risk? - G. Boccuzzi 13:23 V Discussion and audience interaction 13:35 V How to work in interventional cardiology during

pregnancy - my personal experience - M. Velázquez

13:43 V Discussion and audience interaction 13:55 V Session evaluation and key learnings - A. Roguin

12:30 13:30 ROOM 343


CRO / ARO

Planned and ongoing clinical trials: a status update from Cardiovascular European Research Centre (CERC) With the collaboration of Cardiovascular European Research Centre (CERC) Chairpersons: B. Chevalier, M.C. Morice




VTo gain in-depth understanding of trial design

and execution



12:30 V Session objectives - M.C. Morice 12:35 V LEADERS FREE: how will further planned analyses

modulate the conclusions? - M.C. Morice 12:42 V Discussion and audience interaction 12:45 V STRENGTH trial: RenalGuard to prevent contrast-

induced nephropathy in complex PCI and

TAVI procedures for patients with renal failure

recruitment ongoing - H. Sievert 12:52 V Discussion and audience interaction 12:55 V EBC MAIN one or two stents for treating complex

distal left main lesions? Recruitment ongoing - D. Hildick-Smith

13:02 V Discussion and audience interaction 13:05 V VIVA trial: CoreValve in degenerated prostetic

valve recruitment ongoing - B. Chevalier 13:12 V Discussion and audience interaction 13:15 V SENIOR trial is SYNERGY stent superior to bare-

metal stent in patients older than 75-year-old

with similar short-term DAPT - recruitment

finished, population and procedural results - O. Varenne

13:22 V Discussion and audience interaction 13:25 V Session evaluation and key learnings - B. Chevalier



168

12:30 13:30 ROOM 353


Cases

ACS: unusual anatomies, unusual mechanisms Session comprising selected EuroPCR 2016 clinical case submissions Chairpersons: J. Koolen, F. Mauri

12:30 V Vasopastic angina: a forgotten ACS - F. Rey 12:38 V Discussion and audience interaction 12:43 V Key learnings - F. Malik 12:45 V Spontaneous coronary dissection: one problem,

three-step solution 12:53 V Discussion and audience interaction 12:58 V Key learnings - E. Lev 13:00 V Intracoronary imagenology in primary PCI: to

understand mechanism and select treatment

strategy - M. Araya 13:08 V Discussion and audience interaction 13:13 V Key learnings 13:13 V Key learnings - H.M. Garcia-Garcia 13:15 V Care for ladies - spontaneous coronary dissection

in STEMI - A. Pavei 13:23 V Discussion and audience interaction 13:28 V Key learnings - G. Olivecrona

12:30 14:30 ROOM 352B

Complications

Iraq, Jordan and Tunisia share their most educational cases: selected serious complications of PCI - recognition and solutions With the collaboration of the Iraqi Working Group on Interventional Cardiology of the Iraqi Cardio-Thoracic Society, the Jordan Working Group on Interventional Cardiology and the Tunisian Working Group on Interventional Cardiology (GTCI) Chairpersons: I. Alhaddad, T. Alkinani, K. Ben HamdaPanellist: M. Al-Kuraishi


VTo recognise and understand potential serious

complications of PCI

VTo learn different strategies in solving such

complications

VTo share knowledge and experience during

interactive and educational discussion

12:30 V Session presentation - I. Alhaddad 12:33 V Session objectives - T. Alkinani 12:36 V Case 1: coronary perforation during PCI - a safe

ending - M. Albakri 12:44 V Discussion and audience interaction 12:54 V Case 2: iatrogenic aortic dissection during

coronary CTO PCI - Z. Belhadj 13:02 V Discussion and audience interaction 13:12 V Case 3: stent detachment during left main stem

coronary angioplasty - A. Mirza 13:20 V Discussion and audience interaction 13:30 V Case 4: dissection of aorta, left main, left anterior

descending and left circumflex artery during

primary PCI for anterior STEMI - Z. Alqaqa 13:38 V Discussion and audience interaction 13:48 V Case 5: accidental retrieval of a DES after its

deployment - N. Hajlaoui 13:56 V Discussion and audience interaction 14:06 V Case 6: fractured wire and damaged stent caused

by pulling back a folded-over wire - H. Riyadh 14:14 V Discussion and audience interaction 14:24 V Session evaluation and key learnings -

K. Ben Hamda

169

- 13:00 - 13:35 14:35

ROOM MAILLOT

Case in Point

Practical approaches and novel technology to optimise left main procedure outcome Sponsored by MEDTRONIC Chairperson: G. StankovicCo-Chairperson: H.S. Kim


VTo reflect on practical cases of one-stent and

two-stents techniques

VTo benefit from examples of complication

prevention in complex left main cases

VTo learn about usefulness of novel generation

DES dedicated to large vessel treatment

13:35 V Session objectives - G. Stankovic 13:40 V Provisional approach for distal left main stenting -

A. Banning 13:47 V Discussion and audience interaction 13:57 V Technique for double stenting in unprotected left

main - M. Kurdi 14:04 V Discussion and audience interaction 14:14 V Complication prevention in real-word complex

left main cases - J. Escaned 14:21 V Discussion and audience interaction 14:31 V Session evaluation and key learnings - H.S. Kim


Focus Imaging

Images

An image is worth 1,000 words Session comprising selected EuroPCR 2016 image submissions Facilitators: V. Bapat, C. Grasso, M. Radu

Image 38: 03:00 am nightmare 12:30 V Image 38: facilitated audience image

interpretation - V. Bapat 12:33 V Image 38 unveiled and key findings - S.R. Kandan 12:37 V Image 38: discussion and audience interaction -

V. Bapat Image 39: high transmitral gradient early after

transcatheter mitral valve implantation 12:40 V Image 39: facilitated audience image

interpretation - C. Grasso 12:43 V Image 39 unveiled and key findings - G. Capretti 12:47 V Image 39: discussion and audience interaction -

C. Grasso Image 40: unusual cause of pericardial effusion


interpretation - M. Radu 12:53 V Image 40 unveiled and key findings - A. Nicolino 12:57 V Image 40: discussion and audience interaction -

M. Radu Image 41: a paranormal finding on coronary

angiography 13:00 V Image 41: facilitated audience image

interpretation - V. Bapat 13:03 V Image 41 unveiled and key findings - S. Degrauwe 13:07 V Image 41: discussion and audience interaction -

V. Bapat Image 42: is that really a coronary artery?


interpretation - C. Grasso 13:13 V Image 42 unveiled and key findings -

M. Nobre Menezes 13:17 V Image 42: discussion and audience interaction -

C. Grasso Image 43: how should I explain and treat this

angiographic findings? 13:20 V Image 43: facilitated audience image

interpretation - M. Radu 13:23 V Image 43 unveiled and key findings - T. Warisawa 13:27 V Image 43: discussion and audience interaction -

M. Radu




170

13:3514:35 ROOM 241

Symposium

Trialign: transcatheter annuloplasty for the treatment of tricuspid regurgitation Sponsored by MITRALIGN Chairperson: N. Moat


VTo learn about imaging of the tricuspid valve

VTo gain an understanding on tricuspid

regurgitation

VTo understand transcatheter options for tricuspid

regurgitation

13:35 V Session objectives - N. Moat 13:40 V Trialign technology overview - S. Kar13:52 V Discussion and audience interaction

13:57 V Case reports from Hamburg - J. Schofer 14:09 V Discussion and audience interaction

14:14 V The surgeon's experience - J. Seeburger 14:26 V Discussion and audience interaction

14:31 V Session evaluation and key learnings - N. Moat

13:35 14:35 ROOM 253


Cases

Percutaneous treatment of the mitral valve Session comprising selected EuroPCR 2016 clinical case submissions Chairpersons: C. Ruiz, A. Vahanian

13:35 V Session objectives - G. Dangas 13:39 V TAVI: a paradigm shift in the treatment of aortic

stenosis - past, present and future - M.B. Leon 13:47 V Discussion and audience interaction 13:52 V Future perspective and upcoming studies -

P. Vranckx 14:00 V Discussion and audience interaction 14:05 V Solved and unsolved issues of antithrombotic

therapy after TAVI - U. Landmesser 14:13 V Discussion and audience interaction 14:18 V Valve leaflet motion abnormality - R. Makkar 14:26 V Discussion and audience interaction 14:31 V Session evaluation and key learnings - R. Welsh



Cases

Unusual causes of ACS - part 2 Session comprising selected EuroPCR 2016 clinical case submissions Chairpersons: F. Eberli, F. Malik

13:35 V Migration of thrombus from right coronary

artery to circumflex through intercoronary

communication - G. Parale 13:43 V Discussion and audience interaction 13:48 V Key learnings - A. Serra 13:50 V An unusual case of post-operative STE following

CABG surgery - S. Ubaid 13:58 V Discussion and audience interaction 14:03 V Key learnings - F. Burzotta 14:05 V Complete regression of severe left main coronary

artery stenosis after pulse steroid therapy in a

patient with Takayasu arteritis - B. Karadag 14:13 V Discussion and audience interaction 14:18 V Key learnings - P. L' Allier 14:20 V A paradoxal ACS - A. Azzano 14:28 V Discussion and audience interaction 14:33 V Key learnings - O. Varenne



Cases

TAVI in pure aortic regurgitation Session comprising selected EuroPCR 2016 clinical case submissions Chairpersons: J. Goicolea, S. Redwood

13:35 V Is rescue TAVI becoming a possible emergent

therapy? - F. De Vroey 13:43 V Discussion and audience interaction 13:48 V Key learnings - M. Chen 13:50 V First-in-man percutaneous implantation of the

Symetis neotranscatheter heart valve in pure

aortic regurgitation - A.G. Cerillo 13:58 V Discussion and audience interaction 14:03 V Key learnings - K. Hayashida 14:05 V Second-generation transcatheter valve for the

treatment of aortic regurgitation - S. Koul 14:13 V Discussion and audience interaction 14:18 V Key learnings - M. Balghith 14:20 V First-in-man transfemoral TAVI with a self-

expanding valve for the treatment of uncalcified

aortic regurgitation - S. Toggweiler 14:28 V Discussion and audience interaction 14:33 V Key learnings - A.S. Petronio

171

13:35 14:35 ROOM 341


Cases

When do we need FFR? Session comprising selected EuroPCR 2016 clinical case submissions Chairpersons: N.H. Pijls, E. Schampaert

13:35 V FFR-guided revascularisation of the single right

coronary artery - Z. Koszegi 13:43 V Discussion and audience interaction 13:48 V Key learnings - G. Toth 13:50 V IVUS vs. FFR in ostial left main stenosis: an unusual

case - M. Araya 13:58 V Discussion and audience interaction 14:03 V Key learnings - E. Regar 14:05 V Myocardial bridge - ventricular tachycardia and

false positive pressure wire study - S. Sangaraju 14:13 V Discussion and audience interaction 14:18 V Key learnings - M. Meuwissen 14:20 V Myocardial bridging of left anterior descending

presented with ACS: coronary CT angiography,

FFR and IVUS-guided treatment with self-

expandable balloon releasable DES - F. Fouladvand 14:28 V Discussion and audience interaction 14:33 V Key learnings - M. Abdel-Wahab

13:35 14:35 ROOM 253


Cases

Percutaneous treatment of the mitral valve Session comprising selected EuroPCR 2016 clinical case submissions Chairpersons: C. Ruiz, A. Vahanian

13:35 V Successful treatment of severe mitral

regurgitation with mitral valve commissural

prolapse utilising occluder device following

transcatheter edge-to-edge mitral valve repair - S. Kubo

13:43 V Discussion and audience interaction 13:48 V Key learnings - H. Ince 13:50 V Inflatable TAVI in mitral ring to treat mitral

regurgitation - G. Bruschi 13:58 V Discussion and audience interaction 14:03 V Key learnings - R. Kornowski 14:05 V The avant-garde of structural intervention:

simultaneous percutaneous transseptal mitral

valve-in-valve and leak closure - J. Ribeiro 14:13 V Discussion and audience interaction 14:18 V Key learnings - C. Grasso 14:20 V Transseptal implantation of a balloon-expandable

transcatheter heart valve in a minimally calcified

mitral annulus for treatment of radiation-induced

valvulopathy - F. Praz 14:28 V Discussion and audience interaction 14:33 V Key learnings - S. Von Bardeleben



172

13:35 14:35 ROOM 343


CRO / ARO

Planned and ongoing clinical trials: a status update from the Cardiovascular Research Centre (CRC) With the collaboration of Cardiovascular Research Centre (CRC) Chairpersons: A.S. Abizaid, M.C. Morice




VTo gain in-depth understanding of trial design

and execution



13:35 V Session objectives - A. Abizaid 13:39 V Innovative metallic DES clinical programmes:

DISCOVERY, MERIT series - IBiOSS, BIOFREEDOM

FIM/EGO, REVELUTION - R. Costa 13:49 V Discussion and audience interaction 13:52 V Next-generation BRS clinical trials: DESOLVE,

MIRAGE FIM, PHANTOM, MERES - J.D.R. Costa Jr 14:02 V Discussion and audience interaction 14:05 V Applying customised OCT methodologies to

evaluate different BRS - D. Chamié 14:15 V Discussion and audience interaction 14:18 V First-in-man studies to evaluate new transcatheter

valve replacement systems: Symetis ACURATE I /

NAUTILUS / Millipede IRIS / M VALVE DOCK I - A. Abizaid

14:28 V Discussion and audience interaction 14:31 V Session evaluation and key learnings - A.S. Abizaid

13:35 14:35 ROOM 342B


CRO / ARO

Planned and ongoing clinical trials: a status update from Uppsala Clinical Research Centre (UCR) With the collaboration of Uppsala Clinical Research Centre (UCR) Chairpersons: S. James, C. Varenhorst


VTo be updated on ongoing registry based

randomised clinical trials that may change our

future practice

VTo gain in-depth understanding of register

randomised clinical trial design and execution

13:35 V Session objectives - J. Oldgren 13:40 V Bivalirudin vs. heparin in NSTEMI and STEMI

in patients on modern antiplatelet therapy in

SWEDEHEART - D. Erlinge 13:47 V Discussion and audience interaction 13:50 V DETOX-AMI: determination of the role of oxygen

in acute myocardial infarction - R. Hofmann 13:57 V Discussion and audience interaction 14:00 V SWEDEPAD: swedish drug-elution trial in

peripheral artery disease - DES vs. bare-metal

stent and DEB vs. plain old-balloon angioplasty - M. Falkenberg

14:07 V Discussion and audience interaction 14:10 V PROSPECT II: providing regional observations to

study predictors of events in the coronary tree-

two - G.W. Stone 14:17 V Discussion and audience interaction 14:20 V SPIRIT HFPEF: spironolactone initiation registry

randomised interventional trial in heart failure

with preserved ejection fraction - L. Lund 14:27 V Discussion and audience interaction 14:30 V Session evaluation and key learnings -

C. Varenhorst

173

Image 46: a terrifying case of cardiogenic shock 13:55 V Image 46: facilitated audience image

interpretation - A. Wolf 13:58 V Image 46 unveiled and key findings - S. Liu 14:02 V Image 46: discussion and audience interaction -

A. Wolf

Image 47: electoanatomical mapping provides

images on distinct patterns of systolic rotation

of the heart in heart failure 14:05 V Image 47: facilitated audience image

interpretation - G. Ducrocq 14:08 V Image 47 unveiled and key findings -

W. Wojakowski 14:12 V Image 47: discussion and audience interaction -

G. Ducrocq

Image 48: coronary angiogram and...

an incidental finding 14:15 V Image 48: facilitated audience image

interpretation - D. Foley 14:18 V Image 48 unveiled and key findings -

S. Moura-Ferreira 14:22 V Image 48: discussion and audience interaction -

D. Foley Image 49: cough responsible of myocardial

infarction 14:25 V Image 49: facilitated audience image

interpretation - A. Wolf 14:28 V Image 49 unveiled and key findings - N. Zaoui 14:32 V Image 49: discussion and audience interaction -

A. Wolf

13:35 14:35 ROOM 353


Cases

Complications of LAA and ASD closure Session comprising selected EuroPCR 2016 clinical case submissions Chairpersons: S. Berti, H. Sievert

13:35 V An unusual complication of LAA closure - M. Eskandari

13:43 V Discussion and audience interaction 13:48 V Key learnings - E. Garcia 13:50 V Percutaneous retrieval of LAA occluder -

F. Colombo 13:58 V Discussion and audience interaction 14:03 V Key learnings - M.W. Bergmann 14:05 V Successful retrieval of ASD closure device with a

challenging approach - A. Khosravi 14:13 V Discussion and audience interaction 14:18 V Key learnings - M. Behan 14:20 V Lost occluder - two different scenarios - K. Gorican 14:28 V Discussion and audience interaction 14:33 V Key learnings - A. Tzikas


Focus Imaging

Images

An image is worth 1,000 words Session comprising selected EuroPCR 2016 image submissions Facilitators: G. Ducrocq, D. Foley, A. Wolf

Image 44: incidental finding of a bubble-

shaped mass during coronary angiography 13:35 V Image 44: facilitated audience image

interpretation - G. Ducrocq 13:38 V Image 44 unveiled and key findings - T. Bochenek 13:42 V Image 44: discussion and audience interaction -

G. Ducrocq Image 45: a patient with three prior aortic valve

replacements 13:45 V Image 45: facilitated audience image

interpretation - D. Foley 13:48 V Image 45 unveiled and key findings - N. Ryan 13:52 V Image 45: discussion and audience interaction -

D. Foley



174


eeuro

20

16

- 14:00 - 14:45 15:45

MAIN ARENA


Coronary interventions: PCI of complex bifurcation LIVE demonstration Chairpersons: I. Al Rashdan, M. GilardPanellists: E. Eeckhout, K. Hayashida, U. Kaul, P. L' Allier, J. Mehilli, N.E.J. West


LIVE demonstration - I. Al Rashdan 14:50 V LIVE demonstration Rashid Hospital, Dubai

Health Authority - Dubai, United Arab Emirates






Developing basic skills in antegrade CTO intervention Chairpersons: J. Escaned, M. YamanePanellists: E. Barbato, H.J. Büttner, K.T. Chan, M. Lesiak, M. Ochiai, T. SchmitzCommentator: J. Spratt


VTo learn which anatomy is suitable for antegrade

approach to CTO PCI

VTo apply a stepwise approach to antegrade CTO

PCI

VTo understand the benefits of appropriate tool

selection in each step

With continuous LIVE demonstration from Bristol

Heart Institute - Bristol, United Kingdom

With continuous time to React@PCR

14:45 V Session objectives - J. Escaned 14:47 V Review of the tools and technique to be used

during the LIVE demonstration - E. Barbato V Patient selection and procedure planning for

antegrade approach - G. Werner V Wires and catheters for successful antegrade CTO

intervention: the toolbox - Ö. Göktekin V Wire escalation and dissection re-entry

techniques in antegrade approach - G. Sianos 16:12 V Session evaluation and key learnings - M. Yamane







176


Devices for the interventional management of heart failure Chairpersons: D. Burkhoff, S. RedwoodPanellists: J. Bartunek, A. Erglis, T. Santoso, J. Van Der Heyden


VTo understand the role of device-based

interventions within the multidisciplinary

management of heart failure

VTo become familiar with tools for appropriate

patient and procedural selection

VTo learn about the available evidence and clinical

outcomes of device-based interventions in heart

failure

14:45 V Session objectives - S. Redwood 14:48 V Physiological principals and evidence to date -

D. Burkhoff 14:58 V Time to React@PCR 15:05 V Catheter-based interventions for tailored

management of heart failure: why, when and

what? - A. Erglis 15:15 V Time to React@PCR 15:22 V Interatrial shunt device in a patient with heart

failure with preserved ejection fraction: selection

and procedural aspects - Case presentation from

Cardiovascular Centre - Aalst, Belgium - J. Bartunek

16:02 V Time to React@PCR 16:12 V Session evaluation and key learnings - D. Burkhoff



Focus Innovation

Vulnerable plaque: future directions Chairpersons: M. Joner, R. WaksmanPanellists: T. Akasaka, K. Al-Shaibi, V. Farooq, D. Holmes, P.G. Steg, R. Virmani


VTo get an update on novel invasive and non-

invasive imaging tools to detect vulnerable

plaque

VTo become familiar with the new developments

in hybrid intravascular imaging

VTo gain insights about innovative endovascular

approaches of plaque sealing

14:45 V Session objectives - M. Joner 14:50 V Non-invasive imaging: for screening and

preclinical diagnosis - D. Newby 14:58 V Discussion and audience interaction 15:10 V Lessons learnt from the first applications of hybrid

intravascular imaging modalities - C. Bourantas 15:18 V Discussion and audience interaction 15:30 V Attention to the non-culprit lesion: is it hot or

cold? To treat or not to treat? - D. Erlinge 15:38 V Discussion and audience interaction 15:50 V Trials supporting the invasive sealing of high-risk

lesions: status update - P.W. Serruys 15:58 V Discussion and audience interaction 16:10 V Session evaluation and key learnings - R. Waksman

177



Cases

Complications during left main intervention Session comprising selected EuroPCR 2016 clinical case submissions Chairperson: M. SobhyPanellists: F. Kiemeneij, H.M. Kwon, P.H. Lo

14:45 V An ordinary case of exceptional disaster:

a nightmare in left main stenting - M. Bande 14:53 V Discussion and audience interaction 14:58 V Ruptured wire in a heavy calcified left main -

Q. Labarre 15:06 V Discussion and audience interaction 15:11 V I wish I had not done that - U. Rao 15:19 V Discussion and audience interaction 15:24 V Left main stem bifurcation: a divided outcome -

M. Dooley 15:32 V Discussion and audience interaction 15:37 V An unavoidable PCI - A. Deshpande 15:45 V Discussion and audience interaction 15:50 V Shooting in the dark - nightmare in the cathblab -

N.B. Senguttuvan 15:58 V Discussion and audience interaction 16:03 V Always be ready to treat left main bifurcation

during primary PCI - C.F. Lin 16:11 V Discussion and audience interaction


Focus Innovation

Innovation in TAVI: new devices and outlook for new applications Chairpersons: F. Hellig, B. PrendergastPanellists: M. Abdelghani, M. Chen, P.H.L. Kao, G. Yucel


VTo gain insight into novel technology available for

aortic valve implantation

VTo review early data for devices and accessories

which have just been introduced

VTo discuss the future of TAVI procedures in the

light of novel developments

14:45 V Session objectives - F. Hellig 14:50 V Novel devices: most recent first-in-human and

CE-marked TAVI devices - C. Tamburino 15:00 V Discussion and audience interaction 15:10 V Novel device-based approaches for stroke

prevention - E. Grube 15:20 V Discussion and audience interaction 15:30 V New imaging strategies for procedural planning

and follow-up - N. Piazza 15:40 V Discussion and audience interaction 15:50 V Does technological progress allow expansion of

current indications? - A. Vahanian 16:00 V Discussion and audience interaction 16:10 V Session evaluation and key learnings -

B. Prendergast



Learning

Learning mitral edge-to-edge repair with MitraClip Facilitators: E. Brochet, S. Von BardelebenMedia Driver: S. HoussanyExpert Panellist: A. Al Nooryani


VTo identify the key tips and tricks for a successful

MitraClip procedure

VTo understand how to avoid and manage

potential complications



178

14:45 16:15 ROOM 241


Abstracts

New insights in renal denervation Session comprising selected EuroPCR 2016 abstract submissions Chairperson: R. SchmiederPanellists: K. Chawla, Y.G. Yap, F. Zannad

14:45 V Euro16A-OP0733 – Renal denervation with two

radiofrequency catheters: impact of branch vs.

distally focused main renal artery denervation

in a porcine model - F. Mahfoud 14:53 V Discussion and audience interaction 14:58 V Euro16A-OP1074 – New-generation renal artery

denervation systems: assessing lesion size and

thermodynamics using a thermochromic liquid

crystal phantom - S. Al Raisi 15:06 V Discussion and audience interaction 15:11 V Euro16A-OP1079 – Transcatheter perivascular

alcohol denervation addresses technical

challenges of energy-based renal denervation - S. Bertog

15:19 V Discussion and audience interaction 15:24 V Euro16A-OP0228 – Systematic evaluation

of haemodynamic parameters to predict

haemodynamic responders to renal artery

denervation - J. Davies 15:32 V Discussion and audience interaction 15:37 V Euro16A-OP0097 – Renal haemodynamic

changes after renal denervation - C. Ott 15:45 V Discussion and audience interaction 15:50 V Euro16A-OP0091 – Efficacy of percutaneous

renal denervation in a swine model of

mineralocorticoid-induced arterial hypertension - A. Perez de Prado

15:58 V Discussion and audience interaction 16:03 V Euro16A-OP1105 – Cost-effectiveness threshold

analysis of various age and systolic blood pressure

reduction scenarios for renal denervation therapy - R. Schmieder




and in the PCR App.



Cases

PCI of diseased SVG Session comprising selected EuroPCR 2016 clinical case submissions Chairperson: S. BertiPanellists: A. Bartorelli, J. Ezhilan, M.H. Pham

14:45 V Old SVG with important degeneration treated

with self-expandable DES: our experience - C. Moncalvo

14:53 V Discussion and audience interaction 14:58 V Stenting of a SVG through double layer of self-

expandable transcatheter aortic valve struts - D. D'Amario

15:06 V Discussion and audience interaction 15:11 V Local stent delivery technique for challenging

SVG intervention: the treasure key - M. Pellicano 15:19 V Discussion and audience interaction 15:24 V A tough graft - S.T. Rab 15:32 V Discussion and audience interaction 15:37 V Unusual indication of rotational atherectomy:

SVG resistant lesion - B. Zoghlami 15:45 V Discussion and audience interaction 15:50 V Beyond the coronaries: primary PCI of a vein graft -

G. Latsios 15:58 V Discussion and audience interaction 16:03 V IVUS-guided antegrade CTO recanalisation with

contralateral contrast injection through occluded

bypass - S.A. Pyxaras 16:11 V Discussion and audience interaction

179

14:45 16:15 ROOM 251


The role of nurses and allied professionals in managing procedure-related complications Chairpersons: S. Griggio, V. Rodriguez Garcia-AbadFacilitators: L. Hinterbuchner, K. Wilson


VTo understand that prevention is better than cure

VTo know what is the best tool box for nurses and

allied professionals

VTo improve team and patient communication

before, during and after a procedure-related

complication

14:45 V Session objectives - S. Griggio 14:50 V The human factor: the importance of

communication - G. Rocchi Four clinical cases

15:00 V Iatrogenic in structural heart disease - R. Fernandes 15:10 V Discussion and audience interaction 15:14 V Plaque displacement - M. Longoni 15:24 V Discussion and audience interaction 15:28 V Femoral complication - H. Santiago 15:38 V Discussion and audience interaction 15:42 V Air embolisation - V. Rodriguez Garcia-Abad 15:52 V Discussion and audience interaction

15:56 V The nurse and allied professional's role in

complication reduction - M. Bowers


16:10 V Session evaluation and key learnings - V. Rodriguez Garcia-Abad




14:45 16:15 ROOM 252AB


Learning

Learning carotid artery stenting step by step Facilitators: O. Al Shammeri, A. Cremonesi, E. VuruskanMedia Driver: C. JensenExpert Panellist: W. Gray



step:



- Preventing and managing potential procedure-


14:45 16:15 ROOM 242AB


I have my clinical data. How can I analyse it by myself? Facilitators: D. Capodanno, S. Kedev, R.L.J. OsnabruggeExpert Advisors: I. Durand ZaleskiMedia Driver: C. Cavazza


VTo select the right statistical tests for your study

VTo be able to run simple statistics

VTo balance clinical relevance with statistical

significance



Seats are limited.

14:45 16:15 ROOM 243

PCR Sharing Centre

Complex PCI in practice : cardiologists, nurses and allied professionals working together as an effective team to identify, avoid and resolve issues Facilitators: J. Adjedj, S. Carson, G. Cayla, J. Marco, C. O'Sullivan, D. Zughaft

At the end of this collaborative session,

cathlab teams (cardiologists, nurses and allied

professionals) will be able:

VTo identify in a patient's file the essential and

controversial issues

VTo propose solutions and alternatives for optimal

tailored decision-making in order to achieve the

best clinical outcome



180

14:45 16:15 ROOM 341


Abstracts

PCR's Got Talent - round 2: session 3 Session comprising selected EuroPCR 2016 abstract submissions Chairpersons: G. Manoharan, M. ValgimigliJury Members: T. Adriaenssens, S. Al Shaikh, M. Al Zaibag, H. Kelbaek, M.D. Lobo, T. Van Hecke

9 participants selected during the first round will

give a 5min presentation of their abstract using

slides followed by a 3min discussion with the

jury and audience. The jury will deliberate



14:45 16:15 ROOM 342A

ANZET@EuroPCR - Coronary intervention downunder With the collaboration of the Australia and New Zeland Endovascular Therapies Meeting (ANZET) Chairpersons: J. Stewart, W. WijnsPanellists: D. Muller, D. Walters


VTo get insights into the mechanisms of late stent

failure

VTo understand the place of CTO angioplasty in

coronary revascularisation

VTo be updated on PCI in STEMI and left main stem

disease

14:45 V EuroPCR welcomes ANZET - W. Wijns 14:47 V Session objectives - J. Stewart 14:50 V Mechanisms of late stent failure - insights from

OCT - P. Barlis 14:58 V Discussion and audience interaction 15:10 V How to simplify CTO angioplasty? - S. Harding 15:18 V Discussion and audience interaction 15:30 V STEMI intervention: dilemmas on the front line -

R. Bhindi 15:38 V Discussion and audience interaction 15:50 V Case-based insights into left main stem

angioplasty - S. Shetty 15:58 V Discussion and audience interaction 16:10 VSession evaluation and key learnings - D. Walters

14:45 16:15 ROOM 253


Abstracts

PCI in elderly patients: can't we do better? Session comprising selected EuroPCR 2016 abstract submissions Chairperson: C. KaiserPanellists: L. Bolognese, K. Kadota, C. Spaulding

14:45 V Euro16A-OP0357 – Clinical outcome of PCI in

elderly and very elderly patients: one-year results

from a tertiary-centre experience - Monello 14:53 V Discussion and audience interaction 14:58 V Euro16A-OP0654 – A retrospective study of

nonagenarian PCI in the setting of a non-surgical

centre in the United Kingdom - P.P. Sadarmin 15:06 V Discussion and audience interaction 15:11 V Euro16A-OP0213 – Long-term outcomes of first-

and second-generation DES in elderly patients

(KATOWICE-ZABRZE registry) - W. Wanha 15:19 V Discussion and audience interaction 15:24 V Euro16A-OP0328 – Effects of age and sex on

clinical outcomes after PCI relative to CABG in

patients with triple vessel coronary artery disease - K. Yamaji

15:32 V Discussion and audience interaction 15:37 V Euro16A-OP0807 – PCI in octogenarians: a risk-

scoring system to predict outcomes - J. Cockburn 15:45 V Discussion and audience interaction 15:50 V Euro16A-OP0710 – Underuse of coronary

intervention in elderly with myocardial infarction

and its effect on mortality: a propensity-matched

analysis of the Hungarian MYOCARDIAL

INFARCTION registry - A. Komócsi 15:58 V Discussion and audience interaction 16:03 V Euro16A-OP0452 – Effect of aging on ischaemic

and bleeding outcomes in patients undergoing

a prolonged vs. shortened duration of DAPT:

insights from the PRODIGY trial - R. Piccolo 16:11 V Discussion and audience interaction



and in the PCR App.

181

14:45 16:15 ROOM 343


Abstracts

Contemporary DES: focus on bioresorbable polymers - part 1 Session comprising selected EuroPCR 2016 abstract submissions Chairperson: L. Nombela-FrancoPanellists: M. Mani, E. Regar, S. Verheye

14:45 V Euro16A-OP0833 – Contemporary real-life PCI

practices: three-month clinical outcomes in

patients treated with thin- vs. thick-strut DES - data

from two large, international registries - J. Polad 14:53 V Discussion and audience interaction 14:58 V Euro16A-OP0324 – Clinical outcomes in 995

unselected real-world patients treated with

an ultra-thin biodegradable polymer-coated

sirolimus-eluting stent: 12-month results from the

FLEX registry - A. Abhyankar 15:06 V Discussion and audience interaction 15:11 V Euro16A-OP0550 – Long-term clinical outcomes

of coronary DES with bioresorbable coating:

results of the CENTURY study - B. Beleslin 15:19 V Discussion and audience interaction 15:24 V Euro16A-OP0169 – Final five-year clinical

outcomes in the EVOLVE trial: a randomised

evaluation of a novel bioabsorbable polymer-

coated everolimus-eluting stent - I. Meredith 15:32 V Discussion and audience interaction 15:37 V Euro16A-OP0708 – Assessment of strut coverage

of biodegradable polymer DES at one, two and

three months after stent implantation by optical

frequency domain imaging: final results of

DISCOVERY 1TO3 study - B. Chevalier 15:45 V Discussion and audience interaction 15:50 V Euro16A-OP0545 – Long-term clinical outcomes

of patients with multivessel coronary artery

disease after treatment with thin-strut DES with

bioresorbable polymer: results from CENTURY II

trial - B. Chevalier 15:58 V Discussion and audience interaction 16:03 V Euro16A-OP1048 – Randomised comparison

of sirolimus-eluting and biolimus-eluting

bioresorbable polymer stents: the SORT-OUT VII

OCT study - L.N. Andreasen 16:11 V Discussion and audience interaction



and in the PCR App.

14:45 16:15 ROOM 342B


Cases

When OCT gives the diagnostic Session comprising selected EuroPCR 2016 clinical case submissions Chairperson: F. PratiPanellists: G. Cassel, V. Sirbu, H.C. Tan

14:45 V Beware the non-diagnostic angiogram - C.Y. Chin 14:53 V Discussion and audience interaction 14:58 V Hidden tears - B. Vandeloo 15:06 V Discussion and audience interaction 15:11 V Discovering the pearl found in coronary artery -

H.F.D. Chow 15:19 V Discussion and audience interaction 15:24 V Embolic coronary occlusion demonstrated with

OCT - N. Gonzalo 15:32 V Discussion and audience interaction 15:37 V STEMI with normal coronary angiogram: an

unexpected intravascular imaging finding that

led to plaque sealing - M. Oliveira-Santos 15:45 V Discussion and audience interaction 15:50 V Loss of flow in right coronary artery post-PCI:

optical frequency domain imaging saves the day! - A. Khurana

15:58 V Discussion and audience interaction 16:03 V Intraluminal narrowing in ACS value of

intracoronary imaging - S. Khan 16:11 V Discussion and audience interaction



182

14:45 16:15 ROOM 352A

How Should I Treat?

Hungary and Serbia share their most educational cases: complex coronary interventions in ACS patients With the collaboration of the Hungarian Association of Cardiovascular Intervention and the Working Group on Catheterisation and Percutaneous Coronary Interventions of the Cardiology Society of Serbia Chairpersons: B. Merkely, S. Stojkovic


VTo emphasise the role of IVUS in complex left

main coronary artery intervention

VTo understand how to approach a very large left

main coronary artery with new designed self-

expandable DES

VTo highlight feasibility and safety and to disclose

the tips of IVUS-guided two-stent technique in

a bifurcation lesion with heavily calcified side-

branch stenosis in a NSTEMI patient

14:45 V Session objectives - B. Merkely 14:50 V Case 1: IVUS-guided bifurcational left main

coronary artery intervention with self-expandable

DES in ACS - Z. Ruzsa 14:55 V How would I treat the case? - M.A. Nedeljkovic 15:00 V How would I treat the case? - Z. Piroth 15:05 V How did I treat the case? - Z. Ruzsa 15:15 V Discussion and audience interaction 15:25 V Consensus - S. Stojkovic 15:30 V Case 2: IVUS-guided balloon crush technique in a

true bifurcation with heavily calcified side-branch

stenosis in a NSTEMI patient - D. Orlic 15:35 V How would I treat the case? - Z. Piroth 15:40 V How would I treat the case? - M.A. Nedeljkovic 15:45 V How did I treat the case? - D. Orlic 15:55 V Discussion and audience interaction 16:05 V Consensus - B. Merkely 16:10 V Session evaluation and key learnings - S. Stojkovic

14:45 16:15 ROOM 351


Abstracts

TAVI in contemporary practice - part 1 Session comprising selected EuroPCR 2016 abstract submissions Chairperson: N. Van MieghemPanellists: H. Eltchaninoff, C.P. Lin, N. Trehan

14:45 V Euro16A-OP0386 – Clinical impact of aortic valve

predilatation during TAVI with a third-generation

balloon-expandable valve - M. Spaziano 14:53 V Discussion and audience interaction 14:58 V Euro16A-OP0175 – Next-generation transcatheter

heart valves improve clinical outcomes in patients

undergoing TAVI - J.M. Sinning 15:06 V Discussion and audience interaction 15:11 V Euro16A-OP0719 – TAVI with second-generation

Evolut R, comparison with first-generation

CoreValve: a single-centre experience - C. Fiorina 15:19 V Discussion and audience interaction 15:24 V Euro16A-OP0069 – A comparison between first-

generation and second-generation TAVI devices:

a propensity-matched single-centre experience - M.B. Ancona

15:32 V Discussion and audience interaction 15:37 V Euro16A-OP0282 – Improving on current

outcomes: matched comparison of novel vs. first-

generation self-expandable transcatheter heart

valves - L. Conradi 15:45 V Discussion and audience interaction 15:50 V Euro16A-OP0699 – Comparison of balloon-

expandable vs. self-expandable transcatheter

prostheses with regard to the degree of

calcification of the aortic valve and aortic root:

do we need more than one TAVI device? - J. Blumenstein

15:58 V Discussion and audience interaction 16:03 V Euro16A-OP0466 – The repositionable Lotus

Valve for transfemoral aortic valve implantation in

patients with symptomatic severe aortic stenosis:

impact of valve size - B. Gonska 16:11 V Discussion and audience interaction



and in the PCR App.

183

14:45 16:15 ROOM 353


Abstracts

Rotary ablation for heavily calcified stenosis Session comprising selected EuroPCR 2016 abstract submissions Chairperson: C. Di MarioPanellists: J. Elias, E. Khedi, G. Toth

14:45 V Euro16A-OP0866 – Rotational atherectomy in the

DES era: a single-centre experience - D.K. Baruah 14:53 V Discussion and audience interaction 14:58 V Euro16A-OP0071 – The comparison of strategies

to prepare severely calcified coronary lesions:

rotational atherectomy vs. cutting balloon - K. Amemiya

15:06 V Discussion and audience interaction 15:11 V Euro16A-OP0976 – Long-term outcomes of

patients undergoing rotational atherectomy due

to failed PCI depend on the reason of primary

intervention failure - W. Zimoch 15:19 V Discussion and audience interaction 15:24 V Euro16A-OP0606 – Establishing interventional

technologies to treat non-dilatable stents: an

expanding role for excimer coronary laser? - V. Kodoth

15:32 V Discussion and audience interaction 15:37 V Euro16A-OP0107 – Coronary rotational

atherectomy during TAVI: immediate and long-

term results of a consecutive series - F. Ribichini 15:45 V Discussion and audience interaction 15:50 V Euro16A-OP0668 – Long-term clinical outcome

of early-generation vs. new-generation DES in

patients undergoing rotational atherectomy - A. Allali

15:58 V Discussion and audience interaction 16:03 V Euro16A-OP0410 – Direct stenting after orbital

atherectomy - E. Shlofmitz 16:11 V Discussion and audience interaction



and in the PCR App.

14:45 16:15 ROOM 352B

How Should I Treat?

Morocco and Saudi Arabia share their most educational cases: how to manage a dissection or a thrombus during bifurcation PCI With the collaboration of the Working Group on Interventional Cardiology of the Moroccan Society of Cardiology (SMC) and the Saudi Arabian Cardiac Interventional Society (SACIS) Chairpersons: K. Al Faraidy, A. Chaara


VTo discuss bifurcation strategies

VTo discuss complications of PCI specifically acute

stent thrombosis and the use of a circulatory

support

VTo discuss further long-term DAPT

14:45 V Session objectives - K. Al Faraidy 14:50 V Case 1: culotte, when the trousers are too risky -

M. Alasnag 14:55 V How would I treat the case? - M. Sabry 15:00 V How would I treat the case? - A. Waqar 15:05 V How did I treat the case? - M. Alasnag 15:15 V Discussion and audience interaction 15:25 V Consensus - A. Chaara 15:30 V Case 2: double dissection complicating

a bifurcation stenosis - D. Benzarouel 15:35 V How would I treat the case? - A. Waqar 15:40 V How would I treat the case? - M. Sabry 15:45 V How did I treat the case? - D. Benzarouel 15:55 V Discussion and audience interaction 16:05 V Consensus - K. Al Faraidy 16:10 V Session evaluation and key learnings - A. Chaara



184

- 15:00 - 15:50 16:50

MAIN ARENA


Coronary interventions: PCI of complex bifurcation LIVE demonstration Chairpersons: T.H. Koh, R. KornowskiPanellists: M. Balghith, R.J. Gil, D. Hildick-Smith, F. Mauri, S. Saito, D. Tresukosol


LIVE demonstration - R. Kornowski 15:55 V LIVE demonstration from Clinique Pasteur -

Toulouse, France 16:40 V Time to React@PCR






Abstracts

Renal failure: patterns, therapeutic strategies and outcomes Session comprising selected EuroPCR 2016 abstract submissions Chairperson: R. MehranPanellists: B. Goyal, F. Sharif, G.G. Stefanini

14:45 V Euro16A-OP0919 – Impact of prasugrel vs.

clopidogrel in the presence of chronic kidney

disease in ACS PCI: results from the PROMETHEUS

study - J. Chandrasekhar 14:53 V Discussion and audience interaction 14:58 V Euro16A-OP0425 – Renal artery resistance index

and flow-mediated dilation after diagnostic

coronary angiography, a possible correlation: our

experience - A. Dachille 15:06 V Discussion and audience interaction 15:11 V Euro16A-OP0308 – A first-in-man evaluation of a

novel contrast media saving device, the DyeVert

system - J. Sapontis 15:19 V Discussion and audience interaction 15:24 V Euro16A-OP0421 – Outcomes of orbital

atherectomy in patients with end-stage renal

disease on dialysis - E. Shlofmitz 15:32 V Discussion and audience interaction 15:37 V Euro16A-OP0375 – Renal function post-TAVI,

a significant predictor of mortality: introducing

the ACEF-7 score - S. Obeid 15:45 V Discussion and audience interaction 15:50 V Euro16A-OP0447 – Chronic kidney disease

and acute kidney injury stages after TAVI - R.A. Meneguz-Moreno

15:58 V Discussion and audience interaction 16:03 V Euro16A-OP0687 – Unique coronary lesion

characteristics in haemodialysis patients as

assessed by OCT - C.Y. Chin 16:11 V Discussion and audience interaction



and in the PCR App.


185


Focus Innovation

DES and scaffolds Session comprising selected EuroPCR 2016 Cardiovascular innovation pipeline submissions Chairpersons: R. Byrne, H. CallPanellists: C. Bourantas, J.J. Cheng, R. Dawood, B. Eryonucu, G.G. Stefanini, K.K. Yeo

16:30 V Slender sirolimus-eluting coronary stent-on-a-

wire integrated delivery system - G. Amoroso 16:37 V Discussion and audience interaction 16:42 V Mechanical properties of a novel drug-filled

coronary stent: comparison with standard DES - N. Foin

16:49 V Discussion and audience interaction 16:54 V PCI with the angiolite DES: an OCT study.

The ANCHOR study - J. Rodes Cabau 17:01 V Discussion and audience interaction 17:05 V Innovative balloon technology designed to

minimise vessel trauma - C. Lotan 17:12 V Discussion and audience interaction 17:16 V Smart scaffolds - A. Mathur 17:23 V Discussion and audience interaction 17:27 V Combining magnesium and polylactide to create

a novel BRS: Unity hybrid scaffold - Y. Onuma 17:34 V Discussion and audience interaction 17:38 V Fully resorbable stent: programme and update -

S. Dinesh 17:45 V Discussion and audience interaction 17:49 V Multicentric retrospective registry of polymer-free

DES: all-comers and diabetics analysis (INVESTIG8) - G. Sardella


- 16:00 - 16:30 18:00

THEATRE BLEU

Developing basic skills in retrograde CTO intervention Open-end session: it ends when it is open!

Chairpersons: J. Escaned, M. YamanePanellists: Ö. Göktekin, P. Ludman, S. Rinfret, T. Santoso, A. Serra, G. SianosCommentator: J. Spratt


VTo learn which anatomy is suitable for retrograde

approach to CTO

VTo apply a stepwise approach to retrograde PCI

VTo understand the benefits of appropriate tool

selection in each step

With continuous LIVE demonstration from

Bristol Heart Institute - Bristol, United Kingdom

With continuous time to React@PCR

16:30 V Session objectives - J. Escaned 16:32 V Review of the tools and technique to be used

during the LIVE demonstration - Ö. Göktekin V When should retrograde approach be considered

as a primary PCI strategy? - S. Sumitsuji V Selecting collaterals for safe and successful wire

crossing - S. Rinfret V My wire has reached the target vessel - what

now? - H.A. Noor 17:57 V Session evaluation and key learnings - M. Yamane






186


Focus Innovation

CT innovation for TAVI optimisation Chairpersons: K. Hayashida, B. PrendergastPanellists: M. Buchbinder, M. Chen, F. Civaia, A. Ghanem


VTo learn about recent CT innovations for the

diagnosis of aortic stenosis and planning of TAVI

procedures

VTo become familiar with the use of

comprehensive CT analysis to optimise TAVI

outcomes

VTo discuss emerging CT technologies geared

towards online TAVI device selection

16:30 V Session objectives - K. Hayashida 16:35 V Reclassification of aortic stenosis severity using

3D CT analysis - J.J. Bax 16:43 V Discussion and audience interaction 16:55 V Detection of valve leaflet functionality and

thrombosis using 4D dynamic CT - L. Sondergaard 17:03 V Discussion and audience interaction 17:15 V New tools to predict and avoid TAVI complications

using comprehensive CT examination - J. Leipsic 17:23 V Discussion and audience interaction 17:35 V Emerging CT-based technologies to optimise TAVI

device selection - N. Piazza 17:43 V Discussion and audience interaction 17:55 V Session evaluation and key learnings -

B. Prendergast



Learning

Learning pericardiocentesis Facilitators: C. Kyriakakis, M. NtsekheMedia Driver: C. JensenExpert Panellist: F. Bourlon


VTo explore the different types of pericardial

effusion

VTo learn how to choose the most appropriate

approach for pericardial drainage

VTo master the steps for safe pericardiocentesis



Cases

TAVI complications - part 1 Session comprising selected EuroPCR 2016 clinical case submissions Chairperson: S. RedwoodPanellists: K. El Merri, U. Gerckens, M. Gilard

16:30 V Challenging the limit of TAVI - C.K.K. Kwok 16:38 V Discussion and audience interaction 16:43 V A transaortic approach complication case during

TAVI: its management and differences with other

routes - S. Fournier 16:51 V Discussion and audience interaction 16:56 V Unexpected complications in a seemingly

straightforward TAVI case - A.G. Cerillo 17:04 V Discussion and audience interaction 17:09 V Balloon post-dilatation after TAVI implantation:

another source of complication - D. Chin 17:17 V Discussion and audience interaction 17:22 V TAVI: what can go wrong? - W. Mattar 17:30 V Discussion and audience interaction 17:35 V Acute post-procedural left ventricular

deterioration following TAVI - K. Tigen 17:43 V Discussion and audience interaction 17:48 V Unexpected valve-in-valve complication: what we

should have excluded before intervention - D. Dvir 17:56 V Discussion and audience interaction

187



Cases

Challenging PCI in patients with prior CABG Session comprising selected EuroPCR 2016 clinical case submissions Chairperson: A. MehtaPanellists: A. Iyisoy, G. Musumeci, R. Singh

16:30 V PCI of RIMA - the real challenge! - J. Marques 16:38 V Discussion and audience interaction 16:45 V Usefulness of triple-step support system for

severe stenosis in the anastomosis site - N. Kokubu 16:53 V Discussion and audience interaction 17:00 V V-stenting in a LIMA to left anterior descending

artery bypass graft - L.M. Predescu 17:08 V Discussion and audience interaction 17:15 V A recurrent case of unstable angina at site of the

synthetic graft after Bentall operation - T. Shibasaki 17:23 V Discussion and audience interaction 17:30 V Successful revascularisation after open repair for

big pseudoaneurysm of vein graft for distal right

coronary artery - E. Ko 17:38 V Discussion and audience interaction 17:45 V CTO and left main coronary artery stenosis

T-stenting and small protrusion - D. Kumar 17:53 V Discussion and audience interaction



Cases

Atherectomy for the treatment of calcified lesions Session comprising selected EuroPCR 2016 clinical case submissions Chairperson: F. RibichiniPanellists: H. Al Guindy, A. Khan, M. Loutfi

16:30 V Debulking strategy - S. Gupta 16:38 V Discussion and audience interaction 16:43 V Subintimal Tracking And Re-entry (STAR) after

failed rotablation as a bailout alternative - V. Sasi 16:51 V Discussion and audience interaction 16:56 V Acutely recoiling stent after rotablation in

proximal left anterior descending artery:

how to salvage the situation! - A. Khurana 17:04 V Discussion and audience interaction 17:09 V OCT-guided treatment of severely calcified

in-stent restenosis with orbital atherectomy - E. Shlofmitz

17:17 V Discussion and audience interaction 17:22 V The light at the end of the tunnel: the use of laser

atherectomy in complex high-risk PCI - S. Arri 17:30 V Discussion and audience interaction 17:38 V Complex revascularisation in NSTEMI elderly

patient with comorbidities - L. Calmac 17:43 V Discussion and audience interaction 17:48 V When is a buddy not your friend? - G. Fahrni 17:56 V Discussion and audience interaction



188

16:30 18:00 ROOM 242AB


I have completed my study. How to write an abstract and get it accepted? Facilitators: C. Cook, M.C. Morice, D. MylotteExpert Advisors: P. Cummins, P.W. SerruysMedia Driver: C. Cavazza


VTo improve your abstract writing

VTo hear from peers, abstract graders and

programme committee

VTo maximise your chance of beeing accepted

16:30 18:00 ROOM 243

PCR Sharing Centre

How to recognise, anticipate and treat most frequent coronary complications Facilitators: P. Calvert, M. Haude, O. Muller

16:30 18:00 ROOM 241


Abstracts

Long-term clinical outcomes after DES implantation Session comprising selected EuroPCR 2016 abstract submissions Chairperson: S. JamesPanellists: P.H.L. Kao, Q.T. Nguyen, A. Roguin

16:30 V Euro16A-OP0045 – Independent predictors of

major adverse cardiac events at different time

points after the treatment of non-selected

patients with DES: an analysis of the DESIRE

registry - J.D.R. Costa Jr 16:38 V Discussion and audience interaction 16:43 V Euro16A-OP0989 – Long-term outcomes of plain

old balloon angioplasty only compared to DES

performed as landmark analysis more than one

year after procedure in the SCAAR registry - S. Koul 16:51 V Discussion and audience interaction 16:56 V Euro16A-OP0941 – Long-term follow-up in a cohort

of patients with DES (second- and third-generation)

in the setting of acute STEMI - G. Pimentel Morales 17:04 V Discussion and audience interaction 17:09 V Euro16A-OP0709 – Direct implantation of

rapamycin-eluting stents with bioresorbable drug

carrier technology utilising the Svelte coronary

stent-on-a-wire: the DIRECT II study two-year

follow-up - A. Khattab 17:17 V Discussion and audience interaction 17:22 V Euro16A-OP0502 – Clinical event rates and chest

pain five years after treatment with durable

polymer zotarolimus-eluting and everolimus-

eluting coronary stents in participants of the

randomised TWENTE trial - C. Von Birgelen 17:30 V Discussion and audience interaction 17:35 V Euro16A-OP0361 – Safety and efficacy of

treating all-comers with novel zotarolimus- and

everolimus-eluting coronary stents: three-year

outcome of the randomised DUTCH PEERS trial - L.C. Van Der Heijden

17:43 V Discussion and audience interaction 17:48 V Euro16A-OP0404 – Four-year results from the

multicentre PROMUS Element European Post-

Approval (PE-Prove) registry: outcomes in 1,010

unselected patients treated with a platinum-

chromium everolimus-eluting stent - R. Moreno 17:56 V Discussion and audience interaction



and in the PCR App.


189

16:30 18:00 ROOM 252AB

Carotid angioplasty anno 2016 Chairpersons: M. Roffi, A. SauguetPanellists: W. Gray, B. Honton, S. Kedev, P. Montorsi


VTo discuss what is the standard approach for a

safe carotid angioplasty and stenting procedure

today

VTo evaluate new access options and devices

16:30 V Session objectives - A. Sauguet 16:33 V Review of the tools to be used during the LIVE

demonstration - M. Roffi 16:39 V LIVE demonstration from Maria Cecilia Hospital,

GVM Care & Research - Cotignola, Italy 17:39 V Discussion and audience interaction




16:30 18:00 ROOM 251


Cases

Clinical case session for nurses and allied professionals Session comprising selected EuroPCR 2016 clinical case submissions Chairpersons: J. Laub, T. Van Hecke

16:30 V A novel double-guide and triple-kissing

technique of complex distal left main primary PCI - B. Nallaperumal

16:38 V Discussion and audience interaction 16:43 V Combined catheter ablation and LAA closure as a

hybrid procedure for the treatment of persistent

atrial fibrillation - M. Van Der Heijden 16:51 V Discussion and audience interaction 16:56 V Use of an automated chest compression device

during cardiopulmonary resuscitation in our

cathlab - N. Koufakis 17:04 V Discussion and audience interaction 17:09 V A challenging percutaneous transluminal

angioplasty of left subclavian artery - B. Nallaperumal

17:17 V Discussion and audience interaction 17:22 V Usefulness of intracardiac echocatheter in

percutaneous transluminal septal myocardial

ablation for hypertrophic obstructive

cardiomyopathy - A. Yamauchi 17:30 V Discussion and audience interaction 17:35 V Use of real-time patient skin dose imaging

system to prevent significant skin damage during

complex PCI - G. Ison 17:43 V Discussion and audience interaction 17:48 V Right coronary artery dissection - M. Van Der

Heijden 17:56 V Discussion and audience interaction






190

16:30 18:00 ROOM 341


Cases

Difficult and alternative access Session comprising selected EuroPCR 2016 clinical case submissions Chairperson: A. CribierPanellists: J. Mehilli, G. Nickenig, H. Treede

16:30 V A case of TAVI in a tortuous S-shaped aorta - S. Liu 16:38 V Discussion and audience interaction 16:43 V Challenges in TAVI: extreme obesity - K.N. Asrress 16:51 V Discussion and audience interaction 16:56 V Implantation of fully retrievable second-

generation TAVI valve via subclavian access - S. Khogali

17:04 V Discussion and audience interaction 17:09 V Valve-in-valve implantation through

brachiocephalic trunk for severe aortic

paravalvular regurgitation - P. Sbarzaglia 17:17 V Discussion and audience interaction 17:22 V Direct aortic access and sheathless delivery of

fully retrievable second-generation TAVI device - S. Khogali

17:30 V Discussion and audience interaction 17:35 V Transapical valve-in-valve TAVI in a patient with

two failing surgical bioprothesis with Edwards

SAPIEN 3 valves using cerebral protection system - A. Wolf

17:43 V Discussion and audience interaction 17:48 V First transcarotid CoreValve Evolut R implantation -

P. Sbarzaglia 17:56 V Discussion and audience interaction

16:30 18:00 ROOM 253


Abstracts

DEB for in-stent restenosis and de novo lesions Session comprising selected EuroPCR 2016 abstract submissions Chairperson: L. GonçalvesPanellists: D. Foley, C. Kaiser, R. Sethi

16:30 V Euro16A-OP0504 – Clinical performance of

the Pantera Lux paclitaxel releasing balloon vs.

the drug-eluting Orsiro hybrid stent system in

patients with in-stent restenosis: a randomised

controlled trial (BIOLUX RCT) - C.K. Naber 16:38 V Discussion and audience interaction 16:43 V Euro16A-OP0510 – Sirolimus-coated balloon for

in-stent restenosis and de novo coronary artery

disease: results from the multicentre NANOLUTE

registry - P.K. Natarajapillai 16:51 V Discussion and audience interaction 16:56 V Euro16A-OP0562 – Impact of the number of

preimplanted stents on the clinical outcome of

DEB treatment for in-stent restenosis lesions: the

New-Tokyo registry - H. Yabushita 17:04 V Discussion and audience interaction 17:09 V Euro16A-OP1057 – Prospective, large-scale

multicentre trial for the use of paclitaxel-coated

balloons in de novo coronary lesions: the PCB-

ONLY all-comer registry - M. Rosenberg 17:17 V Discussion and audience interaction 17:22 V Euro16A-OP0818 – Sirolimus-coated balloon in

the treatment of small vessel disease - B. Cortese 17:30 V Discussion and audience interaction 17:35 V Euro16A-OP0172 – Treatment of de novo

coronary lesions with a novel second-generation

paclitaxel-coated balloon catheter: five-month

clinical results - J. Benezet 17:43 V Discussion and audience interaction 17:48 V Euro16A-OP0486 – Single-centre all-comer

registry for DEB angioplasty in de novo lesions - A.A. Nuruddin




and in the PCR App.

191

16:30 18:00 ROOM 342B


Cases

Outcome after stenting: place of OCT Session comprising selected EuroPCR 2016 clinical case submissions Chairperson: G. GuagliumiPanellists: A. Al Shamsi, L. Kjoller-Hansen, A. Pichard

16:30 V OCT-guided PCI with stenting of BRS in-stent

restenosis - S. Kasturi 16:38 V Discussion and audience interaction 16:43 V Neoatherosclerotic plaque rupture mimicking

peristent aneurysm treated by self-expandable

DES - L. Paraggio 16:51 V Discussion and audience interaction 16:56 V A case of acute stent recoil - V. Vizzi 17:04 V Discussion and audience interaction 17:09 V Differential healing with everolimus - W. Kristanto 17:17 V Discussion and audience interaction 17:22 V Early left main in-stent restenosis: OCT-guided

treatment - A. Di Giorgio 17:30 V Discussion and audience interaction 17:35 V Optical frequency domain imaging showed

multiple inter-strut hollow nine months after very

late stent thrombosis in everolimus-eluting stent

in bare-metal stent site treated with drug-coated

balloon - Y. Kaetsu 17:43 V Discussion and audience interaction 17:48 V OCT analysis of a restenotic

polytetrafluoroethylene-covered stent implanted

to treat a iatrogenic coronary fistula - S. Nava 17:56 V Discussion and audience interaction

16:30 18:00 ROOM 342A

STENT

FOR LIFE

STEMI and acute stroke: commonalities and divides With the collaboration of Stent for Life Initiative (SFL) Chairpersons: N. Hopkins, P. KalaPanellists: A. Bonafé, G. Olivecrona


VTo discuss the best approach to STEMI treatment

and organisation of care

VTo improve the quality of care of patients

surviving the acute heart attack

VTo learn how acute ischaemic stroke patients can

access to endovascular treatment

16:30 V Session objectives - P. Kala 16:35 V Hot lines in STEMI treatment - F. Weidinger 16:43 V Discussion and audience interaction 16:55 V Endovascular treatment for acute ischaemic

stroke: access to treatment in Stent for Life

Initiative countries - Z. Kaifoszova 17:03 V Discussion and audience interaction 17:15 V Early secondary prevention after myocardial

infarction: Contract4Life - A. Abreu 17:23 V Discussion and audience interaction 17:35 V Stent for Life Initiative achievements in Europe

and beyond - Z. Kaifoszova 17:43 V Discussion and audience interaction 17:55 V Session evaluation and key learnings - N. Hopkins



192

16:30 18:00 ROOM 351


Abstracts

BRS: evolving technologies and applications Session comprising selected EuroPCR 2016 abstract submissions Chairperson: M. Abdel-WahabPanellists: V. Farooq, P. Kumar Sahoo, E. Regar

16:30 V Euro16A-OP0199 – Bench-testing evaluation of a

novel fully drug-eluting BRS - N. Bullett 16:38 V Discussion and audience interaction 16:43 V Euro16A-OP1014 – Early healing after novolimus-

eluting bioresorbable stent implantation in the

treatment of coronary bifurcation lesions: the

BIFSORB pilot study - E.N. Holck 16:51 V Discussion and audience interaction 16:56 V Euro16A-OP0930 – Intraindividual angiographic

comparison of everolimus-eluting BRS and

metallic DES - D. Giacoppo 17:04 V Discussion and audience interaction 17:09 V Euro16A-OP0402 – DESOLVE 150 vs. DESOLVE

100: a comparison study using OCT - N. Boeder 17:17 V Discussion and audience interaction 17:22 V Euro16A-OP0942 – Multicentre evaluation of the

novolimus-eluting, fully BRS: three-year clinical

and imaging endpoints - A. Abizaid 17:30 V Discussion and audience interaction 17:35 V Euro16A-OP0232 – Safety and clinical

performance of the drug-eluting absorbable

metal scaffold in the treatment of subjects with

de novo lesions in native coronary arteries at

12-month follow-up BIOSOLVE-II - R. Tölg 17:43 V Discussion and audience interaction 17:48 V Euro16A-OP0044 – Initial results of the FANTOM

1 trial: a first-in-man evaluation of a novel,

radiopaque sirolimus-eluting BRS - J.D.R. Costa Jr 17:56 V Discussion and audience interaction



and in the PCR App.

16:30 18:00 ROOM 343


Abstracts

Novelties in interventional heart failure management Session comprising selected EuroPCR 2016 abstract submissions Chairperson: J. BartunekPanellists: D. Burkhoff, N. Van Royen, W. Wojakowski

16:30 V Euro16A-OP0048 – New transcatheter treatment

of the dilated ischaemic cardiomyopathy with

Revivent system - M. Hernández-Enríquez 16:38 V Discussion and audience interaction 16:43 V Euro16A-OP0928 – Randomised, double-

blinded, placebo-controlled trial to assess

the effects of intramyocardial bone-marrow-

derived immunoselected CD133+ cells on left

ventricle perfusion and function assessed by

single-photon emission CT and MRI in patients

with inducible ischaemia and refractory angina

(REGENT-VSEL) - W. Wojakowski 16:51 V Discussion and audience interaction 16:56 V Euro16A-OP1018 – Baseline haemodynamic

characteristics of patients in the REDUCE elevated

Left Atrial Pressure in patients with Heart Failure

(REDUCE LAP-HF) trial - D. Burkhoff 17:04 V Discussion and audience interaction 17:09 V Euro16A-OP0853 – Outcome after implantation

of a microaxial-flow pump in patients with

cardiogenic shock - A. Schäfer 17:17 V Discussion and audience interaction 17:22 V Euro16A-OP0565 – The PERKAT system: a novel

right heart assist device - first in vivo data - D. Kretzschmar

17:30 V Discussion and audience interaction 17:35 V Euro16A-OP0759 – First-in-man prolonged

pressure-controlled intermittent coronary sinus

occlusion to treat refractory left ventricular

dysfunction and ischaemia - M.B. Ancona 17:43 V Discussion and audience interaction 17:48 V Euro16A-OP0923 – Effects on haemodynamics

and renal function of a percutaneous ventricular

assist device - F. Schersten 17:56 V Discussion and audience interaction



and in the PCR App.

193

16:30 18:00 ROOM 352B

How Should I Treat?

Portugal and Spain share their most educational cases: challenging vascular disease - degenerated mitroaortic surgical bioprosthesis and very severe calcified aortic stenosis With the collaboration of the Portuguese Association of Interventional Cardiology (APIC) and the Spanish Working Group on Interventional Cardiology Chairpersons: V. Gama Ribeiro, R. Hernandez Antolin


VTo understand how to evaluate and approach

concomitant aortic and mitral disease

VTo learn how to treat very small degenerated

bioprosthetic valves

VTo share how to prevent and manage relatively

frequent and serious complications after TAVI

16:30 V Session objectives - V. Gama Ribeiro 16:35 V Case 1: degenerated aortic Mitroflow 19 and

mitral Carpentier-Edwards 31 - R. Teles 16:40 V How would I treat the case? - J.M. Hernandez 16:45 V How would I treat the case? - P. Canas Da Silva 16:50 V How did I treat the case? - R. Teles 17:00 V Discussion and audience interaction 17:10 V Consensus - R. Hernandez Antolin 17:15 V Case 2: unexpansion of a Portico percutaneous

valve inducing a low implantation in a patient

with severe native valve calcification - M. Pan 17:20 V How would I treat the case? - P. Canas Da Silva 17:25 V How would I treat the case? - J.M. Hernandez 17:30 V How did I treat the case? - M. Pan 17:40 V Discussion and audience interaction 17:50 V Consensus - V. Gama Ribeiro 17:55 V Session evaluation and key learnings -

R. Hernandez Antolin

16:30 18:00 ROOM 352A

Complications

Moldova and Ukraine share their most educational cases: periprocedural complications during PCI With the collaboration of the Moldavian Working Group of Interventional Cardiology and the Ukrainian Association of Interventional Cardiology (UAIC) Chairpersons: M. Postu, M. Sokolov


VTo identify lesion subsets that could lead to

possible complications and to try to prevent

them

VTo be able to use the right tools and techniques

in complicated procedures and discuss various

management strategies

VTo understand that good team work is crucial in

these particular situations

16:30 V Session objectives - M. Postu 16:33 V Case 1: emergency stent implantation as survival

strategy into heavy calcification left main lesion in

patient with NSTEMI and cardiogenic shock - I. Danylchuk

16:39 V Discussion and audience interaction 16:47 V Case 2: rupture of the left circumflex artery -

A. Surev 16:53 V Discussion and audience interaction 17:01 V Case 3: no-reflow syndrome, calcified coronary

artery and hemopericardium, left ventricular

septum rupture - three problems, three lessons

for the future - A. Krivchun 17:07 V Discussion and audience interaction 17:15 V Case 4: distal left anterior descending coronary

artery rupture during PCI in a patient with STEMI

presented at 12 hours after symptom onset - A. Grib

17:21 V Discussion and audience interaction 17:29 V Case 5: unexpected left main artery complication

after coronary angiography procedure - D. Sebov 17:35 V Discussion and audience interaction 17:43 V Case 6: coronary dissection during primary PCI -

E. Calenici 17:49 V Discussion and audience interaction 17:57 V Session evaluation and key learnings - M. Sokolov



194



Cases

Mitral paravalvular leak closure Session comprising selected EuroPCR 2016 clinical case submissions Chairperson: E. GarciaPanellists: J. Abdullakutty, H. Sievert, W.H. Yin

16:30 V Percutaneous transcatheter closure of prosthetic

mitral paravalvular leak - O. Millan Iturbe 16:39 V Discussion and audience interaction 16:45 V Paravalvular leakage after mitral valve-in-valve:

what you need to expect - D. Dvir 16:54 V Discussion and audience interaction 17:00 V Concomitant percutaneous mitral paravalvular

leak closure and mitral valve-in-valve - A. Tanaka 17:09 V Discussion and audience interaction 17:15 V Large mitral valve leak initially treated

percutaneously to stabilise the patient that

got fixed surgically in a second procedure - L.L. Gheorghe

17:24 V Discussion and audience interaction 17:30 V Failed attempt to occlude a large mitral

paravalvular leakage - M. Neuss 17:39 V Discussion and audience interaction 17:45 V An usual complication after percutaneous closure

of a mitral para-annular / valvular leak - S. Fournier 17:54 V Discussion and audience interaction

16:30 18:00 ROOM 353


Abstracts

Pulmonary embolism management and aortic endovascular repair Session comprising selected EuroPCR 2016 abstract submissions Chairperson: M.J. BosiersPanellists: P. Musialek, C. Nienaber, T. Zeller

16:30 V Euro16A-OP0905 – High-risk pulmonary

embolism thrombectomy using 8Fr Judkins right

guiding coronary catheter (urgent, cheaper and

feasible) - L.E. Berumen Dominguez 16:38 V Discussion and audience interaction 16:43 V Euro16A-OP0438 – Ultrasound-assisted

catheter-directed thrombolysis in high-risk and

intermediate-high-risk pulmonary embolism:

a meta-analysis - C. Kaymaz 16:51 V Discussion and audience interaction 16:56 V Euro16A-OP0813 – Refined balloon pulmonary

angioplasty driven by combined assessment

of intra-arterial anatomy with IVUS / OCT and

physiology with pressure wire in patients with

non-operable distal chronic thromboembolic

pulmonary hypertension - M. Roik 17:04 V Discussion and audience interaction 17:09 V Euro16A-OP0538 – Stent repair for interruption of

the aortic arch in children and adults: immediate

and follow-up findings - J. Suarez de Lezo 17:17 V Discussion and audience interaction 17:22 V Euro16A-OP1045 – Endovascular treatment for

coarctation of the aorta: a four-year experience in

one centre - O. Millan Iturbe 17:30 V Discussion and audience interaction 17:35 V Euro16A-OP0428 – New stent grafts for the

thoracic and thoracoabdominal segment: the

valiant thoracoabdominal design - P. Kelly 17:43 V Discussion and audience interaction 17:48 V Euro16A-OP1087 – Complicated type B aortic

dissection: case report - O. Gomez-Monterrosas 17:56 V Discussion and audience interaction



and in the PCR App.

195


eeuro

20

16

- 09:00 - 09:0009:55

MAIN ARENA


Valvular interventions: LIVE demonstration Chairpersons: J. Fajadet, W. WijnsPanellists: M. Al Mutairi, J. Escaned, H. Ince, P. Kala, F. Malik, C. Tamburino



09:05 V LIVE demonstration from Contilia Heart and

Vascular Centre, Elisabeth Hospital - Essen,

Germany






CBS@EuroPCR - Strategies for left main coronary artery disease and complex bifurcation lesions With the collaboration of the Left Main and Coronary

Bifurcation Summit (CBS) and the Asian Bifurcation Club

Chairpersons: S.-L. Chen, G. StankovicPanellists: B. Alekyan, O. Bertrand, H.G. Bezerra, L.L. Chen, D. Dash, S.T. Rab


VTo understand stenting strategies for left main

coronary artery disease

VTo discuss the importance of intravascular

imaging modalites in guiding complex

bifurcation stenting

VTo evaluate the advantages / disadvantages of

BRS in complex bifurcation lesions

09:00 V EuroPCR welcomes CBS and the Asian Bifurcation

Club - G. Stankovic

09:02 V Session objectives - S.-L. Chen

09:05 V How complex are complex bifurcation lesions -

J.-J. Zhang


demonstration - S.-L. Chen

09:16 V LIVE demonstration from Fu Wai Hospital,

Chinese Academy of Medical Sciences, National

Centre for Cardiovascular Diseases - Beijing,

China


10:11 V Left main bifurcation stenting: evaluation,

techniques and outcomes - I. Sheiban


10:19 V BRS in complex bifurcation lesions - N. Jepson


10:27 V Session evaluation and key learnings - S.-L. Chen







198

wx

高亮



Cases

Balloons and wires related complications during PCI Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: F. EberliPanellists: B.K. Koo, T. Mabin, A.J. Peace

09:00 V Nightmare during balloon predilation -

B. Majumder


09:13 V Unusual left main culotte - M.B. Ancona


09:26 V Unusual guidewire entrapment -

W. Kehasukcharoen


09:39 V Provisional stenting in calcified lesion - B. Enany


09:52 V Wire complication during a staged procedure -

I.J. Gudmundsdottir


10:05 V An unwanted diversion - W. Tassanawiwat


10:18 V Rotablation and broken wire with coronary

dissection - Y.L. Cheng




Cases

Complication Forum Session comprising selected EuroPCR 2016 clinical case

submissions

Chairpersons: E. Eeckhout, M. HaudePanellists: J. Belardi, S. Doucet, S. El Tobgi, S. Mathew, A. Mehta, G. Yucel

09:00 V All just a little bit of history repeating - D. Collison


09:15 V Very late aneurysm formation after DES

implantation - T. Ozawa


09:30 V Left atrial mass related to coronary intervention -

M.E. Ozpelit


09:45 V Complex PCI guided by OCT in a young patient

with STEMI and cardiogenic shock -

H.D. Mejia-Renteria


10:00 V Percutaneous closure of iatrogenic VSD after TAVI -

A.C. Garcia


10:15 V Percutaneous retrieval of LAA occluder -

F. Colombo


199



Learning

STENT

FOR LIFE

Learning STEMI: how to treat the culprit and non-culprit lesions Facilitators: A. Banning, T. Cuisset, M. NocMedia Driver: L. Tapp


VTo learn how to identify the culprit lesion in cases

with multivessel presentation

VTo understand how to investigate ischaemia in

non-culprit vessels

VTo discuss the best management strategy for

non-infarct-related arteries in STEMI



Cases

Endovascular options for renal interventions Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: F. RibichiniPanellists: B. Honton, M. Roffi, C.S. Su

09:00 V Renal artery CTO recanalisation via radial artery

access - Z. Ruzsa


09:15 V No reflow during renal artery angioplasty -

H. Abu-Hantash


09:30 V Bilateral renal artery occlusion: response to

percutaneous intervention - R. Vijayvergiya


09:45 V Percutaneous exclusion of giant renal artery

aneurysm with endoprosthesis - C. Moncalvo


10:00 V Percutaneous treatment of iatrogenic post-

operative arteriovenous fistula - Z. Stankov


10:15 V Flash pulmonary oedema associated with severe

renal artery stenosis and solitary functional

kidney: impact of renal artery angioplasty -

S. Moura-Ferreira



Focus Innovation

Transcatheter mitral valve implantation: proof of concept in human subjects Chairpersons: R. Kornowski, H. MoellmannPanellists: J. Hancock, T. Modine, B. Prendergast, D. Tchétché


VTo become familiar with the new catheter-based

mitral valves that have obtained proof of concept

in human

VTo understand the emerging indications, patients

candidates and the preparations needed for

transcatheter mitral valve implantation

VTo acknowledge initial clinical outcomes of

transcatheter mitral valve replacement

09:00 V Session objectives - R. Kornowski

09:05 V Clinical indications for transcatheter mitral valve

implantation - A. Vahanian


09:25 V Imaging assessment prior to transcatheter mitral

valve implantation - R. Rajani


09:45 V Transcatheter mitral valve implantation: device

and procedural overview - V. Bapat


10:05 V Transcatheter mitral valve implantation: early

clinical outcomes - I. Meredith



H. Moellmann



200

09:00 10:30 ROOM 242A


Abstracts

Percutaneous mitral edge-to-edge repair: outcome in selected subsets of patients Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: G. NickenigPanellists: J. Bartunek, D. Davidson, M.H. Pham

09:00 V Euro16A-OP0495 – Interventional transvascular

repair of the mitral valve is less successful in

patients with regurgitation due to chordal

rupture - M. Neuss


09:13 V Euro16A-OP0100 – Tricuspid regurgitation is a

predictor of mortality after successful MitraClip -

J. Schofer


09:26 V Euro16A-OP0406 – Comparison of percutaneous

mitral valve repair in functional and degenerative

mitral valve regurgitation using the Mitral Valve

Academic Research Consortium criteria - J. Seeger


09:39 V Euro16A-OP0746 – Acute ischaemic mitral

regurgitation: safety and efficacy of MitraClip

implantation - M. Adamo


09:52 V Euro16A-OP0036 – Novel procedure for residual

mitral regurgitation after transcatheter edge-to-

edge mitral valve repair using an occluder device -

S. Kubo


10:05 V Euro16A-OP0774 – Effectiveness of MitraClip

therapy in patients with refractory heart failure -

G. Bruschi


10:18 V Euro16A-OP0951 – Transcatheter mitral repair

for radiation-induced mitral regurgitation: a case

series - N. Buzzatti




and in the PCR App.



Cases

When to perform a VSD closure Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: E. GarciaPanellists: M. Chopda, B.R. Kannan, H. Thiele

09:00 V Percutaneous closure of VSD from a gunshot

wound - M. Coello


09:18 V Percutaneous closure of an iatrogenic VSD, a rare

complication after TAVI - F. Del Furia


09:36 V Simultaneous ventricular septal rupture and

cardiac free wall rupture following acute

myocardial infarction treated with rescue balloon

closure - J. Zalewski


09:54 V Percutaneous post-infarction VSD closure -

S. Tarbine


10:12 V Focal right coronary sinus rupture with fistula

in right ventricular outflow tract after TAVI -

M.B. Ancona


09:00 10:30 ROOM 241


Abstracts

PCR's Got Talent - round 3 Session comprising selected EuroPCR 2016 abstract

submissions

Chairpersons: C. Di Mario, R. VirmaniJury Members: S. Ewen, M. Joner, G. Lutter, C. Setacci, A. Witkowski

The 6 finalists will give an 8min presentation

of their work followed by a 5min discussion

with audience and jury members. The jury will

deliberate to select the EuroPCR 2016 Best

Abstract Award Winner, to be announced and

presented in the Main Arena at 12:07.

201

09:00 10:30 ROOM 251


TAVI: what's new! Chairpersons: S. Griggio, P. Lüttge ThomassenPanellists: M. De Ronde, M. Oberhoff


VTo be updated on the newest generation of

transcatheter aortic valve types

VTo learn about the nursing care during

interventions under local / general anaesthesia

VTo assist in the prevention of TAVI procedure-


09:00 V Session objectives - P. Lüttge Thomassen

09:05 V Update on the new generation of aortic valves -

P. Jimenez-Quevedo


09:18 V Key steps of the nursing care during a TAVI

procedure - B. Wulff

Three clinical case complications:

09:43 V Vascular complications - J. Buhl Stentoft


09:57 V Heart perforation: pericardial effusion, pericardial

tamponade - F. Germinal


10:11 V Valve embolisation - M. Lacueva


10:25 V Session evaluation and key learnings - S. Griggio




09:00 10:00 ROOM 242B


Cases

BRS thrombosis Session comprising selected EuroPCR 2016 clinical case

submissions

Chairpersons: F. Saia, R. Waksman

09:00 V BRS subacute thrombosis managed with

thrombus aspiration and IIb / IIIa inhibitors -

N. Salvatella


09:13 V Key learnings - H. Nef

09:15 V Neointimal coverage of BRS via coronary

angioscopy with late scaffolds thrombosis -

T. Nakayoshi


09:28 V Key learnings - N.E.J. West

09:30 V Very late BRS thrombosis: an interplay of factors -

C. Jorge


09:43 V Key learnings - D. Capodanno

09:45 V Not everything is what it seems... - M. Nobre

Menezes


09:58 V Key learnings - H. Khamis




202

wx

高亮

09:00 10:30 ROOM 252B


Abstracts

Contemporary DES: focus on bioresorbable polymers - part 2 Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: A. LafontPanellists: R. Byrne, S. Sathe, M. Vrolix

09:00 V Euro16A-OP0540 – Safety and efficacy of

biodegradable polymer DES in management of

patients with acute STEMI: MASTER study - one-

year clinical outcomes - S. Kedev 09:08 V Discussion and audience interaction 09:13 V Euro16A-OP0694 – Long-term clinical outcomes

of thin-strut biodegradable-coated sirolimus-

eluting stents implanted in an all-comer patient

population - M. Jelonek 09:21 V Discussion and audience interaction 09:26 V Euro16A-OP0279 – External validity of the all-

comers design: insights from the BIOSCIENCE trial -

A. Franzone 09:34 V Discussion and audience interaction 09:39 V Euro16A-OP0278 – Angiographic complexity

of coronary artery disease according to

SYNTAX score and clinical outcomes after

revascularisation with newer-generation DES:

a substudy of the BIOSCIENCE trial - A. Franzone 09:47 V Discussion and audience interaction 09:52 V Euro16A-OP0448 – Biodegradable polymer sirolimus-

eluting stents vs. durable polymer everolimus-

eluting stents in patients with STEMI: two-year

follow-up of the BIOSCIENCE trial - R. Piccolo 10:00 V Discussion and audience interaction 10:05 V Euro16A-OP0926 – Multicentre, prospective,

randomised, single-blind, consecutive enrollment

evaluation a novolimus-eluting coronary stent

system with bioabsorbable polymer compared to

a zotarolimus-eluting coronary stent system: final

long-term (60-month) clinical follow-up from the

EXCELLA BD study - R. Costa 10:13 V Discussion and audience interaction 10:18 V The multicentre LONGPRIME registry: everolimus

DES in long lesions 10:26 V Discussion and audience interaction



and in the PCR App.

09:00 10:30 ROOM 252A


Cases

Complex techniques, complex decisions Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: M. LesiakPanellists: M. Degertekin, M. Kurdi, O. Sakhov

09:00 V Unusual presentation of an unusual complication

after rescue angioplasty for acute myocardial

infarction - S. Kubba


09:13 V Direct scaffolding of the culprit lesion without

predilatation during transradial primary

angioplasty - T. Ghose


09:26 V The use of DEB in STEMI patient with

unrecognised hypertrophic cardiomyopathy -

D. Nikolic


09:39 V Complex bifurcation lesion in anterolateral STEMI

after unsuccessful thrombolysis - G. Sitafidis


09:52 V ACS with diffuse three-vessel disease -

A.R.G. Francisco


10:05 V Rescue PCI of 100% left main on STEMI by

bilateral radial approach - M. Vanegas


10:18 V Primary PCI for inferior STEMI, triple vessel disease,

multiple CTO, etc. What to do and what to leave? -

W. Elabbassi


203

09:00 10:30 ROOM 341


Abstracts

Conduction disturbances after TAVI: predictors and outcome Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: M. AbdelghaniPanellists: S. Chaudhury, A.S. Petronio, N. Trehan

09:00 V Euro16A-OP0454 – Predictors of pacemaker

implantation with a self-expanding repositionable

transcatheter aortic valve - I. Meredith


09:13 V Euro16A-OP0536 – The fate of right bundle

branch block in TAVI: a multicentre collaboration -

L. van Gils


09:26 V Euro16A-OP0460 – Influence of calcium,

implantation depth and oversizing on the

occurrence of conduction disturbances and need

for pacemaker implantation after implantation of

the balloon-expandable Edwards SAPIEN 3 valve -

B. Gonska


09:39 V Euro16A-OP0537 – Aortomitral continuity

calcification predicts new pacemaker insertion

and new atrial fibrillation in patients undergoing

TAVI - M. Spaziano


09:52 V Euro16A-OP0695 – Comparison of new

pacemaker insertion rates between two

generations of the balloon-expandable

transcatheter heart valve - F. Sawaya


10:05 V Euro16A-OP0441 – New permanent pacemaker

request with retrievable vs. non-retrievable self-

expanding prosthesis in the TAVI - J. Roa-Garrido


10:18 V Euro16A-OP0288 – Does the timing of pacemaker

implantation after TAVI affect costs? - S. Clancy




and in the PCR App.

09:00 10:30 ROOM 253


Abstracts

Application of BRS in challenging anatomical subsets Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: A. BartorelliPanellists: Y.L. Han, S.R. Khan, H. Mehta

09:00 V Euro16A-OP1024 – One-year outcomes

of the use of BRS to treat long lesions -

J. Molina-Martin de Nicolas


09:13 V Euro16A-OP0080 – Clinical outcomes following

BRS implantation in small vessels vs. large vessels -

A. Tanaka


09:26 V Euro16A-OP1036 – Full plastic jacket PCI with

everolimus-eluting BRS: results from the Italian

multicentre RAI registry - G. Masiero


09:39 V Euro16A-OP0189 – One-year clinical outcomes

following BRS implantation for diffuse coronary

lesions: a substudy from the GHOST-EU registry -

H. Kawamoto


09:52 V Euro16A-OP1015 – Clinical outcomes of BRS use

in patients with small vs. large vessels coronary

artery disease: results from the Italian multicentre

RAI registry - B. Cortese


10:05 V Euro16A-OP0891 – Sealing spontaneous coronary

artery dissection with BRS implantation: results on

a cohort of 18 patients from the RAI registry -

A. Ielasi


10:18 V Euro16A-OP0251 – Long-term clinical outcomes

following BRS implantation for the treatment of

coronary in-stent restenosis: an Italian multicentre

experience - E. Moscarella




and in the PCR App.



204

09:00 10:30 ROOM 342B


Cases

How to manage an iatrogenic aortic dissection? Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: M. NtsekhePanellists: C. Butter, B. Goyal, A. Low

09:00 V Aorto-ostial dissection of left main coronary

artery during primary PCI - M. Hassan


09:13 V A disastrous approach for the treatment of simple

right coronary artery stenoses - C. Brenner


09:26 V Retrograde aortic dissection after rotational

atherectomy - D. Kaewkes


09:39 V The spiral of evil - P. Canova


09:52 V Guide to disaster - K. Hassan


10:05 V Iatrogenic aortic dissection caused by

extracorporeal membrane oxygenator arterial

cannula and overcomed by a novel method -

J. Lee


10:18 V Nothing is simple at 33! Successfully managing

a series of complications / dissections in a single

PCI procedure - G. Katsimagklis


09:00 10:30 ROOM 342A

GRCI@EuroPCR - Rotational atherectomy: an old friend always within your reach With the collaboration of the Groupe de Réflexion sur la

Cardiologie Interventionnelle (GRCI)

Chairpersons: P. Aubry, J. MonséguPanellists: K. Boughalem, B. Livarek


VTo understand the role of plaque debulking

VTo share experience on rotational atherectomy

VTo learn how to prevent complications

09:00 V EuroPCR welcomes GRCI - M. Buchbinder

09:02 V Session objectives - P. Aubry

09:05 V Rationale for primary and bailout rotational

atherectomy - H. Benamer


09:25 V Tips and tricks for a safe rotablation - C. Brasselet


09:45 V How to avoid and how to manage complications

with rotablation? - G. Rangé


10:05 V Present and future of the rotational atherectomy -

B. Faurie


10:25 V Session evaluation and key learnings - J. Monségu

205

09:00 10:30 ROOM 351


Cases

Special tips and tricks for CTO intervention Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: Ö. Göktekin Panellists: H.J. Büttner, D. Desai, M. Ochiai

09:00 V CTO of an invisible left anterior descending -

A. La Manna


09:13 V Combined excimer laser and rotational

atherectomy - a RASER CTO case - M. Orzalkiewicz


09:26 V Successful PCI for CTO lesion with contralateral

angiography using a single 5Fr sheathless guiding

catheter - F. Yoshimachi


09:39 V Jailed side branch under the dissection after

retrograde CTO revascularisation - Z. Valuckiene


09:52 V CT-guided PCI at stumpless left anterior

descending CTO, obscured by cross-over stent

with very hard neointima of diagonal artery -

S.M. Park


10:05 V Retrograde left anterior descending CTO

recanalisation through a septal side-branch and

ping-pong catheter technique - S.A. Pyxaras


10:18 V A step backward to move forward - S. Padhi


09:00 10:30 ROOM 343


Cases

Stent deformation and dislodgement Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: P. L' AllierPanellists: K. Kadota, B.K. Kim, A. Yearoo

09:00 V Vanished proximal left anterior descending stent -

A. Mechery


09:15 V An unusual complication of bifurcation PCI -

H. Ben Ahmed


09:30 V Rescue retrieval of dislodged stent and expanded

stent in NSTEMI - Y.C. Huang


09:45 V IVUS detection of a rare coronary stent

complication - C. Cigalini


10:00 V The twisted metal demolition derby - R. Good


10:15 V Beware of the calcium in coronaries: dehiscence

of the stent shaft with successful retrieval -

S. Sangaraju




206

09:00 10:30 ROOM 352B


Cases

IVUS in the management of PCI Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: F. Alfonso ManterolaPanellists: H. Al Lawati, B.C. Kalmath, D. Walters

09:00 V Retrograde percutaneous recanalisation of CTO of

left anterior descending artery: one-year follow-

up after sirolimus stents with IVUS - S. Tarbine


09:13 V Intramural haematoma caused by balloon rupture

in CTO coronary vessels - Y.L. Cheng


09:26 V Flush occlusion of the left anterior descending -

P. Tajti


09:39 V IVUS / Crusade microcatheter-assisted parallel

wiring technique for a case with left circumflex

CTO


09:52 V Stent deformation by intramural haematoma in a

patient with the catheter-induced right coronary

artery dissection - Y. Antoku


10:05 V From caesarean section to coronary dissection:

the use of multimodality imaging in the

management of post-partum spontaneous

coronary artery dissection - L. McClenaghan


10:18 V Successful PCI in haemophilia patient with acute

myocardial infarction - S.M. Park


09:00 10:30 ROOM 352A

Gender bias in infarction: is it the end of the myth or not yet? With the collaboration of the EAPCI Women Committee

Chairpersons: Y. Appelman, M.C. MoricePanellists: Z. Kaifoszova, F. Mauri, J. Mehilli


VTo appreciate gender differences in outcome after

ACS and STEMI

VTo learn about gender differences for diagnosis

and treatment of ACS in Europe

VTo discuss how gender differences can be

overcome

09:00 V Session objectives - Y. Appelman

09:05 V Higher mortality among young women with ACS -

still true in France? - S. Manzo-Silberman


09:25 V Impact of gender gap in time-to-treatment on

mortality - lessons from United Kingdom and

Sweden registries - V. Kunadian


09:45 V Impact of treatment strategy on gender

differences in STEMI outcomes - lessons from

Catalonia registry - N. Salvatella


10:05 V Gender differences in secondary prevention

among STEMI patients in The Netherlands -

M. ten Haaf


10:25 V Session evaluation and key learnings - M.C. Morice

207



Abstracts

New evidences for femoropopliteal angioplasty Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: M.J. BosiersPanellists: Y. Gouëffic, M.S. Mourali, T. Zeller

09:00 V Euro16A-OP0862 – Safety and efficacy of radial

artery access for aortoiliac and femoropopliteal

lesion interventions - A. Roy


09:13 V Euro16A-OP0848 – Paclitaxel self-expanding

stents demonstrate favourable one-year

outcomes in simple and complex superficial

femoral artery lesions - A. Roy


09:26 V Euro16A-OP0720 – Plaque modification with

an orbital atherectomy system enhances drug

distribution in calcified peripheral arteries -

A. Tzafriri


09:39 V Euro16A-OP0796 – Long-term antirestenotic

efficacy of drug-eluting vs. plain balloon

angioplasty in patients with femoropopliteal

artery disease: an updated frequentist and

Bayesian meta-analysis - D. Giacoppo


09:52 V Euro16A-OP0234 – First clinical experience with

the Multi-LOC multiple stent delivery system

for focal stenting in femoropopliteal lesions -

K. Amendt


10:05 V Euro16A-OP0265 – Six-month results of a global

all-comers registry using drug-coated balloon in

infrainguinal artery disease - T. Zeller


10:18 V Euro16A-OP0587 – Efficacy of a novel

fluoropolymer-coated paclitaxel-eluting

peripheral stent in a familial hypercholesterolemic

swine model of balloon-injured femoral arteries -

T. Zeller




and in the PCR App.

09:00 10:30 ROOM 353


Abstracts

IVUS-guided therapies of coronary artery disease Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: H. MudraPanellists: K. Al Faraidy, D. Dudek, H.M. Garcia-Garcia

09:00 V Euro16A-OP0727 – The impact of coronary

plaque composition assessed by integrated-

backscatter IVUS on coronary circulation

improvement after PCI - H. Ota


09:13 V Euro16A-OP0625 – Do we need to image more

than the proximal left anterior descending artery

to detect early cardiac allograft vasculopathy with

IVUS? - V. Flore


09:26 V Euro16A-OP0734 – Limitations of OCT in

identifying and quantifying lipid components: an

in vivo comparison study with IVUS near-infrared

spectroscopy - L. Di Vito


09:39 V Euro16A-OP0070 – IVUS predictors of major

adverse cardiovascular events after implantation

of everolimus-eluting stents for long coronary

lesions - S.Y. Lee


09:52 V Euro16A-OP0947 – IVUS-guided DES

implantation: an updated meta-analysis of

randomised control trials - A. Steinvil


10:05 V Euro16A-OP0050 – Effect of ezetimibe in

combination with statins on coronary plaque

regression in patients after coronary stenting -

K. Sadamatsu


10:18 V Euro16A-OP1001 – Changes of coronary artery

plaque phenotypes during lipid-lowering therapy

in diabetic vs. non-diabetic patients: study with

3D IVUS and virtual histology - A. Kral




and in the PCR App.



208

- 10:00 - 10:45 12:15

THEATRE BLEU

Rotational atherectomy for challenging cases Chairpersons: E. Barbato, A. SerraPanellists: T. Mabin, S. Mathew, A. Ong, F. Ribichini, G. Szabo, H.C. Tan


VTo learn how to perform rotational atherectomy

in challenging coronary lesions

VTo prevent and / or manage complications

related to rotablation

VTo understand when to stop rotational

atherectomy

10:45 V Session objectives - E. Barbato

10:50 V How to prevent and deal with complications: burr

lodging, wire and burr fracture, perforation -

A. De Belder



demonstration - J. Wykrzykowska


Vascular Centre, Elisabeth Hospital - Essen,

Germany


12:12 V Session evaluation and key learnings - A. Serra




09:3011:30 ROOM 243

PCR Sharing Centre

Join a team of young interventional cardiologists sharing their collaborative learning experience at EuroPCR Facilitators: P. Calvert, G. Cayla, M. Gilard, J.Marco, G. TothTeam of young interventional cardiologists: I.J Amat-Santos, I. Colaiori, K. De Silva, L.L. Gheorghe, R. Hammami, E.W. Holy, M. Lanocha, K. Mahmoud, M. Mokbel, J.C. Moreno Samos, A. Roy, G. Shenoda, J. Wintzer-Wehekind, A. Wood, P. Xaplanteris


VTo better understand the questions, the points of

controversy, the cognitive conflicts that a group

of young cardiologists have identified before

EuroPCR 2016 and that require clarification in

order to improve their proficiency

VTo discuss with this group the results of the

collective learning they have developed by

sharing and synthesising their independent

thinking on the educative content delivered

during EuroPCR

09:5510:50 MAIN ARENA


Coronary interventions: Left main PCI LIVE demonstration Chairpersons: J. Fajadet, W. WijnsPanellists: M. Al Mutairi, J. Escaned, H. Ince, P. Kala, F. Malik, C. Tamburino


LIVE demonstration - W. Wijns


Vascular Centre - Essen, Germany





209



Cases

TAVI complications - part 2 Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: A. CribierPanellists: J. Kefer, S. Roy, W.H. Yin

10:45 V Unexpected nightmare! - W. Mattar


11:03 V The harms of tortuosity: an extreme TAVI case -

L. Paraggio


11:21 V Dilated ascending aorta and pure aortic

regurgitation: a scary combination - M. Taramasso


11:39 V Ascending aorta dissection after right coronary

artery PCI and unsuccessful TAVI


11:57 V Bicuspid aortic valve stenosis: are we ready to

treat with TAVI? - V. Voudris




Cases

Acute complications during PCI Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: F. WeidingerPanellists: J. Ezhilan, D. Pahlajani, L. Pathak

10:45 V Left atrial mass related to coronary intervention -

M.E. Ozpelit


10:57 V Osteal left aterior descending PCI: precise stent

position matters! - H. Gilhotra


11:09 V Entrapment and fracture of a side branch

guidewire during PCI and DES implantation

of a bifurcation stenosis - T. Butz


11:20 V Two true lumens - B. Lambert


11:31 V A hard-to-imagine complication of late

hypotension after PCI - N.Q. Nguyen


11:42 V How to successfully treat iatrogenic left main

dissection - T. Satoh


11:53 V Complications - have we seen everything yet? -

S. Surowiec


12:04 V What are the true predictors and outcomes

of coronary perforation - an insight from a

contemporary national registry? - T. Kinnaird

12:11 V Discussion and audience interaction D+1 Find slides, videos, cases, exclusiveinterviews and daily reports onwww.pcronline.com onlineonline



210



Learning

Learning BRS Facilitators: I. Al Rashdan, H. Nef, N.E.J. WestMedia Driver: J. Molina-Martin de NicolasExpert Panellist: A. Colombo


VTo learn how to select the appropriate patient

VTo understand the importance of lesion

preparation, optimal technique for BRS

implantation and to better assess the role of

imaging



Cases

Aortic coarctation management Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: M.J. BosiersPanellists: O. Al Shammeri, F.Y. Kuo, T. Zeller

10:45 V Challenging endovascular reconstruction of type

A and B interrupted aortic arches with one-year

follow-up - K. Amber


10:58 V Recanalisation of interrupted aortic coarctation by

below-the-knee CTO technique - M. Ostovan


11:11 V Coarctation of aorta: self-expanding stenting of

aortic arch - S. Kasturi


11:24 V A successful endovascular treatment of isthmic

total aortic coarctation in adult woman? -

T. Umemoto


11:37 V Thoracic endovascular aortic repair for aortic

transection in a 12-year-old male - J. Brooks


11:50 V One year follow-up of the first ever successful

endovascular treatment of type B aortic

dissection in a child - I. Petrov


12:03 V Endovascular treatment of acute aortic syndrome

associated with spontaneous renal artery

dissection - O. Millan Iturbe



Focus Innovation

Innovations in Cardiovascular Interventions@EuroPCR With the collaboration of Innovations in Cardiovascular

Interventions (ICI)

Chairpersons: R. Beyar, C. LotanPanellists: A. Abizaid, O. Bertrand, T. Brinton, J. Ormiston


VTo understand the importance of biotechnical

innovations

VTo evaluate outstanding examples of medical

innovations presented at ICI 2015

VTo discuss and understand unmet future needs in

the cardiovascular arena

10:45 V Introduction and objectives - R. Beyar

10:48 V The ICI technology parade and presentation of

the 2015 ICI innovation of the year Award Winner -

C. Lotan

10:58 V DiACardio - 2015 ICI innovation of the year Award

Winner - H. Goldman-Aslan


11:09 V The changing world of biomedical innovation:

the digital revolution - A. Segev


11:20 V Implant-based non-invasive isolation

of the pulmonary veins: Fulgur Medical -

G. Van Langenhove


11:31 V Aortic arch endograft: the endospan first-in-man

experience - D. Planer


11:42 V RealView holographic display and interface for

medical imaging applications - A. Kaufman


11:53 V The interface between physician, entrepreneur

and bioengineer - what is needed for innovation? -

R. Beyar


12:04 V Future clinical needs in the cardiovascular arena -

R. Beyar, T. Brinton, H. Call, C. Lotan


12:12 V Session evaluation and key learnings - C. Lotan

211

10:45 12:15 ROOM 241


Abstracts

Remaining issues in daily TAVI practice Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: T. ModinePanellists: M. Chen, B. Hanif, A.S. Petronio

10:45 V Euro16A-OP0939 – IVUS vs. multidetector CT for

annular sizing during TAVI - D. Hakim


10:58 V Euro16A-OP0409 – Impact of suture-mediated

femoral access site closure with the Prostar XL

compared to the Perclose ProGlide system on

outcome in TAVI - J. Seeger


11:11 V Euro16A-OP0033 – Predilatation prior to TAVI: is it

still a prerequisite? - M. Pagnesi


11:24 V Euro16A-OP0426 – Impact of renal dysfunction

on transcatheter aortic valve replacement

outcome in a large multicentre cohort - A. Levi


11:37 V Euro16A-OP0509 – Long-term outcomes

following TAVI for severe aortic stenosis in elderly

patients with a low left ventricular ejection

fraction: a single-centre registry of 2,000 patients

(TAVIK register) - P. Tzamalis


11:50 V Euro16A-OP0307 – The impact of coronary artery

disease on survival after TAVI - J.M. Sinning


12:03 V Euro16A-OP0997 – Percutaneous device closure

of paravalvular leak: combined experience from

the United Kingdom and Ireland - P. Calvert




and in the PCR App.



Cases

Transcatheter closure: a solution for some situations Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: E. GarciaPanellists: H. Khamis, H. Thiele, R. Trillo Nouche

10:45 V 3D-printed heart model to guide a successful

left ventricular post-surgical pseudoaneurysm

percutaneous closure - M. Stolcova


10:58 V Alternative percutaneous technique for closure of

severely tortuous arteriovenous collaterals using

coronary stents and a vascular plug - Successful

treatment of haemoptysis in a complex

congenital heart disease patient - M. Nassif


11:11 V Percutaneous closure of ascending aorta

pseudoaneurysm - K. Kalogeras


11:24 V Transcatheter closure of patent ductus arteriosus

in interrupted left sided inferior vena cava with

hemiazygos continuation: subclavian venous

approach - S. Patra


11:37 V Successful percutaneous closure of three ASD

with interlocking devices in an adult patient -

O. Narayan


11:50 V Percutaneous closure of iatrogenic VSD after TAVI -

A.C. Garcia


12:03 V A sword in the heart - D. Chin




212

10:45 12:15 ROOM 252A


Abstracts

Novel stents for diabetic coronary disease Session comprising selected EuroPCR 2016 abstract

submissions

Chairperson: C. SpauldingPanellists: M.A.K. Akanda, J. Mehilli, K. Punamiya

10:45 V Euro16A-OP0729 – Impact of diabetes mellitus

on clinical outcomes after deployment of the

abluminal sirolimus-coated bioengineered stent

in an all-comer registry at one-year follow-up -

D. Kalkman 10:53 V Discussion and audience interaction 10:58 V Euro16A-OP0204 – Impact of diabetic status on

outcomes following revascularisation with DES

in relation to coronary artery disease complexity:

a patient-level pooled analysis of 6,081 patients -

K. Koskinas 11:06 V Discussion and audience interaction 11:11 V Euro16A-OP0520 – Five-year clinical outcomes in

patients with diabetes treated with polymer-free

sirolimus and probucol-eluting stents vs. new-

generation zotarolimus-eluting stents - Y. Harada 11:19 V Discussion and audience interaction 11:24 V Euro16A-OP0401 – Two-year clinical outcomes

of a bioabsorbable polymer-coated, everolimus-

eluting coronary stent in patients with diabetes -

I. Meredith 11:32 V Discussion and audience interaction 11:37 V Euro16A-OP0160 – BIOFLOW-III satellite Israeli

diabetic prospective registry with the Orsiro

sirolimus-eluting stent and comprehensive diabetic

care: one-year clinical outcomes - U. Landes 11:45 V Discussion and audience interaction 11:50 V Euro16A-OP0347 – One-year clinical outcome

of amphilimus polymer-free DES in diabetes

mellitus patients: insight from the ASTUTE registry

(AmphilimuS iTalian mUlticenTer rEgistry) - C. Godino 11:58 V Discussion and audience interaction 12:03 V Euro16A-OP0518 – Clinical outcomes of patients

treated with a novel abluminal-coated sirolimus-

eluting stent: an overall analysis and a subgroup

analysis from an all-comer en-ABL e-registry - S. Dani 12:11 V Discussion and audience interaction



and in the PCR App.

10:45 12:15 ROOM 242A


Cases

Complications during or after PCI Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: J.F. TanguayPanellists: Z. Ghazzal, G. Musumeci, S. Rathnavel

10:45 V STEMI responsible of stomach ulcer (for the

cardiologist) - N. Zaoui


11:00 V Acute STEMI: when primary PCI is not enough! -

T. Alkinani


11:15 V Cardiac arrest following no-reflow during primary

PCI: a close save - D.K. Baruah


11:30 V Sudden death within 20min of a successful

multivessel angioplasty in an elderly male: what

went wrong? - S. Kubba


11:45 V Friend or foe? In myocardial infarction - Y.C. Huang


12:00 V Coronary cameral fistula: a rare complication

post-myocardial infarction - D. Kodati


10:45 11:45 ROOM 251


I am a cathlab nurse / allied professional. I would like to be involved in research and studies. What will be the challenges? Facilitators: L. Kløvgaard, K. WilsonPanellists: J. Laub, T. Van Hecke, D. Zughaft


VTo appreciate the opportunity and challenges to

be part of a research team

VTo learn from expert research nurses

VTo understand how to optimise your workflow as

a research nurse / allied professional




213

10:45 12:15 ROOM 253


Cases

Intracoronary thrombus management during primary PCI Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: S. KhanPanellists: K. Al Faraidy, I. Kranjec, A. Yildirir

10:45 V Deferred stenting in NSTEMI with high thrombus

burden - C. Camaro


11:00 V Your best friend can be your worst enemy -

S.F. Chui


11:15 V Treatment options for high thrombus burden in a

left anterior descending - A. Mechery


11:30 V A young male with STEMI successfully treated by

lone manual thrombus aspiration - M. Kodaira


11:45 V Catch me if you can - N. Salvatella


12:00 V Large refractory intracoronary thrombus after

systemic thrombolysis in a patient suffering from

STEMI: innovative solutions for an unresolved

problem - I.J. Amat-Santos


10:45 12:15 ROOM 252B


Cases

TAVI in complex cases Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: D. TchétchéPanellists: J. Abdullakutty, M.K.Y. Lee, S.A. Pyxaras

10:45 V Is it suitable for TAVI? - J.L.K. Chan


10:58 V Emergency TAVI in a dying heart - C.K.K. Kwok


11:11 V TAVI in depressed ventricular function with low

flow, low gradient aortic stenosis assisted with

extracorporeal membrane oxygenation -

J. Quintanilla


11:24 V Emergency TAVI for early and acute failure of

sutureless perceval aortic valve - N. Bouhzam


11:37 V Percutaneous implantation of self-expandable

aortic valve in a patient with homozygous familial

hypercholesterolemia, severe aortic stenosis and

porcelain aorta - M. Levent Sahiner


11:50 V Concomitant structural procedures: why not? -

M. Taramasso


12:03 V TAVI in a patient with severe aortic valve stenosis,

concomitant aortic root aneurysm and aortic

coarctation - M. Mach




214

10:45 12:15 ROOM 342A

WCCI@EuroPCR - BRS: a journey from present to the future With the collaboration of the Warsaw Course on

Cardiovascular Interventions (WCCI)

Chairpersons: H. Amin, R.J. GilPanellists: E. Khedi, A. Witkowski


VTo learn about the use of BRS in different clinical

scenarios

VTo understand the role of intravascular imaging

in guidance of BRS implantation

VTo share current experience with new metallic

BRS

10:45 V EuroPCR welcomes WCCI - H. Amin

10:47 V Session objectives - R.J. Gil

10:50 V BRS in ACS - D. Dudek


11:10 V How and when to use OCT to guide BRS

deployment - F. Prati


11:30 V Complex coronary interventions with BRS - are

we ready today? - M. Lesiak


11:50 V Current status of metallic BRS - M. Haude



A. Witkowski

10:45 12:15 ROOM 341


Cases

Complications that you may avoid Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: O. GämperliPanellists: B. Livarek, G. Sianos, H. Warda

10:45 V When dealing with CTO, be prepared that

everything can happen - L. Bryniarski


10:58 V Nightmare of CTO treatment: importance of

confirmation of wire position by IVUS - Y. Kinoshita


11:11 V Endless case: the best of the worst - W. Ammar


11:24 V PCI to CTO of left circumflex artery complicated

by coronary perforation - S. Sangaraju


11:37 V Contained coronary rupture post-BRS

implantation - H. Kawamoto


11:50 V Periprocedural complication during retrograde

CTO PCI - P. Tajti


12:03 V Septal perforation complicating retrograde CTO

revascularisation: have you ever seen worse? -

M. Boukhris


215

wx

高亮

10:45 12:15 ROOM 343


Cases

When lumen to lumen approach is not possible Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: H.J. BüttnerPanellists: S.R. Khan, G. Navasundi, S. Rinfret

10:45 V Plaque modification helps in CTO - D. Kumar


11:00 V Unconventional view help in wiring the right

lumen in difficult left anterior descending CTO -

S. Banerjee


11:15 V Antegrade dissection re-entry for CTO right

coronary artery - H. Shaalan


11:30 V What if you can't stick or move the proximal cap

of left anterior descending CTO? - S. Mansour


11:45 V How to prepare to open a CTO in a patient with

chronic kidney disease and previous failure

attempt - L. Bryniarski


12:00 V PCI for CTO implanted BRS - S. Hosogi


10:45 12:15 ROOM 342B


Cases

Dissections during PCI Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: J. WöhrlePanellists: B.C. Kalmath, H. Kelbaek, A.G. Osiev

10:45 V Left system dissection: a nightmare - A. Mirza


10:58 V Management of iatrogenic left main stem

dissection - C. McQuillan


11:11 V Right at the edge - K. Sandhu


11:24 V Primum non nocere: could I have avoided this? -

M. Swierad


11:37 V Unfrequent PCI complication in severely tortuous

vessels - A. Furukawa


11:50 V Unusual cause of left main dissection: acute

treatment strategy? - S. Matiullah


12:03 V A spider in the cathlab... - B. Brochado





216

10:45 11:45 ROOM 352A


Will PARTNER II change my practice? Chairpersons: H. Eltchaninoff, L. Sondergaard









10:45 V Introduction - the trial headlines - H. Eltchaninoff


I treat? - R. Makkar


work?

11:00 V What was known before PARTNER II? -

P. MacCarthy


B. Prendergast


to change practice?


practice? - R. Makkar


11:40 V Concluding remarks - L. Sondergaard

10:45 12:15 ROOM 351


Cases

Very complex CTO Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: M. OchiaiPanellists: V. Aytekin, B.K. Kim, N. Qamar

10:45 V Successfully managing CTO... only to discover a

hidden bifurcation lesion - A. Mastrokostopoulos


11:00 V Solving problems with high-risk CTO - A. Kristensen


11:15 V The retrograde ultimatum. Angioplasty of an

ostial flush occlusion / CTO of a venous graft

via a heavily calcified and tortuous native vessel -

H.K. Bali


11:30 V Reverse controlled antegrade and retrograde

subintimal tracking for CTO - Never say never

again - T. Hussain


11:45 V Retrograde left anterior descending ostial CTO:

when an already complex procedure turns out to

be even more complex! - T. Alkinani


12:00 V Anatomical mimicking misleads diagonal stenting

as left anterior descending in distal left anterior

descending CTO - S. Banerjee


217

10:45 12:15 ROOM 353


Cases

Mitral, aortic, tricuspid paravalvular leak closure Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: E. EeckhoutPanellists: J. Goicolea, L. Nombela-Franco, S. Venkatesh

10:45 V Minimally invasive transradial percutaneous

closure of aortic paravalvular leaks: following the

steps of PCI - G. Giacchi


10:58 V Transradial paravalvular leak closure three years

after successful transapical TAVI using Amplatzer

Vascular Plug III


11:11 V Self-expandable TAVI to treat paravalvular

regurgitation of a balloon-expandable valve -

G. Bruschi


11:24 V Large tricuspid paravalvular leak: percutaneous

closure using two muscular VSD occluders -

R. Anantharaman


11:37 V Complete percutaneous valvular reconstruction -

E. Karacop


11:50 V Simultaneous closure of a perivalvular

bioprothesis mitral leak and ASD - J. Palazuelos


12:03 V Angioplasty for paravalvular leak closure -

C.K.K. Kwok


10:45 12:15 ROOM 352B


Cases

How to deal with aneurysms after stent implantation? Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: H. PereiraPanellists: O. Al Baghal, M. Loutfi, A. Ochala

10:45 V Coronary artery aneurysm formation following a

stent post-dilatation - A. Hailan


10:58 V How to overcome the aneurysm, fracture and

in-stent restenosis with transradial approach? -

J.H. Heo


11:11 V Pseudoaneurysm after DES implantation -

B.U.A. Gill


11:24 V Very late aneurysm formation after DES

implantation - T. Ozawa


11:37 V Coronary pseudoaneurysm after CTO angioplasty:

IVUS findings and management - N. Ben Mansour


11:50 V A case of iatrogenically-induced coronary artery

aneurysm after DES insertion - R.Y. Lim


12:03 V Giant coronary artery aneurysm after

implantation of DES: clinical dilemma and

management - D.K. Baruah




218



Valvular interventions: TAVI LIVE demonstration Chairpersons: A. Cremonesi, J. FajadetPanellists: G. Guagliumi, F. Hellig, T.H. Koh, S. Redwood, W. Wijns, S. Windecker


demonstration - W. Wijns

11:00 V LIVE demonstration from Fu Wai Hospital,

Chinese Academy of Medical Sciences, National

Centre for Cardiovascular Diseases - Beijing,

China





- 11:00 - 11:45 12:15

ROOM 251


Ceremony

Nurses and Allied Professionals Best Abstract and Clinical Case Awards - Closing ceremony Chairpersons: S. Griggio, L. Kløvgaard, D. ZughaftPanellists: M. Gilard, M. Oberhoff

11:45 V Session objectives - S. Griggio

11:47 V EuroPCR 2016 Nurses and Allied Professionals Best

Abstract and Clinical Case Awards announcement -

D. Zughaft

11:49 V Presentation of the Best Abstract

11:54 V Presentation of the Best Clinical Case

12:03 V The importance of nurses and allied professionals

in a clinical trial - D. Capodanno

12:13 V Closing the EuroPCR 2016 Nurses and Allied

Professionals programme - L. Kløvgaard



Cases

FFR in complex situation Session comprising selected EuroPCR 2016 clinical case

submissions

Chairperson: M. BalghithPanellists: N. Amabile, B.K. Koo, A. Rajagopal

10:45 V Out-of-hospital cardiac arrest in a patient with

a total occlusion of the left anterior descending

protected by large collateral formation -

G. Wijntjens


10:58 V Dedicated self-expandable bifurcation DES for

the left main and retrograde right coronary artery

CTO re-opening through RIMA: IVUS and FFR

(with microcatheter) guided procedure -

F. Fouladvand


11:11 V A complex left main and left anterior descending /

D1 bifurcation stenting case with IVUS and FFR

guidance - J.J. Zhang


11:24 V Treatment modification in complex left main

bifurcation stenosis - P. Dingli


11:37 V Acute myocardial infarction due to left anterior

descending occlusion in patient with well-

collateralised CTO of left circumflex and

right coronary artery: do we need complete

revascularisation? - M. Araya


11:50 V FFR-guided PCI in non-culprit vessels post-STEMI:

is the functional assessment reliable? - L. Leite


12:03 V Does Takotsubo cardiomyopathy affect FFR? -

A. Ferrara


219

- 12:00 - 12:00 12:07

MAIN ARENA

Ceremony

EuroPCR 2016 Best Clinical Case Award Chairpersons: A. Cremonesi, J. FajadetPanellists: G. Guagliumi, F. Hellig, T.H. Koh, S. Redwood, W. Wijns, S. Windecker

12:00 V EuroPCR 2016 Best Clinical Case Award

announcement - A. Cremonesi

12:02 V EuroPCR 2016 Best Clinical Case presentation


Ceremony

EuroPCR 2016 Best Abstract Award Chairpersons: A. Cremonesi, J. FajadetPanellists: G. Guagliumi, F. Hellig, T.H. Koh, S. Redwood, W. Wijns, S. Windecker

12:07 V Announcement of the winner of the 2016 PCR's

Got Talent competition - W. Wijns

12:09 V EuroPCR 2016 Best Abstract presentation

12:2012:30 MAIN ARENA

Ceremony

EuroPCR 2016 Closing Ceremony Chairpersons: A. Cremonesi, J. FajadetPanellists: G. Guagliumi, F. Hellig, T.H. Koh, S. Redwood, W. Wijns, S. Windecker

12:20 V Closing and adjourn - A. Cremonesi, S. Windecker



220


eeuro

20

16

Training Village

222

The number of participants is limited for the Training sessions. To reserve your seat, please send an email to the following contacts or go to the corresponding registration desk, located in front of each Training Room of the Training Village.

BIOTRONIK

R Sarah Kocher: [email protected] R In addition to the set programme, walk-in hands-on sessions will be available

CARDINAL HEALTH INVENTORY MANAGEMENT SOLUTIONS: R Tracy Howard: [email protected]

CORDIS R Laurence Hazard: [email protected]

GE HEALTHCARE R Erika Saillant: [email protected] – phone : +33 6 64 08 15 49 R Please indicate the following subject in your email : ‘workshop GE EuroPCR 2016’

MEDTRONIC R Jennifer Cardle: [email protected]

PHILIPS VOLCANO RNo pre-booking available

ST. JUDE MEDICAL R Birgit De Weerdt: [email protected]

Training sessions are practical. Come to the Training Village located on level 1 to actively participate to a training session including hands-on and practical tips

and tricks on a specific technology.

223

Room BiotronikBRS

p.229

BRSp.229

BRSp.230

Room

Cardinal HealthRFIDp.228

RFIDp.230

Room Cordis

Sheathless approach

p.227

PEVARp.229

Room

GE HealthcareImaging

p.229Imaging TAVI

p.230

Room

MedtronicTAVIp.227

TAVIp.228

TAVIp.229

Room

Philips Volcano

R4

ImagingLAA closure

p.227IVUSp.228

IVUSp.230

ImagingLAA closure

p.231

Room Philips Volcano

R5

ImagingLAA

closurep.228

IVUSp.229

IVUSp.230

Open

hands-on

training

p.231

Room

St. Jude MedicalFellow programme

p.228

11:00 12:00 13:00 14:00 15:00 16:00 17:00 18:0011:30 12:30 13:30 14:30 15:30 16:30 17:30 18:30

Coronary Valvular Disease and Heart Failure Peripheral Hypertension and Stroke224

Room BiotronikBRS

p.232

BRSp.233

BRSp.234

Room


RFIDp.237

RFIDp.240

Room CordisBifurcation

p.234Clinical articles

p.236

Radial approachp.239

Room

GE Healthcare

Imagining TAVIp.233

Imagingp.235

Imaging FFRp.237

Imagingp.238

Imagingp.241

Imaging LAA closure

p.241

Room

MedtronicTAVIp.232

TAVIp.234

TAVIp.238

TAVIp.239

Room Philips

Volcano

R4

IVUSp.233

iFR Scoutp.235

ImagingLAA closure

p.236iFR / FFR

p.238

iFR / FFRp.240

Room Philips

Volcano

R5

IVUSp.234

iFR /FFRp.236

ImagingLAA closure

p.238iFR / FFR

p.239

Imagingp.241

Open

hands-on

training

p.242

Room

St. Jude Medical

FFRp.232

FFRp.233

FFRp.235

Heartmate Percutaneous Heart Pump

p.237

FFRp.239

FFR in ACSp.240

FFR in ACSp.241

OCTp.232

OCTp.234

OCTp.236

OCTp.237

OCTp.239

OCTp.240

OCTp.242

TAVIp.232

TAVIp.234

TAVIp.236

TAVIp.237

TAVIp.239

TAVI for Nurses and Allied

Professionalsp.240

TAVIp.242

LAA occlusionp.232

LAA occlusionp.234

LAA occlusionp.236

LAA occlusionp.237

LAA occlusionp.239

LAA occlusionp.240

LAA occlusionp.242

09:00 12:00 15:0010:00 13:00 16:0014:00 17:00 18:0011:0009:30 12:30 15:3010:30 13:30 16:3011:30 14:30 17:30

225

Room BiotronikBRS

p.243

BRSp.244

BRSp.245

BRSp.248

BRSp.249

BRSp.250

Room


RFIDp.249

Room Cordis

Sheathless approach

p.243

Radial approach

p.250

Room

GE HealthcareImaging

p.244Imaging FFR

p.246Imaging TAVI

p.247

Imagingcomplex

lesions - p.248Imaging CTO

p.250

Room

MedtronicTAVIp.244

TAVIp.245

TAVIp.248

TAVIp.249

Room Philips

Volcano

R4

ImagingLAA closure

p.244

IFR / FFRp.245

ImagingLAA closure

p.247Hands-on EchoNavigator

p.248

Room Philips

Volcano

R5

ImagingLAA

closurep.245

Imagingp.246

Echo-

Navigator

p.248

Open hands-on trainingp.248

Room

St. Jude Medical

Heartmate Percutaneous Heart Pump

p.243

FFRp.244

FFRp.246

FFRp.247

FFRp.249

FFRp.250

FFRp.251

OCTp.243

OCTp.245

OCTp.246

OCTp.247

OCTp.249

OCTp.250

OCTp.251


Professionalsp.243

TAVIp.245

TAVIp.246

TAVIp.248

TAVIp.249


Professionalsp.250

TAVIp.251

LAA occlusionp.243

LAA occlusionp.245

LAA occlusionp.246

LAA occlusionp.248

LAA occlusionp.249

LAA occlusionp.250

LAA occlusionp.251

FFR in ACSp.250

09:00 12:00 15:0010:00 13:00 16:0014:00 17:00 18:0011:0009:30 12:30 15:3010:30 13:30 16:3011:30 14:30 17:30


Room Cardinal Health

By appointment - RFID

p.252

Room Philips

Volcano

R4

Hands-on EchoNavigatorp.252

Room Philips

Volcano

R5

Open hands-on trainingp.252

10:00 11:00 12:0010:30 11:30

227

Tuesday 17 May 2016

- 11:00 - 11:0011:40

ROOM MEDTRONIC

Understand advanced techniques and technologies in TAVI imaging, patient sizing and selectionSponsored by MEDTRONIC


VTo learn that sizing matters

VTo understand the value of multiple imaging

modalities

VTo learn how to identify good CT quality via

optimal CT recommendations

VTo assess step by step the anatomy in order

to find the correct valve size

VMedtronic clinical imaging screening services

for heart valve therapies, with a unique expertise

with more than 25,000 TAVI cases reviewed

- 12:00 - 12:0013:00

ROOM PHILIPS

VOLCANO R4

EchoNavigatorSponsored by PHILIPS VOLCANO

Physician Trainers: P. Biaggi, R. Corti


VTo understand the role of imaging in planning

LAA closure procedures for device size selection,

placement and confirmation of device position

VTo learn how 3D Echo and X-ray fusion imaging

is used during LAA closure procedures in five

easy steps

VTo get hands-on experience using 3D Echo and

X-ray fusion imaging during crucial steps in a LAA

closure procedure

VCan LAA closure be performed easier and faster

with use of 3D Echo-X-ray fusion technology?

VThe importance of imaging before, during, and

after the procedure

VClosing the left atrial appendix in five easy steps

using 3D Echo and X-ray fusion

VMultiple EchoNavigator station preloaded with

LAA closure case in five easy steps

- 13:00 - 13:0014:00

ROOM CORDIS

Sheathless vs. introducer sheath: downsizing PCISponsored by CORDIS

Physician Trainer: G. Amoroso


VTo know about benefits and challenges around

the latest innovations in sheathless approach



13:3018:30 ROOM ST. JUDE

MEDICAL

Fellow programme - introduction to coronary and structural heart interventionsSponsored by ST. JUDE MEDICAL


VTo be introduced to the latest technology and

therapy options in structural heart and coronary

interventions

VTo have a first hands-on experience with TAVI,

LAA occlusion, FFR and OCT imaging coached

by experts in the field

- 14:00 -14:0015:00

ROOM PHILIPS

VOLCANO R4

IVUS image interpretationSponsored by PHILIPS VOLCANO

Physician Trainers: A. Banning, E. Infante De Oliveira,

J. Ligthart, G. Werner


VTo know more about normal arterial morphology;

basics of IVUS image interpretation

VTo learn about plaque composition, plaque

eccentricity, plaque disruption

VTo know more about area measurements,

lumen area and total vessel area, plaque area,

percentage plaque burden

VTo understand calcifications and type of vessel

remodeling

VHow to overcome challenges with IVUS image

interpretation; how to easily understand what

you are seeing; how co-registration can help you?

13:0014:00ROOM CARDINAL

HEALTH

How to reduce your cardiovascular cost using radio frequency identification technologySponsored by CARDINAL HEALTH INVENTORY

MANAGEMENT SOLUTIONS


VTo learn how to reduce expired product, more

accurately capture usage and increase patient

safety with our innovative suite of solutions

13:0013:30 ROOM PHILIPS

VOLCANO R5



VEchoNavigator hands-on



13:3014:10 ROOM MEDTRONIC





modalities








229






modalities









VOLCANO R5


Physician Trainer: A. Sharp

V IVUS image interpretation hands-on

15:1515:45 ROOM BIOTRONIK

Magnesium biocompatibility and resorption process Sponsored by BIOTRONIK

Physician Trainer: J. Maier


VTo know more on magnesium biocompatibility

and its resorption process

14:3015:30 ROOM

GE HEALTHCARE

How does high-definition IVUS, touch panel diagnostics and high-speed pullback enhance my clinical practice?Sponsored by GE HEALTHCARE in collaboration with

ACIST

Physician Trainer: S. Krishnan


VTo learn how high-definition imaging can help

increase visibility in intravascular imaging

VTo understand how this technique integrates in

routine workflow

VHands-on: leverage one or several cases from

the expert to try by yourself the new technology

from ACIST


Magmaris BRS user shares his experience: tips and tricks for a successful implantationSponsored by BIOTRONIK

Physician Trainer: H. Degen


VTo learn tips and tricks from an experienced

product user

- 15:00 -15:0016:00

ROOM CORDIS Percutaneous endovascular abdominal

aortic aneurysm repair for interventional cardiologists: are we ready for the challenge?Sponsored by CORDIS

Physician Trainer: A. Cremonesi


VTo learn about the latest innovations in

endovascular abdominal aortic aneurysm repair

treatment

VTo perform abdominal aortic abdominal cases via

percutaneous approach


16:0017:00 ROOM

GE HEALTHCARE

Using advanced imaging techniques to help you with TAVI care pathwaySponsored by GE HEALTHCARE

Physician Trainer: C. Butter


VTo learn how to evaluate the cusps and flow

to define the aortic pathology with cardiac

ultrasounds

VTo learn how VALVE ASSIST 2 can help with

accuracy and reproducibility of measurements;

look for protrusive atheroma, and for high

sinuosity and major calcifications

VTo learn how calcification enhancement facilitates

visibility of natural landmarks to help position

valves in challenging conditions

VTo learn how post-operative follow-up is done

with echocardiography

VHands-on: leverage TAVI cases from Prof. Butter

Brandenburg Heart Center, Bernau, with Vivid E95

VHands-on sessions on AW workstation with VALVE

ASSIST 2


VOLCANO R5

IVUS in complex cases / Co-registrationSponsored by PHILIPS VOLCANO


VSyncVision hands-on


VOLCANO R4

IVUS in complex casesSponsored by PHILIPS VOLCANO

Physician Trainers: J.M. De La Torre Hernandez,

J. Legutko, G. Werner


VTo understand how to simplify complex lesions

with the use of IVUS

VTo know more about the use of IVUS in left main

and bifurcations

VTo know more about the use of IVUS for

bioresorbable vascular scaffolds implantation

VClinical value of IVUS and co-registration in clinical

practice for complex lesions and beyond

VHow to use IVUS in your clinical practice for left

main and complex lesions with emphasis on

guidelines for workflow

V Insight into use of IVUS for bioresorbable vascular

scaffolds implantation

- 16:00 - 16:0017:00 ROOM CARDINAL

HEALTH








Magmaris BRS mechanical propertiesSponsored by BIOTRONIK


VTo know more about the new BIOTRONIK

magnesium resorbable scaffold mechanical

properties

231

- 17:00 - 17:0018:00

ROOM PHILIPS

VOLCANO R4







VTo learn how 3D Echo and X-ray fusion imaging is

used during LAA closure procedures in five easy

steps



closure procedure




after the procedure






VOLCANO R5

Open hands-on training sessionSponsored by PHILIPS VOLCANO


Wednesday 18 May 2016

- 09:00 - 09:0009:30 ROOM BIOTRONIK





product user


MEDICAL

PCI optimisation - focus on FFR: FFR step-by-step technique made easySponsored by ST. JUDE MEDICAL


VTo experience the advantages of an improved

and simplified cathlab workflow




of coronary physiology measurements in stable

patients and patients with ACS


MEDICAL

PCI optimisation - focus on OCT: OCT image interpretationSponsored by ST. JUDE MEDICAL


VTo gain expertise in OCT image interpretation

VTo improve daily clinical practice through a more

accurate decision-making process using (angio

co-registered) OCT imaging

VTo discuss the role of OCT in guiding PCI in DES

and BRS


MEDICAL

Focus on TAVISponsored by ST. JUDE MEDICAL


VTo get introduced to the St. Jude Medical TAVI

programme

VTo discuss the advantages of a fully resheathable

transcatheter aortic valve

VTo experience the repositionability and

retrievability features of the Portico TAVI system


MEDICAL

Focus on LAA occlusionSponsored by ST. JUDE MEDICAL


VTo understand the anatomical complexity of the

LAA

VTo learn about device size selection, placement

and confirmation of device position

VTo experience Amplatzer Amulet and latest

technology update






modalities





VMedtronic clinical imaging screening services for

heart valve therapies, with a unique expertise


233


VOLCANO R4


Physician Trainers: A. Banning, E. Infante De Oliveira,

J. Ligthart, G. Werner


VTo know more about normal arterial morphology;

basics of IVUS image interpretation

VTo learn about plaque composition, plaque

eccentricity, plaque disruption

VTo know more about area measurements,

lumen area and total vessel area, plaque area,

percentage plaque burden

VTo understand calcifications and type of vessel

remodeling

VHow to overcome challenges with IVUS image

interpretation; how to easily understand what

you are seeing; how co-registration can help you?


Magnesium biocompatibility and resorption processSponsored by BIOTRONIK





- 10:00 -10:0011:00

ROOM

GE HEALTHCARE

Using advanced imaging techniques to help you with TAVI care pathwaySponsored by GE HEALTHCARE

Physician Trainer: C. Butter


VTo learn how to evaluate the cusps and flow

to define the aortic pathology with cardiac

ultrasounds

VTo learn how VALVE ASSIST 2 can help with

accuracy and reproducibility of measurements;

look for protrusive atheroma, and for high

sinuosity and major calcifications

VTo learn how calcification enhancement facilitates

visibility of natural landmarks to help position

valves in challenging conditions

VTo learn how post-operative follow-up is done

with echocardiography

VHands-on: leverage TAVI cases from Prof. Butter

Brandenburg Heart Center, Bernau, with Vivid E95

VHands-on sessions on AW workstation with VALVE

ASSIST 2


MEDICAL













VOLCANO R5

IVUS image interpretation / Co-registrationSponsored by PHILIPS VOLCANO


V IVUS image interpretation / SyncVision hands-on

- 11:00 - 11:0012:00

ROOM CORDIS

Treatment of complex bifurcations: latest trends from the expertSponsored by CORDIS

Physician Trainer: Y. Louvard


VTo review the latest consensus and trends on

bifurcation stenting

VTo discuss about tips and tricks from Dr Louvard’s

and complication management






modalities



VTo assess step by step the anatomy in order to

find the correct valve size





MEDICAL







VTo discuss the role of OCT in guiding PCI

with DES and BRS


MEDICAL




programme

V To discuss the advantages of a fully resheathable





MEDICAL




LAA




technology update






properties

235

11:3012:30 ROOM

GE HEALTHCARE

Using advanced imaging techniques can help you on a daily routine help simplify vessel and structural heart proceduresSponsored by GE HEALTHCARE

Physician Trainer: P. Guerin


VTo learn how VALVE ASSIST 2 with its image fusion

technique can on a daily routine help simplify

vessel and structural heart procedures

VTo review cases done by Prof. Guerin: pulmonary

artery angioplasty, pulmonary vein valve

implantation, mitral valve repair, LAA closure,

aortic coarctation, patent ductus arteriosus

closure

VLeverage cases from Prof. Guerin, University

Hospital Nantes

VHands-on: practice and learn how to size and

prepare your 3D volume from CT scan through

hands-on sessions on AW workstation with VALVE

ASSIST 2


MEDICAL

PCI optimisation - focus on FFR: advanced FFR and FFR in ACSSponsored by ST. JUDE MEDICAL




VTo learn about the advanced troubleshooting for

FFR measurements in complex lesions




VOLCANO R4

Physiology challenging casesSponsored by PHILIPS VOLCANO

Physician Trainers: J. Davies, F. Hellig, E. Van Belle


VTo know more about resolving serial and diffuse

lesions with the new iFR Scout physiology

pullback feature

VTo understand how iFR Scout can help deciding

which patients needs PCI and which needs

surgery

VTo know how iFR modality can help simplify

complex cases

VChallenging cases - physiology measurements in

serial lesions, diffuse disease

VCase reviews and theory lectures for left main,

serial lesions and diffuse disease

11:3012:30 ROOM CARDINAL

HEALTH








- 12:00 - 12:3013:30

ROOM PHILIPS

VOLCANO R4









steps



closure procedure




after the procedure






VOLCANO R5

Physiology challenging casesSponsored by PHILIPS VOLCANO

V iFR / iFR Pullback hands-on

- 13:00 - 13:0014:00

ROOM CORDIS

How to read clinical articles: translating data into actual clinical practiceSponsored by CORDIS

Physician Trainer: D. Capodanno


VTo understand all about clinical data and how

to use their results in your daily practice


MEDICAL

PCI optimisation - focus on OCT: OCT in complex patients and lesionsSponsored by ST. JUDE MEDICAL






VTo review the role of angio co-registered OCT in

guiding and optimizing PCI in complex lesions /

indications


MEDICAL




programme

V To discuss the advantages of a fully resheathable





MEDICAL




LAA




technology update

237


MEDICAL







VTo discuss the role of OCT in guiding PCI with DES

and BRS


MEDICAL




programme






MEDICAL




LAA




technology update

13:0014:00 ROOM CARDINAL

HEALTH







13:0014:00 ROOM

GE HEALTHCARE

The role of imaging in physiology measurement in the cathlab: comparing wire-based FFR to image-based FFRSponsored by GE HEALTHCARE in collaboration with

MEDIS

Physician Trainer: A. Neylon


VTo learn how MEDIS image-based FFR can be

used in physiology measurement in the cathlab

VTo evaluate the accuracy of image-based FFR vs.

gold standard wire-based FFR


routine workflow

VLeverage one or several cases from ICPS Massy to

try by yourself the new technology from MEDIS


MEDICAL

PCI optimisation - Heartmate Percutaneous Heart Pump to support complex PCISponsored by ST. JUDE MEDICAL


VTo understand the indications for Heartmate

Percutaneous Heart Pump system to support

complex PCI

VTo be updated on the Percutaneous Heart Pump

technology and system

VTo learn about the early evidence showing the

benefits of Percutaneous Heart Pump in complex

PCI


- 14:00 - 14:0015:00

ROOM PHILIPS

VOLCANO R4

Physiology disparitySponsored by PHILIPS VOLCANO

Physician Trainers: J. Escaned, R. Petraco, A. Sharp


VTo understand the nuances of the procedure and

the potential technical pitfalls of the physiological

assessment

VTo understand using flow why iFR / FFR disagree

VTo understand which parameter to choose when

FFR is positive and iFR is negative and when iFR is

positive and FFR is negative

VWhen physiologic indices disagree what should

you do?

VHow to overcome challenges with physiology

measurements

14:3015:30 ROOM

GE HEALTHCARE


ACIST






routine workflow



from ACIST






modalities









VOLCANO R5

EchoNavigator hands-onSponsored by PHILIPS VOLCANO






239

- 15:00 -15:0016:30

ROOM CORDIS Complex lesions via radial approach:

where are the limits?Sponsored by CORDIS

Physician Trainers: F. Hernandez, M. Mamas


VTo review and discuss complex cases and

understand Dr. Mamas and Dr. Hernandez’s

experiences on radial access






modalities









VOLCANO R5


V iFR / iFR Pullback hands-on


MEDICAL











MEDICAL








and BRS


MEDICAL




programme






MEDICAL




LAA




technology update



MEDICAL

TAVI for Nurses and Allied ProfessionalsSponsored by ST. JUDE MEDICAL


VTo discuss TAVI challenges today


programme from a technician’s point of view




MEDICAL




LAA




technology update

- 16:00 - 16:0017:00 ROOM CARDINAL

HEALTH








VOLCANO R4

Physiology from justification to guidanceSponsored by PHILIPS VOLCANO

Physician Trainers: J. Escaned, F. Hellig, S. Sen


VTo understand when to use physiology

measurements in the cathlab

VTo understand the physiological basis for iFR/FFR

VTo find out more about iFR modality in clinical

practice: real world coronary physiology

VMoving from justification to guiding PCI - the role

of physiology in today’s cathlab

VUnderstanding the importance of iFR / FFR and

other indices


MEDICAL










MEDICAL








guiding and optimising PCI in complex lesions /

indications

241

- 17:00 -17:0018:00

ROOM

GE HEALTHCARE

How advanced imaging techniques can help you guide your LAA closure procedure planning and device positioningSponsored by GE HEALTHCARE

Physician Trainer: P. Garot


VTo learn how VALVE ASSIST 2 can help simplify the

LAA closure planning with previously acquired CT

scanner, including device sizing and determine

optimal zone for the transeptal puncture

VTo learn how the CT images overlay onto the

fluoro live images helps guide the procedure

VTo review different clinical cases in which these

advanced imaging techniques were used

VHands-on: leverage LAA closure cases from

Dr. Garot, ICPS Massy

VHands-on session on AW workstation with VALVE

ASSIST 2


MEDICAL









16:0017:00 ROOM

GE HEALTHCARE

Using advanced imaging techniques can help you on a daily routine help simplify vessel and structural heart proceduresSponsored by GE HEALTHCARE

Physician Trainer: P. Guerin


VTo learn how VALVE ASSIST 2 with its image fusion

technique can on a daily routine help simplify

vessel and structural heart procedures

VTo review cases done by Prof. Guerin: pulmonary

artery angioplasty, pulmonary vein valve

implantation, mitral valve repair, LAA closure,

aortic coarctation, patent ductus arteriosus

closure

VLeverage cases from Prof. Guerin, University

Hospital Nantes

VHands-on: practice and learn how to size and

prepare your 3D volume from CT scan through

hands-on sessions on AW workstation with VALVE

ASSIST 2


VOLCANO R5

Physiology from justification to guidanceSponsored by PHILIPS VOLCANO

V iFR / iFR Pullback / IVUS image interpretation /

SyncVision hands-on



MEDICAL









indications


MEDICAL




programme






MEDICAL




LAA




technology update


VOLCANO R5


243

Thursday 19 May 2016

- 09:00 - 09:0009:30 ROOM BIOTRONIK





product user


MEDICAL

PCI optimisation - Heartmate Percutaneous Heart Pump to support complex PCISponsored by ST. JUDE MEDICAL


VTo understand the indications for Heartmate

Percutaneous Heart Pump system to support

complex PCI

VTo be updated on the Percutaneous Heart Pump

technology and system

VTo learn about the early evidence showing the

benefits of Percutaneous Heart Pump in complex

PCI


MEDICAL








and BRS


MEDICAL









MEDICAL




LAA




technology update

09:3010:30 ROOM CORDIS

Sheathless vs. introducer sheath: downsizing PCISponsored by CORDIS

Physician Trainer: M. Mamas


VTo know about benefits and challenges around

the latest innovations in sheathless approach








modalities









VOLCANO R4









steps



closure procedure




after the procedure











- 10:00 - 10:0011:00

ROOM GE

HEALTHCARE


ACIST






routine workflow



from ACIST


MEDICAL









245


VOLCANO R5






- 11:00 - 11:0011:40

ROOM MEDTRONIC





modalities









VOLCANO R4


Physician Trainers: J. Escaned, R. Petraco, A. Sharp


VTo understand the nuances of the procedure and

the potential technical pitfalls of the physiological

assessment

VTo understand using flow why iFR / FFR disagree

VTo understand which parameter to choose when

FFR is positive and iFR is negative and when iFR is

positive and FFR is negative

VWhen physiologic indices disagree what should

you do?

VHow to overcome challenges with physiology

measurements


MEDICAL








and BRS


MEDICAL




programme






MEDICAL




LAA




technology update






properties



MEDICAL




programme






MEDICAL

Focus on left LAA occlusionSponsored by ST. JUDE MEDICAL



LAA




technology update

- 12:00 - 12:0013:00

ROOM PHILIPS

VOLCANO R5


V iFR / iFR Pullback / IVUS image interpretation /

SyncVision hands-on

11:3012:30 ROOM

GE HEALTHCARE

The role of imaging in physiology measurement in the cathlab: comparing wire-based FFR to image-based FFRSponsored by GE HEALTHCARE in collaboration with

MEDIS

Physician Trainer: A. Neylon


VTo learn how MEDIS image-based FFR can be

used in physiology measurement in the cathlab

VTo evaluate the accuracy of image-based FFR

vs. gold standard wire-based FFR


routine workflow

VLeverage one or several cases from ICPS Massy to

try by yourself the new technology from MEDIS


MEDICAL











MEDICAL









indications


247

13:0014:00 ROOM

GE HEALTHCARE

Using advanced imaging techniquesto simply help you guide your TAVIprocedure planning and valve positioningSponsored by GE HEALTHCARE

Physician Trainer: T. Hovasse


VTo understand, measure and anticipate the

potential difficulties ahead of the case with VALVE

ASSIST 2

VTo learn how to improve the accuracy and

reproducibility of measurements, look for

protrusive atheroma, and look for high sinuosity

and major calcifications

VTo learn how new live imaging mode facilitates

visibility of natural calcification landmarks to help

position valves in challenging conditions

VHands-on: leverage TAVI cases from Dr. Hovasse,

ICPS Massy

VHands-on session on AW workstation with VALVE

ASSIST 2


MEDICAL










MEDICAL








and BRS


VOLCANO R4









steps



closure procedure




after the procedure





- 13:00 - 13:0014:00 ROOM CARDINAL

HEALTH








- 14:00 -14:0014:30 ROOM BIOTRONIK





product user


VOLCANO R4

Hands-on session - EchoNavigatorSponsored by PHILIPS VOLCANO

VOpen session on EchoNavigator


VOLCANO R5


14:3015:30 ROOM

GE HEALTHCARE

Using advanced imaging techniques to guide your procedures for complex lesions (including BRS)Sponsored by GE HEALTHCARE AND ABBOTT VASCULAR

Physician Trainer: H. Benamer


VTo learn how PCI ASSIST can be routinely used to

guide stent placement

VTo understand how to determine optimal

apposition of proximal part of main branch stent

VTo precisely position the stent in the side branch

VTo minimise stent overlap and avoid gaps

between two stents

VLeverage cases from Dr. Benamer, ICPS Massy

VCase 1: young patient who has two lesions: one

on the left anterior descending artery and a

long one on the circumflex artery, where two

connected BRS have to be used

VCase 2: left main bifurcation stenting


MEDICAL




programme






MEDICAL




LAA




technology update






modalities









VOLCANO R5





249







- 15:00 -15:0016:00 ROOM CARDINAL

HEALTH












modalities









MEDICAL











MEDICAL








and BRS


MEDICAL




programme






MEDICAL




LAA




technology update



MEDICAL









MEDICAL




LAA




technology update

- 17:00 - 17:0018:00

ROOM

GE HEALTHCARE

Advanced imaging techniques that can help you optimise dose in long CTO proceduresSponsored by GE HEALTHCARE

Physician Trainer: T. Lefevre


VTo learn how step-by-step and practically during

CTOs you can optimise your clinical outcome

and dose

VTo learn about dose results in CTO procedures

using all the dose reduction, monitoring and

awareness tools, available at table side

VTo learn how Dose Map, InnovaSense, dose

optimisation protocols could help you to achieve

similar results

VClinical cases: leverage CTO cases from Dr Lefèvre,

ICPS Massy

15:3016:30 ROOM CORDIS

Complex lesions via radial approach: where are the limits?Sponsored by CORDIS

Physician Trainer: B. Faurie


VTo review and discuss challenging cases and

understand some experiences on radial access




VTo know more about the new Biotronik


properties


MEDICAL











MEDICAL









indications

251


MEDICAL




LAA




technology update


MEDICAL











MEDICAL








and BRS


MEDICAL




programme







Friday 20 May 2016

- 10:00 - BY APPOINTMENT

ROOM CARDINAL

HEALTH








VOLCANO R4

Hands-on session - EchoNavigatorSponsored by PHILIPS VOLCANO

VOpen session on EchoNavigator


VOLCANO R5


253

254

3D Systems, Simbionix M13

Abbott Vascular F12 + F13

Abiomed M64

ACIST M50

Acrostak M2

Adept Medical M34

Alvimedica F23

American College of Cardiology N4

Andanza N10

APT Medical N13

Asahi Intecc N3

B.Braun Melsungen P1

Balton M72

Bentley InnoMed M32

Biosensors F10 + F11

Biotronik F18

Boston Scientifi c F17

Cardialysis N14

Cardinal Health Inventory Management Solutions F22

CardioBridge M11

Cardionovum M61

Celonova Biosciences P8

CERC (Cardiovascular European Research Center) M6

Concept Medical N21

Control Medical Technology P7

Cook Medical M65

Cordis, a Cardinal Health Company F22

Coronado Medical N15

DGMR/Global Intercepts M40

Direct Flow Medical P2

EBIT - Esaote Group M3

Edwards Lifesciences F15

Elixir Medical F7

Envision Scientifi c N21

Eurocor P4

GE Healthcare N11

Genae Associates M9

Goodman Co. P6

Heartstitch M17

Hexacath N20

i-cor P10

IDA Ireland M46

IHT - Cordynamic N2

IMDS N1

iVascular P12

JenaValve Technology M63

Lepu Medical M41

MAVIG N12

MDT X-Ray N17

Medis Medical Imaging Systems M10

Medtronic F19 + F20 + F21

Mentice N5

Meril Life Sciences F6

Merit Medical M62

MicroPort M59

Minvasys P15

Mitralign P13

Multimedics M1

Natec Medical P5

Novella Clinical M20

NVT M36

Occlutech M39

Opsens M43

OrbusNeich M70

Perouse Medical N19

Philips Volcano M71

Pie Medical Imaging M5

Qualimed M48

RenalGuard M19

REVA Medical M4

Rontis P16

S3V Vascular Technologies M45

Siemens Healthcare M38

Sino Medical Sciences Technology Inc. (SINOMED) N16

SIS Medical M44

SMT F8

St.Jude Medical F16

Stentys M68

Sungwon Medical P11

SurModics/Creagh Medical M47

Svelte Medical Systems N18

Symetis M8

Terumo F14

The Medicines Company M67

Toray M12

Translumina Therapeutics M18

Tryton Medical M35

Valtech Cardio F24

Vascular Solutions P3

Zoll Medical Corporation M60

Worldwide Innovations & Technologies (RADPAD) M42

StartingBlock suites

Caliber Therapeutics Room 335M

Guidewave Room 339M

HLT Room 331M

MVRx Room 330M

ShockWave Medical Room 336M

Conference and Media Partners

AICT Congress 2016 M30

CardioAlex M16

Cardiovascular News M23

CBS & JCIC, NJ, China M14

CIT M29

CRTonline M15

EAPCI N8

European Society of Cardiology N8

EVToday CIToday M25

Incathlab M49

JIM 2017 M21

Radcliff e Cardio M22

Stent For Life N7

TCT M28

TCTAP 2017 M26

TOBI 2016 M24

Wisepress M27

M8

M9

M59

M1

M61

M63M62

M60 M64 M70 M71

M65

M67

M68 M72

M2 M3 M4 M5M6

M44

M45

M46 M47

M49

M50M48

M39

M41 M43

M42M40

M28 M29 M30

M34

M32 M36

M35M38M23

M26

M22

M25

M21

M24

M27

M20M19M18

M12 M11

M10M13

Café Maillot

Café Concorde*

Bag pick-up

BOOTHS M1 TO M72

RoomMaillot

GuestLounge

M16 M15M14

M17

Charging tower


Level 1 Level 2

N21

N20

N18N17N16N15N14N13

N12N11

N10

Training Room St Jude

P8

P7

P10

P11

P12P5

P4

P13 P3

P15

P16P1

P6N8

N4N3

N2

N1

F19F14

F10

F8F7

F6

F13

F16

F11

F12F15F17F20Café

Trocadero*

Café Elysées

F18F21F23PCR TV

F24

BOOTHS P1 TO P16

BOOTHS F7 TO F26

BOOTHSN1 TO N21

Exhibitor Support Centre

Room Learning

Main Arena

N7

Training Room Volcano / Philips

Training RoomGE

N19

N5

P2

F25

F22

F26

RoomTernes 1

RoomTernes 2

Training Room Cordis and

CardinalHealth

Training RoomMedtronic Training Room

Biotronik

PCR overflow

PCR overflow

Charging tower
